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THE PIG VETERINARY SOCIETY (PVS)
The Pig Veterinary Society (PVS) is based in the United Kingdom and was founded in
Cambridge in 1963, making it the World’s oldest dedicated pig veterinary society. It currently
has over 250 full and associate members drawn from all walks of the pig industry worldwide,
with full membership being open to qualified veterinary surgeons.
PVS is a specialist division of the British Veterinary Association and is consulted on many aspects of pig related subjects by the
Government, the industry and the public. PVS exists to allow its members to exchange knowledge on all aspects of pig health,
welfare and management, and promote the study of these subjects. It does this by providing a forum for discussion and the
exchange of these ideas.
THE EUROPEAN COLLEGE OF PORCINE HEALTH MANAGEMENT (ECPHM)
The European College of Porcine Health Management (ECPHM) was given provisional
recognition by the European Board of Veterinary Specialisation (EBVS) in 2004 and is currently working towards full recognition.
It is the governing body for postgraduate veterinary specialisation in Europe within the field of porcine health and its associated
management.
ECPHM is the awarding body for the European Diploma (DipECPHM) that is granted on completing the correct training phase
and passing the relevant examinations. There are currently 148 diplomates of the ECPHM, who are also recognised as European
Veterinary Specialists in Porcine Health Management.
THE EUROPEAN ASSOCIATION OF PORCINE HEALTH
MANAGEMENT (EAPHM)
The European Associaton of Porcine Health Management (EAPHM) was founded in 2010 at
the 2nd ESPHM held in Hannover, Germany. It was set up to represent the interests and to
serve the needs of all veterinarians specialised in pig and pork production throughout Europe.
The objectives of the EAPHM are primarily educational in order to increase contact and interaction across an increasingly
borderless Europe. It also aims to represent pig veterinary interests and views on increasingly important aspects of welfare,
health and production as they come to the forefront in the future.
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WELCOME FROM THE PRESIDENT
On behalf of the local organising committee, it gives me the
greatest pleasure to welcome all delegates, partners, supporters
and guests to the 5th European Symposium of Porcine Health
Management (ESPHM) here in Scotland’s capital city Edinburgh.
This symposium follows the tremendous success of the previous
one held in Bruges, Belgium in 2012 and is on target to attract
a similar number of delegates – more than 800 have already
registered – and over 250 submitted abstracts.
The previous symposium was a joint venture between the
European College of Porcine Health Management (ECPHM)
and the European Association of Porcine Health Management
(EAPHM) aimed at bringing together the knowledge and
experience of research and clinical veterinary medicine.
The 2013 builds upon that basis but with an added significance.
The reason that this symposium has come to the UK is that
2013 represents the 50th anniversary of the Pig Veterinary
Society – the oldest institution of its kind in the world. The local
organising committee, which has worked tirelessly, has been
drawn from PVS and is charged with delivering a symposium
to mark that anniversary and link with the two European bodies
in their common aims. The PVS was established in 1963 to
share and distribute knowledge between all veterinary surgeons
that had an interest in pig health, welfare, medicine, production
and management. Over the years its membership has widened
to include animal scientists in the pig field and it has become
far more active politically such that it has a strong voice within
the British Veterinary Association and plays a key role in
influencing policy at government executive level.
As part of the event, the gala dinner will bring together as
many as possible of the 25 surviving past presidents of PVS
(sadly 13 are no longer with us) to mark the anniversary.
The scientific programme of the symposium will spread over
three days and will mix keynote speakers with presenters of
submitted short papers including contributions from ECPHM
residents, in the early stages of their pig veterinary career, and
our industrial partners who will present cutting edge scientific
information from the commercial sector. The keynote lectures
will cover a number of themes including emerging threats,
swine influenza, a look at the future for vaccinology and
environmental control, and dietary provision linked to
immunology. We are very grateful to the army of volunteer
scrutinisers who assessed the submitted papers dividing those
accepted into oral presentations and a large poster section.
The symposium takes place in the dedicated conference
facilities of the Edinburgh International Conference Centre –
purpose built in the 1990’s in the heart of the city. It offers
first class conference facilities with a unique layout that
enables us to switch between full plenary session and
subgroups for parallel sessions. Please enjoy the symposium,
the City, the facilities and the highest quality of science on
offer and leave enriched.
Mark E C White
Mark White, President of 5th ESPHM Meeting,
Chairman of Organising Committee
Dear Colleagues
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BAYER PLC ANIMAL HEALTH www.bayer.com
Bayer: Science for a better life.
Bayer Animal Health is a leading global animal health company committed to research and
development in order to provide innovative medicines for livestock and companion animals.
Bayer offer solutions to help manage the well being and productivity of farm animals as well
as ensure a healthy relationship between companion animals and pet owners.
BIOMIN www.biomin.net
BIOMIN, a leading company focusing on Health in Animal Nutrition, develops and produces
feed additives, premixes and services to improve animal health and performance, in an
economically viable way.
Leveraging on the latest technologies and extensive R&D programs, BIOMIN offers
sustainable quality products which include solutions for mycotoxin risk management, a
groundbreaking natural growth promoting concept as well as other specific solutions which
address dietary requirements for swine.
BOEHRINGER INGELHEIM ANIMAL HEALTH
www.boehringer-ingelheim.com/products/animal_health.html
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies.
Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more
than 44,000 employees.
Since it was founded in 1885, the family-owned company has been committed to
researching, developing, manufacturing and marketing novel medications of high therapeutic
value for human and veterinary medicine.
As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible.
Involvement in social projects, caring for employees and their families, and providing
equal opportunities for all employees form the foundation of the global operations.
Mutual cooperation and respect, as well as environmental protection and sustainability are
intrinsic factors in all of Boehringer Ingelheim’s endeavours.
In 2011, Boehringer Ingelheim achieved net sales of about €13.2 billion. R&D expenditure
in the business area Prescription Medicines corresponds to 23.5% of its net sales.
ELANCO www.elanco.com
Elanco is a global animal health company established in 1954. A division of Eli Lilly and
Company, an innovation-driven pharmaceutical corporation. Elanco has more than
35 agricultural and animal health products approved in more than 80 countries worldwide.
A world leader in developing products and services that enhance animal health, wellness and
performance. But ultimately, people benefit from Elanco’s work. That’s reflected in the vision
shared by Elanco’s more than 2,500 employees: food and companionship enriching life.
SYMPOSIUM PARTNER INFORMATION
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HIPRA www.hipra.com
HIPRA is a veterinary pharmaceutical company dedicated to the research, production
and marketing of products for Animal Health. At HIPRA we are convinced that the future
lies in prevention.
We are specialists in developing innovative preventive solutions that make it possible
to identify existing threats on any poultry or livestock farm before they occur, in such a
way that we can act to prevent them or minimise their effects. We have a broad range of
highly innovative Biological products, an advanced diagnostic service and our own line of
Diagnostic kits.
We are located in more than 20 countries with our own commercial subsidiaries and
production plants strategically situated in Europe and America. Likewise, our large global
distribution network enables our products to reach customers in more than 100 countries
on all five continents. At HIPRA we maintain a commitment to excellence, to service to
livestock farms, to our people and to social, economic and environmental improvement.
HUVEPHARMA NV www.huvepharma.com
Huvepharma® is a rapidly expanding innovative pharmaceutical company. The highlight
is put on animal health pharmaceuticals, anticoccidials, feed additives, veterinary medicated
premixes, veterinary products, enzymes and enzyme complexes, APIs.
Our key factor is fermentation, which Huvepharma® has been an expert in for more than
half a century, currently operating the biggest European veterinary fermentation facilities,
totalling 6,000m3 fermentation capacity.
We distribute more than 80 products in more than 70 countries worldwide. A few of our
well-known brands are Pharmasin® (tylosin), Tilmovet® (tilmicosin), Vetmulin® (tiamulin)
and HydroDoxx® (doxycycline) – veterinary range and Lianol® product range. Our on-going
investment program and R&D initiatives guarantee that the company has a filled “pipeline”
with new formulations and products to be launched on the key markets in the coming years.
Dedicated to guarantee utmost product quality and human food safety, through quality
assurance in every step of the production cycle, we, at Huvepharma®, are ready to meet
tomorrow’s market challenges.
IDT BIOLOGIKA GMBH www.idt-biologika.de
The IDT Biologika GmbH is an innovative medium-sized German company, which provides
since more than 90 years pharmaceutical products and services for human and animal health.
The IDT Animal Health unit operates own facilities for R&D (15% of net sales expenditure
in R&D) as well as manufacturing of animal health vaccines. IDT is marketing authorisation
holder of very innovative Swine vaccines in Europe.
In 2011 the sales were €125 million with a growth of 14 percent. At headquarter in Dessau-
Rosslau, Germany, the family owned company of the Klocke-Group operates with more
than 1,000 employees.
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LABORATOIRE SOGEVAL www.sogeval.fr
SOGEVAL is a French veterinary pharmaceutical company that develops, manufactures and
markets medicines and veterinary specialities for pets and livestock on a worldwide basis.
SOGEVAL contributes to the health and wellbeing of animals by:
n Investing its efforts in the prevention and treatment of animal diseases by offering a wide
range of products.
n Participating in improving the performance of livestock farming operations and industries.
SOGEVAL is present worldwide. Our growth and development are supported by a network
of more than 60 distributors and 2 subsidiaries, in US and in Denmark.
Sogeval livestock division is:
n An international leader in stock housing disinfection and hygiene programs.
n The specialist for collective oral treatments (soluble antibiotics and medicated premixes)
for pigs, poultry, rabbits and veal calves.
n Developing throughout Europe a range of products (Pracetam 20% powder, Pracetam 20%
solution and Pracetam 10% Premix) for treating fever and pain in pigs.
MERIAL – A SANOFI COMPANY www.merial.com
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive
range of products to enhance the health, well-being and performance of a wide range
of animals.
Merial employs approximately 5,600 people and operates in more than 150 countries
worldwide. Its 2011 sales were more than €2 billion ($2.8 billion). Merial is a Sanofi company.
MSD ANIMAL HEALTH www.msd-animal-health.com
Today’s Merck is a global healthcare leader working to help the world be well. MSD Animal
Health, known as Merck Animal Health in the United States and Canada, is the global animal
health business unit of Merck. MSD Animal Health offers veterinarians, farmers, pet owners
and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and
health management solutions and services.
MSD Animal Health is dedicated to preserving and improving the health, well-being and
performance of animals. It invests extensively in dynamic and comprehensive R&D resources
and a modern, global supply chain. MSD Animal Health is present in more than 50 countries,
while its products are available in some 150 markets. For more information, visit our website.
NOVARTIS ANIMAL HEALTH www.ah.novartis.com
Novartis Animal Health is a leader in developing new and better ways to prevent and treat
diseases in pets, farm animals and cultivated fish.
Our innovative, high-quality medicines contribute to the quality of life, health and welfare
of animals around the world. For pets, our products are effective aids to prevent internal and
external parasites and treat ailments such as arthritic pain and kidney, heart and allergic
diseases. For farm animals, we offer therapeutic products to treat parasitic and bacterial
diseases and are also continually developing new vaccines to prevent diseases in livestock
and cultivated fish. Specific needs of food producers in the area of farm bioprotection are
met by providing innovative fly control products and services.
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PIC www.pic.com
PIC’s mission is to be the leading worldwide supplier of genetic improvement to pork chain
customers through innovative and outstanding genetic technology, health and services.
A subsidiary of biotechnology leader Genus plc, PIC’s business is the genetic improvement
of pigs. PIC is able to produce improved breeding stock by identifying desirable traits that
are heritable, setting selection objectives and then running intensive breeding programs,
enabling PIC to deliver significant value to its customers.
New advancements in the PIC genetic improvement program is relationship based genomic
selection. By using genomic data to better estimate relatedness between animals, PIC is
leading the global livestock-genetics industry in generating faster rates of genetic progress.
The implementation of relationship based genomic selection requires significant investment
by PIC in terms of research, development, validation and implementation. The depth and
scale of how PIC is using genomic data is creating a truly differentiated product and is focused
entirely on increasing the profitability of the swine production chain for our customers.
VETOQUINOL LTD www.vetoquinol.com
Vétoquinol is an independent veterinary pharmaceutical laboratory serving both the
companion animal and livestock markets. This family-owned group are the 10th largest
animal pharmaceutical company world wide with more than 80% of Vétoquinol’s revenues
coming from outside France. Vétoquinol engages in the research and development,
production and marketing of medical and nutraceutical products.
The Group currently distributes its products in one hundred countries throughout Europe,
Americas and Asia, with subsidiaries in 23 different countries and a network of 140 distributor
partners. The Company has more than 1,750 employees worldwide and sold products to the
value of €284.1 million in 2011.
ZOETIS www.zoetis.com
Zoetis, formerly the animal health business of Pfizer, is a global animal health company
dedicated to supporting its customers and their businesses in ever-better ways. Building on
60 years of experience, we deliver quality medicines and vaccines, complemented by
diagnostics products and genetics test and supported by a range of services. We are working
every day to better understand and address the real-world challenges faced by those who
raise and care for animals in ways they find truly relevant.
Our name, Zoetis (zo--EH-tis), has its root in zo, familiar in words such as zoo and zoology
and derived from zoetic, meaning “pertaining to life”. It signals our company’s dedication
to supporting veterinary surgeons and livestock farmers everywhere who raise and care for
the animals on which we all depend.
As a leading Animal Health company in the world, Zoetis is dedicated to transforming the
care of animals for a healthier world.
Zoetis strives to provide full animal health solutions to veterinarians, livestock producers,
and companion animal owners. We work to assure a safe, sustainable worldwide food supply
from healthy beef and dairy cattle, swine, poultry and fish and to help dogs, cats and horses
live healthier longer lives.
Zoetis is a world leader in the discovery, development and manufacture of innovative animal
vaccines, medicines and veterinary diagnostic products. We have an extensive research and
development network with major research centres on four continents. Zoetis professionals
offer a broad array of animal health services and solutions. We aspire to be the trusted
partner of choice for veterinarians around the world – that trust earned by consistently
anticipating and meeting needs with reliability and integrity.
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SYMPOSIUM PARTNERS
Many thanks to the following companies who have supported the Symposium for 2013
VISIT US at the
ESPHM 2013
Edinburgh
www.esphm2013.org
22nd-24th May 2013
Trust...Use Medicines Responsibly (www.noah.co.uk/responsible).
References: 1Rypula K. and Porowski M., IPVS (June 2004) Hamburg. Efficacy and economic benefit of Baycox 5% (toltrazuril) for the 
treatment of diarrhoea in pigs. 2Mavromatis I. et al Efficacy and cost benefit study on the use of toltrazuril for the control of neonatal coccidiosis 
in pigs due to Isospora suis under field conditions. IPVS (June 2004), Hamburg. 3Viel L (2005). Troup Sovvent aubliée. Pensez a la 
coccidiose... Porc magazine  Nr. 391. Baycox® 50 mg/ml contains 50 mg/ml toltrazuril. ® Registered Trademark of Bayer AG. Please 
refer to appropriate data sheet, further information available on request. Bayer plc, Animal Health Division, Bayer House, Strawberry Hill, 
Newbury, Berkshire RG14 1JA. Tel: 01635 563000. POM-V    
PREVENT DISEASE – PROTECT PROFIT
  Increase weight gains and feed conversion efficiency1
 Reduce the need for treatment with antibiotics2 
  Produce more uniform body weights at weaning3
Effective, ready to use, convenient, single dose oral suspension 
PREVENTING
COCCIDIOSIS
CAN HELP YOUR CLIENTS DRAW HIGHER RETURNS
research.biomin.net
Naturally ahead
Turning science 
into sustainable solutions
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ABCD
Protecting pigs, 
feeding the world, 
shaping the future.
pigs protected with Ingelvac CircoFLEX®
Stellamune® Once is a Mycoplasma hyopneumoniae vaccine used for active immunisation of piglets from one week of age to reduce lung lesions 
related to infections by Mycoplasma hyopneumoniae in fattening pigs. Each 2ml dose of vaccine contains 4.5 to 5.2 log10 Relative Potency Units of 
inactivated Mycoplasma hyopneumoniae. Strain NL1042, 0.025ml of Amphigen Base, and 0.075ml of Drakeol 5 (mineral oil).
Legal category: POM-V.
MA No. Vm00006/4119
ALWAYS CONSULT YOUR VET BEFORE USING.
Further information is available from: Elanco Animal Health, Lilly House, Priestley Road, Basingstoke RG24 9NL.
USE MEDICINES RESPONSIBLY. www.noah.co.uk/responsible.
Early vaccination from 1 week of age 
Fast one shot immunity
Life long protection from weaning to slaughter 
E A R L Y  P R O T E C T I O N  A G A I N S T  M Y C O P L A S M A
Full Protection at Weaning
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and manufacturer: ?????????? ??????????????????????????????????????????????????????????? ??Legal Category and marketing authorization number: ???????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????
?? ??????????????????????? ?????????????????????
Laboratorios Hipra, S.A.
???????????????????
???????????????????
?????
??????????????????????
?????????????????????
???????????????
?????????????

02
/1
3 
1.
0
    ” In my eyes, Shigatoxin is the issue.“
Find out more at
www.shigatoxin.com
IDT Biologika GmbH
Am Pharmapark • 06861 Dessau-Roßlau • Germany
Phone +49 34901 885-5382 • www.idt-biologika.de
Oedema disease?
Animal Health
STOP THE FEVER
BEFORE THE CHAIN REACTION
STARTS...
Respect the prescription of your veterinarian
?
?
?
A decrease of the temperature, even limited
allows an improvement of the clinical status of animals (pigs)*
PRACETAM 20 % ORAL POWDER FOR PIG – Composition: Paracetamol 0.2 g. Excipients qs 1,0 g - Properties: Paracetamol or acetaminophen or N-acetyl-para-aminophenol is a paraminophenol derivative 
with analgesic and antipyretic properties. Its antipyretic effect maybe explained by its ability to inhibit brain cyclo-oxygenases. Paracetamol is only a weak inhibitor of COX-1 synthesis and, thus, no gastro-
intestinal side effects and has no effect on platelet-aggregation. - Target species: Weaned pigs. - Indications for use: Symptomatic treatment of fever in the context of respiratory diseases in combination 
with an appropriate anti infective therapy, if necessary. - Posology: Oral route. 30 mg of paracetamol per kg body weight and per day, as long as the pigs are suffering from pyrexia for a maximum duration 
treatment of 5 days. The product will be orally administered continuously in the drinking water, equivalent to 1.5 g of oral powder per 10 kg body weight. The intake of medicated drinking water depends on 
the clinical condition of the animals. In order to obtain a correct dosage, the concentration in the drinking water must be adjusted accordingly. - Contraindications: Do not use in animals with known hyper-
sensitivity to paracetamol and to any other ingredients of the product. Do not use in animal with severe hepatic impairment. Do not use in animal with severe renal impairment. Do not use in animal suffering 
from dehydration or hypovolemia. - Special warnings: Animals with reduced water intake and/or disturbed general condition have to be treated parenterally. In case of combined viral and bacterial etiology 
of the disease, an appropriate anti infective therapy should be given concomitantly. - Adverse reactions: In rare cases, at therapeutic doses, transient soft faeces can occur and can persist up to 8 days after 
????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ????
have not detected any teratogenic nor foetotoxic effects at therapeutic doses. The administration of the product up to three times the recommended dose, during pregnancy or lactation, didn’t result in adverse 
effects. - Special precautions to be taken by the person administering the veterinary medicinal product to animals: Wear appropriate protective clothing, gloves and a mask and goggles to protect the face 
??????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????
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Withdrawal period: Meat and offal: zero days. - Marketing authorization holder: SOGEVAL Laboratories, 200, route de Mayenne, BP 2227, 53022 Laval cedex 9, FRANCE
*Pracetam 10% premix - Mutual regocnition procedure

Effective, safe and animal friendly in a single dose
The FIRST
intradermal
M Hyo vaccine
Porcilis M Hyo ID Once
Take the leap forward with easy-to-use
needle free vaccinations
P
M
12
_0
02
5.
09
.2
01
2 
©
 2
01
2,
 In
te
rv
et
 In
te
rn
at
io
n
al
 B
.V
. a
 s
u
b
si
d
ia
ry
 o
f 
M
er
ck
 &
 C
o
., 
In
c.
, W
h
it
eh
o
u
se
 S
ta
ti
o
n
, N
J,
 U
S
A
. A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
Intervet International bv
P.O. Box 31, 5830 AA Boxmeer
The Netherlands
Phone  +31 (0)485 587600
Fax  +31 (0)485 577333
Email  info@merck.com
www.msd-animal-health.com
Take pride...
... in healthy pigs
For a healthy herd, free from costly respiratory, enteric and joint disease, you can count on Denagard.
Denagard is proven for the treatment of Mycoplasma-related infections including enzootic pneumonia1, polyarthritis2 and respiratory 
pathogens that can contribute to PRDC1. Denagard is also considered the drug of choice for enteric diseases such as ileitis, swine 
dysentery and colitis3,4.
The productivity and profit performance of Denagard for mixed infections complicated by the presence of a complex of respiratory and 
enteric pathogens including immuno-suppressive viruses is well established5.
So for pigs that do well throughout the production cycle, Denagard will do you proud.
1. Stipkovits L, et al (2001). Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida 
and Actinobacillus pleuropneumoniae with various antibiotics. Canadian Journal of Veterinary Research 2001;65:213-222.  2. 
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finishing pigs. Proceedings19th IPVS Congress, Copenhagen, Denmark.
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SYMPOSIUM SUPPORTERS
Many thanks to the following companies who have supported the Symposium for 2013
SYMPOSIUM MEDIA SUPPORTERS
Many thanks to the following companies who have supported the Symposium for 2013
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SOCIAL PROGRAMME
All social activities must have been pre-booked during the registration for the Symposium
WELCOME RECEPTION
Wednesday May 22nd 19:00hrs
(This is included in the registration
fee for the delegates)
Join us in the Symposium’s Social Space over a drink or two to
catch up with colleagues from across the World. Introduce
yourself to our Commercial Partners and have a look through
the posters that have been accepted for presentation. A perfect
way to start the evening before heading out into Edinburgh to
sample the delights the City has to offer.
PVS PAST PRESIDENTS RECEPTION
Thursday May 23rd 19:00hrs
(This event is by invitation only)
To celebrate the 50th year of the UK Pig Veterinary Society, all
past Presidents have been invited to a pre-dinner Reception,
hosted in the Music Hall Bar at the Assembly Rooms. Please
note this event is by invitation only.
GALA DINNER
Thursday May 23rd 20:00hrs
(Pre-booking required)
The superbly renovated Assembly Rooms, having reopened less
than 12 months previously, is to host the main dinner event of
the Symposium. Built in the 18th Century, the Assembly Rooms
have played host to many major events, from Royal banquets
to ceilidhs, readings from major literary giants to Edinburgh
Festival Fringe shows. It has always been the place in Edinburgh
for people to meet, talk and be entertained.
Symposium guests will be treated to a full 3 course Scottish
themed dinner within the beautiful surroundings of the Music
Hall and Ballroom, both restored to their former glory and
providing an elegant backdrop to our main social event.
Assembly Rooms, 54 George Street, Edinburgh EH2 2LR
Tel: 0131 220 4348
Number 28 on the Edinburgh Map – page 26
ACCOMPANYING PERSONS PROGRAMME
Wednesday, May 22nd
09:30 – 11:30 Royal Mile Walking Tour
11:00 – 15:00 Half Day Whisky Tour
19:00 – 20:30 Welcome Reception
21:00 – 22:00 Evening Walking Tour
Thursday, May 23rd
10:00 – 16:30 Full day City of Edinburgh Tour
20:00 – 22:30 Symposium Gala Dinner
Friday, May 24th
All Day – Golfing opportunities
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LOCAL ORGANISING COMMITTEE
Mark White
Duncan Berkshire
Stan Done
David Strachan
Ben Strugnell
Paul Thompson
Jill Thomson
Mike Wijnberg
Nigel Woolfenden
BOARD OF THE EUROPEAN COLLEGE
OF PORCINE HEALTH MANAGEMENT
President: Dominiek Maes, Belgium
Vice-President: Joaquim Segales, Spain
Past President: Thomas Blaha, Germany
Treasurer: Elisabeth grosse Beilage, Germany
Secretary: Tomasz Stadejek, Poland
Member: Dan Tucker, UK
Member: Catherine Belloc, France
BOARD OF THE EUROPEAN ASSOCIATION
OF PORCINE HEALTH MANAGEMENT
President: Peter Hoegedal, Denmark
Vice President: Enric Marco, Spain
Past President: John Mackinnon, UK
Treasurer: Jean-Luc Sevin, France
Secretary: Heiko Nathues, UK
Member: Rick Jenssen, The Netherlands
Member: Oliver Duran, Germany
The members of the local organising and scientific committees of the 5th ESPHM, The European College
of Porcine Health Management, and The European Association of Porcine Health Management gratefully
acknowledge the support of the sponsors, both partners and supporters.
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GENERAL AND PRACTICAL INFORMATION
The 5th meeting of the ESPHM and the 50th Anniversary of The Pig Veterinary Society will be held at
Edinburgh ICC, Morrison Street, Edinburgh, EH3 8EE, Telephone 0131 3003000.
HOUSE RULES
NO SMOKING –The EICC operates a strict no smoking policy.
Smoking is allowed in dedicated areas outside the EICC.
Smoking is also prohibited in hotels, restaurants, bars and
virtually all enclosed spaces in the UK.
MOBILE PHONES AND VIDEO RECORDING – The use of
mobile phones and video recording devices is strictly forbidden
during all sessions.
NO DRINKING/EATING IN THE LECTURE ROOMS
USE OF THE INTERNET
WIFI is free and available throughout the EICC.
To log in enter the following:
Username: ESPHM2013
Password: edinburgh
REGISTRATION AND INFORMATION
DESK OPENING HOURS
Wednesday, 23rd May 08:00 to 18:00
Thursday, 24th May 08.00 to 18:00
Friday, 25th May 08.00 to 13:30
LOST AND FOUND
Contact the Queries and Information desk in the Strathblane
foyer.
CONTACT INFORMATION DESK
Contact the Queries and Information desk in the Strathblane
foyer or call +44 (0)20 78085624
FIRST AID
Contact the Conference team at the Queries and Information
desk or any EICC stewards should you require assistance.
CLOAKROOM
A cloakroom is located in the Strathblane foyer and is free
of charge.
BUSINESS CENTRE
The business centre located in the Strathblane foyer can
assist with printing, copying and other secretarial services.
Charges apply.
NAME BADGE
Your personal name badge is your entrance ticket to all sessions
and the exhibition. Please remember to wear your badge at
the congress centre and the social events. Exhibition passes do
not allow access to the scientific sessions.
COFFEE BREAKS AND MEALS
Coffee/tea breaks are included in the registration fee and will be
served from Wednesday-Friday. Lunch is included on Thursday
only. Pre-ordered lunch boxes on Friday can be collected from
the Strathblane foyer (ticket required).
OTHER FACILITIES
BANKS – most open from 09.30-15.30 – The closest ATM to
the EICC is on Morrison Street near Sainsbury supermarket.
POST OFFICES –most open 09.00-17.00
EXCHANGE FACILITIES – Bureau de change facilities are
available in most banks, post offices and major hotels, as well
as at Edinburgh Airport and Waverley train station.
CLIMATE AND DRESS
Usually mild but chilly at night. Dress is informal.
ELECTRICAL SUPPLY
This is 220 Volts.
INSURANCE LIABILITY
The 5th ESPHM does not accept liability for personal medical
expenses/travel expenses/losses of any nature.
EMERGENCY SERVICES
For Police, Fire and Ambulance dial 999.
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PROGRAMME
WEDNESDAY, MAY 22ND 2013 – REGISTRATION 08:00 TO 18:00
13:00-14:20 Opening & Keynote Addresses – Pentland Suite
13:00-13:10
Welcome Address
Mark White – ESPHM 2013 President
13:10-13:45
The UK Pig Industry
Stewart Houston CBE
13:45-14:20
Emerging Clinical Threats
Joaquim Ségales
14:20-15:20 Clinical Club – Part 1 – Pentland Suite
14:20-14:35
Diagnosis of recent leptospirosis outbreaks in pigs in England
Susanna Williamson, Alex Barlow, Catriona Gaudie, Ben Strugnell, Charlotte Featherstone, Paul Duff & Lee Smith
14:35-14:50
Importance of microbial culture to identify (novel) highly beta-hemolytic Brachyspira species
E. de Jong, M. Mahu, V. Vandenbroucke, T. Vandersmissen, F. Boyen & C. Miry
14:50-15:05
Control of Glässer’s disease when introduced into a naïve SPF herd
Axel Sannö, Lena Eliasson-Selling & Per Wallgren
15:05-15:20
Description of a Streptococcus suis serotype 7 infection in an Austrian piglet producing farm
C. Unterweger, M. Höcher, L.Fischer, A. Weiss & I. Hennig-Pauka
15:20-15:50 Coffee Break – Cromdale Hall
15:50-16:50 Clinical Club – Part 2 – Pentland Suite
15:50-16:05
Klebsiella pneumoniae subsp. pneumoniae sequence type 25: re-emergence as a cause of
septicaemia in piglets in 2012
Cornelia Bidewell, Susanna Williamson, Jon Rogers, Therese Carson, Cath Clark, Richard Ellis & Manal AbuOun
16:05-16:20
Successful PRRSV elimination in a gilt rearing farm
Katja Brase, Helmut Wilke, Pieter Mesu, Gabriele Schagemann & Sabine Schrauth
16:20-16:35
The effect of all-in all-out management by site on infection with Mycoplasma hyopneumoniae
and Actinobacillus pleuropneumoniae in finishers
Marie Erika Busch, Henriette Steinmetz & Torben Jensen
16:35-16:50
Pigs with undocked tails in a conventional nursery and fattening unit – a report
Michael Alt, Heiko Janssen & Hartwig Fehrendt
16:50-17:30 Scientific Quiz – Pentland Suite
17:30-18:30
Pentland Suite
ECPHM AGM
Poster Session – Cromdale Hall
18:30-19:00 EAPHM AGM
19:00-20:30 Welcome Reception – Cromdale Hall
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THURSDAY, MAY 23RD 2013 AM – REGISTRATION 08:00 TO 18:00
08:00-08:30 Nominated Poster Presentations – Cromdale Hall
08:30-10:00 Keynote Addresses – Influenza – Pentland Suite
08:30-09:05
Pigs And Pandemic Influenza: Getting Closer To The Truth
Kristien van Reeth
09:05-09:40
Practical On-Farm Solutions To Tackle Swine Influenza
Giampetro Sandri
09:40-10:00 Round Table Discussion
10:00-10:20 Coffee Break – Cromdale Hall
10:20-12:00 Parallel Session Residents’ Session
10:20-10:40
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Molecular epidemiology of porcine
reproductive and respiratory syndrome
infections in England
Jean-Pierre Frossard, Ben Strugnell,
Catherine Fearnley & Susanna Williamson
Si
dl
aw
 R
o
o
m
Actinobacillus pleuropneumoniae
colonisation before weaning in
offspring from sows on two endemically
infected farms
T.J. Tobias, D. Klinkenberg, A. Bouma,
J. van den Broek, A.J.J.M. Daemen,
J.A. Stegeman &J.A. Wagenaar
10:40-11:00
Risk assessment of the introduction of
Porcine Reproductive and Respiratory
Syndrome into Switzerland via boar semen
Christina Nathues, Urs Zimmerli, Ruth Hauser,
Heiko Nathues, Elisabeth grosse Beilage &
Gertraud Schüpbach-Regula
Efficacy of vaccination against Actinobacillus
pleuropneumoniae on pleuritis lesions in
slaughter pigs and their technical and
economic performance in Belgium
Rubén Del Pozo Sacristán, Annelies Michiels,
Marc Martens, Freddy Haesebrouck &
Dominiek Maes
11:00-11:20
Evidence of recurrent Influenza
infections in pig farms and associated
epidemiological characteristics
N. Rose, S. Herve, E. Eveno, N. Barbier, F. Eono,
V. Dorenlor, C. Camsusou, F. Madec & G. Simon
Case report: Peracute outbreak of
Haemophilus parasuis infection in
suckling piglets in a self-recruiting,
specific pathogen free herd
Odd Magne Karlsen, Tone Bjordal Johansen,
Hans Gamlem & Tore Framstad
11:20-11:40
Efficient protection of a swine pandemic
H1N1 influenza virus vaccine against
the newly emerged H1N2 pandemic virus
reassortant
Ralf Dürrwald & Michael Schlegel
Slaughterhouse examination of culled
sows in commercial pig herds
E. de Jong, R. Appeltant, J. Beek, F. Boyen,
K. Chiers, A. Van Soom & D. Maes
11:40-12:00
Investigation of anomalous H1N2
serology results on swine influenza-
infected pig farms
Catriona Gaudie, Susanna Williamson,
Cornelia Bidewell, Ben Strugnell, Chris Russell
& Ian Brown
Action-related repetitive myoclonus
(congenital tremor) in piglets –
a case report
J. Beek, T. Vraeghe, I. Cornelis, F. Van Looveren
& D. Maes
12:00-13:00 Lunch – Cromdale Hall
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THURSDAY, MAY 23RD 2013 PM – REGISTRATION 08:00 TO 18:00
13:00-15:15 Partners’ Session – Pentland Suite
13:00-13:15
Mutant Prevention Concentration: a tool to support the responsible use of antimicrobials in
swine production – Bayer PLC Animal Health
Raúl Vázquez
13:15-13:30
Worldwide occurrence of fumonisins and their effective counteraction in vivo – Biomin
Diego Padoan, Karin Naehrer, Dieter Moll & Carlos Mallman
13:30-13:45
Different PCV2 vaccine protocols reduce PCV2 viraemia by the same magnitude –
Boehringer Ingelheim Animal Health
Brian Payne, Amanda Sponheim & Keith Bretey
13:45-14:00
An optimised swine management approach and its value to the industry – Elanco
Alvaro Hidalgo
14:00-14:15
HIPRA PRRS approach under field conditions – Hipra
Isaac Rodríguez
14:15-14:30
Effect of Tilmovet® and KetoProPig® on post-weaning diarrhoea and Streptococcus suis in piglets –
Huvepharma NV
Wouter Depondt, Stefaan Demarez, Mike Overend, Henk Lecuyse & Alain Kanora
14:30-14:45
Development of a subunit vaccine containing recombinant Stx2e against Oedema Disease of pigs
and its impact in the field – IDT Biologika GmbH
Olaf Bastert, Regine Fricke, Olaf Lüder, Volker Florian, Rolf Bauerfeind & Hans-Joachim Selbitz
14:45-15:00
Efficacy and tolerance of Pracetam in the reduction of post-operative pain following the
castration of piglets – a comparison of two dosages versus a placebo – Laboratoire Sogeval
Anne Trotel, Valérie Courboulay, Anne Hémonic, Florian Voisin, Eric Pagot, Nathalie Capdevielle,
Arnaud Anty, Claudine Zemirline
15:00-15:15
Efficacy of GRIPOVAC®3/RESPIPORC® FLU3 against challenge with a recent H1N2 Swine Influenza
Virus in pigs – Merial – A Sanofi Company
K. van der Meulen, P. Elskens, M. Schlegel, R. Dürrwald, H.-J. Selbitz, T. Vila, M. Bublot, F. Joisel & K. Van Reeth
15:15-15:45 Coffee Break – Cromdale Hall
15:45-16:30 Partners’ Session continued – Pentland Suite
15:45-16:00
Efficacy of a new combination vaccine against E.coli & Clostridium spp. on a Dutch farm
undergoing a Clostridium perfringens type A infection – MSD Animal Health
M.R.T.M. Martens, M.J.S. Reijnders, K. Redhead, M.H. Witvliet & A.S. Eggen
16:00-16:15
Detection of PRRSV antibody in oral fluid specimens from individual boars using a commercial
PRRSV serum antibody ELISA – PIC
A. Kittawornrat, M. Engle, J. Johnson, J. Prickett, C. Olsen, T. Schwartz, D. Whitney, K. Schwartz, A. Rice,
A. Ballagi, S. Lizano, C. Wang, J. Zimmerman & G. Shepherd
16:15-16:30
Using electronic clinical score in swine herds to set management decisions: one year of experience
of IPC in Europe – Zoetis
O. Azlor, A. Dereu, P. Doncecchi, A.C. Piñeiro & J. Morales
16:30-18:00 Keynote Addresses – Disease Management Horizons – Pentland Suite
16:30-17:05
Immunological Innovations In The Future Of Pig Health Management
Dan Tucker
17:05-17:40
Future Environmental Control For Pig Production
Hugh Crabtree
17:40-18:00 Round Table Discussion
19:00-20:00 PVS Past Presidents’ Reception – Assembly Rooms
20:00-23:00 Symposium Gala Dinner – Assembly Rooms
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FRIDAY, MAY 24TH 2013 – REGISTRATION 08:00 TO 13:30
08:00-08:45 PVS AGM – Pentland Suite
08:45-10:15 Keynote Addresses – Young Pig Gut – Pentland Suite
08:45-09:20
Microbiota, Metabolism and Immunity
Mick Bailey
09:20-09:55
Feed intake in young pigs and its importance for the ‘post-antibiotic era’
Paul Toplis
09:55-10:15 Round Table Discussion
10:15-10:35 Coffee Break – Cromdale Hall
10:35-12:35 Parallel Sessions
10:35-10:55
Pe
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Results of a field trial for vaccine against
oedema disease
X. Sidler, S. Mattei, R. Fricke, W. Schmid,
O. Bastert, O. Lüder & A. Becker
Si
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An integrated system for pig health and
welfare monitoring – fact or fiction?
Sue.C.Tongue, Richard P. Smith, Carla Gomes,
Toby Floyd, Elizabeth Marier, Guanghui Wu &
Susanna Williamson
10:55-11:15
Observations on the latest epidemic
strain of Salmonella in pigs: monophasic
S. Typhimurium
G. Crayford & R. Davies
Occurrence and severity of lung lesions
in slaughter pigs vaccinated against
M. hyopneumoniae with different strategies
Sonja Hillen, Hermann Willems,
Stephan v. Berg & Gerald Reiner
11:15-11:35
Severe acute gastritis in grower pigs
associated with acute monophasic
S. Typhimurium infection after withdrawal
of acidified water
B.W. Strugnell & R.J. Evans
Variability of ovulation in gilts; associated
factors and consequences on reproductive
performances in 4 pig farms
E. Sallé, M. Le Jeune, Y. Huang & S. Boulot
11:35-11:55
Development and validation of a
Streptococcus suis serotype 2 meningitis
challenge model in pigs
David Reddick & Cliff Ramage
An ultrasonographical, histological and
immunohistochemical investigation of the
growing mammary gland in the pig
David Sporn, Axel Wehrend, Johannes Seeger
& Johannes Kauffold
11:55-12:15
Septicaemic pasteurellosis in free-range
pigs in Spain: an emerging disease?
F. Cardoso-Toset, J. Gómez-Laguna, M. Callejo,
A.I. Vela, L. Carrasco, J.F. Fernández-Garayzábal,
A. Maldonado & I. Luque
Bone formation and resorption
throughout the reproductive cycle of
primiparous and multiparous sows
M.M.J. Van Riet, S. Millet, A. Liesegang,
E. Nalon, F.A.M. Tuyttens, D. Maes &
G.P.J. Janssens
12:15-12:35
Association between blood haemoglobin
concentration in sows and neonatal piglets
Anna Kathrine Jensen & Jens Peter Nielsen
Longevity of gestating sows statistically
related to lameness, leg and claw problems
Elisabeth Okholm Nielsen,
Lisbeth Ulrich Hansen,
Hanne Midtgaard Rasmussen,
Flemming Thorup & Mai Britt Friis Nielsen
12:35-12:50 6th ESPHM Presentation – Pentland Suite
12:50-13:00 Closing Address & Handover of PVS Presidency – Pentland Suite
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KEYNOTE SPEAKERS
STEWART HOUSTON
The UK Pig Industry
Stewart is a director in a family business focused on pig production. He is Chair of the British
Pig Executive (BPEX) and was the most recent past Chair of the National Pig Association.
He is a David Black Award winner and a Fellow of the Royal Agricultural Society. Stewart was
awarded a CBE in the 2007 Queen’s Birthday Honours for services to agriculture.
JOAQUIM SEGALES
Emerging Clinical Threats
Professor Joaquim Segalés is a world-renowned figure in the world of pig diagnostic
pathology and applied research into important pig diseases. He qualified as DVM in 1991,
achieved his PhD in 1996, became a diplomate of the European College of Veterinary
Pathologists in 2000 and a diplomate and founding member of the European College of
Porcine Health Management in 2004.
His current position is the director of the Centre de Recerca en Sanitat Animal (CReSA) and
Associate Professor at the Veterinary School of the Universitat Autònoma de Barcelona,
where his everyday work is focussed on pathology and swine clinics.
Prof. Segalés has also been a diagnostician at the Pathology Department of the Veterinary
School of Barcelona since 1996, where he has responsibility for the pathological diagnostic
activity in swine.
As a leading world researcher in pig matters, Prof. Segalés has been involved in research of
swine diseases since 1993, mainly infectious diseases (including infections by porcine
reproductive and respiratory syndrome virus (PRRSV), Aujeszky’s disease virus, porcine
circovirus type 2 (PCV2), swine hepatitis E virus, swine Torque teno sus viruses (TTSuV),
Haemophilus parasuis and Mycoplasma hyopneumoniae). He has co-authored more than
200 articles in international peer-reviewed journals.
KRISTIEN VAN REETH
Pigs And Pandemic Influenza: Getting Closer To The Truth
EDUCATION AND TRAINING
2000 Visiting post-doctoral fellowship Dept. Of Pathobiological Sciences, School of
Veterinary Medicine, University of Wisconsin-Madison, USA.
1998 PhD in Veterinary Sciences, Laboratory of Virology, Faculty of Veterinary Medicine,
Ghent University, Belgium.
1985-1991 Veterinary Medicine at the Faculty of Veterinary Medicine, Ghent University,
Belgium.
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WORK EXPERIENCE
Associate Professor, Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University,
Belgium.
Main research fields: Pathogenesis and immune response to swine influenza virus, public health
aspects of swine influenza virus, pathobiology of the porcine respiratory disease complex.
Member of the executive committee of OFFLU (OIE/FAO network of expertise on animal
influenza); co-chair of the OFFLU swine influenza virus group.
Member and expert Chamber of Veterinary Medicines, Belgium.
Member of the Royal Academy for Medicine of Belgium.
Member of professional societies for virology, microbiology and swine health: European
Society for Veterinary Virology (ESVV), American Society for Microbiology (ASM), American
Association for the Advancement of Science (AAAS), Belgian Society for Microbiology (BSM),
International Pig Veterinary Society (IPVS) Belgian Branch.
GIAMPIETRO SANDRI
Practical On-Farm Solutions To Tackle Swine Influenza
Giampietro Sandri achieved his DVM from the University of Parma in 1981, having written
his thesis on porcine stress syndrome. He has worked for Gruppo Veronesi, the largest
integrated swine producer in Italy, since 1983 and is currently Health Director of the swine
business, leading a team of nine vets. Dr. Sandri is a well known and regular speaker at
national and international scientific meetings and congresses and well as courses for swine
veterinarians and producers.
Dr. Sandri was a board member of SPIAS (the Italian Society of Swine Pathology and
production) between 1989 and 1994 and between 1999 and 2006, serving as Vice president
during this second term. He was Secretary of the organising committee of the XLV IPVS
Congress in Bologna and a board member of the IPVS. He was awarded the ‘Porco Bravo’
industry award in 2007.
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DAN TUCKER
Immunological Innovations In The Future Of Pig Health Management
A.W. (Dan) Tucker is Senior Lecturer in Veterinary Public Health at the University of
Cambridge’s Department of Veterinary Medicine (www.vet.cam.ac.uk) where he is
responsible for teaching pig medicine and veterinary public health. He is a Fellow of
Pembroke College, Cambridge (www.pem.cam.ac.uk). His research interests are focused on
respiratory infections of pigs and more generally the interface between emerging
technologies and pig health. He maintains clinical activity and has long term links with the
pig breeding and animal health industries. He is a Diplomate of the European Colleges of
Porcine Health Management and the European College of Veterinary Public Health. He is
member of the UK Animal Health and Veterinary Laboratories Agency (AHVLA) Pig Expert
Group, and served for a number of years on the Executive of the UK’s Pig Veterinary Society
and also on the UK Pig Levy Board’s (BPEX Ltd) Pig Technical Committee.
HUGH CRABTREE
Future Environmental Control For Pig Production
Hugh Crabtree gained a first class honours degree at Reading University and continued with
post graduate research into thermal performance in pig buildings. A founder member of
Farmex Ltd in 1980 the company has gone on to become the market leader in ventilation
systems for pig production in the UK. Three times winner of the New Equipment Award at
the British Pig & Poultry Fair Farmex is now at the forefront of real-time production
monitoring both in the UK and the States.
Hugh is a Fellow of the Institution of Agricultural Engineers and a past Vice Chairman of
the National Pig Association. He is a current member of the Allied Industries Group of the
NPA. Outside business, Hugh is a past Chairman of Reading RFC, runs a touring band –
Feast of Fiddles, collects wine and is restoring a 1955 Sunbeam Mk III. Hugh is married with
three children.
MICK BAILEY
Microbiota, Metabolism And Immunity
Mick graduated from Bristol Veterinary School in 1979 and immediately started a PhD at
Cambridge on immune responses to parasite infections. After the PhD, he spent a year in
practice, then took up a postdoc at Bristol working on immune responses to food antigens
around weaning. Over the last 25 years, he has been studying the factors determining
development of immunological competence in young piglets, gradually focusing on the role
of early microbial colonisation. Because of the similarities between this process and the
role of early-life microbiota in human infant allergies, his group have developed the use of
young piglets as immunological models for human infants in addition to their economic
importance as agricultural species. This, in turn, has resulted in an interest in comparative
evolution of immune systems. As a sideline, his group has been involved with several other
groups interested in large animal models of transplantation including laryngeal, vascular,
intestinal and corneal allografts. One of the main approaches they have used has been
quantitative imaging, and they also collaborate on non-immunological projects using this
technology, including identifying meiotic stages of the animal pathogen Trypanosoma brucei
brucei in tsetse flies. Mick was appointed to a chair in Comparative Immunology in 2006.
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PAUL TOPLIS
Feed intake in young pigs and its importance for the ‘post-antibiotic era’
After graduating, Paul joined RHM Agriculture as an assistant nutritionist working on
ruminant, pig and poultry nutrition. Paul was appointed National Pig Nutritionist in 1976
and after four years became RHM’s Chief Nutritionist. In 1982 Paul was appointed manager
of the company’s centralised diet formulation department with responsibility for 15 feed
mills manufacturing over 1 million tonnes of compound feed. In 1985 Paul moved into the
premix industry where he increasingly specialised in commercial pig formulations and began
regular export work.
In 1989 Paul joined SCA Nutrition with a remit to begin export activity. In 1994 SCA
Nutrition were awarded the Queen’s award for Export Achievement (and remain the only
livestock feed manufacturer to ever win this award). Paul left SCA in 1996 with three fellow
directors to form Primary Diets where he still serves as Technical Director.
Paul has and continues to serve of numerous industry committees and boards including;
over twenty years on the Agricultural Industries Federation Legal Affairs and Scientific
Committee, current member of both the Responsible Use of Medicines in Agriculture Board
and NPA Allied Industry Committee and two recent terms on the Pig Veterinary Society
Executive. In 2011 Paul received the David Black award for outstanding and sustained
contribution to the UK pig industry.
Paul has maintained an on farm advisory role throughout his career, both in the UK and
overseas, and normally visits one or more pig units each week to help with problem solving
or to give feeding recommendations.
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STRUCTURE OF THE UK PIG INDUSTRY
Stewart Houston
The total number of pigs recorded in the UK June Agricultural
Census rose slightly in 2012, for the first time since 2006. The
total was up by 0.9 per cent, to stand at 4.48 million head. The
female breeding herd on the other hand fell by 1.5 per cent to
425,000 head. The total breeding pig herd was virtually
unchanged between 2011 and 2012 and stood at 523,000
head. On the back of improved sow productivity, the number
of fattening pigs rose by one per cent to 3.96 million head. The
number of in-pig sows increased by nearly five per cent but
the number of suckling or dry sows fell sharply. This may reflect
increased replacement levels since maiden gilt numbers were
up by nine per cent. The increase in the UK pig herd was also
reflected in the English, Welsh and Northern Irish herds, all of
which were slightly larger than in 2012. In contrast, the
Scottish herd suffered a further decline, falling by seven per
cent to just 363,000 head. The Scottish breeding herd fell even
more sharply. Since the June census was undertaken, feed
prices have increased sharply. This is thought to have led to a
fall in the size of the breeding herd of perhaps as much as five
per cent. This will be clarified when results from the December
census are published in March 2013. There were 10,900
commercial agricultural holdings with pigs in the UK in 2011
(figures for 2012 are not yet available), 6,000 of which had
female breeding pigs and 9,000 of which had fattening pigs.
This implies that just over 4,000 holdings had both breeding
and fattening pigs. The average number of female breeding pigs
on each commercial holding was 72. However, excluding those
holdings with five or fewer breeding pigs, the average number
was 153. The average size of breeding herds has fallen steadily
over the last decade from a peak of 92 in 2002. The average
number of fattening pigs on each holding was 437. Excluding
holdings with fewer than ten pigs, the average was 768. This
average has also fallen over the last decade. The figures above
include many holdings which keep pigs but which are also
engaged in other agricultural activities. When holdings were
classified based on their predominant activity, there were 5,600
specialist pig holdings in the UK in 2010 (the latest year for
which figures are available). Of the specialist pig holdings, only
1,600 were in England. These holdings accounted for 71 per
cent of pigs on commercial holdings in England. The 1,100
specialist pig holdings with breeding pigs had an average of
300 breeding pigs. Pig holdings with other pigs had an average
of 1,500. Pig producers are highly geographically concentrated.
Of the 4.5 million pigs in the UK, around 81 per cent are in
England, with 10 per cent in Northern Ireland, nine per cent in
Scotland and less than one per cent in Wales. In 2010, well over
half of England’s pigs were concentrated in just four counties:
Norfolk, Suffolk and North and East Yorkshire. There are also
significant concentrations in Northern Ireland, to the South &
East of Lough Neagh. The decline in abattoir numbers has led
to a high degree of concentration. The 16 specialist pig
abattoirs accounted for around 70 per cent of all pigs
slaughtered during 2010. In fact, the seven largest plants
(including one non-specialist) killed around two-thirds of all
pigs. The four largest companies, with nine sites between them,
killed around three-quarters of English pigs. The majority of
holdings with pigs are not specialist pig farms. This is
particularly true of those involved in finishing pigs, but many
pig breeders are also not specialists. It is therefore, impossible
to accurately determine the contribution of these farms to the
workforce involved in pig production. In England, around
40 per cent of the commercial pig breeding herd are kept
outdoors. This percentage varies little between different stages
in the breeding cycle and has risen from under 30 per cent five
years ago. The remaining 60 per cent of sows and gilts are kept
in indoor systems but here there are differences across the
breeding cycle. During farrowing and whilst sows are suckling
piglets, most are kept on fully or partly slatted floors, although
a significant minority are kept on straw. However, for the
remainder of the breeding cycle, most indoor sows are kept on
straw-based systems. Almost all indoor maiden gilts are kept
on straw. Outdoor breeding pigs are typically housed at a
density of around 15 sows/gilts per hectare. In around 80 per
cent of cases, outdoor pigs are used as part of a rotation
system, with pigs spending an average of 17 months in a
paddock before they are rotated. Most outdoor producers
provide pig arcs for shelter, with some using cabins or tents as
well as or instead of arcs. Once piglets have been weaned,
they are less likely to be kept outdoors. Only around one in
five weaners (between 7 and 30kg) are housed outdoors,
with stocking densities much higher than for breeding
pigs, typically close to 400 per hectare. Where weaners are
housed indoors, over half are on straw with the remainder
mainly on fully-slatted floors. At later stages in the feeding
process, pigs are much less likely to be housed outdoors. Only
three per cent of commercial growers (between 30 and 65kg)
and finishers (over 65kg) are kept outdoors, although these
figures are likely to be higher for smaller producers, for whom
equivalent figures are not available. The majority of pigs which
are housed indoors are on straw, a proportion which has
increased in recent years. Finishers are more likely to be on
slatted floors than growers.
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THE THREAT OF EMERGING AND
RE-EMERGING DISEASES IN PIGS
Joaquim Segalés
Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, and Departament
de Sanitat i Anatomia Animals, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
The World Health Organisation (WHO) defines an emerging
disease as one that has appeared in a population for the first
time, or that may have existed previously but is rapidly
increasing in incidence or geographic range. These have
increased over the last 20-30 years. Most of them are
infectious diseases; their transmissibility and maintenance in a
population is favoured by a number of phenomena, including
intensive rearing practices and globalised/international trading.
The last 10 years have shown a significant increase in the
knowledge of newly discovered infectious agents particularly
viruses of unknown pathogenicity. This presentation discusses
the general and particular causes of the appearance of new
diseases or novel presentations of known diseases and the
recently recognised infections of as yet unknown impact.
Mechanisms of emergence and re-emergence of diseases and
the duality of “disease and infection” are discussed in general.
The infectious component is usually a significant element
which guarantees, that transmission and infection would
occur in a relatively large number of individuals. Of course,
once a new or a re-emerging disease spreads into a population
of naïve animals reared under intensive conditions, human
action plays a major role in its evolution. Firstly, measures are
established to limit the transmission of the pathogen. Over
time, the infection may be endemically maintained causing
minimal (sub-clinical) or sporadic disease. Eventually, the
infection can be eradicated, recreating a population of
susceptible animals.
The differentiation between infection and disease is relevant. In
fact, a pathogen-exposed animal may eventually develop illness
subjected to a number of factors. Factors influencing host
susceptibility or resistance to disease include age, immuno-
competency, vaccination status, genetic predisposition,
concomitant disease problems, stress, environment,
management, and nutritional status. Another factor is the
intrinsic virulence of the infectious agent which is variable
within types, serotypes or genotypes of a given pathogen.
Traditionally, veterinarians have dealt with overt diseases, with
the main task of counteracting them and getting profitability
of the production system represented by a farm or a group of
farms. Moreover, several decades ago, the most important
diseases affecting pigs(such as ASF) were considered mostly
“uni-factorial” and these have been controlled or are under
control. The control of these diseases increased the awareness
of less devastating but economically important infections such
as Mycoplasma hyopneumoniae, Brachyspira hyodysenteriae,
Actinobacillus pleuropneumoniae, porcine reproductive and
respiratory syndrome (PRRS) virus, and porcine circovirus type
2. All of them are considered “multi-factorial” since the mere
presence of the agent is not sufficient to trigger the disease.
There are some exceptions such as certain serotypes of A.
pleuropneumoniae in naïve herds or the reproductive form of
PRRS in sero-negative farms which may be considered as “uni-
factorial”. Other diseases have probably been there all the time,
but their relevance has increased over 20 years, such as
colibacillosis, Glässer’s disease, proliferative enteropathies, and
swine influenza. Finally, there is a third category of infectious
agents of unknown clinical significance. Most of these latter
infections are ubiquitous in the swine population but have a
poorly understood epidemiology and pathogenicity.
The risk of emerging and re-emerging diseases with significant
economic losses and infections with unknown impact on
production is high. Pig production is a good example of a
globalised industry, and swine veterinarians and researchers
in conjunction with producers, consumers, and stakeholders
should join efforts for more global, collaborative, and action-
oriented approaches towards logical and practical solutions.
Definitively, the concept of “one world, one health” and its
related disciplines are corner-stones to keep swine production
as a high quality, friendly, safe, consumer-acceptable, and
profitable activity.
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PIGS AND PANDEMIC INFLUENZA:
GETTING CLOSER TO THE TRUTH
Kristien Van Reeth
Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
Pigs have been assigned a role in the generation of pandemic
influenza viruses for humans for decades. In theory, such
pandemic viruses could emerge following a) adaptation of a
strain of avian origin to humans by mutations and/or genetic
re-assortment with a human influenza virus or b) adaptation
of an established swine strain to humans. The classic viewpoint
is that pigs are more susceptible to avian influenza viruses
than humans, and that they are essential intermediate hosts
for the introduction of avian viruses or avian virus genes in
the human population. This central dogma apparently needs
to be revised, as shown by recent zoonotic flu infections and
experimental studies. Some 700 human cases of infection
with the highly pathogenic H5N1 bird flu virus have occurred
since 2003. These cases were invariably due to direct contact
with infected poultry, not with pigs. The H5N1 virus so far fails
to spread efficiently between humans and thus could not
cause a human pandemic. Avian influenza viruses including
H5N1 have been able to infect pigs under experimental
conditions and in nature. However, there is clearly a strong
barrier to infection of pigs and the avian viruses lack the
capacity to spread between pigs. In fact there is no evidence
that pigs are more susceptible to avian viruses than humans
or that pigs serve as unique “mixing vessels”, since genetic re-
assortment between avian and mammalian influenza viruses
can also occur in several bird species.
On the other hand, the same influenza virus subtypes that
infect humans – H1N1, H3N2 and H1N2 – are endemic in
swine populations worldwide. Many of these viruses are
entirely or in part of human origin, but they follow a different
evolution in swine and in humans. Such swine-adapted H1
and H3 viruses occasionally jump (back) to humans, but as for
wholly avian influenza viruses second generation transmission
is extremely rare. The 2009 pandemic H1N1 virus is the first
virus of presumed swine origin that resulted in efficient
transmission between humans. The latter virus is a re-
assortant between established swine influenza viruses from
North America and Europe, with gene segments of avian,
human and swine origin. Still, it remains unknown how, when
and where this specific re-assortant emerged. In 2011 and
2012, another swine-origin re-assortant, subtype H3N2, has
infected some 300 children at pig fairs in North America.
Unlike the 2009 pandemic H1N1 virus, this so-called “H3N2
variant” virus did not spread readily between humans.
Unfortunately, we still have a very limited understanding of
what is needed for adaptation of avian influenza viruses to
pigs, for influenza virus transmission from pigs to humans, and
for sustained transmission of such viruses in the human
population. On the positive side, the 2009 pandemic has given
a boost to swine influenza virus surveillance, as well as to
experimental research of the host barriers for influenza viruses
in pigs and other animals. In my lecture I will review the major
lessons learned from these complicated studies. I will also
address the role of the veterinarian in the prevention of
zoonotic swine influenza virus infections.
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PRACTICAL ON-FARM SOLUTIONS
TO TACKLE SWINE INFLUENZA
Giampietro Sandri
Agricola tre Valli, Gruppo Veronesi – Verona, Italy.
Swine Influenza Virus (SIV) is known to be a primary
respiratory pathogen for swine, inducing typical lung lesions.
In Europe and in Italy subtypes H1N1, H3N2 and H1N2 are
almost endemic in many pig producing areas although there
are different prevalences in different countries at different
times. In most of the cases, SIV induces an acute infection of
the respiratory tract whose consequences depend on the
“intrinsic pathogenicity/virulence” of the specific virus, the
pig’s immune status and the pig’s immune system reactivity.
In the field, we may observe basically two different forms of
Swine Influenza (SI). The most common is the Epizootic form
affecting adult animals of different ages, all at the same time
or in a short period of time. It usually has a sudden, acute
onset, with pigs showing clinical signs within the first 12 to 48
hours after being infected. Affected animals show prostration,
fever, anorexia, hard coughing, dyspnoea and nasal discharge.
Secondary bacterial infections may contribute to complicate
the course of the viral infection. The Enzootic form mostly
affects young animals in the nursery period. The clinical
appearance may be similar to the epizootic form but the final
outcome is largely dependent on the dynamic of population
immunity. This form is frequently seen on farrow-to-finish
farms and when or where the mothers are not regularly
vaccinated. The gross lesions caused by SIV start to develop as
soon as 24 hours after infection and are usually limited to
cranial and middle lobes of the lungs. In the most severe cases
almost all of the lungs may be affected. Swine Influenza may
be suspected every time there is a sudden acute respiratory
disease affecting a large proportion of the pigs in a herd, but
to confirm the diagnosis, virus isolation or detection using a
PCR is required. The best samples to submit are the lung tissue
of dead animals or a few nasal swabs taken from sick, high-
fever animals. The hemagglutinins and neuraminidases are
then determined using specific inhibition tests. I would not
suggest using serology to diagnose influenza because of the
interference of both maternal antibodies in young animals
and vaccine immunity in vaccinated animals. Of course, there
is no specific treatment for Swine Influenza. Affected animals
only need careful nursing providing a good, warm and nicely
ventilated environment. Antipyretics (aspirin or paracetamol)
are very useful to treat pigs during the acute phase of the
disease. Antibiotic treatment may only be used to treat
concurrent or secondary bacterial infections. Biosecurity
measures (All In/All Out management of groups, quarantine
period of incoming animals, strict management of access to
pigs) play a major role in preventing SIV infection.
Nevertheless, these measures alone are not enough to
efficiently prevent infection in densely pig populated areas
where airborne spread may contribute to Influenza epidemics
over relatively large geographical areas. Vaccination is
therefore the most important tool to reduce the incidence of
this infection/disease not only in sow herds but also in
growing and finishing pigs. In Italy there are only two licensed
inactivated vaccines on the market. Both have the H1N1 and
H3N2 strains and only one has the new H1N2. The evaluation
of the economic effect of SI vaccination may be contradictory
and certainly requires and accurate evaluation of prevalence
(hence the need for a monitoring programme) and costs (need
to evaluate the cost of every single outbreak) in order to be
able to evaluate the supposed benefits. In sow herds, besides
protecting the mothers themselves, vaccination is aimed at
reducing or possibly stopping transmission from the dam to
the offspring, so the supposed economic benefits will also be
transferred – if we may say so – to the following production
stages. Surveillance and active monitoring of SIVs changes
remain a primary requirement. Understanding where SIVs are
coming from and how they enter pig farms is also crucial.
Despite the degree of protection provided by the available
vaccines and the experimental challenges of these appear to
be more than satisfactory, there is still the need to gather
more scientific and economic evaluation of their real
performances in the field. This is before their acceptance
becomes more widespread. Nevertheless, when correctly
applied, vaccination is today by far the most efficient tool –
available for veterinarians and producers – to prevent and
control SI.
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IMMUNOLOGICAL INNOVATIONS IN THE
FUTURE OF PIG HEALTH MANAGEMENT
A.W. (Dan) Tucker
Department of Veterinary Medicine, University of Cambridge, UK.
The work outlined above emphasises the dependence of a
herd’s health on the inter-relationships between individual pig
susceptibility, the environment and the local pathogen profile.
The industry needs to focus on applying these approaches to
ensure long term sustainability of a food source that is vital for
the human population. Drivers will include the need for cost
effective production through better feed efficiency, reduced
disease losses, reduced dependence on antimicrobials, and
preparedness for new emerging diseases and zoonoses. History
emphasises that pigs are an important source of emerging
infectious diseases, with significance for both pig and human
health, and a number of factors make pigs a suitable platform
for disease emergence and transmission to humans. To
maximise the herd health benefit from our understanding of
pig immunity and vaccinology we should combine this with
better approaches to understand the ever-changing threat
posed by pig pathogens – whether they are endemic,
everyday, infections such as Mycoplasma hyopneumoniae or
epizootic pathogens such as African Swine Fever virus.
The term ‘dynamics of infectious disease’ describes changes in
prevalence and biology of specific pathogens within and
between given populations over time. This information is
important in better targeting existing management or
vaccine-based controls. Typically, highly specific diagnostic
tools are required in order to track pathogen strains within
populations and the new, high throughput sequencing
technologies could make these tests affordable and practical
at herd level in the coming years. For example, better
understanding of Streptococcus suis infection dynamics could
simplify and strengthen eradication programmes, maybe
without the need for repopulation. However, a given pig
population may be colonised with multiple strains of S. suis
and molecular tests are needed that can discriminate those
strains that actually have potential significance for disease.
These tools could allow better understanding of the
prevalence, transmission and duration of carriage by relevant
strains, and could lead to new approaches for control. Similar,
sequence based, approaches that account for the whole
genome (rather than the snapshot permitted by existing PCR-
based testing), could support our understanding of PRRSV
infection. Parallel infection of herds with multiple PRRSV
strains is possible and understanding the dynamics of these
combined infections in field populations using existing PCR
approaches is not feasible. Whole genome approaches, which
are becoming cheaper and increasingly applicable at field level,
could shed light on host immunological factors and virus
determinants that are associated with natural control, or the
appearance of mutants able to escape immunity.
New advances in immunology and vaccine design promise real
benefits to pig health, leading to downstream production
efficiency, better food safety and pig welfare. Veterinarians
have an important role in facilitating the acceptance and
uptake of new technologies by producers. In the reverse
direction, veterinarians should make use of their position at
the interface of science and animal production to keep abreast
of emerging technologies so that further applications, that
may not be apparent to the fundamental scientists who drive
them, can be identified.
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FUTURE ENVIRONMENTAL CONTROL FOR PIG PRODUCTION
– MORE OF THE SAME OR RADICAL CHANGE?
Nick Bird & Hugh Crabtree
Directors, Farmex Ltd.
The basic physics involved in environmental control in pig
production do not change. Practitioners may need regularly
reminding of the basis on which ventilation systems are
designed for example, but the starting point is always the
same: a heat balance and contaminant removal. There has
been a significant change in the number of animals each
stockperson is expected to look after. More and more pigs are
being looked after by fewer and fewer people. This means
there will need to be an increasing investment in information
technologies. If producers are going to achieve increased
output at less environmental cost at the same time as
satisfying consumer demands for high standards of animal
health and welfare; then they will need to have the
information and communication technology (ICT) tools
available to them.
The trend is going to be for automatic data analysis with
readily usable notifications delivered to operators using
mobile devices. New buildings are likely to incorporate new
ICT tools but if the type of performance changes that are
required are going to be achieved existing buildings will also
have to take on board real time monitoring.
There is a wide range of performance across the UK pig
industry. The challenge is to get most producers to achieve
top 10% performance. That would be a radical change indeed
but it could be achievable with the routine use of new ICT
tools that allow producers to get more right more of the time.
Monitoring has been shown to modify behaviour in
production management – if significant energy waste is
exposed for example it quickly gets rectified.
Measuring water use by growing pigs is crucial as it provides
important insights across all aspects of environmental control.
This is already clearly understood in poultry production but is
only just gaining credence in pig production. Understanding of
growth, feed intake, and metabolism is improved through water
use monitoring. Water data also has practical benefits such as
leakage detection, batch on batch growth comparisons,
monitoring labour and early illness detection for example.
If monitoring and ICT tools are to help producers achieve
radically improved efficiency then they must focus on
extracting maximum value from low cost, robust and available
devices that use cloud-based technologies to deliver decision
support where it’s wanted, how it’s wanted and to whom it’s
wanted. A shared knowledge resource will emerge and it could
be exploited by the whole industry through professional
technical support dedicated to gaining commercial advantage.
Process monitoring in pig production is the radical change
that is taking place across Europe now and is set to deliver
significant efficiency gains to those that invest in it.
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MICROBIOTA, METABOLISM AND IMMUNITY: THE ROLE OF
EARLY-LIFE EVENTS IN DETERMINING PIGLET PERFORMANCE
Mick Bailey1, Zoe Christoforidou1, Sylvia Grierson2, Marie Lewis1, Chris Stokes1
1 School of Veterinary Science, University of Bristol, Langford House, Langford, Bristol BS40 5DU;
2 Animal Health and Veterinary Laboratories Agency, Woodham Lane, Addlestone KT15 3NB.
ABSTRACT
Increasing evidence over the last decade has suggested that
the complex process by which the intestinal tract is colonised
with bacteria after birth has profound effects on development
both of the immune system and of metabolism in human
infants. Importantly, it is now apparent that very early-life
events may have prolonged, sustained effects on both of these
systems. The link between early-life microbial colonisation and
later allergic or autoimmune disease (the ‘hygiene hypothesis’)
was proposed two decades ago. Initially, early-life exposure to
pathogens was hypothesised to be the major protective factor.
However, the development of high-throughput sequencing
approaches to characterise the entire gut microbial ecosystem
have demonstrated marked differences between individual
humans in the initial establishment and subsequent
development of normal commensal microbiota. In rodent
models, specific components of the gut microbiota have
dramatic effects on the function of the mucosal immune
system. More recently, it has become apparent that changes
in this pattern of microbial colonisation are also linked to a
range of juvenile and adult metabolic diseases in humans,
including diabetes, obesity, atherosclerosis. Thus, the evidence
now indicates that very early events which affect microbial
colonisation of human infants (maternal microbiota, weaning
age, diet, environmental ‘hygiene’) have long-term effects on
health and disease.
In contrast, the idea that very early-life events can have long-
term effects on pig health and performance has not achieved
wide publicity. The suckling period is frequently regarded
simply as a way of delivering a sufficient number of weaned
piglets of an acceptable weight into the growing stage.
However, the immune and metabolic systems are key
determinants of later pig performance, governing resistance
to infectious disease and conversion of feed to body mass.
Early life events which have persistent, long term effects on
these systems are likely to be key targets for improving pig
health, welfare and performance in future.
Our recent studies have used experimental systems ranging
from highly reductionist, defined colonisation of gnotobiotic
piglets through specific intervention in isolator-reared piglets
to comparisons of piglets under different rearing conditions.
Under highly controlled conditions, colonisation with defined,
three-component microbiota results in expansion and
development of the B-cell, T-cell and antigen-presenting-cell
compartments of the mucosal immune system of neonatal
piglets. By comparing piglets from different farm sources,
either reared on the sow or moved to SPF isolators, we have
further demonstrated that rearing environment during the
first 24 hours, and from 1 day until weaning, have independent
and interacting effects on development of function of antigen-
presenting cells and T-cells in the intestinal mucosa. Finally,
we have shown that specific intervention with pre- or
probiotic from weaning or from the first day of life can have
significant effects on development of the mucosal immune
system and on metabolism.
Our results clearly demonstrate that treatments which
influence the intestinal microbiota in young piglets have
surprisingly persistent effects on intestinal microbiota in later
life, and that these differences are linked to long-term
alterations in the structure and function of the immune and
metabolic systems. We have not examined the impact of
these manipulations on pig performance in commercial
situations. However, on-farm studies have demonstrated
significant differences between farms in development of the
immune system in young piglets. It seems likely that these
differences reflect differences in the type of antigenic and
microbial challenge between farms. While there is
considerable potential for intervention at birth and at weaning
aimed at improving pig health and performance throughout
the growing and finishing periods, such interventions may
need to be targeted at specific conditions on specific farms –
the equivalent of the ‘stratified medicine’ approaches
proposed for human populations.
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FEED INTAKE IN YOUNG PIGS AND ITS IMPORTANCE
FOR THE ‘POST-ANTIBIOTIC ERA’
P. Toplis1, I.J. Wellock1, K. Almond1, P. Wilcock2, C.L. Walk2
1 Primary Diets, Ripon, Yorkshire, UK; 2 AB Vista, Marlborough, Wiltshire, UK.
The importance of promoting feed intake following weaning
is often underestimated as a contributory factor towards
reducing antimicrobial use. The focus of this paper is to discuss
nutritional factors that influence feed intake and the potential
consequences for a post-antibiotic era. Other important
factors outside this area of research, most notably health
status and management, are beyond the scope of this paper.
Pig production remains an economic activity, not an academic
one and pig producers must deliver many of the changes
necessary to reduce antimicrobial usage. It is incumbent on
all involved in the pig industry to find cost effective ways to
reduce antibiotic use which work not only at the test facility
but repeatedly at farm level. Antibiotic reduction is more
achievable and sustainable with highly digestible diets (usually
higher cost), but current levels of profitability prevent
widespread adoption of this route. Profitability is as much a
reflection on consumer demands and pork retail price as
producer efficiencies and cost control.
Weaned piglets would be expected to become hungry and seek
food sources, yet they are often poorly motivated to ingest
solid feed. Poor growth performance is commonly
accompanied by an increased susceptibility to enteric disorders
which has led to prophylactic use of antibiotics around the
world. Having taken account of a variety of measures (villus
height, crypt depth, intestinal permeability and inflammation
and brush border enzyme activity) as indicators of small
intestine integrity the authors propose the order of importance
for enhancing gut health and subsequent growth performance,
are firstly feed intake followed by feed ingredient choice and
lastly nutrient level. Feed intake is the clear priority.
As feed intake appears to be the top priority, The Feed Industry
continues to fund research to identify dietary measures which
will facilitate a reduction in antimicrobial use while
maintaining feed intake. For example, novel avenues of
research are focusing on the impact of phytase superdosing
(>1250FTU/kg) and the efficacy of pharmaceutical levels of
zinc oxide on performance.
Feed intake should be promoted pre- and post-weaning
utilising the full armoury of dietary, ingredient, management,
and health measures at the disposal of the pig industry.
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DIAGNOSIS OF RECENT LEPTOSPIROSIS OUTBREAKS
IN PIGS IN ENGLAND
Leptospirosis in pigs can occur due to infection with a range
of Leptospira serovars, in particular those which are pig-
adapted (for example, Bratislava and Pomona) but also those
adapted to other hosts. Confirmation of disease due to
leptospire infection depends on detection of the organism,
seroconversion and/or histopathology. Polymerase chain
reaction (PCR) tests have tended to replace other methods of
detecting leptospires, allowing more rapid diagnosis and
implementation of interventions such as vaccination,
treatment and rodent control. An improved diagnostic PCR
was introduced in 2011 to detect pathogenic leptospires in
diagnostic submissions to Animal Health and Veterinary
Laboratories Agency laboratories. Since its introduction, five
outbreaks were diagnosed in 2011-2012 compared to just
two from 2005 to 2010. The outbreaks involved systemic
disease in growing pigs or reproductive disease in breeding
pigs. In growing pigs, jaundice prompted suspicion of, and
testing for, leptospires. Porcine circovirus-2 associated
hepatitis, septicaemias, phenol toxicity and Mycoplasma suis
were differentials considered for jaundiced pigs. The PCR
detects pathogenic leptospires but does not identify the
infecting serovar for which serology is vital. This was
undertaken on four recent cases and mainly implicated
infection with Leptospira Icterohaemorrhagiae and L.
Bratislava. Outbreaks mostly occurred in late autumn probably
associated with increased contact with wild rodents as
temperatures fall and food sources become scarcer; significant
rodent populations featured on affected farms. As leptospire
infections are zoonotic, advice was given to limit the risk of
human infection, especially to avoid contamination of
people’s mouths, noses, eyes or open wounds by pig urine,
afterbirth, aborted and stillborn piglets. Effective rodent
control is also important as urine from infected rodents
represents a transmission risk to humans as well as pigs.
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IMPORTANCE OF MICROBIAL CULTURE TO
IDENTIFY (NOVEL) HIGHLY BETA-HEMOLYTIC
BRACHYSPIRA SPECIES
Brachyspira hyodysenteriae is considered the primary etiological
agent of swine dysentery, causing severe mucohemorrhagic
diarrhoea. Up till now, the presence of strong beta-hemolysis
and positive ring-phenomenon differentiates the highly
pathogenic B. hyodysenteriae from weak hemolytic – less
pathogenic – species (B. innocens, B. murdochii and B.
intermedia). However, recent data suggest that also other
strongly beta-hemolytic Brachyspira species, identified as B.
intermedia, can induce a dysentery-like disease in pigs (1). In a
routine monitoring protocol, two gilts were presented for
necropsy. Soft, watery colonic content was found. Microbial
culture of fecal content revealed strongly beta-hemolytic, ring
phenomenon-positive spirochetes, indicative for B.
hyodysenteriae. In additional samples taken at the farm, strongly
beta-hemolytic Brachyspira isolates, with ring phenomenon were
again found on microbial culture, whereas PCR analysis
(ADIAVET BRACHY) did not confirm the presence of B.
hyodysenteriae. In order to elucidate this discrepancy, additional
PCRs were performed targeting the 16S rRNA, 23S rRNA, nox,
hlyA and tlyA genes of different swine-related Brachyspira spp
(2,4). PCRs targeting nox and 23s rRNA specific for B. intermedia
were positive. However, all isolates were also positive for tlyA
and hlyA gene, hemolysins considered being virulence factors of
B. hyodysenteriae. The hlyA gene was properly located between
fabG en fabF genes encoding an ACP-reductase and –
synthetase(4). A sequencing protocol, targeting a highly variable
region of the Brachyspira nox gene(3), was performed, identifying
the isolates as B. intermedia. Additionally, the obtained sequence
showed high (>99%) similarity with sequences of previously
published strongly hemolytic B. intermedia isolates(1). This case
report highlights the fact that strongly hemolytic isolates,
belonging to “less pathogenic” Brachyspira species can be
isolated from field cases in Europe. While the presence of strong
beta-hemolysis and ring phenomenon might indicate the
pathogenicity (1), intense genotypic testing is required to
correctly identify these isolates to the species level.
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CONTROL OF GLÄSSER’S DISEASE WHEN
INTRODUCED INTO A NAÏVE SPF HERD
In July 2012, apathy and locomotor disorders were recorded in
a pregnant gilt in an integrated SPF herd with 160 sows. Two
weeks later, similar signs were recorded in a recently inseminated
group of sows/gilts. Blood analysis indicated acute infections.
Two sows/gilts died, and necropsy of one revealed an acute
purulent encephalomeningitis, a fibrous pleuritis and pericarditis.
Affected sows responded to Trim-sulpha and NSAIDs.
One week later, the first demonstration of Hemophilus
parasuis in the herd was made in a dead piglet. At this stage,
no clinical signs of disease were recorded in the four fattening
units located only two corridors away, and the hygiene barriers
within the herd were trimmed. Further, all sows were
vaccinated against Glässer’s disease, as well as all piglets
before transfer to the fattening units.
No further signs of disease were recorded and vaccinations of
growers were terminated two months later. However, signs of
Glässer’s disease were recorded in the first unvaccinated group
in the fattening unit, followed by disease in the oldest group
that not had been vaccinated. About 5% of the unvaccinated
pigs developed disease and 1-2% died. All unaffected market
weight pigs were sent for slaughter. All younger pigs were
vaccinated and all pigs with disease were treated with Trim-
sulpha and NSAIDs. The vaccinated groups remained
unaffected and no more signs of disease have been recorded
since. The low number of diseased animals and the slow
spread of disease contradict other reports on severe
consequences when naïve herds are exposed to Hemophilus
parasuis. Subtyping of Hemophilus parasuis is therefore
ongoing. However, since the microbe obviously was
pathogenic, the high standard of the biosecurity might have
contributed to the low morbidity. The onset of disease among
sows/piglets was also unexpected and curious, and the way
of introduction remains obscure.
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DESCRIPTION OF A STREPTOCOCCUS SUIS
SEROTYPE 7 INFECTION IN AN AUSTRIAN
PIGLET PRODUCING FARM
A Streptococcus suis (S. suis) serotype 7 infection in an Austrian
piglet producing farm with 1000 sows is described. Two weeks
after weaning piglets at five to eight weeks of age developed
symptoms of meningitis (2%) and arthritis (2,5%). Mortality
rate was approximately 2% in spite of antibiotic treatment.
Cleaning and disinfection protocols were at high standard and
a clear separation between all age groups was guaranteed.
Routinely, newborn piglets were treated parenterally with
ceftiofur on the 3rd day of live and with amoxicilline for ten
days in medicated food after weaning. When symptoms
occurred, amoxicilline treatment was continued later. Brain and
joint samples of euthanised piglets (n=18) with symptoms of
meningitis and/or arthritis were examined bacteriologically.
Twenty-five S.suis isolates (medium to high-grade bacterial
growth) were recovered, 15 of them were serotyped by
coagglutination technique resulting in serotype 7 in all
samples. All isolates were tested by multiplex-PCR using primer
pairs specific for virulence-associated genes mrp
(muraminidase-released protein), ef (extracellular factor), ofs
(serum opacity factor) and sly (suilysin). All isolates were
positive for mrp, but negative for epf, ofs and sly. No other
pathogens typical for causing meningitis or arthritis could be
isolated from clinical samples. Additional symptoms typical for
S. suis infection as endocarditis, wasting, pneumonia or
polyserositis were not seen on the farm. Four serotype 7
isolates were chosen for farm-specific vaccine production,
which was applicated to suckling piglets in the first and third
week of life, but without a protective effect. This case shows
that not only S. suis serotype 2 (most common serotype in
Austria), but also serotype 7 can cause clinical disease in
Austrian pig farms. A vaccination program must be adjusted to
specific farm conditions taking a potential interference with
maternal antibodies and the time-point of outbreak of clinical
disease into account.
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KLEBSIELLA PNEUMONIAE SUBSP. PNEUMONIAE
SEQUENCE TYPE 25: RE-EMERGENCE AS A CAUSE OF
SEPTICAEMIA IN PIGLETS IN 2012
Septicaemias due to Klebsiella species in pigs occurred
sporadically until outbreaks of Klebsiella pneumoniae subsp.
pneumoniae (Kpp) septicaemia were diagnosed in England on
six pig units between July and September in 2011. No further
cases were diagnosed until three farms were affected in July
and August 2012. The case definition was of pigs found dead
with lesions consistent with septicaemia and pure/predominant
growths of Kpp isolated from internal sites in multiple pigs.
Possible predisposing factors were investigated and included
characterisation of the bacterial isolates. Epidemiological data
collected from affected units has not, so far, explained the
emergence of this pathogen. However there is a clear seasonal
pattern of disease and all nine outbreaks were diagnosed on
outdoor breeding units in Eastern England with disease
occurring only in pre-weaned pigs from two weeks old. Isolates
from the nine outbreaks were compared with historic isolates
from pigs. Multilocus sequence typing (MLST) was performed
following methods described at the Klebsiella pneumoniae
MLST Database (http://pubmlst.org/kpneumoniae/). MLST
revealed that all case isolates were in sequence type 25 (ST25
Kpp), while historic isolates were a variety of clades, none being
ST25. Analysis of virulence gene content of case isolates showed
that all possessed identical profiles, with all having the rmpA
gene, which again differed from those of the historical isolates.
The plasmid profile of the outbreak isolates also differed with
ST25 Kpp having a 4.5kb plasmid which was absent in the
historic isolates. Investigation of porcine upper respiratory tract
carriage of Kpp in diagnostic carcase submissions and further
analysis of the 4.5kb plasmid are being undertaken to progress
understanding of the emergence of this pathogen.
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SUCCESSFUL PRRSV ELIMINATION IN
A GILT REARING FARM
In late December 2011 PRRSV antibodies were detected in
blood samples in a so far PRRSV-negative gilt rearing farm in
the north of Germany. The farm has about 3000 places in six
separate buildings on three sites and is supplied with four
weeks-old piglets from a PRRS negative multiplier located in
a distance of 100 km. PRRSV-infection with type 2 (US) virus
with 99% homology with VR2332 was confirmed by
additional blood samples in three buildings on all of the three
sites, whereas samples of the multiplier gave no evidence of
PRRSV-infection. No clinical signs were observed and virus was
probably introduced via trucks used for the delivery of gilts or
via aerosols from a neighbouring fattening farm. It was
decided to attempt a PRRSV-elimination with the live vaccine
Ingelvac® PRRS MLV without perpetuation of vaccine virus. In
PRRSV-positive buildings all pigs were vaccinated twice with
2ml Ingelvac® PRRS MLV (February and March 2012). In each
of the six buildings 10-17 blood samples were tested in a
monthly interval from February to September 2012 for
antibodies and PRRSV-genome. Due to the number of
separate buildings, PRRSV-positive/vaccinated and PRRSV-
negative animals could be reared and managed separately by
different personnel. Vaccinated animals were successively sold
out and emptied buildings where cleaned, disinfected and
restocked with PRRSV negative pigs. Since February 2012 no
PRRS positive blood samples have been detected in non-
vaccinated animals. Because of different virus vectors the
hygiene measures have been tightened at the most extreme.
The transport of the negative piglets and vaccinated gilts was
carried out with different vehicles and transportation routes
did not overlap. Since blood tests until October were negative,
it can be concluded that the PRRS virus has been successfully
eliminated by vaccination and consistent management
measures have prevented the spread and persistence of
vaccine virus.
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THE EFFECT OF ALL-IN ALL-OUT
MANAGEMENT BY SITE ON INFECTION WITH
MYCOPLASMA HYOPNEUMONIAE AND
ACTINOBACILLUS PLEUROPNEUMONIAE IN FINISHERS
In all-in all-out (AIAO) production systems, it is possible to
produce batches of finishers that do not show signs of infection
with the respiratory diseases that exist in the sow herd of
origin. However, the success rate is often low. In finishing units
managed AIAO by room, one of the possible sources of
infection is pigs in other rooms. AIAO management by site
eliminates this source of infection. The objective of this study
was to compare the occurrence of infection with M.
hyopneumoniae (Mh) and A. pleuropneumoniae (App) in
finishing units managed AIAO by site and finishing units
managed AIAO by room. Two production systems were
included in the study. Each system consisted of one sow unit
(comprising, respectively, 1300 and 2100 sows, infected with
Mh and App), one weaner unit, and several finishing sites. Each
of the two systems included a finishing site managed AIAO by
room (4-6 batches on the site at a time) and a finishing site
managed AIAO by site. From each of these four finishing sites,
6-7 batches of pigs were included in the study. At slaughter,
pigs from each batch were bled, and lungs were examined
macroscopically. Each batch was defined as infected or non-
infected with Mh and App on the basis of serological analysis
and pathology. On the two sites managed AIAO by room, 11
batches out of 13 were infected with Mh. On the two finishing
sites managed AIAO by site, 2 batches out of 13 were infected
with Mh (P=0.002). All batches except one were infected with
App. On finishing sites managed AIAO by site, significantly
fewer batches were infected with Mh than on sites managed
AIAO by room. Thus, it seems that transmission between
rooms can be a significant source of infection with Mh. No
difference was found for App.
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PIGS WITH UNDOCKED TAILS IN A CONVENTIONAL
NURSERY AND FATTENING UNIT – A REPORT
Despite of European Directives which specify that tail docking
in pigs should not be practised routinely, more than 98 %of the
piglets in the EU are weaned with docked tails for the purpose
to prevent tail biting. In order to reduce the prevalence of tail
docking in Lower Saxony a series of investigations has begun. In
this trial weaned piglets of 12 litters were divided in four groups:
Females and castrated males, one half with docked tails and the
other half with entire tails, were introduced in the nursery. Six
weeks later 108 of these were brought into the fattening unit,
where 50 % of the pens provided additional floor space (1,0 m²
per pig). All animals were checked twice a week. The prevalence
of tail and ear biting, the necessity of applying control measures
as treatment, separation of animals and providing toys were
recorded. Temperature, humidity, as well as air and feed quality
were controlled permanently. Weight gain, length of tails and
carcass examinations were recorded for each pig. Despite of a
generally high health standard and only three animal losses the
percentage of injured pigs reached up to 30 % in the undocked
groups in the nursery unit whereas only very single cases of tail
biting occurred in the other pigs. Providing additional floor space
had no effect. Treatment of injured animals and in severe cases
separation limited the problem as well as providing additional
toys. Regular control of air quality and a feeder/animal ration of
1:1 seemed to be useful. In general measures like the Husbandry
Advisory Tool (HAT, Taylor et al., 2012) should be applied on a
farm before leaving pig tails undocked.
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MOLECULAR EPIDEMIOLOGY OF PORCINE
REPRODUCTIVE AND RESPIRATORY SYNDROME
INFECTIONS IN ENGLAND
Porcine reproductive and respiratory syndrome (PRRS) is a
contagious viral disease endemic in Great Britain. PRRS is
diagnosed in submissions mainly by the use of PCR and this
provides material for further characterisation of the viruses
causing disease in GB. Sequencing of a region of the viral RNA
genome provides an opportunity to examine the potential
relatedness of viruses from different origins through
phylogenetic analysis. In this study, the genetic sequence
encoding the GP5 protein of genotype 1 (European) PRRS
viruses from a number of selected cases in England was
determined, and these were compared to probe potential links
between viruses. The links detected sometimes supported
likely epidemiological connections which had been identified.
These included geographic proximity, shared staff, and
common piglet supply sources. Additionally, the sequence data
analysis identified instances of multiple infection by different
PRRS virus strains on a given farm, and over time, on units
where infection persisted long-term, progressive evolution of
the virus was detected. The percentage of diagnostic
submissions in which PRRS was diagnosed from January to
March 2012 increased compared to the same quarter in 2011
and the last quarter of 2011 (11.4% compared to 7.7% and
8.6% respectively) and provided an impetus to provision of
sequencing as a commercially available test. PRRS virus
sequence analysis has been a useful tool in identifying possible
sources of infection for PRRS virus, determining if outbreaks
are linked, differentiating field virus from vaccine virus, and
demonstrating the innate ability of PRRS virus to become
more diverse with time. This latter property presents
challenges to both diagnostics and control of PRRS virus.
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RISK ASSESSMENT OF THE INTRODUCTION OF
PORCINE REPRODUCTIVE AND RESPIRATORY
SYNDROME INTO SWITZERLAND VIA BOAR SEMEN
Semen imports from PRRSV infected European countries to
Switzerland, which had always been PRRSV free, have
increased during the last couple of years. Since the virus can
be transmitted via semen and the risk of PRRSV introduction
was unknown, a risk assessment was conducted to estimate
the annual probability of importing PRRSV positive semen
into Switzerland. A quantitative stochastic model was set up
with data comprised by import figures of 2010, interviews
with importers or corresponding boar studs and expert
opinions. It resulted in an annual median number of 0.18
imported ejaculates (= imported semen doses from one
collection from one donor) from PRRSV infected boars or the
import of one positive ejaculate every 6 years. A median
number of 10 sows or one herd would be infected by one
positive ejaculate respectively. These results suggested that
under the circumstances in 2010 there was a substantial risk
of PRRSV introduction into Switzerland via imported boar
semen and that measures to enhance safety of imports should
be taken. The time from infection of a previously negative boar
stud to its detection had the highest impact on the number of
imported “positive” ejaculates. Therefore, emphasis should be
placed on PRRSV monitoring protocols in studs. Results
indicated that a substantial increase in safety could only be
achieved with much more intensive sampling protocols than
currently performed. These outcomes were supported by a
PRRSV outbreak in Switzerland that occurred in November
2012 after an infection of an exporting boar stud followed by
the import of PRRSV positive semen.
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EVIDENCE OF RECURRENT INFLUENZA INFECTIONS
IN PIG FARMS AND ASSOCIATED EPIDEMIOLOGICAL
CHARACTERISTICS
Repeated infections by different Influenza A virus subtypes
within pig farms increase the risk of emergence of new virus
reassortant. The objectives of this study were to characterise
the epidemiology of recurrent swine influenza virus (SIV)
infections for a better understanding and identification of
main determinants. A longitudinal study was carried out in 3
selected farms. Three batches were followed within each farm
from piglet birth to slaughter through a representative sample
of 40 piglets per batch. Piglets were monitored individually
on a monthly basis for serology and daily for clinical and
virological investigations when a flu outbreak occurred, during
the whole clinical outbreak.
Influenza outbreaks, confirmed by Influenza A virus detection,
were observed at least once in each batch followed. These
outbreaks occurred at constant age within farms, most often in
nursery and were correlated with an increase in the frequency
of sneezing and coughing fits. Avian-like swine H1N1 and
human-like reassortant swine H1N2 viruses from European
enzootic lineages, as well as reassortant viruses generated from
these parental enzootic viruses, were identified consecutively
and sometimes simultaneously according to studied batches.
These concomitant detections suggested co-circulation of
different viruses at the farm, batch and sometimes individual
levels. A great variability was observed between farms in terms
of dynamics of infection (Ro estimation), and humoral immune
response. Propagation of the epidemics was slowed down in the
presence of maternal derived antibodies but persisted a longer
time at the population level. Failings in increasing
hemagglutination inhibition titers in sera following SIV infection
were also observed in piglets infected before 50 days of age in
the presence of maternal derived antibodies. All these results
suggest that enzootic persistence of SIVs within pig farms is
strongly influenced by rearing conditions, age at infection, and
level of passive immunity transmitted by the dam.
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EFFICIENT PROTECTION OF A SWINE PANDEMIC H1N1
INFLUENZA VIRUS VACCINE AGAINST THE NEWLY
EMERGED H1N2 PANDEMIC VIRUS REASSORTANT
Since 2009 the pandemic H1N1 virus (panH1N1) was
transmitted frequently to pig herds in all over Europe. In most
cases farmers were the source of infection. The virus spread
between pig herds but infection cycles were limited. In central
Europe the virus got a new quality by acquiring the gene
coding for neuraminidase 2 of the porcine H3N2 viruses. The
first strain of this novel reassortant was isolated in autumn
2010 in Germany. Since 2011 this virus was isolated at regular
level indicating that a new line of swine influenza viruses has
been established which is capable to spread very efficiently
between pigs herds.
Commercially available trivalent vaccines based on porcine
viruses H1N1, H1N2, and H3N2 do not cross-react sufficiently
with the hemagglutinin of panH1N1. Therefore a monovalent
vaccine containing panH1N1 is in development which can be
integrated in the vaccination schemes of the trivalent
vaccines.
In order to investigate the efficacy of the monovalent panH1N1
vaccine a challenge trial was performed. Thirteen pigs were
vaccinated with an inactivated panH1N1 vaccine, 13 pigs were
vaccinated with a pandemic H1N2 virus (panH1N2) vaccine,
and another 13 pigs remained unvaccinated. Seven days after
second administration of the vaccines pigs were infected via
aerosol with strain A/sw/Papenburg/IDT12653/2010
(panH1N2). The unvaccinated pigs underwent a long period of
severe dyspnea from day 1 after infection (pi) on reflecting the
high virulence of this virus. One pig of this group died 5 days pi
having 100% lung lesions. All other unvaccinated pigs had lungs
with macroscopic lung lesions of about 70%. Vaccinated pigs
of both groups had highly significant lower lung lesions and
lower viral lung load in comparison to unvaccinated pigs and
showed less symptoms.
A new line of virulent influenza A viruses has been emerged in
Europe. PanH1N1 vaccines are means of prevention.
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INVESTIGATION OF ANOMALOUS H1N2 SEROLOGY
RESULTS ON SWINE INFLUENZA-INFECTED PIG FARMS
The haemagglutination inhibition test (HAIT) is the primary
serological test for detection of antibodies to swine influenza
virus (SIV) and has the advantage of being strain-specific. Low-
level serological cross reactions between SIV strains occur and
it is important to use a panel of representative SIV strains for
serology from the country in which the pigs tested reside.
Government-funded SIV surveillance is performed in GB by the
Animal Health and Veterinary Laboratories Agency and the four
strains detected circulating in GB in the last 20 years are
included in the panel; avian-like H1N1, H1N2, pandemic H1N1
2009 and H3N2, although H3N2 virus has not been detected
in GB since 1997. Knowledge of the SIV strains circulating is
important for pig producers as well as those involved in pig
disease and SIV surveillance; it allows appropriate use of SIV
vaccine and can assist in epidemiological investigations. Novel
strains are only identified through surveillance detecting virus
however, serology is still used as a monitoring and diagnostic
tool by veterinary practitioners. Since 2005, sera from recovered
pigs on occasional farms with confirmed H1N2 infection failed
to demonstrate convincing HAIT seropositivity to the H1N2
used in the serological panel. In 2012, this anomaly was noted
more frequently. Investigations were initiated including use of
a selected recent H1N2 isolate for comparative HAIT on units
with anomalous results, wider testing of sera submitted for
monitoring and diagnostic purposes and genetic analysis of
recent H1N2 virus isolates. These investigations will be
described, their aim being to determine the reason for the
anomalous results and the nature of any genetic changes found
in recent GB H1N2 viruses. The implications for the diagnosis of
swine influenza and the importance of maintaining surveillance
to know what strains are active and enable appropriate changes
to the serological panel will be emphasised.
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ACTINOBACILLUS PLEUROPNEUMONIAE
COLONISATION BEFORE WEANING IN OFFSPRING
FROM SOWS ON TWO ENDEMICALLY INFECTED FARMS
We hypothesise that colonisation with Actinobacillus
pleuropneumoniae (App) in young piglets is a risk factor for
developing pleuropneumonia as finishers. An improved
understanding of the epidemiology of App on farms could help
to design control measures that prevent colonisation in
piglets. The objective of this study was to determine
colonisation of suckling piglets with App before weaning on
endemic infected pig farms and its association with sow
characteristics such as parity and antibody levels. A cohort
study was performed on two farrow-to-finish herds in two
cohorts per farm. Farmers had to comply with a strict hygiene
and animal management protocol (e.g. limited cross fostering)
to obtain independent litter observations. Serum and tonsil
brush samples from 76 sows were obtained three weeks
before parturition, and tonsil samples from 871 offspring were
obtained three days before weaning. The samples were
obtained in compliance with the Dutch Act on the Practice of
Veterinary Medicine. Serum samples were analysed by
serology (apxI, apxII, apxIII ELISA) and tonsil samples by
apxIVA qPCR (Tobias, 2012). Colonisation at litter and
individual piglet level was assessed and associations with
sow’s parity and serum and brush sample results were
evaluated using logistic regression models. Whereas all sows
tested positive in qPCR and three apx antibody assays, in 41%
of the litters none of the piglets tested positive for App. Litters
status was not associated with the explanatory variables. In
positive tested litters however, the probability for piglets to
test positive was positively associated with piglets’ age at
sampling and negatively with sow parity (OR=0.59). There
were strong indications for a negative association with apxII
titer (OR=0.73) and amount of App DNA from the sow. It is
concluded that App colonisation in suckling piglets is clustered
within litters and that colonisation is negatively associated
with maternal immunity.
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EFFICACY OF VACCINATION AGAINST
ACTINOBACILLUS PLEUROPNEUMONIAE ON PLEURITIS
LESIONS IN SLAUGHTER PIGS AND THEIR TECHNICAL
AND ECONOMIC PERFORMANCE IN BELGIUM
The efficacy of vaccination against A. pleuropneumoniae on
pleuritis lesions, lung lesions, mortality, days of additional
treatment (DAT) and weight gain (WG) was investigated in
two farrow-to-finish pig herds (A and B) affected by chronic
pleuritis. In total, 1161 pigs were included. The pigs were
randomly allocated to one the following groups at four weeks
of age: A-Non Vaccinated (A-NV; n=280), A-Vaccinated (A-V;
n=281), B-NV (n=300) and B-V (n=300). At six and ten weeks
of age, pigs of the vaccinated groups were injected with
Porcilis-APP®, whereas unvaccinated controls pigs were
injected with Diluvac Forte®. At slaughter (26 weeks), pleuritis
and pneumonia lesions were assessed. Mortality and DAT were
registered from 6 to 26 weeks. All pigs were weighted
individually at 6 and 26 weeks and WG and average daily gain
(ADG; g/pig/day) calculated. Data were analysed using binary
logistic regression or ANOVA for proportions or continuous
variables, respectively. The prevalence of pleuritis and
pneumonia was [A-NV=19.2, A-V=7.9, B-NV=17.9, B-V=0.7,
(P=0.000)] and [A-NV=42.4, A-V=21.2, B-NV=46.7, B-
V=19.0, (P=0.000)], respectively. The average SPES was
A-NV=3.22, A-V=3.21, B-NV=2.50, B-V=2.00. The mortality
during the experiment was: A-NV=5.7, A-V=1.8, B-NV=2.3,
B-V=1.0, (P=0.007). The DAT (average±sd) was: A-
NV=3.78±2.13, A-V=3.75±2.17, B-NV=4.39±2.42,
B-V=3.40±2.94, (P=0.000). The ADG was A-NV=632±157, A-
V=647±91, B-NV=660±115, B-V=670±81, (P=0.066). The
present field study in two herds affected with pleuritis showed
a significant improvement of the prevalence of pleuritis and
pneumonia and a numerical improvement of performance for
both vaccinated groups in both herds.
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CASE REPORT: PERACUTE OUTBREAK OF HAEMOPHILUS
PARASUIS INFECTION IN SUCKLING PIGLETS IN A
SELF-RECRUITING, SPECIFIC PATHOGEN FREE HERD
In an outbreak of Haemophilus parasuis in a specific pathogen
free herd there was a 19 % (n=172) mortality in two to three
week old piglets from 82 litters during 2 ½ days. Subsequent
outbreaks made mortality reach 30 %.
Diseased piglets were clinically evaluated and dead piglets were
autopsied on-farm. Whole piglets and tissue samples, fresh,
frozen and formaldehyde fixated, were collected and submitted
to the Norwegian Veterinary Institute for pathologic evaluation.
Half of the piglets (400) were injected with procain-penicillium
to prevent further mortality while awaiting definitive diagnosis.
Interviews regarding management routines, biosecurity and
environmental factors were performed. Blood samples from
ten piglets were analysed for hemoglobin concentration.
The piglets died without any prior signs of disease. The autopsy
findings were consistent with septicemia and anaemia.
Haemophilus parasuis was detected by bacteriological
examination from most tissue samples. The piglets injected
with procain-penicillium stopped dying whereas 50 piglets died
during the forthcoming night in the untreated group.
Immunohistochemistry performed were negative for Porcine
Circovirus type 2 and Influenza A virus. Hemoglobin
concentration in the blood samples were on average 66.5 g/L.
Iron paste given to the piglets within the first 24 hours after
farrowing was the only iron supplementation. There were no
cleaning and disinfection between batches in the farrowing
room and the ventilation was operated manually. The herd was
self-recruiting with no evident breach in the biosecurity. Four
sows had fever (>40oC), were lame and ataxic.
It was concluded that Haemophilus parasuis caused the 30 %
mortality in the piglets. Anaemia is known to impair immunity.
Poor iron supplementation routines, a manually operated
ventilation system and poor hygiene likely contributed to the
outbreak. The causes of the apparent lack of protecting
maternal antibodies is unknown. Only eight of the 82 sows
were first parity sows.
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SLAUGHTERHOUSE EXAMINATION OF CULLED SOWS
IN COMMERCIAL PIG HERDS
This study investigated reasons for culling of sows from
commercial pig herds and post-mortem lesions of the
reproductive tract of these sows. Reproductive organs of 502
females from seven herds were examined. Macroscopic
examination focused on uterus (cervix, corpus and corni),
ovaries (including bursa ovarica) and oviducts. The phase of the
reproduction cycle was determined according to the presence
of follicles or corpora lutea/albicantia on the ovaries. In 20% of
the uteri bacteriological and histopathological examination was
carried out to determine the presence of bacteria respectively
inflammation. The mean parity of the culled sows was five
(min: 0, max: 13). Sows with parity 6 and 7 were most
frequently culled. Insufficient performance was the most
common reason for culling (53%), with no pregnancy (18%),
poor nursing performance (14%) and no heat (10%) as most
frequent causes. Macroscopic examination of the uteri revealed
no abnormalities (77%), purulent endometritis (18%) and
pregnancy (5%). Ovaries were normal in 54% of the animals,
28% showed inactivity and 18% (para-) ovarian cysts. (Para-)
oviductal cysts were found in 10% of the animals. Sixty-two
percent of the uteri were bacteriologically positive, with E. coli
(18%) and Enterococci (12%) most frequently isolated. Sixty
percent of the uteri showed a mild to severe inflammation,
mainly in a chronic state (41%). Macroscopical endometritis
was associated with bacteriological endometritis (OR=2.4,
p<0.001) and histopathological endometritis (OR=0.66,
p<0.001). No association was found between bacteriological
and histopathological endometritis (OR=2.1, p>0.05). For all
parameters, significant differences between herds were present.
In conclusion, macroscopic examination of culled sows is a
helpful tool to optimise the culling policy of sows in pig herds.
As many reproductive organs showed no macroscopical
abnormalities, histopathological examination seems to be a
more reliable method to diagnose endometritis in sows.
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ACTION-RELATED REPETITIVE MYOCLONUS
(CONGENITAL TREMOR) IN PIGLETS – A CASE REPORT
Introduction – Sporadically the occurrence of piglets with
congenital tremor is reported. Congenital tremors are divided
into type A (5 varieties of the disorder with known cause) and
type B (of unknown origin). Features like percentage of litters
affected and duration of outbreak differ, but the common
lesion consists of a hypomyelination or demyelination.
Description of the case – In a closed herd with 440 Belgian
Negative (BN) Landrace sows, recurrently litters with
congenital tremor were born over the last 5 years. Between
March and October 2012, 51 out of 797 litters were affected
(6.4%). Piglets with congenital tremor had normal birth
weights and showed no symptoms of concurrent disease.
Mean parity of sows with affected litters (2.92 ± 0,25) was
significantly lower than parity of sows with non-affected
litters (4,27 ± 0,10)(P<0.01). From the 51 affected litters, 49
were crossbred (BN x Piétrain), 1 was purebred (BN x BN) and
1 of unknown breed, resulting in an odds ratio of 10.23 [1.40-
74.75] for occurrence of the disorder in crossbred litters. There
was no recurrence of the problem within the same sow during
successive litters (252 sows with ≥2 litters). Preterm farrowing
(D100-D113) was not associated with the disorder (P=0.30).
Electromyography of two 3-day-old piglets with typical
symptoms revealed spontaneous electrical activity in muscles
of the thoracic limb in both piglets, and in muscles of the
pelvic limb in one piglet. Necropsy did not reveal gross lesions.
Histological examination of tissues samples is ongoing.
Samples of brain and brainstem were negative for PCV1 and
PCV2 by virus isolation and PCR test.
Conclusion – Several potential causes of congenital tremor
type A could be excluded. Pedigree analysis may allow
distinguishing between the possible hereditary disposition and
congenital tremor type B. Final conclusions will be presented
at the conference.
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MUTANT PREVENTION CONCENTRATION: A TOOL TO
SUPPORT THE RESPONSIBLE USE OF ANTIMICROBIALS
IN SWINE PRODUCTION
Antibacterial treatment in swine production is facing
challenges due to new disease complexes, antibiotic resistance
development and increasing regulatory restrictions. Even
though biologicals and other preventative measures are
applied, antibacterials are still a need. Responsible use is a must
to prolong the efficacy of the existing antibacterials. A tool to
support the successful treatment and delay the resistance
development is the detection of the ratio between the Mutant
Prevention Concentration (MPC) and the Minimal Inhibitory
Concentration (MIC) and pharmacokinetic parameters in dose
dependant antibiotics. This system has been used in human
medicine and is currently applied in some countries in animal
health. Fluroquinolones have been under strict scrutiny, but as
they are dose dependant, MPC and MIC ratio detection can be
helpful for selecting an appropriate treatment in the swine
veterinary practice. Results of Enrofloxacin resistance
monitoring during the last 18 years show the benefit of a high
ratio between MPC and MIC and pharmacological parameters.
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WORLDWIDE OCCURRENCE OF FUMONISINS AND
THEIR EFFECTIVE COUNTERACTION IN VIVO
Fumonisins are a concern in pig nutrition due to the almost
ubiquitous occurrence of the fumonisin producing pathogen
Fusarium verticillioides in regions of warm climate. Fumonisin
toxicosis in swine has been related to porcine pulmonary
edema (PPE) since the reported outbreak of swine deaths in
1981. This work focuses on results obtained between 2004
and 2011 in which more than 9,000 samples were collected
worldwide and analysed for fumonisins (FUM), a sum of
fumonisin B1 and fumonisin B2. Analyses were performed
either by high performance liquid chromatography or enzyme-
linked immunosorbent assay. For the purpose of data analysis,
non-detection levels were based on the quantification limits
of the test method. Out of all tested samples, 62% of the
samples coming from Southern Europe and 56% of the
samples coming from Central Europe were contaminated with
FUM. An even higher prevalence of fumonisins was found in
South America (80%) and Africa (76%). Contrary to regions
which have a typical tropical or subtropical climate, only 27%
of samples coming from Eastern Europe tested positive for
FUM. About 75% of corn samples were contaminated and the
average contamination was 2 299µg/kg while the maximum
concentration found in corn was 53 700µg/kg. All other
commodities such as soybean, wheat and wheat bran, dried
distillers grains with solubles and finished feeds were
contaminated with FUM. So far, no single adsorbent has
been tested effective against most types of mycotoxins,
including fumonisins and an alternative way of
detoxification of non-adsorbable mycotoxins is via enzymatic
detoxification (biotransformation). FUMzyme® is an enzyme
– carboxylesterase that hydrolyses the two tricaballylic acid
side chains of fumonisins, changing them into hydrolysed
fumonisins. Finally, the biotransformation of fumonisins into
non-toxic metabolites might be a promising strategy in the
counteraction of these undesirable substances in animal feed.
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DIFFERENT PCV2 VACCINE PROTOCOLS REDUCE PCV2
VIREMIA BY THE SAME MAGNITUDE
Some farms routinely vaccinating pigs for PCV2 over the past
5 years have recently reported a lack of PCV2 detection using
common sampling schemes (30hd/farm) and qPCR tests (cut-
off=104). The objectives of the two studies described here
were to evaluate viremia and the reduction of viremia in
vaccinated pigs compared to non-vaccinated pigs, and to
compare the impact of different vaccination schedules on
viremia, utilising a new, sensitive PCV2 qPCR test (detection
limit <102). Both trial A and B included non-vaccinated
controls (NVx). In addition, trial A included pigs vaccinated
either with a single dose of Ingelvac CircoFLEX®-MycoFLEX®
(FLEXcombo) or 2 doses of another PCV2-M hyo combination
product (PCVM). Trial B included pigs vaccinated with either a
single dose of Ingelvac CircoFLEX® (CF) or a single dose of an
inactivated chimeric PCV1/PCV2 vaccine (chimera). In trial A,
pigs were serially sampled at 3,10,13,16,19 and 22 weeks of
age; in trial B at 3,7,10,14,19 and 23 weeks of age. Serum was
evaluated by qPCR for PCV2 levels. Average log level of viremia
was calculated at each time point. In trial A, viremia was
significantly reduced in Vx compared to NVx on weeks 10, 13,
19, and 22 (P=0.01, P=0.02, P<0.0001, P<0.0001,
respectively) and in trial B on week 23 (P<0.0001). In trial A,
percent PCV2 positive samples peaked at 19 weeks and was
75% (NVx), 41% (FLEXcombo) and 39% (PCVM). In trial B,
peak percent PCV2 positive occurred at 23 weeks, and was
71% (NVx), 19% (CF) and 20% (chimera). Viremia between
the vaccinated groups was not different (P>0.10) at any time
points measured in either trial. These studies indicate
commercial PCV2 vaccines significantly reduce viremia
compared to NVx and reduce viremia by the same magnitude.
These viremia studies also confirm that vaccines do not
completely eliminate viremia.
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AN OPTIMISED SWINE MANAGEMENT APPROACH
AND ITS VALUE TO THE INDUSTRY
Full Value Pigs (FVP) is a profitability-focused business model
that takes a population of pigs and constraints of facility and
market to determine the optimum performance for a swine
operation. A Full Value Pig is a pig that achieves at least 90% of
the Margin Over Feed Cost (MOFC) of the single optimum pig
as determined by feed intake, feed costs and payment grids.
While some producers are currently benchmarking their FVPs
compared to historical data, many are still using single point
production parameters that are solely cost-focused or
misleading. Although many areas of swine production influence
the number of FVPs, four key areas include Disease Management,
Feed Optimisation, Precision Harvest and Assurance & Access.
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HIPRA PRRS APPROACH UNDER FIELD CONDITIONS
Porcine reproductive and respiratory syndrome (PRRS) is one
of the most costly diseases affecting swine worldwide.
Mainly there are 2 solutions to face PRRS, eliminate vs control.
The elimination of PRRSV entails a high investment, a high
coordination among the different statements, and usually a
change of mentality. Therefore nowadays, the reality comes
to control PRRSV in European swine farms. There are many
tools to start the PRRS control in a swine farm: diagnostic,
management, biosecurity, vaccines one of the most important
tools controlling whatever disease is the vaccination. The main
challenge of PRRSV vaccination nowadays is the heterologous
protection. The strategy to manage the heterologous
protection in field conditions is mainly based on vaccination
and the knowledge to manage the PRRSV infection in farm.
Thus the key points to control PRRS are related with the
knowledge about how the wild virus is circulating on the farm,
and how high is the infection pressure. There are different
steps in order to evaluate the infection pressure on farm:
1. Evaluate the farm production system.
2. Evaluate the management of replacement gilts.
3. Evaluate the dynamic of PRRSV infection in pigs and sows.
There are two steps to start the herd vaccination. First step is
the breeder vaccination in order to improve the reproductive
parameters and to reduce and stop the birth of viraemic
piglets. Secondly, piglet vaccination is advisable in order to
improve the fattening pig performance.
Therefore nowadays, we have the right knowledge to control
PRRS, through serumprofiles which is a helpful tool to
understand the PRRS dynamic of infection, and through the
use of life vaccines which are the most effective tool to
stabilise faster the farm.
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EFFECT OF TILMOVET® AND KETOPROPIG® ON
POST-WEANING DIARRHOEA AND STREPTOCOCCUS
SUIS IN PIGLETS
A 300-sow farm was positive for PRRS and Mycoplasma
hyopneumoniae. Every 4 weeks 720 piglets were weaned.
Recurrent outbreaks of post-weaning diarrhoea (PWD) and
Streptococcus suis compromised animal welfare and
zootechnical results, such as mortality (4%) and end weight
(22.7kg at 10 weeks of age). On a regular basis between
January 2011 and December 2012 affected animals were
necropsied at Animal Health Center Flanders where
Escherichia coli and Streptococcus suis was diagnosed and the
isolated pathogens were tested on their susceptibility to
several antibiotics. The antibiogram indicated a colistin-
resistant Escherichia coli strain but sensitive to
aminoglycosides and a Streptococcus suis strain sensitive to
penicillin. Colistin was replaced by an aminoglycoside and
amoxycillin was retained from day 10 to day 20 after weaning.
No improvement was observed in the control of PWD and
Streptococcus suis. At the end of November 2012,
Mycoplasma hyopneumoniae was diagnosed on the farm. This
is why an alternative treatment was imposed. Tilmovet® at
16mg/kg in feed for 14 days after weaning and KetoProPig®
at 3mg/kg at day 5 and 11 after weaning were chosen as a
treatment. In addition to the control of Mycoplasma
hyopneumoniae, PWD and Streptococcus suis were also
controlled with this treatment scheme. As a result mortality
rate dropped from 4% to 1.5%, no further curative treatments
were needed and the end weight increased by 4.7%. An
explanation might be as already described by Jens Laurits
Larsen (1986) that macrolides interfere with the colonisation
phase of enteropathogenic E. coli. Also Streptococcus suis was
controlled, despite the low in-vitro susceptibility of the
isolated strains to macrolides. The explanation might be that
Streptococcus suis was a secondary disease causing pathogen
and the combination of Tilmovet® and KetoProPig® controlled
the primary provoking factor.
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DEVELOPMENT OF A SUBUNIT VACCINE CONTAINING
RECOMBINANT STX2E AGAINST OEDEMA DISEASE OF
PIGS AND ITS IMPACT IN THE FIELD
Edema Disease (ED) caused by Shigatoxin Stx2e producing
strains of E. coli occurs worldwide and is responsible for high
mortality during the nursery period and substantial economic
losses. Therefore, a new vaccine (ECOPORC SHIGA) was
developed containing a genetically modified Stx2e antigen. A
one shot injection into piglets from an age of 4 days on
induces a humoral immune response against Stx2e and
ensures protection from ED during the entire nursery period
after weaning.
For antigen production a recombinant E. coli strain was
constructed containing a plasmid coding for the genetically
modified Stx2e antigen being highly reduced in toxicity.
Administration into suckling piglets via intramuscular routes
induced production of Stx2e-neutralising antibodies in a dose-
dependent manner as determined by a Stx2e-specific serum
neutralisation assay. In challenge studies weaned piglets with
detectable amounts of these antibodies proved to be
protected against the impact of Stx2e.
Vaccine safety was assessed in laboratory as well as in field
trials showing no adverse reactions regarding local reactions at
injection site, body temperature or general condition after
vaccination.
Vaccine efficacy was demonstrated in laboratory and field
studies by significant reduction of morbidity and mortality of
vaccinated pigs compared to control animals and by detection
of neutralising antibodies after immunisation. Due to
vaccination mortality was lowered from 100 % to 6.7 %
among piglets experimentally challenged with Stx2e
(p<0.001) and from 11.4 % to 0 % (p<0.0001) in a field trial.
Better growth of vaccinated pigs was partially observed during
the nursery period. Furthermore, a significant reduction
considering the use of orally administered antibiotics against
ED was noticed in the course of longitudinal field studies.
The vaccine ECOPORC SHIGA is a safe and effective tool against
ED and has the potential to replace oral antibiotic treatment in
herds affected by outbreaks of this life-threatening disease.
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EFFICACY AND TOLERANCE OF PRACETAM IN THE
REDUCTION OF POST-OPERATIVE PAIN FOLLOWING
THE CASTRATION OF PIGLETS – A COMPARISON OF
TWO DOSAGES VERSUS A PLACEBO
The castration of piglets under 7 days old is still the most widely
accepted solution that slaughterhouses have found to control
the risk of “boar taint” in the finished product. It has been
demonstrated that this practice causes pain and acute stress.
Alleviation of this pain has become absolutely essential.
Paracetamol is an analgesic-antipyretic molecule, which could
reduce the level of post-castration pain in piglets. The present
study was designed to compare the effect of two doses of
paracetamol (Pracetam®20% solution) and a placebo, by
measuring hormonal and behavioural response. A total of 289
male piglets were included in this blinded, randomised,
controlled trial. The piglets were individually identified and
followed from the day before castration to weaning. For each
batch, a farrowing room was set up to monitor the hormonal
responses and another for behavioural observations, so that the
taking of blood samples would not have an effect on the
animals’ behaviour. In the first room, 4 groups were randomly
chosen: two receiving paracetamol before castration (one at a
dose of 30 mg/kg and the other at 60 mg/kg), a placebo group
“P” and a control group “C”, which was not subject to castration
but underwent a simulation, which would provide the basal
cortisol and ACTH levels. In the second room, only the first 3
groups were used. The effectiveness criteria used were the blood
levels of ACTH and cortisol 30 mins after castration, behavioural
responses (scored) and the average daily weight gain between
castration and weaning (ADG). The obtained data showed a
significant effect in terms of post-operative pain response
behaviour, which was significantly lower in the group treated
with paracetamol at a dose of 60 mg/kg compared to placebo
on the day of castration and on the day following the procedure.
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EFFICACY OF GRIPOVAC®3/RESPIPORC® FLU3
AGAINST CHALLENGE WITH A RECENT H1N2 SWINE
INFLUENZA VIRUS IN PIGS
Introduction
GRIPOVAC®3/RESPIPORC® FLU3 is a trivalent vaccine
containing each of the three swine influenza virus (SIV)
subtypes that are endemic in pigs in Western Europe. We have
examined the efficacy of this vaccine against intratracheal (IT)
challenge with a recent H1N2 SIV. Additionally, we compared
the IT challenge method with intranasal (IN) challenge, which
is closer to the natural route of infection.
Materials and methods
Twenty-four influenza-negative pigs were vaccinated twice,
24 pigs were left unvaccinated. Three weeks after the second
vaccination, a vaccinated and a challenge control group of 12
pigs each were challenged by IT or IN route with 7 log10
EID50 of A/sw/Gent/102/07 (H1N2). The pigs were monitored
for serum haemagglutination-inhibition antibody titres before
challenge and for clinical and virological protection post
challenge. Virus titres were determined in nasal swabs and
lung samples.
Results
After the second vaccination, all pigs had antibodies against all
three vaccine strains and the challenge virus. In most
unvaccinated controls IT challenge induced fever, tachypnea
and/or dyspnea, whereas IN inoculation produced a largely
subclinical infection. In both vaccinated groups, clinical signs
were observed in fewer animals and they were milder.
Both inoculation methods resulted in high virus titres in the
lungs of unvaccinated control pigs. Both vaccinated groups
had reduced mean virus titres in the lungs, but the reduction
was only significant at selected time points. Nasal virus
excretion was delayed after IT as compared to IN inoculation.
With both challenge methods, there was a reduction in nasal
swab virus titres in the vaccinated pigs, but it was not
significant after IN challenge.
Conclusion
GRIPOVAC®3/RESPIPORC® FLU3 induces a protective
response against challenge with a recent European H1N2
strain with 95,5% amino acid homology (HA1) with the
H1N2 vaccine strain. The IN challenge method could be used
as an alternative for the technically difficult IT method in SIV
vaccination-challenge studies.
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EFFICACY OF A NEW COMBINATION VACCINE
AGAINST E.COLI & CLOSTRIDIUM SPP. ON A DUTCH
FARM UNDERGOING A CLOSTRIDIUM PERFRINGENS
TYPE A INFECTION
A novel clostridial vaccine ought to be efficacious not only
against C. perfringens (C perf) type C but also against type A
strains. This study was carried out using a new coli-clostridium
combination vaccine (Porcilis ColiClos). The farm had a high
level of piglet mortality against which a traditional combination
vaccine was not proving effective. It was considered that by
using Porcilis Porcoli DF as a control, any additional efficacy of
the new vaccine against C. perf could be demonstrated.
In this blinded trial, sows were vaccinated with either Porcilis
ColiClos or Porcilis Porcoli DF, and both sows and their progeny
compared between groups. Over a period of 8 months,
pregnant sows and gilts were vaccinated six and two weeks
prior to their estimated farrowing date. 75 sows were
vaccinated with Porcilis ColiClos, and 40 with Porcilis Porcoli
DF. Sows were re-vaccinated, with a single dose of the
appropriate vaccine, during their next pregnancy. The safety
of Porcilis ColiClos was assessed by observing the general
health and appetite of the sows. Efficacy in their litters was
assessed on the basis of mortality, clinical signs and fecal
consistency and composition scored.
The sows in the Porcilis ColiClos group showed significantly
better general health and appetite than the control sows. Piglets
in the litters born to Porcilis ColiClos-vaccinated dams scored
significantly better in all categories. Furthermore, mortality in
the first week decreased from 5.9 % in the Porcilis Porcoli DF
group to 2.8 % in the Porcilis ColiClos group (p<0.009). In the
first 10 weeks a reduction from 3.8% to 9.3% (p<0.0001) Of
the 14 litters needing oral antibiotic treatment, 2 belonged to
the Porcilis ColiClos group, and 12 to the control group.
The study showed that the clostridial component of the novel
vaccine added to the efficacy induced by the coli components.
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DETECTION OF PRRSV ANTIBODY IN ORAL FLUID
SPECIMENS FROM INDIVIDUAL BOARS USING A
COMMERCIAL PRRSV SERUM ANTIBODY ELISA
Introduction
Oral fluid specimens are used in human medicine for the
detection of a variety of infectious agents, hormones, and
drugs. Oral fluid samples are of interest in swine medicine
because they are easily collected, yet highly efficacious for the
surveillance of PRRSV and other pathogens using PCR-based
assays.1, 3 Recent work showed that a commercial PRRS
serum antibody ELISA (IDEXX Laboratories, Inc., Westbrook,
ME USA) could be adapted to detect PRRSV antibody in oral
fluid specimens. 2 In the current study we describe the kinetics
of the ELISA-detectable anti-PRRSV IgG response in oral fluids
collected from individually-housed boars.
Materials and methods
The study was conducted in 72 boars ranging from 6 months
to 3.6 years in age. Boars were under the ownership of PIC
North America (Hendersonville, TN USA) and housing, study
procedures, and protocols were approved and supervised by
the PIC USA Health Assurance and Welfare department.
Boars were assigned to three trials (I, II, III). Boars (n = 24) in
Trial I were intramuscularly (IM) inoculated with 2ml of a
modified live virus (MLV) vaccine (RespPRRS®, Boehringer
Ingelheim Vetmedica, Inc., St. Joseph, MO USA). Boars (n = 22)
in Trial II were IM inoculated with 2ml of a Type 1 PRRSV field
isolate. Boars (n = 24) in Trial III were IM inoculated with 2ml
of a PRRSV Type 2 isolate (MN-184).
Boars were monitored for 21 days post inoculation (DPI). Oral
fluid samples were collected daily using 5/8” 3-strand 100%
cotton rope. Serum samples were collected from all boars on
DPI -7, 0, 7, 14, 21 and from 4 randomly selected boars on
DPIs 3, 5, 10, and 17. Thereafter, serum and oral fluid were
assayed for PRRSV antibody using the ELISA protocol
appropriate for each sample type (serum or oral fluid).
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USING ELECTRONIC CLINICAL SCORE IN SWINE
HERDS TO SET MANAGEMENT DECISIONS:
ONE YEAR OF EXPERIENCE OF IPC IN EUROPE
Individual Pig Care protocol (IPC) is based on a daily individual
observation of the pigs, early detection of their health
problems and prompt and accurate reaction to those,
supported by a fast electronic data collection and
management system. IPC is currently implemented in 33
farms in UK, France, Germany, Italy, Spain, Belgium, Lithuania
and Poland, and after one year of experience first results are
shown. Digestive disorders represent 26% of total diseases,
mainly appearing in the immediate post-weaning phase (26 to
32 days of age), while a second peak is observed at 90-95 days
of age. Respiratory signs (23% of the total) appear at different
moments: at about 40 days of age, end of nursery (about 60
days of age) and in growing period (at about 100 days of age).
Unspecific clinical signs, mainly associated with runt pigs, are
the most frequently scored and treated (33%) in the fattening
period, following a similar pattern than lameness occurrences,
the fourth cause of disease in prevalence (15%). Neurological
and biting cases are infrequent (1% both). About 80% of sick
pigs were treated in early stage, when severity of disease is
lower and success probability of treatment is higher.
Enrofloxacin is the first AIF used for digestive, respiratory and
unspecific disorders. Mortality mainly occur in nursery period
and main cause is also unspecific (runt-pigs; 54%), followed by
digestive (18%), respiratory (11%) and neurological (10%)
cases. In total, 0.57 injectable treatments were applied per pig.
In conclusion, early detection of symptoms is the key point
of the IPC, allowing a faster reaction and better results based
on accurate clinical data information obtained real-time.
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RESULTS OF A FIELD TRIAL FOR VACCINE AGAINST
OEDEMA DISEASE
Shigatoxin producing E. coli (STEC) induce edema disease in
pigs, mostly after weaning. After attaching with fimbria
adhesins F18 at the intestinal cell wall, toxic Shigatoxin (Stx2e)
is produced, that penetrates into the bloodstream and causes
major organ damages. Because treatment of stx2e diseased
pigs is mostly not effective, prophylaxis is of great importance.
The recombinant subunit vaccine ECOPORC SHIGA (IDT
Biologika GmbH, Dessau-Rosslau Germany) was tested for
safety and efficacy in a field trial in two runs. In the affected
farm the mortality rate due to edema disease temporarily
reached 25% despite oral antibiotic medication. 336 randomly
selected piglets were either blinded vaccinated with 1ml (i.m.)
at the age of 4 days (n=167) or served as placebo treated
control animals (n=169). Piglets were weaned at the age of 28
days. Blood samples were taken at weaning to measure
protective antibodies against Stx2e.
No adverse reactions to the vaccine were observed.
No occurrence of edema disease was observed during the
first run. In the second run mortality due to edema disease
was 13.5% in the control group and 1.4% in the vaccinated
group (p=0.009). The number of pigs with neutralising
antibodies against Stx2e was significantly higher in the
vaccinated group (81.3% vs. 0% at weaning, 89.7% vs. 3.2%
at end of nursery period in the first run). At weaning, in
the second run, 100% of the vaccinated pigs and 13.3%
of the control pigs and at the end of nursery period 92.6%
of the vaccinated and 7.7% of the unvaccinated pigs
showed neutralising antibodies against Stx2e (p<0,001 at
both times).
Vaccination against edema disease represents a safe and
effective tool to reduce mortality due to edema disease and
reduces consequently the use of antibiotics on affected farms.
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OBSERVATIONS ON THE LATEST EPIDEMIC STRAIN OF
SALMONELLA IN PIGS: MONOPHASIC S. TYPHIMURIUM
The evolution of Salmonella has been punctuated by the
emergence of epidemic and multi-drug resistant (MDR) strains.
Examples include Salmonella Enteritidis, associated with laying
hens, and Salmonella Typhimurium DT104, mainly associated
with cattle. These strains are of concern to public health
because of their ability to spread widely and rapidly. Epidemic
strains have been responsible for many outbreaks in humans,
and their resistance to multiple antimicrobial drugs can make
treatment more difficult. In the past two decades, monophasic
strains of S. Typhimurium (mST) have demonstrated rapid
worldwide emergence and in Europe the main reservoir species
appears to be pigs (Hopkins et al., 2010). In Europe, mST strains
are now the second most common serotype isolated from pigs,
and the fourth most common from humans (European Food
Safety Authority, 2012). There are many variants of mST and
while some are sensitive to antimicrobial drugs, many are
resistant to between 1 and 10 different antimicrobials (Animal
Health and Veterinary Laboratories Agency, unpublished data).
mST and classical S. Typhimurium strains appear to share
almost identical pathogenicity gene repertoires (Hauser et al.,
2010). Consequently, there should be greater focus on the
control of mST, given the ecological success of S.Typhimurium.
Monophasic and biphasic variants of Salmonella Typhimurium
phage type DT193 have both been shown to survive longer in
pig faeces than other serotypes, which may facilitate
transmission and therefore contribute to their increased
prevalence (Rajtak et al., 2012). The role of pigs in generating
and propagating epidemic strains is an important phenomenon
that should be considered when studying the epidemiology of
Salmonella. Until effective control measures, such as
vaccination, are implemented it is necessary to maintain
awareness of the presence of such epidemic strains,
improve surveillance and attempt to understand the host-
pathogen interaction.
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SEVERE ACUTE GASTRITIS IN GROWER PIGS
ASSOCIATED WITH ACUTE MONOPHASIC S.
TYPHIMURIUM INFECTION AFTER WITHDRAWAL
OF ACIDIFIED WATER
Salmonella infection in growing pigs is commonly subclinical
but under some circumstances can result in severe sometimes
fatal enterocolitis and septicaemia. Factors which increase the
likelihood of clinical disease include high bacterial dose, lack
of host immunity and infection with a virulent organism. Mild
gastritis is a common sequel of clinical salmonellosis and
severe acute gastritis is sometimes seen. Clinical salmonellosis
is the most common systemic disease of growing pigs
diagnosed by AHLVA. In recent years, monophasic Salmonella
Typhimurium has been increasingly reported in pigs and other
species in the European countries.
In November 2011 sudden deaths were noted in 10 week old
grower pigs on an indoor fully slatted PRRS positive EP positive
wean to finish pig unit receiving 400 weaners per week from
a distant breeding unit under the same ownership. Pigs were
found dead 5-10 days after a move to a fully slatted building
comprising six rooms, operated on an All-in All-out basis by
room, with cleaning and disinfection between batches. Prior to
this stage, from 4-10 weeks of age, the pigs’ water was
acidified. On gross post mortem examination, severe acute
gastritis with marked mucosal erythema and mucus
deposition was seen in almost all acutely dead pigs. Stomachs
contained large amounts of brown slightly viscous fluid and
little food. Histology revealed acute fibrinonecrotising gastritis.
Salmonella 4,12:I: phage type 193 (likely monophasic
Salmonella Typhimurium) was cultured from stomach
contents, colon and liver. A severe mouse infestation was
noted on the unit and the same organism was cultured from
mouse droppings. We suggest that the inclusion of acid in the
first stage pigs may have suppressed salmonella infection
while maternal immunity waned, resulting in naive pigs
entering the grower house where they met a high-dose
Salmonella challenge spread by mice. Results of intervention
to be reported.
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DEVELOPMENT AND VALIDATION OF A
STREPTOCOCCUS SUIS SEROTYPE 2 MENINGITIS
CHALLENGE MODEL IN PIGS
Streptococcus suis is an -haemolytic streptococcus of major
importance to the pig industry due to the economic impact of
disease outbreaks, prevention, control and welfare implications
for infected herds. Thirty five (35) serotypes have been
described with serotype 2 responsible for the majority of the
infections in diseased pigs in most countries. The objective of
this work is to develop and validate an experimental challenge
model for serotype 2 to facilitate the efficacy testing of novel
vaccines and therapeutics.
Materials and methods
Animals were challenged by the intranasal route with a recent
UK field isolate of S. suis while the control group received
saline by the same route.
Post challenge, clinical observations were carried out and
consisted of assessments of demeanour, behavioural/
CNS abnormalities and rectal temperature (°C). Additional
observations relating to behavioural or neurological problems
were also recorded.
Any animals showing unacceptable levels of disease following
challenge were euthanased on welfare grounds and a necropsy
performed. On Day 7 all remaining study animals were
necropsied following clinical observation. Brain and tonsil
tissues were removed for bacteriological analysis.
Results
The first clinical signs in the S.suis challenged animals were
observed between 36 and 48 hours post challenge and
characterised by initial pyrexia, quickly followed by nervous
signs such as reduced coordination, unsteadiness, and some
lameness. Over 12 to 24 hours, the severity of the nervous
signs increased until animals were unable to stand. These signs
are consistent with a field type infection.
All challenged animals were euthanased within 7 days of
challenge and the challenge isolate was recovered from all but
one animal.
The study demonstrated that the intranasal challenge is
reproducible and consistent with a low level of variability
between animals and will be applicable in the testing of
veterinary medicinal products to control and prevent S.suis
infection in pigs.
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SEPTICAEMIC PASTEURELLOSIS IN FREE-RANGE PIGS
IN SPAIN: AN EMERGING DISEASE?
Pasteurella multocida is associated with a broad disease
spectrum in animals, constitutes a frequent cause of porcine
pneumonia, and may play a central role in the porcine
respiratory disease complex. Systemic infections are rarely
reported, although cases of acute septicaemia due to capsular
serotypes B and D have been reported in India, Asia and
Australia. In this study, an acute outbreak of pasteurellosis with
a high morbidity (70%) and lethality (95%) in a free-range pig
farm is described. Signs of coughing and severe dyspnoea were
observed, as well visible inflammation of the throat, which
acquired a cyanotic and necrotic appearance. The predominant
necropsy findings were a severe oedema, congestion and
haemorrhages in lungs and haemorrhagic foci in mediastinal
lymph nodes. Diffuse, haemorrhagic and fibrinous
pleuroneumonia and acute, focally extensive and hemorrhagic
myositis and panniculitis were observed in the histopathological
analysis. Pasteurella multocida subsp. multocida capsular type
B, biovar 13, was isolated from different tissues obtained from
dead animals. Pulsed field gel electrophoresis (PFGE) revealed
that all P. multocida isolates displayed undistinguishable
macrorestriction patterns with Bsp120I restriction enzyme,
which demonstrated a single strain infection. Multilocus
sequence typing (MLST) was also determined, and these isolates
were assigned to the new allelic profile ST47. Natural infections
are generally by inhalation and ingestion of contaminated
material. The extensive breeding systems, where is possible a
contact with wild ruminants, could be the entry of the bacteria
on the farm, maintained and spread by animals, by horizontal
via, through nasal secretions. More studies are necessary to
determine if the pigs can be harboured of this pathogen in the
crypt of tonsils that could represent a risk of diffusion between
swine herds.
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ASSOCIATION BETWEEN BLOOD HAEMOGLOBIN
CONCENTRATION IN SOWS AND NEONATAL PIGLETS
Background
Haemoglobin (Hb) concentrations in sows tend to decrease
during pregnancy. Low Hb levels may result in still-births due
to inadequate oxygen transport to foetuses Piglets with a high
Hb value at birth have an increased chance of survival until
weaning. The purpose of this study was to study the
association between Hb-concentrations in sows, stillbirth rate
in litters and Hb-concentrations in piglets.
Materials and methods
In a Danish 1700 sow herd, 21 sows and 138 offspring piglets
were studied at the time of farrowing. Piglet birth order was
recorded and a drop of blood was obtained from sows before
farrowing and from new-born piglets before intake of
colostrum. Hb-concentrations were measured with a
HemoCue 201+ photometer. Statistical analysis was
performed using a linear mixed model: Hb_ piglet = Hb_sow
+ piglet_no + parity*total born.
Results
The anaemia prevalence defined as Hb concentration ≤100 g/L,
was 0.38 [0.19; 0.61] in sows and 0.08 [0.04; 0.14] in piglets.
Piglet Hb-concentration was found positively correlated to sow
Hb-concentration (parameter estimate + 0.54; P<0.001) and
negatively correlated to the piglets number in the birth order
(parameter estimate -0.08; P = 0.04) and to the combined
effect of parity and the number of total born piglets in the litter
(parameter estimate -0.01; P = 0.02).
The percentage of stillborn piglets in litters was not significantly
correlated to sow Hb-concentration (= -1.16; P = 0.24) and
sows with Hb-concentrations ≤100g/L did not have increased
rate of stillbirths (P = 0.55).
Conclusion
Piglets from sows with high Hb level had higher Hb levels at
birth which will increase their chances of survival until weaning.
Apparently, piglets from older sows which are born in the last
part of large litters have the highest risk of low Hb values.
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AN INTEGRATED SYSTEM FOR PIG HEALTH AND
WELFARE MONITORING – FACT OR FICTION?
The improvement of pig health and welfare is fundamental to
securing the sustainability of the English pig industry. Disease
causes significant cost to pig farmers, limits productivity, and
is inextricably linked to welfare. Key areas for the development
of health and welfare targets for 2020 are outlined in the BPEX
(British Pig Executive) 20:20 Pig Health and Welfare Strategy.
To measure the effectiveness of any initiatives, allow
assessments of change over time and recognise emerging
challenges or threats, the pig industry needs to know what
the current status is and to monitor changes that may occur.
BPEX required a critical evaluation of the wide range of existing
data sources collected by the industry, researchers and from
government-led surveillance systems, in order to establish their
potential, identify the current gaps and recommend the next
steps to be taken.
We have identified and collated information about current
available data sources on health, disease and welfare
measurements from the English pig industry. Thirteen data
sources, including abattoir lesion reports, disease surveillance,
quality assurance schemes, welfare assessments and data
collected by private vets, were fully evaluated using a
standardised framework for the evaluation of animal health
surveillance systems – SERVAL http://www.rvc.ac.uk/VEPH/
SERVAL.cfm. The key findings of the evaluations, in terms of
the strengths, weaknesses, opportunities and threats of each
of the selected data sources, were summarised. Existing
baseline estimates and currently effective and/or potential
monitoring mechanisms were extracted. Methods for
analysing, interpreting and disseminating information on
health and welfare were sourced and reviewed.
We identified deficiencies in data collection that hamper the
potential integration of data sources and their use for
epidemiological analysis and monitoring purposes, plus we
found some gaps.
We propose a framework for an integrated system for pig
health and welfare monitoring and highlight the potential
benefits and limitations.
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OCCURRENCE AND SEVERITY OF LUNG LESIONS
IN SLAUGHTER PIGS VACCINATED AGAINST
M. HYOPNEUMONIAE WITH DIFFERENT STRATEGIES
Objectives
Mycoplasma hyopneumoniae (Mhp) is a major concern for
worldwide swine production. The aetiological agent of Porcine
Enzootic Pneumonia causes significant losses, particularly in
combination with secondary pathogens. Major economic
impact results from reduced daily weight gain, feed efficacy
and carcass quality.
Vaccination against Mhp is routinely conducted in Germany.
Distinct vaccination schemes are based on one – or single
dose strategies. There has been some evidence from the field,
showing differences in vaccination efficacy. The aim of the
present study was to evaluate such differences based on
mycoplasma-associated alterations and Mhp loads in lungs of
slaughter pigs, provided with different vaccination strategies.
Material and methods
We investigated lungs from slaughter pigs of 20 randomly
selected herds with different vaccination strategies, in a
blinded study. Groups 1 (8 herds) and 2 (6 herds) had a history
of vaccination with one of two different Mhp single dose
vaccines. Group 3 (6 herds) had been vaccinated with a two
dose vaccine. A minimum of 30 lungs per herd was scored
using the method described by Madec and Kobisch (1982,
J.Res.Porc.France 14, 405-412). Six lungs were randomly
chosen for sampling from each herd for further investigations:
histological lesions typical for Mhp infection were scored and
Mhp was quantified by real time PCR. Additionally, each
sample was screened for other respiratory agents.
Results and discussion
All tested parameters – gross lesions, histological lesions and
PCR-results – were significantly correlated. Lowest gross
lesions, histological lesions and Mhp numbers were found in
herds after two dose vaccination (group 3). One of the one
dose vaccinated groups tended to more pronounced
alterations (group 2). The second one dose group (group 1)
differed significantly from group 2 and 3 in each of the tested
parameters.
The present work substantiates significant differences in
vaccination efficiency of different Mhp vaccination strategies.
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VARIABILITY OF OVULATION IN GILTS: ASSOCIATED
FACTORS AND CONSEQUENCES ON REPRODUCTIVE
PERFORMANCES IN 4 PIG FARMS
Introduction
Adequate timing of insemination close to ovulation is a key
determinant of reproduction performances. The objective of
this work was to investigate factors associated with variability
of ovulation in different herds and possible impacts on
reproduction of young gilts.
Material and methods
The study was performed in 4 conventional farms on 68 gilts.
Measurements included daily recordings of estrus and ovarian
status using transcutaneous ultrasound technique (3.5-5Mhz
probe, Exago®, ECM). We collected information about number
and timing of inseminations (AI), backfat (BF) at AI, last
altrenogest-to-estrus intervals, health status, treatments, and
subsequent performances.
Results
67 gilts exhibited estrus and ovulated within 8 days after
weaning and 1 ovulated silently. Onset and duration of estrus
and timing of ovulation exhibited large variations according
to gilts with significant farms differences. Last altrenogest-to
estrus intervals ranged between 100 to 162 h (132.8 ± 15 h).
Estrus duration (51.6 ± 13.7h) varied between 36 to 96 h
according to gilts. Ovulation occurred at 68.6 ± 32.8 % of
estrus duration, 33.9 ± 13.9 h after the onset of estrus, with
large gilt variations (-3 h to +58 h). Last altrenogest-to-estrus
interval was the best predictor of ovulation and estrus
duration (p<0.01) in 3 of 4 farms. BF (10 to 20.5mm) was
related to last altrenogest-to-ovulation interval (p<0.05). Gilt
were inseminated 2 to 4 times and fertility was high (86 to
100% according to farms). Low BF (≤13mm) and late
ovulations (>35h after estrus) were associated with lower
fertility (p<0.01).
Conclusions
Results confirmed variability of ovulation and the importance
of good estrus detection procedures to adapt AI protocols.
Impact of BF and management of young gilts should deserve
further attention, specially in farms with lower fertility.
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A ULTRASONOGRAPHICAL, HISTOLOGICAL AND
IMMUNOHISTOCHEMICAL INVESTIGATION OF THE
GROWING MAMMARY GLAND IN THE PIG
The amount of colostrum/milk that is available per piglet largely
depends on litter size and the ability of the sow to produce
colostrum/milk. As average litter size has increased over the last
decade sows are required to also produce more amounts of milk
to sufficiently nurse their litters. However, research into the
porcine mammary gland is still patchy. A study was therefore
conducted with the aim of investigating the mammary gland of
pigs at the age of 60 (n=10), 120 (n=10) and 180 days (n=10)
of two different breeds (conventional versus hyperprolific; 5 pigs
each for the age groups, respectively) by ultrasonography (US;
parameters: echotexture, echogeneity, homogeneity, shape and
size), histology and immunohistochemistry (estrogene receptor
alpha (ESR-alpha) and molecular immunology borstel-1 (MIB-
1) as a marker for cell proliferation). As measured by US the
thickness of the mammary gland increased with increasing age.
All other US parameters were not different either between and
among breeds of the same or of different ages. Histologically,
the number lactocytes increased with increasing age. Only
lactocytes were positive for ESR-alpha. Intensity of ESR-alpha
staining was not related to age or breed. In contrast, intensity
of MIB-1 staining was higher in 60 days old than in older
pigs. In conclusion, with the methodology used in this study
it seems that breeds do not differ with respect to mammary
gland architecture and functionality. Results suggest that
the age of 60 days is crucial for mammary gland development
in the pig.
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BONE FORMATION AND RESORPTION
THROUGHOUT THE REPRODUCTIVE CYCLE OF
PRIMIPAROUS AND MULTIPAROUS SOWS
Bone mineralisation is important for an optimal sow health
and may differ between parities. The aim of this descriptive
study was to determine bone mineralisation parameters
during the reproductive cycle of the high prolific sow on a herd
and to compare primiparous with multiparous sows.
Blood samples were taken before feeding in the morning from
5 primiparous and 10 multiparous sows at fixed time intervals
during gestation (day -5, insemination, 21, 42, 63, 84),
parturition (day -7, -3, parturition, 3) and lactation (day 7, 14,
28). Sera were analysed for osteocalcin, a bone formation
marker, and crosslaps, a bone resorption marker.
The crosslap pattern differed between primiparous and
multiparous sows. At the moment of insemination bone
resorption was low in primiparous sows (0,5 ng/ml) but
declined in multiparous sows that had previously been in
lactation from 3,5 to 1 ng/ml. At parturition, the marker
declined in both parity groups to 0,7 ng/ml, whereas the
concentrations increased during lactation to 2 and 3,2 ng/ml
for primiparous and multiparous sows, respectively. The
osteocalcin pattern was similar in both primiparous and
multiparous sows. The osteocalcin concentration decreased at
parturition to 89 and 57 ng/ml and increased at the end of
lactation to 139 and 94 ng/ml for primiparous and
multiparous sows, respectively.
The present results supports previous findings that bone
resorption increases during early lactation as a consequence of
calcium mobilisation for milk production. Whereas in most
situations bone resorption behaves inversely to bone formation,
bone resorption seems uncoupled from bone formation during
lactation, independently of the parity number.
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LONGEVITY OF GESTATING SOWS STATISTICALLY
RELATED TO LAMENESS, LEG AND CLAW PROBLEMS
Sows are often culled or euthanised young due to locomotor
problems. The aim of this study was to identify traits in leg
conformation, claws or the locomotor function that relate to a
shorter longevity of the sow. Sows from eight Danish herds were
included in the study. All sows were group-housed, either in free
stalls or with an electronic sow feeder system. A total of 3,535
sows were examined visually in the pen for seventeen different
parameters. The sows were examined in the first (1,889 sows)
or third (1,646 sows) trimester of the pregnancy. The findings on
legs and claws were related to whether the sow was selected for
mating after weaning. The statistical analysis used was
multivariable logistic regression by SAS programming.
Results: Observation of long claws or long dewclaws in the first
trimester were significantly associated with shorter longevity
(P=0.06 and P=0.04). In the third trimester, findings of
ulceration near the claw and/or the dewclaw were significantly
associated with shorter longevity (P=0.05) and (P=0.04). These
sows had a lower probability of being mated after weaning. In
the first trimester, 16% of the sows had long claws and 12%
had long dewclaws. In the third trimester, 24% of the sows had
lesions on the claw and 11% of the sows had lesions on the
dewclaws. The sows were examined for stance and gait, but
the findings were not significantly associated with a shorter
longevity in the multivariate analysis. In conclusion, it is
important to observe lesions to the lower limb and long claws
and dewclaws, since these are associated with the longevity of
the sows. Further studies into the prevention of leg problems
in sows will be needed, particularly in light of the requirement
that all sows in EU countries be loose-housed from 2013.
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SUDDEN DEATH WITH RESPIRATORY
INVOLVEMENT IN GROWER PIGS BY
STREPTOCOCCUS SUIS
Streptococcus suis is a major pathogen of swine, causing meningitis,
arthritis, pericarditis, polyserositis, bronchopneumonia, septicemia,
and sudden death of weaning piglets as well as growing pigs, there by
inflicting severe economic losses in the swine industry. It is an
emerging zoonotic disease mainly affecting the people who have close
contact with swine or pork by-products. Thirty-five capsular serotypes
of S. suis have been described (types 1/2 and 1 through 34). Although
serotype 2 is considered to be the most virulent serotype in most
countries, strains belonging to other serotypes can also cause disease
in pigs. 10 grower pigs with history of sudden death were presented
for necropsy at the postmortem facility, Division of Pathology, Indian
Veterinary Research Institute. External examination revealed
generalised cyanosis of skin and blood tinged frothy discharge from
nostrils. Gross examination of visceral organs showed thickened
pericardium with clear fluid in pericardial sac, froth and blood clots
filled trachea, severely congested non collapsed lungs, enlarged
severely congested liver and severely engorged mesenteric blood
vessels. Histopathological examination revealed bronchopneumonia
with alveolar heamorrhage, alveolar and inter-alveolar edema and
severe infiltration of inflammatory cells. Bronchi and bronchioles
contained desquamated epithelium and inflammatory cells. Gram
staining of smear from Brain Heart infusion (BHI) broth of lung
inoculum showed gram positive coccoid, ovoid organisms occurring
singly, in pairs or in short chains. DNA isolated from BHI culture was
amplified by PCR targeting 16S rRNA. The amplicons were sequenced
and their sequence analysis confirmed that the isolates belonged to
S. suis serotype 2 and 9.
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CLOSTRIDIUM NOVYI INFECTION AS
POSSIBLE CAUSE OF SOW MORTALITY IN A
COMMERCIAL PIG HERD IN PORTUGAL
A clostridial infection was the suspected cause of sudden death of
thirty one gestating sows in a five hundred sow farrow to finish farm
located in Azambuja, Portugal. The most affected ones were the sows
in the last trimester of gestation.
Necropsy findings included timpanism, purple discolouration of the
skin, generalised subcutaneous edema with foul-smelling bloodstained
fluid in the pleural, pericardial, and peritoneal cavities and enteritis.
The liver was friable and uniformly infiltrated with gas bubbles,
presenting a spongy appearance on the cut surface.
Large numbers of gram-positive rods were observed in smears from
the heart, lungs and liver. Histopathological examination revealed
non-staining cavities (gas bubbles) and necrotic lesions in these
tissues. All samples showed a marked autolytic degradation.
Even though the diagnosis of some Clostridium infections in swine
is difficult due to rapid postmortem invasion, and although no
microbial isolation or molecular biology assays were performed in
this case, the history of sudden death of gestating sows, along with
the identification of clostridial organisms and the presence of
emphysema and rapid postmortem decomposition of internal organs
in the absence of any other detectable cause of death, suggests death
due to Clostridium novyi.
Control measures, such as medication in feed coupled with vaccination
of sows, were taken with some relative success.
Analysis of the causes of sow mortality has received less attention
compared with investigation of mortality in lactating and growing pigs.
This clinical case illustrates the importance of an early postmortem
examination and collection of samples as soon as possible after death
as tools for the correct management of cases of unexpected mortality
in sows.
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IMPACT OF INFLUENZA A(H1N1)PDM09
VIRUS ON LIVE WEIGHT OF DUROC BOARS
DURING THE GROWTH PHASE
Data was collected during an investigation of an outbreak of Influenza
A(H1N1)pdm09 at a boar testing station from April to July 2011. There
were 1152 boars at full capacity. The station receives young boars (70-
85 days old) from closed self-recruiting nucleus herds to monitor the
boars’ performance including daily feed intake and daily weight.
Cohorts of 72 boars are kept in groups of 12 in 6 equal sized pens (14
m2) in one room where they remain for an average 72 days until they
reach a bodyweight of 100kg. Serological and virological tests were
performed on 375 boars from all 16 rooms on 8 occasions. A synopsis
of the results is presented based on results of one room where 8 Durocs
were confirmed positive. 23 uninfected Duroc boars were selected for
comparison. The growth curves of the group means of live weights of
the two groups (infected vs uninfected) were compared. Student t-
test was used to test significance in the differences between the two
group means at different days of age. If the lower limit of 95%CI
(Group mean difference minus 1 tailed t-distribution at 0.05 sig level
with 31 degrees of freedom (1.695) x SD of group mean difference) is
greater than zero, than the difference was considered significant at the
0.05 level. The growth curves of uninfected and infected Duroc boars
appear to diverge just before 85 days of age. This coincided with the
detection of the virus on 14 April 11.
However using one-tailed t tests on group means difference, show
that the higher live weights in the uninfected boars were not
consistently significant at the 0.05 level. Uninfected boars from 132
days till 140 days did appear to have a statistical significant higher
weight than infected boars.
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INVESTIGATION ON PRACTICALITY AND
EFFICACY OF ISOFLURANE NARCOSIS
DURING PIGLET CASTRATION ON
MEDIUM-SIZED PIG FARMS IN GERMANY
In the context of the discussion about animal welfare during pork
production the castration of piglets is of major interest. Therefore
this study tested the applicability of isoflurane narcosis for pain
alleviation on three medium-sized pig farms. Extent of anaesthesia,
wound healing and growth after castration were examined and
compared to traditional castration without narcosis. In addition the
microbiological status of the anaesthetic device was investigated to
assess the risk of carryover of pathogens between different farm
divisions. So far 1545 piglets were monitored (771 with narcosis
(WN)/774 without (W)). Both groups were of similar average
bodyweight and age. As the investigations are not completed yet, the
interim results show, that there are no differences in wound healing
or growth between the groups 10 days after castration (p.c.) as well
as at the time of weaning (wound healing score 10 days p.c.: mean
WN = 13.18/mean W = 12.94; mean of bodyweight at weaning:
WN= 7.63kg/W= 7.60kg). But only 76% of the anaesthetised piglets
had an adequate depth of narcosis. 24% of these piglets still showed
obvious reactions to the castration. The bodyweight of the piglets
had a significant impact on the stage of anaesthesia. Small piglets
(<1.0kg) and piglets with a bodyweight above 3.0kg showed
significantly more pain reactions than piglets with an bodyweight
between 1.0kg and 3.0kg. The results of the microbiological
investigations demonstrated a risk of pathogen spreading within the
farm divisions by the anaesthetic device because bacterial as well as
viral pathogen accumulated on the breathing mask. As the handling
of the anaesthetic device was assessed as good by the farmers the
isoflurane narcosis seems to be a practicable method for pain
reduction during piglet castration if the piglet’s bodyweight and
simple hygiene arrangements are observed strictly.
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FARMERS EXPERIENCES WITH ORAL
ADMINISTRATION OF MELOXICAM FOR
SOWS TO IMPROVE SOW WELFARE
Throughout the lifetime of a sow the number of injections is huge.
First of all, the sows are routinely vaccinated several times, and on top
of that the sows receive a number of intramuscular injections of
antibiotics, NSAIDs etc. The stress and pain induced by injection is a
welfare problem and therefore, a reduced number of injections will
improve the sow welfare.
The aim of this study was to evaluate oral meloxicam given to sows
shortly after farrowing, compared to treatment by injection. Farmers
filled in a questionnaire covering handling of the product, reaction of
the sow to oral treatment as well as advantages and disadvantages
compared to injection seen from the farmers point of view. Sows
were treated twice with 0.4 mg/kg body weight of oral meloxicam
(Metacam®, Boehringer Ingelheim) with an interval of 24 hours and
the first treatment was given within 6 hours after end of farrowing.
Totally, 42 farmers answered the questionnaire, which was prepared
with open questions, thus giving the farmers the opportunity to
describe their experiences with their own words.
The overall evaluation of the treatment was predominantly positive,
with 90.5 % answering that administration of the product was easy
and convenient. Only 4 farmers (9.5 %) thought that giving the oral
treatment was a bit difficult. Most of the farmers reported that the
sows liked the treatment, with many sows being more interested in
the second treatment than the first one. Seven farmers reported that
20-30% of their sows were not too happy to eat the drug. Regarding
advantages and disadvantages, the most predominant statement was
that it was an advantage to avoid injections. In conclusion, the oral
formulation of meloxicam can be regarded as a large improvement
of sow welfare and as a good alternative to NSAIDs given by injection.
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THROMBOCYTOPENIA PURPURA AS THE
CAUSE OF DEATHS IN PIGLETS
Thrombocytopenia purpura in piglets due to passively transferred
anti-platelet antibody is a bleeding disorder. Over a period of two
months, Thrombocytopenia purpura was diagnosed as the cause of
post castration deaths among piglets five to six days of age in two
different farms.
Herd visits and on-farm autopsies were performed. Farmers were
interviewed regarding the history of the dead piglets. Photographs
of typical lesions were taken and sent to the Norwegian School of
Veterinary Science for examination. Blood samples from remaining
littermates were collected and analysed for thrombocyte count.
In the first farm, 13 piglets, from three different litters, died after
castration, first males then females. After questioning the farmer, it
was evident that all the diseased piglets originated from one, fourth
parity sow but some of her piglets had been fostered to other sows
after the ingestion of colostrum. In the second farm, one piglet from
a third parity sow died. On-farm autopsies revealed pale piglets with
heamorrhages in the subcutaneous tissue and internal organs. In the
males, most of the heamorrhages were intra-peritoneal, presumably
originating from the cut arteria testicularis. Blood samples were
collected from two of the remaining piglets and analysis showed
thrombocyte count of 107 and 163 109/L. Normal values in 30-50kg
pigs are 211-887 109/L.
The diagnosis was not verified by identifying sow-derived iso-
antibodies to piglet platelets or the presence of anticoagulant in body
tissues. Post mortem findings, blood samples and the fact that only
piglets from single, multiparous sows were affected were highly
indicative of the diagnosis.
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THE ‘GRIMACE SCALE’: DO PIGLETS IN PAIN
CHANGE THEIR FACIAL EXPRESSION?
With the increase in attention to animal welfare, researchers have
focused their interest on the assessment of pain in farm animals. In
humans who cannot self-report, such as infants and unconscious
patients, the observation of facial expression is frequently used for
pain assessment (Prkachin, 2009). The possibility to assess pain
through changes of facial expression has also been studied in animals,
and pain scales developed which include the ‘Mouse Grimace Scale’
(Langford et al., 2010), the ‘Rat Grimace Scale’ (Sotocinal et al., 2011)
and the ‘Rabbit Grimace Scale’ (Keating et al., 2012). Although with
some species differences, the three scales focus on the eyes, nose,
cheeks, ears and whiskers of an animal.
Although pigs have fewer muscles for facial expression, there are
subtle changes in appearance (Flecknell & Watermann-Pearson 2000),
but there are currently no published pain scales based on facial
expression in pigs. The aim of this research was to investigate if it is
possible to observe changes in piglets’ facial expressions immediately
after painful procedures. Thirty-one piglets were subjected to tail
docking by cautery, while held by the farmer. Images of faces were
taken immediately before and after this procedure. These images were
sorted and those in which piglets had closed eyes were excluded.
Images were evaluated by two treatment-blind observers, scoring
from 0 to 2 (0 was no evident tension and 2 very evident tension).
Because of the non normal distribution, data were analysed with the
non-parametric Wilcoxon Signed Rank Test, which showed that the
cheek tension score significantly increased from before to after the
procedure (P<0.042). This result shows promise for the adoption facial
expression as a tool for acute pain assessment in pigs. Results from a
subsequent study on surgical castration of piglets will be presented.
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FIELD CASE OF CLASSICAL SWINE FEVER
WITH PCV-2 CO-INFECTION IN THREE DAYS
OLD PIGLETS
A case of Classical Swine Fever (CSF) occurred in a 6,000 sows farm.
Congenital infection was found in young sow offspring at three days
old with acute and chronic symptoms and lesions. The acute clinical
signs in piglets were purple cyanotic discolouration of skin at
abdomen, inner thighs, and ears. The hemorrhagic gross lesions such
as petechial heamorrhage of lymph nodes, tonsil, kidney, urinary
bladder, stomach, lung, and subcutaneous tissue were detected from
piglets died after natural infection. The chronic signs occurred in
young sows unit, 1st parity, at the same farrowing batch. Piglets in
the first week of age show congenital tremor and posterior paresis.
Some piglets showed both signs. Direct immunofluorescence (FA test
on cryostat section) detected the viral antigen from tonsil, lymph
node, kidney, spleen, and ileum samples derived from acute cases The
PCV-2 antigen was detected by PCR while PRRSV antigen was
negative. The final diagnosis was acute and congenital infection from
young sow with both virulent and less virulent strains while lived
vaccine of CSF was routine used in lactating sows. There might be a
factor caused immune suppress and PCV-2 was suspected the
predisposing cause of CSF in this case. Normally, the congenital
infection of CSF was less incident than post-weaning infection, the
investigation of infectious status in herds by virus neutralisation test,
the neutralising peroxidase-linked assay (NPLA) was conducted for
the further interpretation. For controlling, the infected sows and
piglets were culled. Lived vaccine might be booster to sows and
weaning pigs. Strict biosecurity practice was implemented to avoid
horizontal transmission. The serological test might be repeated for
monitoring the herd status three months later.
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IS MASS VACCINATION A FEASIBLE METHOD
TO CONTROL PORCINE RESPIRATORY AND
REPRODUCTIVE SYNDROME (PRRS) IN A PIG
DENSE REGION – CASE STUDY
A PRRS mass vaccination trial was set up in Shrophram (Norfolk,
England), classified as a pig dense region (2.20 pigs/acre over a 6 mile
radius). The trial had 2 objectives: (i) to answer the question “can and
will pig producers collaborate to control disease” and (ii) to establish
whether mass vaccination is a feasible method to control PRRS in a
pig dense area. This pilot trial required participating farmers to meet
certain criteria: (1) provide blood samples where possible from 10
sentinel (unvaccinated) pigs within the two weeks preceding
slaughter to determine PRRS status of the herd and (2) supply
performance data including average daily gain (ADG), mortality rates,
feed conversion ratio (FCR) and antibiotic usage prior to and during
the period of vaccination. Collaboration of the farmers was
monitored by: (i) Attendance at the inaugural and review meetings
(80% of vets with clients in the focus area attended) and (ii) the
percentage of herds willing to PRRS vaccinate (99% of sows and 81%
of growing pigs were vaccinated). To achieve the objectives of the
project, as many pigs within the area needed to be vaccinated
simultaneously; therefore comparative performance could only be
assessed against each herd’s performance of pig’s pre-PRRS
vaccination and not as a direct cohort group. Substantial
improvement in terms of ADG and reduction in mortality rates was
observed in some but not all herds. Virology results concluded that
the strains of PRRS virus in the focus area are closely related, but
dissimilar to the live vaccine used which may explain results obtained.
Thus it can be concluded that the precedent is there that farmers
can collaborate which should bring benefits to disease control.
However virological testing is required to determine if mass
vaccination can be considered feasible to control PRRS.
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VACCINATION AGAINST OEDEMA DISEASE
IN A COMMERCIAL PIG FARM
Oedema Disease caused by Shigatoxin Stx2e producing E. coli (STEC)
is responsible for severe illness in pigs resulting in a high mortality
during the flatdeck period and substantial economic loss. In a
commercial sow farm the vaccine ECOPORC SHIGA was tested to
evaluate the safety and efficacy as well as the reduction of oral
medication to avoid edema disease.
In 2011, in the affected farm the mortality rate due to edema disease
temporarily reached 15% in the flatdeck despite extended oral
antibiotic medication. From 2012 on, all farrowed piglets where
vaccinated by one shot of 1ml (i.m.) ECOPORC SHIGA (n=5415)
within first week of life. Mortality rate caused by edema disease, use
of oral medication and growth performance where observed for
vaccinated pigs till end of nursery phase and compared to historical
data at the farm.
No adverse reactions to the vaccine were observed. In the vaccinated
groups, mortality due to edema disease was 0 to 1,2%. Oral
medication against edema disease where fade out completely. While
in 2011 oral medication where given 3-4 weeks in nursery phase, in
2012 weaned piglets where only treated 1-1,5 weeks against
Enterotoxin producing E.coli, causing diarrhoea. With the control of
edema disease by vaccination, the farmer increased energy and protein
density in nursery feed to archive higher average daily weight gain.
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PCV2 ASSOCIATED CLINICAL SIGNS IN
FINISHING PIGS AFTER PCV2 PIGLET
VACCINATION PROGRAMME WAS CHANGED
– A CASE REPORT
The case farm was a finishing farm with 536 fattening pigs. Since
2006 this farm received PCV2 and Lawsonia intracellularis vaccinated
piglets from one 140-sow breeding farm, without experiencing any
major health issues.
In December 2011 the finishing pigs showed clinical signs, starting in
mid-finishing (at about 40 to 50kg of weight): Inappetence with fever
(up to 41°C), wasting with cases of sudden death, reduced ADG,
aggression (tail biting), and impaired carcass quality. In February 2012
about 20% of the finishing pigs were affected. Most remarkable was
the inhomogeneity in growth mid-to-late finishing, wasting and the
high mortality. A post-mortem examination was carried out on 5 pigs
(3 dead and 2 typically diseased pigs euthanised). Findings included:
wasting, icterus, multiple enlarged lymph nodes, yellowish diarrhoea
in one pig with bell shaped abdomen, and as secondary finding
pericarditis in 2 pigs. Tissue samples were sent to the lab for further
investigation. Lymphoid depletion and granulomatous inflammation
as well as an interstitial tubulo-nephritis were found in 3 pigs.
Microscopic findings were compatible with PCV2-infection, which
was confirmed by immunohistochemistry.
An investigation on the breeding farm revealed that the PCV2 piglet
vaccination programme had been changed from a 1-ds subunit
vaccine (1ml/dose) to a 1-ds whole-cell vaccine (0.5ml/dose) in
September 2011. As an immediate action (based on that information)
all vaccinated piglets that were still present on the breeding farm were
re-vaccinated, and the whole piglet vaccination programme was
switched back to the 1-ds subunit vaccine. During the last farm visit
in October 2012 an obvious improvement in the health situation was
observed, despite the fact that in-feed medication at placement was
stopped in August 2012. Feed intake, growth and homogeneity were
improved, while mortality was markedly decreased.
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SEROLOGICAL AND VIROLOGICAL PCV2
STATUS IN THE FARROWING UNIT ON ONE
FRENCH FARROW-TO-FINISH FARM
Experimental studies have shown that PCV2 can be involved in
reproductive failure and can be transmitted to foetuses in utero.
However no field study in Europe has investigated PCV2 epidemiology
in the farrowing unit to evaluate in-utero transmission. The objective of
this study was to initiate the evaluation of PCV2 infection in farrowing
sows and possible in-utero transmission to foetuses.
We selected a French farm with reproductive failures characterised
by a high number of mummified piglets and a pre-weaning mortality
above the average. The selected farm was a 240 sow farrow-to-finish
farm. Eight (8) sows were selected from one batch, colostrum
samples were harvested at the start of farrowing and blood samples
at the end. Pre-suckling piglets (n=83) were blood sampled about 1h
after birth. PCV2 PCR was run on sow sera and colostra, and on
pooled piglet sera. PCV2 Elisa was run individually on sow and on
pooled piglet sera. PCV2 DNA was not detected in any of the samples
tested. 85% (7/8) of the sows were PCV2 antibody positive,
compared to only 2/83 piglets (from the same litter). This study gives
a first insight in PCV2 epidemiology and in-utero infection on a
French farm with reproductive clinical signs. The high percentage of
seropositivity in sows confirms that PCV2 is widespread in the sow
herd. Only 2 piglets from the same litter show PCV2 antibodies, but
no viremia, indicating that not all foetuses were infected and that
PCV2 infection took place after day 70 of gestation.
Future studies are needed to confirm if this is a regular finding on
French farms, and to investigate the reasons and implications of the
differences compared to other studies.
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A FARROW-TO-FINISH HERD FREE
FROM SWINE DYSENTERY 13 YEARS
AFTER ERADICATION
In 1996, a specialised fattening herd converted into a two-site farrow-
to-finish herd with 80 sows. Clinical symptoms of swine dysentery
(SD) were seen in the fatteners and SD was most likely introduced in
1995 with the purchase of growers. In 1998, clinical symptoms of SD
were also observed in sows and piglets. Brachyspira hyodysenteriae
was demonstrated in 13 out of 23 samples (57%). Samples were
negative for salmonella and pathogenic E. coli.
In 1999 an eradication program was undertaken where sows were
treated with tiamulin by injections and water medication. In brief,
sows received an injection (10 mg/kg) 11 days before they were
washed, disinfected and transferred to a disinfected unit where they
received a second injection. They were also water medicated for 14
days from the time of the first injection until three days after
allocation in disinfected units. The stable units were cleaned and
disinfected after being emptied and before sanitised pigs entered.
Cleaning of units consisted of pressure-wash, drying and disinfection
using glutaraldehyde. Slats were removed to allow thorough cleaning
and disinfection. Manure pits were emptied and manure was removed
from yard surfaces. Rodent control was enforced and cats and dogs
were treated with tiamulin in water. All fecal samples collected after
the eradication have been negative for B. hyodysenteriae (n=210) but
other Brachyspira spp. (n=102) including B. pilosicoli (n=5) have been
demonstrated. The most recent sampling was performed in September
2012. Bloody diarrhoea was seen in a number of fatteners and gilts 2½
years after the eradication. Laboratory investigations determined
Lawsonia intracellularis to be the cause of the symptoms. In
conclusion, the eradication program for SD proved to be successful in
the long term. However, eradication of other Brachyspira spp. was not
achieved. Neither was L. intracellularis eradicated although tiamulin is
effective in treating proliferative enteropathy.
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“PROFESSIONAL PIG PRACTICE” –
A GAME-BASED E-LEARNING CONCEPT
WITH VIRTUAL PIG HERD VISITS
Background: Herd visits are extremely important for practising clinical
skills during veterinary education. However, such activities have a high
cost and therefore the student confrontation time is limited. This
causes major worries among students that face professional contact
with clients/patients after graduation. A possible solution could be to
provide a safe, virtual environment to practice such skills in an easy-
accessible, interactive setting. Hence, the objective of this project was
to develop, document and test a game-based E-learning concept
where students visit virtual farms, interact with the farmer, examine
the animals, perform autopsies and finally identify and diagnose the
problem and suggest appropriate action.
Methods: The project combines veterinary research and professional
skills, pedagogical disciplines (didactics and learning methods) and
computer science. In short, students draw a herd at random (with a
well-defined disease or problem). The visit (game) starts at the stable
door where certain safety procedures should be applied to avoid
contamination (change clothes, wash hands etc.). There will be
several lines of dialogue with the farmer, some leading to important
clues, others not. By selecting a pen (point and click) a video
sequence shows typical clinical signs and behavioural patterns of
affected pigs. Certain animals can be selected for closer examination
and autopsy where close-ups will be provided and students must
notice and identify pathological changes. It will be possible to select
material for laboratory examinations and receive the results of i.e.
culturing during the visit. The visit is concluded by selecting the
correct diagnosis and prescribe appropriate treatment and/or action.
The game design resembles adventure – and simulation games and
students obtain points by correct actions.
Results: By now a playable demo is produced and will be demonstrated
(10-15 minutes) if this abstract is accepted for oral presentation.
Otherwise, screen dumps will be presented on poster.
NOTES
POSTER PRESENTATIONS: CLINICAL
107
P015
Marina Štukelj1, Ivan Toplak2
1 University of Ljubljana, Veterinary faculty, Institute for the health care of
pigs, Gerbičeva 60, 1000 Ljubljana, Slovenia;
2 University of Ljubljana, Veterinary faculty, Institute for Microbiology and
Parasitology, Gerbičeva 60, 1000 Ljubljana, Slovenia.
AN ATTEMPT TO ELIMINATE THE PORCINE
REPRODUCTIVE AND RESPIRATORY
SYNDROME (PRRS) ON THREE SMALL
FARMS BY VACCINATION
Objective: An understanding of porcine reproductive and respiratory
syndrome virus (PRRSV) persistence and transmission within the
breeding herd is critical for successful eradication and/or control of
the disease. Vaccination is one strategy among the strategies that
have been promoted. Vaccination and following the strict biosecurity
protocols are very important measures for the success of the
program. The objective of this study was elimination of PRRSV from
three small pig farms in Slovenia by vaccination.
Material and method: The study was conducted on three one-site pig
farms. Farms 1, 2 and 3 have 15, 48 and 35 breeding sows respectively.
After confirmation of PRRS infection on a farm, serum samples were
collected from the breeding sows every 3 months for the period of 18
months. On the farm 1, 2 and 3 vaccination was provided at least once
with modified-live vaccine (MLV). All farms accepted strict biosecurity
protocols and herd closure for at least 200 days. For detection of
antibodies, IDEXX X3 ELISA was used and PRRSV detection and
sequencing was done as previously described (Toplak et al., 2012).
Results: The decreasing of S/P ratios was observed on all farms six
months after the vaccination but later S/P ratios increased again in
spite of herd closure and biosecurity measures. The nucleotide identity
(ORF7) between reference strain Lelystad and PRRS strain detected
from the farm 1 was 89,5%, from the farm 2 was 88-89,1% and from
the farm 3 was 93,4%.
Conclusions: The detected high heterogeneity between field and
vaccine strain is likely to be the main obstacle for the effective
elimination of PRRSV. According to the serological results the
vaccination did not result in great improvement. On the other hand
the regular vaccination approximately every three months improves
the clinical signs, reproduction and food conversion.
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CLINICAL CASE REPORT OF SWINE H3N2
INFLUENZA IN FRANCE
Introduction: According to the last survey of swine influenza viruses
(SIV), H1N1 and H1N2 subtypes are the major subtypes circulating
in France. H3N2 subtype has not been isolated for 12 years despite
it is circulating in adjacent countries. This case report illustrates the
re-emergence of H3N2 subtype in France.
Materials and methods: The farm located in the Northern of France,
10 kilometres far from the Belgian border was a 300-sow farrow-to-
finish unit. The herd was serologically positive to PRSSV but no virus
circulation was evidenced in post-weaning. Piglets were vaccinated
against PCV2 and M hyo at weaning. No flu vaccination plan on
going. Respiratory disease complex revealed by coughing and
anorexia used to occur in fatteners and sometimes in post-weaners.
Mortality rate weaning-to-slaughter was 7.5% and increased during
outbreaks. In January 2012, coughing, anorexia and sudden deaths
were observed despite normal rectal temperature. Swine flu was
suspected. Mass non-steroid anti-inflammatory (NSAI) treatment
was implemented. Nasal swabs in two 100-day-old fatteners were
taken and sent to the National Reference Laboratory (ANSES,
Ploufragan). A-type SIV RT-PCR, virus subtyping by both RT PCR and
IHA tests, isolation on MDCK (Madin Darbin Canine Kidney) cells and
genome sequencing were performed.
Results and discussion: The isolate (A/Sw/France/59-120031/12) was
confirmed to be a type A influenza virus and belonged to the European
human-like reassortant swine H3N2 lineage. The herd health status
returned back to normal after the NSAI treatment but heterogeneity
at slaughter was evidenced in the affected batch. Vaccination of the
sows with GRIPOVAC®3 was implemented in the farm resulting in
cessation of cough during post-weaning and decrease of suspected
“viral episodes” during fattening. New epidemiological survey is
ongoing to determine SIV subtypes prevalence including re-emerging
H3N2 subtype, in the Northern part of France.
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MUSIC CAN IMPROVE OR DETERIORATE
WELFARE IN PIGS
Objectives: Music is occasionally used to improve housing, rearing,
milking or pre-slaughter conditions in farm animals. However, detailed
scientific information on the effects is extremely rare. Because of direct
linkage between music and specific action (e.g. milking), most examples
are just instance of classical conditioning. In other cases, positive effects
of music are assumed, taking for granted, (often positive) effects of
music on humans. The goal of the present study was to understand
effects of music of different styles, on pigs of different breeds under
experimental housing conditions.
Material and methods: Ten Large White, 18 Pietrain and 18
Miniature pigs were used to study effects of music on the “species”
pig. Bach Orchestral Suite No 3 (BMV 1068) and Heavy Metal
(Indestructible/Disturbed) were used at a volume of just 60db to
compare extremely different music styles. No music served as the
negative control. The Behaviour of the pigs was recorded with a video
camera and analysed later. A total of 27 different behavioural
parameters were statistically clustered into activity and stress related
behaviour.
Results: Pietrain and Large White pigs showed a similar behavioural
pattern. Music of both styles increased activity and stress related
behaviour and decreased lying activity. Miniature pigs, however showed
a contrary behaviour. With more stress, they showed increased time
with lying and reduced activities. Heavy metal led to significantly
increased stress related behaviour. Even convulsions were observed in
Pietrain pigs. Bach increased activity related behaviour, although some
elements were able to induce stress-related behaviour.
Conclusion: Music as an unfamiliar factor for the pigs was able to
induce stress related behaviour, even in its Classic style, although
with significant quantitative effects between styles. Some Classic
pieces of music however, led to a behavioural activation of the pigs,
improving their well-being in an inactive environment.
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INSIGHTS IN BRACHYSPIRA HYODYSENTERIAE
DETECTION ON NINE BELGIAN PIG HERDS
Brachyspira hyodysenteriae – the etiological agent of swine dysentery
– is an increasing problem on Belgian pig herds and causes important
financial losses. The aim of the study was to create insights in the
detection of the disease on infected farms.
Nine pig herds were selected based on the presence of diarrhoea and
a positive PCR test (Adiavet Brachy). At each farm, thirty-six
individual fecal samples were taken in randomly selected pigs. The
sampling was done in four different groups: weaners (n=9), at 40kg
(n=9), at 80kg (n=9) and in the group where diarrhoea was seen
(n=9). Sampling was done before administration of antibiotics. The
samples were tested by PCR and the fecal consistency was scored.
Over the nine farms, thirty-one fecal samples were positive for
Brachyspira hyodysenteriae. In the groups where diarrhoea was detected
0-7/9 of the collected samples tested positive at PCR. In the other three
age groups, 0-5/27 samples tested positive. Thirty-six percent of the
positive samples had a normal fecal consistency. The remaining sixty-
four percent of the positive samples were scored as fluent or flat. The
within herd prevalence fluctuated between six and twenty percent.
As seen in the results, the possibility exists that, even in a group
where diarrhoea can be seen, none of the taken samples are positive
for B. hyodysenteriae at PCR. This conclusion makes it very difficult
to set up a screening protocol for pig herds.
Given the fact that more than one third of the positive samples had
a normal consistency, the bacteria can be found in samples of animals
without diarrhoea. Sampling asymptomatic gilts during the
quarantine period can thus be useful.
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A CLINICAL CASE OF CONGENITAL
TREMORS IN PIGLETS WITHOUT EVIDENCE
OF PCV-1 AND PCV-2
Congenital tremor (CT) is a disease of newborn pigs characterised by
spontaneous clonic contractions of one or more groups of voluntary
muscles. Besides suspected or confirmed etiologies of CT such as
classical swine fever virus, pseudorabies virus, Japanese
encephalomyelitis virus, hereditary disorders in Landrace or Saddleback
pigs, organophosphorus poisoning etc., porcine circovirus (PCV) has
been described as a potential cause of CT. The type AII seems to be
the most common form of CT. Although a potential association
between PCV1 or PCV2 and CT-AII has been observed, about 50% CT
cases described up till now are caused by unknown reasons.
In a PCV-seropositive 108-sow, farrow-to-finish Belgian pig farm
breeding hyperprolific Landrace, 42 litters with shaking piglet(s) were
reported since June 2006. On March 2012, piglets born from four sows
of a 27 sow batch demonstrated CT. After exclusion of main etiologies
of CT from these CT-affected piglets, it was hypothesised that PCV1
or PCV2 could be the reason. Necropsies (n=8) and histopathology
(n=3) were performed and no evidence of macroscopic or microscopic
lesions were seen in cerebrum, cerebellum and spinal cord. Pre-suckled
and post-suckled (after 3 days of colostrum uptake) serum samples
were also collected from 9 piglets to determine PCV1- and PCV2-
specific Ab titres by an immuno-peroxidase monolayer assay (IPMA).
No PCV-specific Ab titres were observed in pre-suckled serum samples
(≤40), whereas IPMA Ab titres of ≥640 were observed in post-suckled
serum samples. Both PCV1 and PCV2 could not be isolated (<101.7
TCID50/g tissue) from 4 tested piglets (in heart, brain and lungs). The
present results do not support the hypothesis that PCV1 or PCV2 are
linked to CT in newborn piglets.
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STUDY ON FEASIBILITY OF UDDER
CONFORMATION MEASURES IN SOWS
The aim of this study is to develop practical measures of udder
conformation, quantify the changes of udder traits during the sows’
cycle life and investigate the correlations between these traits and
piglets’ survival, health and performance. In a preliminary study, udder
traits were based on measurements of udder position, teat size and
placement. Measures were taken twice daily to assess record
repeatability from the time of entry into the farrowing house until
parturition. 5 measures are taken when the sow was lying down on
side: distance between the two teat rows; distance from the base of
the teats in the upper row to the abdominal line; distance from the
teat base in the upper row to the ground; distance from the teat base
of the lower row to the abdominal line and distance from the teat
base of the lower row to the ground. 3 measures are recorded on the
standing sow: distance from teat tip to the ground; distance between
the tip teats from one row to the other and distance from the fore
udder abdominal attached to the ligament of the leg on both side left
and right. Teat traits are the number of functional teats, the
placement and the size, measured as length and diameter at the base.
Six point linear scales were developed to define teat position and
five score to define teat shape. Result will be show on the poster.
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MULTILOCUS SEQUENCE TYPING (MLST)
OF ESCHERICHIA COLI ISOLATED FROM MILK
OF SOWS WITH MASTITIS AND HEALTHY
CONTROL SOWS
Coliform mastitis as one main symptom of puerperal disorders in sows
subsumed under the term Postpartum Dysgalactia Syndrome (PDS)
affects both the sow and the piglets seriously. It is known as a
multifactorial disease, and bacteria, especially Escherichia coli (E. coli),
have often been isolated from diseased animals. Although multilocus
sequence typing (MLST) is a common tool in bacteria typing, due to
our knowledge it has so far not been used for further investigations of
isolated strains from sows’ milk samples. Therefore, this study aimed at
the characterisation of E. coli-isolates from sows affected with PDS
(PDS+) and from healthy control sows (PDS-). Bacteriological
identification of E. coli was performed from milk samples of five farms.
A selection of 432 E. coli-isolates, 194 isolates from PDS+ sows, and
238 isolates from PDS- sows, was examined via MLST. For this purpose,
the Achtman MLST scheme (http://mlst.ucc.ie/mlst/dbs/Ecoli) was
elaborated, sequencing seven housekeeping genes. In total, 82 different
sequence types (ST) were detected with ST10 (21.8%), ST877 (7.1%)
and ST101 (6.4%) as the most frequent ones. Whereas ST10 and
ST877 were detected more often in E. coli from PDS- sows (ST10:
59.0%, ST877: 54.8%), ST101 was more frequently observed in E. coli
from PDS+ sows (60.7%). The subsequent MLST-based phylogenetic
analysis represents the distribution and relationship between the ST of
E. coli taking into account the effects of PDS and farm.
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USE OF ALTRENOGEST (MATRIX™) AT
WEANING IN PRIMIPAROUS SOWS
Altrenogest is a common reproductive tool widely used in the US
pork industry. Commercialised under the brand name Matrix™ in
North America, this synthetic analogue of progesterone is approved
for estrus synchronisation in gilts that came in estrus at least once.
It is well-known that primiparous (P1) sows experience a decrease
in their second-litter size and that they are more sensitive to summer
infertility than older sows: delayed return to estrus after weaning
and reduced conception rates are common in P1 sows. The purpose
of this study was to assess if giving Matrix™ (15 mg of altrenogest)
for seven days to the sows after their first weaning could maintain
farrowing rate and improve the number of piglets born alive at the
second pregnancy. This study was conducted on a commercial farm
of 4000 primiparous sows. On the day of weaning, sows were
randomly assigned to control or treated group. Results obtained from
the first 1158 and 1119 sows in the control and treatment groups,
respectively, showed that the farrowing rate following the first
insemination was not different (81.5% and 80.4%, respectively),
whereas the sows treated with Matrix™ gave birth to 0.5 alive piglets
more (p<0.05) and tended to wean 0.3 piglet more (p=0.06) than
the control sows. The second parity depression in litter size was
demonstrated in this herd (-0.44 piglets born alive at P2 in the
control group) but was suppressed by the administration of Matrix™
(0.02 piglet more at P2). Also, the number of sows culled because
they did not come back to estrus after parity one was less (33 versus
69; p<0.05) in the treated group than in the control group.
Postponing the insemination of P1 sows for one week gives sows
time to restore their energy reserves used during the first lactation
and improves fertility results.
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PCV2 EVIDENCING IN OVIDUCTS OF
CULLED SOWS: A CASE REPORT
Introduction: Implication of PCV2 in reproductive disorders has been
reported by several authors. It has also been demonstrated that all
cells of the young embryos are susceptible to PCV2 as soon as they
get rid loss of the zona pellucida. Replication of PCV2 in embryos in
early pregnancy possibly leads to embryonic death. In farms suffering
from reproductive disorders, PCV2 prevalence in the genital tract of
culled sows is consequently of particular interest.
Material and methods: Data was collected in a French 84-sow
farrow-to-finish operation. The herd was PRRSV-free. Sows were
routinely vaccinated against porcine parvovirus. Sows and piglets
were not vaccinated against PCV2. In September 2010, abnormal
number of returns to oestrus were observed. PCV2 circulation was
evidenced serologically in sows.
Five culled sows from parity 1 to 3 were necropsied at slaughterhouse.
Ischiatic and uterine lymph nodes were sampled for histology and
immunohistochemistry. One oviduct per sow was collected using
aseptic techniques, including single use instruments and assayed by
PCV2 PCR.
Results and conclusion: A slight hypoplasia of the lymphoid tissues
was found in the lymph nodes of two sows. However, no
immunohistochemical staining evocative of PCV2 infection was found
in any of the organs. PCV2 DNA was found in two sows out of five in
accordance with previous findings (Bielanski et al., 2004). The positive
sows were primiparous. No correspondence between the slight lesions
and the presence of PCV2 DNA was found. Nevertheless, the presence
of PCV2 in the oviduct represents an early risk of contamination and
further on of infection and death to the embryos. Additional large
scale investigations are required to evaluate the prevalence of PCV2
presence in the oviduct of sows in PCV2 positive herds.
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EVALUATION OF DIFFERENT FARROWING
INDUCTION PROTOCOLS IN SOWS
Dead born piglets mostly die during parturition due to intra-partum
asphyxia. Inducing parturition may reduce the variation in onset of
parturition between sows and allow supervision to be more convenient,
especially when parturitions can be concentrated during working hours
(22-32h after first injection, WH). Three protocols for farrowing
induction using prostaglandin (PG) and/or oxytocin (OT) are well
known: single injection of PG (1xPG), combination of PG + OT 24h later
(PG+OT) and two injections of PG with 6 hours interval (split-dose-
technique). The latter protocol uses a double dose of PG. We
investigated the effects of using two times half of the dose of PG
(2x½PG). One-hundred and eleven Topigs-20 sows, stratified for parity
(1-7) and backfat levels, were randomly divided into 4 groups: 1xPG,
PG+OT, 2x½PG, and control using Gabbrostim®. Induction was
performed at day 114 of gestation. Following parameters were
measured: time between first injection and onset of parturition (Tip),
parturition duration, average birth interval, % dead born piglets, and
need for parturition assistance. Continuous variables with normal
distribution and homogeneity of variance were compared using ANOVA
with LSD post-hoc tests. Ordinal or not-normally distributed variables
were analysed using a Kruskal-Wallis non-parametric approach with
post-hoc pairwise comparisons using Bonferroni correction.
All induction protocols had a significantly shorter Tip(min) than the
control group (p=0.006) but did not differ mutually (PG:1363,
PG+OT:1472, 2x½PG:1530, control:1925). More sows started
farrowing during WH for PG+OT (68%, p=0.001) and 2x½PG (52%,
p=0.035) compared with the control (23%) while PG (46%) did not
differ significantly from the other groups. All other observed variables
were comparable between the four groups.
In the present herd with strict supervision of sows during farrowing,
applying PG+OT or 2x½PG for farrowing induction led to significantly
more sows farrowing during WH without negative effects on other
tested variables.
NOTES
P025
Declerck I., Dewulf J., Piepers S., Maes D.
Faculty of Veterinary Medicine-Ghent University, Merelbeke, Belgium.
FACTORS AT FARM AND SOW LEVEL
ASSOCIATED WITH COLOSTRUM
PRODUCTION PER LITTER
The litter size of sows has substantially increased during the last
decade. Therefore, it is a major challenge to provide all piglets with
sufficient colostrum. Insufficient colostrum intake has been identified
as one of the main causes of neonatal mortality. This study aims at
estimating colostrum production and identifying factors at farm and
sow level associated with colostrum production. For this purpose
hundred randomly selected sows and their offspring originating from
ten pig herds (10 sows per herd) were included in the study. Sow
colostrum production during 24 hours after start parturition was
assessed based on the colostrum intake of the litter, which was
estimated by the weigh-suckle-weigh method. Linear mixed
regression models with farm as random effect were used for the
analysis (SPSS 19.0 IBM). The average colostrum production per sow
was 4.75kg (min. 0.65 – max. 9.42). There was no significant effect of
parity, gestation length or parturition duration. Breed (P=0.03) and
litter size (P<0.01) had a significant effect. Litter size was positively
associated with colostrum production. From the total variance of
colostrum production, most resided at the farm level (61%), less at
sow level (39%). At farm level, breed and litter size explained 80% of
the total variation. We can conclude that the majority of variance of
sow yield between farms can be explained by the breed. As colostrum
composition is a very critical issue, further analyses will give the
opportunity to identify factors associated with colostrum quality.
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ANALYSIS OF PHEROMONES AND
TESTOSTERONE IN SALIVA OF LANDRACE
AND MINIPIG BOARS
There is anecdotal evidence that minipig boars are more potent in
stimulating females at estrus than boars commonly used in
commercial swine production. This study was conducted to test the
hypothesis of differences in salivary pheromones in Göttingen minipig
(GMB) and German landrace boars (GLB). A total of 10 GMB and 16
GLB were sampled either in December (GMB) or February (GLB), and
saliva (0.5 to 2.0ml) was obtained during semen collection using
collection systems designated for use in humans. Salivary 5a-androst-
16-en-3-one, 5a-androst-16-en-3a-ol and -3b-ol were determined
using GC-MS analyses, and testosterone using an in-house enzyme
immunoassay (EIA). Mean concentration of 5alpha-androst-16-en-3
alpha-ol was 0.18 + 0.13 and 9.20 + 8.57µg/ml, respectively, in GLB
and GMB. For 5alpha-androst-16-en-3beta-ol it was 0.02 + 0.01
versus 0.42 + 0.37µg/ml and for 5alpha-androst-16-en-3-one 0.04 +
0.03 versus 1.70 + 1.42µg/ml. Salivary testosterone levels were 3.05
+ 3.32 ng/ml in GLB versus 223.7 + 266.3 ng/ml in GMB boars. In
conclusion data demonstrates that there is a breed difference in
salivary 16-androstene and testosterone concentration. This might,
at least in part, be in fact part of the observation of a better libido of
minipig compared to landrace boars.
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EFFECT OF MASS VACCINATION WITH
INGELVAC CIRCOFLEX® ON REPRODUCTIVE
PERFORMANCE OF SOWS
PCV2 infection can be with reproductive failure. However, nowadays
in France, no PCV2 vaccine has a specific indication for reducing
PCV2 associated reproductive failure. Based on the successful
implementation of sow vaccination reported from other countries, a
field observation was initiated on a 170 sow farrow-to-finish, infected
with PCV2 and affected by reproductive failure.
Mass vaccination of sows with Ingelvac CircoFLEX® (Boehringer
Ingelheim Vetmedica, 1ml per sow, intra-muscular injection) was
implemented mid-December 2011. As sows can be affected by PCV2
associated clinical signs in all stages of pregnancy, the full effect of
sow vaccination is only expected when sows are vaccinated at least
3 weeks before mating. Therefore 3 distinct observation periods were
defined: A) Before sow vx: 5 batches (A1-E1) mated April to July 2011;
B) Transition period: 5 batches (A2-E2) mated early August to
December 2011; C) After sow vx: 5 batches (A3-E3) mated January
to May 2012. Gilts were vaccinated twice before being introduced
into the gestation unit.
No adverse reactions have been observed during or following mass
vaccination of the sows. Evaluating the reproductive parameters, an
increase in the farrowing rate (Before-after: 81.7% vs 88.7%) and
the number of piglets born alive was observed (12.2% vs 12.9%),
leading to increased number of piglets weaned per sow (10.1 vs 10.9).
No difference was observed in pre-weaning mortality (15.6% vs
15.5%). This finding can be explained by the fact that management
of sows was not adapted to the higher number of piglets per sow,
leading to an increase in the number of pigs crushed.
In conclusion, this field observation on a French farm confirmed results
generated in other countries. Mass vaccination of sows with Ingelvac
CircoFLEX® was safe and improved reproductive performance. In
addition, piglet health and vitality at birth was improved as well.
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CLIMATE FACTORS ASSOCIATED WITH SOWS
RETURNING TO SERVICE DURING SUMMER
IN JAPANESE COMMERCIAL BREEDING HERDS
The objective of this study was to quantify the associations between
summer risk factors and sows returning to service. The study analysed
76,099 parity records of sows that had first-serviced between June
and September each year from 2007 to 2009; the sows were in 103
herds located in humid subtropical areas across Japan. Average daily
maximum temperature (HT) and relative humidity (RH) for 15 days
post-service of a sow were obtained from 21 weather stations and
coordinated with performance data from respective local herds. The
returns to service were classified into regular (RR: 18 to 24 days),
irregular (IR: 25 to 48 days) and late categories (LR: 49 days or later).
Two-level mixed-effects models were applied to the data by using a
herd at level 2 and an individual record at level 1.In mated sows, the
occurrences of RR, IR and LR were 3.3, 3.4 and 2.6%, respectively.
Higher occurrences of returns to service were associated with higher
HT, lower parity and a weaning-to-first-mating interval (WMI) of 7
days or later (P<0.05), but not with either RH (P>0.56) or lactation
length (P>0.12). For each 5°C increase in HT, sows with any WMI
were 1.22 (1.04^5) times more likely to have an occurrence of RR.
Such a 5°C increase in HT also increased the occurrence of IR and LR
by 1.27 (1.05^5) and 1.33 (1.06^5) times, respectively, in sows with
WMI 0 to 6 days. However, there was no effect of higher HT on IR or
LR for sows with WMI 7 days or more (P>0.42). Therefore, in order to
prevent returns to service it is recommended that producers install
cooling systems for sows during the post service periods in summer.
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INTERSEX PIGS, ALSO IN THE WILD BOAR
Introduction: Intersex piglets is a common malformation in the
domesticated pig and in the conventional pig production. A Swedish
study (Bäckström & Henricson 1971) showed a prevalence of 0.2 %
in over 17,000 piglets examined. The study also found strong
evidence for a genetic predisposition for intersex and a tendency to
increased numbers of malformations and scrotal hernias in litters
with intersex piglets.
To our knowledge, no reports on the presence or prevalence of
intersex individuals among wild boars have been published.
Case presentation: Within the national surveillance program of
fallen wildlife, material from a wild boar (Sus scrofa) was sent to the
Swedish National Veterinary Institute. The wild boar was shot during
normal hunting, was in good body condition, and estimated to be
older than one year. The body appearance and external genitals
resembled that of a gilt but with a considerably prominent clitoris.
The reproductive organs were taken out by the hunters after
photographing them in situ. The right testis was located in the
scrotum and one rudimentary testis was found in the abdomen close
to the left kidney. The tubular genital part consisted of a uterus that
connected the two testis and the corpus and the uterine lumen was
partly filled with a semi-translucent fluid. A second tubular part
without connection to the former protruded from the middle section
out to a vagina with labia and vulva. From the site of the clitoris a
3cm long penislike structure protruded. Several histological sections
have been done from various parts of the material. No ovaries or
structures resembling ovaries were found.
The wild boar was diagnosed to be a pseudohemaphrodite male.
References:
Bäckström L. & Henricson B., 1971 Intersexuality in the pig. Acta
vet. scand. 12, p.257-273.
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INFLUENCE OF THE AGE AT 2ND
VACCINATION WITH IMPROVAC® IN MALE
FATTENERS ON TESTES WEIGHT AND
PARAMETERS OF BOAR TAINT
Objective: Aim of the study was to examine, if the age of male
fatteners at the time of the 2nd vaccination with Improvac® has an
influence on testes weight and boar taint and if testes weight in early
vaccinated pigs can therefore be used as parameter to decide if a pig
is definitely vaccinated twice as is necessary.
Material and methods: A whole of 161 male fattening pigs were
included in the study. All pigs received the 1st vaccination at the age
of 11 weeks. Pigs of group A (n=82) received the 2nd vaccination at
the age of 21 weeks, pigs of group B (n=79) at the age of 18 weeks.
All pigs were slaughtered at the age of 26 (55 pigs of each group) or
27 weeks (remaining pigs), respectively. Testes weight was evaluated
in all pigs. Androstenon, skatole and indol concentrations in back fat
were examined in 40 pigs of each group.
Results: Testes weight was significantly lower in the earlier vaccinated
pigs of group B (median 40.0 g, minimum 22.8 g, maximum 371 g) as
in group A (93.3 g, 57.8 g, 400 g). There was, however a wide deviation.
In seven pigs of group A and 10 pigs of group B, androstenon
concentration was slightly above detection limit of 75 ng/g. Skatol
and indol concentrations were at 57 ng/g and 25 ng/g in group A and
55 ng/g and 26 ng/g in group B. No differences between the groups
could be observed.
Conclusion: Although testes weight in pigs earlier receiving 2nd
vaccination with Improvac® is significantly lower than in pigs with
later vaccination, testes weight is no absolute save criterion to decide
if one pig is vaccinated twice or not, because pigs with high testes
weight were observed in both groups. Parameters of boar taint,
however, were not elevated in those pigs.
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POST-PARTUM DYSGALACTIA SYNDROME
FOR PRACTITIONERS
Early postpartum disorders seem more frequent and to occur in very
good herds where productivity is very high and management skills
are developed. In fact postpartum dysgalactia syndrome (PDS) is a
common problem for practitioners in field faced with more subtle
symptoms that by the past with Mastitis, metritis and agalactia
syndrome (MMA). Some risk factors for PDS have been elucidated
mainly related to nutrition, housing, and management practices. A
central role of endotoxins and cytokines in the development of the
problem has also been suggested. However, the pathophysiology of
PDS remains unclear. The objective of this paper was to propose a
plausible model for it on which to draw a systematic method to
investigate clinical cases in field. A total of 94 papers were selected
by a snowball method from an initial search in classical textbooks,
conference proceedings and PubMed. The concept of homeorhesis
appeared to be an interesting perspective in the explanation of this
multifactorial disease and its handling in practice. It encompasses
dynamic systems that return to a trajectory, referring to orchestrated
changes in metabolism of body tissues to prioritise a physiological
state (such as gestation or lactation). We hypothesised that an
unsuccessful change in homeorhesis when shifting from gestation to
lactation could be at the heart of PDS and that three major
components closely related were potentially contributing to it: the
body-building syndromes, the endotoxemia component linked to the
innate immunity system and stress related mechanisms. If our model
does not pretend to be able to solve all the PDS situations
encountered in field, it ensures clinicians to have the holistic
approach necessary to tackle modifications that often occur before
farrowing but remain asymptomatic before revealing animals such as
piglets are present, and that affect the optimum expression of the
sows’ productive capacity.
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SKIN TUMOUR IN AN AGED GERMAN
LANDRACE SOW
Neoplasms are infrequently reported in domestic swine because of
the short life span of most farm animals (1). With the increasing
popularity of production animals such as swine, sheep, and goats, but
also miniature pigs as pets, a geriatric population of farm animals is
now developing diseases which are rarely seen in animals raised for
meat production (2). Due to the increased incidence of neoplastic
diseases in any geriatric population, the increase of tumors in swine
species kept as pets has to be expected (1).
A case of the occurrence of a squamous cell carcinoma located in the
skin at the center of the udder of a 14-year-old German Landrace sow
is presented. The tumor was spherical and 17.0cm in diameter. The tissue
of the distal pole had a cauliflowerlike appearance, was black and
ulcerated with a malodorous exudation. The sow did not show any signs
of reduced general condition caused by the tumor. No evidence of
metastasis was noted in regional lymph nodes and in the lung.
The tumor, which weighed 2.4kg, was surgically removed. The
histopathology revealed infiltratively growing pleomorphic tumor cells
and cell aggregations with prominent squamous differentiation. Cells
were strongly positive for several cytokeratins by immunhistochemistry.
The present findings confirmed the diagnosis of squamous cell
carcinoma. After surgery, the sow recovered without complications and
remained without recurrence at the follow-up three months later.
References:
1. Swenson et al., (2009), J. Vet. Diagn. Invest. 21, 905-909
2. Munday and Stedman (2002), Vet. Pathol. 39, 580-583
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DETECTION OF THE ENZOOTIC
FORM OF SWINE INFLUENZA BY
ORAL FLUID SAMPLING
Objective: Swine flu outbreaks were detected in Spain as early as 1981
(H1N1) and 1986 (H3N2) following an epidemic pattern. Recent
epidemiological studies have shown high seroprevalence of the 3
subtypes common in Europe. However, this disease deserves nowadays
scarce attention from the farmers and practitioners, and there is little
information about the presence of endemic forms of SIV. The recent
availability of oral fluid samples, a sensitive and convenient method,
offers new opportunities to detect and characterise the circulation of
this and other virus in production farms. Therefore, our objective was
to use this new technique to study the co-circulation of PRRSV and SIV
in farms experiencing respiratory symptoms in the post-weaning
and/or fattening.
Material and methods: Oral fluid samples (1-3) were taken in the post-
weaning and/or fattening units of 97 farms with a variable number of
animals experiencing respiratory signs, and fever, dullness growth
retardation or heterogeneity. Samples were analysed for both PRRSV
and SIV by RT-PCR. Fischer exact test was used to analyse prevalence
differences within and between production phases. Results were
stratified according to the number of samples per farm (1,2 or more).
Results and discussion: For single sampled farms (n=33), none of the
virus was detected in 13 of them (39.4%), the PRRS+/FLU- pattern
was detected in 3 farms (9%), 11 (33.3%) farms showed a PRRS-/FLU+
result, and the remaining 6(18.2%) yielded positive results for both
viruses (p=0.50, NS). However, in farms with 2 or more samples (n=64)
the corresponding figures were: 15.6%, 14%, 35.9%, and 34.4% (p=1,
NS). Both, single or multiple samples yielded comparable results but
these data were not adjusted for production phase or age. This
preliminary study is a clear indication of a high prevalence of endemic
flu in our conditions as a single infection or associated with PRRSV.
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EVALUATION OF QUANTITATIVE MULTIPLEX
REAL-TIME PCR FOR DIAGNOSIS OF SWINE
BACTERIAL ENTEROPATHIES
The aim of this work was the adoption of a Real-time PCR (RT-PCR)
assay to detect Brachyspira hyodysenteriae, Brachyspira pilosicoli and
Lawsonia intracellularis in swine fecal samples at the same time,
overcoming limitations of current tests due to long incubation time
of bacterial cultures, low PCR sensitivity from feces and presence of
mixed infections. The RT-PCR was compared to culture for
Brachyspira spp. and to conventional PCR for L. intracellularis on a
set of field fecal samples and kappa coefficient was calculated to
estimate level of agreement.
Fecal samples spiked with Brachyspira bacterial cells and a Lawsonia
vaccine were tested for the evaluation of Real-time PCR parameters.
Sixty Nine (69) field fecal samples, from 24 outbreaks of enteritis in
growers and fatteners were analysed using the RT-protocol in parallel
with culture and conventional PCR. Bacterial DNA from stool samples
was extracted and analysed by a quantitative multiplex RT-PCR,
according to Willems H. (2010). Kappa values were evaluated as
suggested by Altman.
Analytical sensitivity was 2,7x103 DNA copies/gr feces for B.
hyodysenteriae and 1,1x104 DNA copies/gr feces for L. intracellularis.
Loss of sensitivity due to matrix effect, compared to initial
contamination, was below one order of magnitude. The k-values were
0,32 for B. pilosicoli, 0,63 for B. hyodysenteriae and 0,91 for L.
intracellularis, corresponding to a fair, good and very good strength
of agreement, respectively. RT-PCR detected more positives than
traditional techniques for all the three pathogens considered. For B.
hyodysenteriae, 11/12 RT-PCR positive samples and negative by
culture were from B.hyodysenteriae-positive herds; moreover, the
four B. pilosicoli positive fecal samples detected by RT-PCR and not
by culture were characterised by a low DNA copy number.
These results, along with the possibility of quantification of bacterial
load, suggest that this test could be a useful tool for rapid diagnosis
of pig enteritis.
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AMBIENT TEMPERATURE STORAGE OF
PORCINE ORAL FLUID SAMPLES FOR PRRSV
RT-PCR TESTING USING FTA CARDS
The use of oral fluid (OF) as a diagnostic medium is a growing field
of research interest across the EU. Reverse transcription polymerase
chain reaction (RT-PCR) has been shown to successfully detect RNA
pertaining to the Porcine Reproductive and Respiratory Syndrome
virus (PRRSv) in swine OF samples. However, inconsistencies have
been found in the RT-PCR results of OF samples from known PRRSv
positive pig herds in the UK (Strugnell 2010), and the ways in which
samples are handled and stored post-collection highlighted as key
areas for further investigation. Flinders Technology Associates (FTA)
cards are treated with a patented formula to allow the storage and
recovery of nucleic acids from biological samples. Storage of swine
OF using FTA cards has been shown to significantly reduce the
diagnostic sensitivity of RT-PCR for PRRSv (Linhares, Rovira et al.,
2012). Here, we demonstrate recovery of PRRSv RNA by RT-PCR from
porcine OF dried onto FTA cards with a detection limit of around
4pg/ml RNA. A series of optimisation experiments involving PRRSv
RNA and culture supernatant spiking of swine OF lead to the highly
sensitive limit of detection reported, and characterised the decrease
with storage time at ambient temperature. Successful storage of
porcine OF at ambient temperatures using FTA cards will significantly
simplify existing chill/freeze protocols for OF sample handling for
swine disease diagnostics.
Linhares, D. C. L., et al., (2012). Evaluation of Flinders Technology
Associates cards for collection and transport of samples for detection
of Porcine reproductive and respiratory syndrome virus by reverse
transcription polymerase chain reaction. Journal of Veterinary
Diagnostic Investigation 24 328-332.Strugnell B. (2010). Final Report
for BPEX Project: Evaluation of a PCR assay for Porcine Reproductive
and Respiratory virus in oral fluids from growing pigs and its
applications for diagnosis and surveillance in the UK pig industry.
Thirsk AHVLA: 26pp.
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EFFECT OF SALIVA STABILISERS ON THE
PRESERVATION OF QRT-PCR DETECTABLE
PORCINE REPRODUCTIVE AND RESPIRATORY
SYNDROME VIRUS IN ORAL FLUID
In the USA, porcine oral fluids are already used for the monitoring of
PRRSV infections. The complex composition of oral fluids however
could require important optimisations of preservation methods. Until
now it was recommended to store oral fluids at 4°C. Since it can be
expected that immediate cooling of samples is not always feasible,
alternative options have to be considered. Therefore we analysed the
capacity of three commercial saliva stabilisers (Oragene RNA (DNA
Genotek), Aware Messenger (Calypte Biomedical Corporation) and
the Saliva Gene Collection Method (Stratec)), to preserve PRRSV in
oral fluid at room temperature for downstream detection by qRT-
PCR. Porcine oral fluid, with or without saliva stabilisers, was spiked
with PRRSV, stored at 4°C or room temperature and tested for the
presence of PRRSV by qRT-PCR. When oral fluid was spiked with
103.5 TCID50/mL and stored at 4°C, only a non-significant reduction
was observed within 7d. When this oral fluid was stored at room
temperature, clear degradation of PRRSV RNA occurred resulting in
a 10-fold reduction in the number of detectable PRRSV copies within
24h and a 100-fold reduction within one week. Interestingly, addition
of the Oragene RNA stabiliser was able to inhibit PRRSV RNA
degradation at room temperature for at least 1 week. In contrast,
addition of both other stabilisers resulted in faster RNA degradation
than when oral fluid was stored without addition of stabilisers. When
oral fluid was spiked with the lower concentration (100.5
TCID50/mL), PRRSV could be detected for 7d when kept at 4°C or
stabilised with Oragene RNA. In contrast, copy number dropped
below the detection limit within four hours when treated with both
other stabilisers and within 3d for samples kept at room temperature.
Our results demonstrated the importance of correct conservation of
oral fluid samples to preserve PRRSV to allow detection by qRT-PCR.
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IMPACT OF ROPE MATERIAL ON TOTAL
AND PRRSV-SPECIFIC ANTIBODY RETRIEVAL
FROM ORAL FLUID
Several studies already evaluated the use of oral fluid as an alternative,
non-invasive collection method for the diagnosis, monitoring and
surveillance of various pathogens. Currently these oral fluid samples
are collected through cotton ropes. However, little is known about
the influence of rope material on the analytes of interest for
subsequent diagnostic tests. Therefore, the aim of the present study
was to evaluate the impact of different rope materials on the amount
of collected total antibodies and virus-specific antibodies. Three
PRRSV-naïve Belgian Landrace pigs were vaccinated IM with a live
attenuated PRRSV vaccine and received a booster two weeks later.
One pig served as a negative control. Oral fluids were collected at -1,
14 and 28 days post vaccination with four different ropes: cotton,
hemp, polyamide and polyester. The total amount of isotype-specific
antibodies present in the oral fluid samples were measured by a
commercial direct sandwich ELISA and confirmed by means of
Western Blotting. As was expected, the amount of total IgA was 3-4
times higher than total IgG and IgM. However, depending on rope
type, significant differences on the amount of total isotype-specific
antibodies were obtained. Synthetic ropes retrieved 2-3 times more
total IgA. Nevertheless, these rope types were less efficient in total IgG
retrieval. IgA, IgG and IgM antibodies to PRRSV proteins were detected
by immuno peroxidase monolayer assay (IPMA). Preliminary results
show that although the total amount of IgA in oral fluid is much
higher than IgG, IgG is the dominant PRRSV-specific antibody in oral
fluids. Our results show that in order to detect PRRSV antibodies in
oral fluid by means of ELISA, ropes of natural material are preferred.
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INFLUENCE OF EXTRACTION AND
AMPLIFICATION METHOD ON THE
DETECTION OF PORCINE REPRODUCTIVE
AND RESPIRATORY SYNDROME VIRUS
(PRRSV) IN ORAL FLUIDS.
Multiple commercial nucleic acid extraction and PCR amplification
kits exist for the detection of viruses in blood, serum and organs. So
far, their applicability for virus detection in oral fluid, a complex body
fluid containing multiple possible inhibitors and degrading proteases,
has not been fully evaluated. Therefore, the aim of the present study
was to evaluate the influence of extraction-amplification methods on
the detection of PRRSV RNA by qRT-PCR in oral fluid. Four commercial
RNA extraction kits (MagMAX Pathogen RNA/DNA kit(Life
Technologies), Ultraclean Tissue and Cells RNA isolation Kit (Mobio),
QIAamp Viral RNA Mini Kit (Qiagen) and High Pure Viral Nucleic Acid
Kit (Roche)) and two real time RT-PCR kits for PRRSV (TaqMan NA
and EU PRRSV Reagents (Life Technologies) and Adiavet PRRS EU/NA
Realtime (Adiagene)) were examined for their diagnostic performance
using a dilution series of PRRSV-spiked oral fluid (1 x 104.7 to 1 x 100
TCID50/mL). All extraction-amplification combinations were able to
detect PRRSV RNA in oral fluid, but the limit of detection varied
between the combinations ranging from 1 TCID50/mL to 100
TCID50/mL. Based on the limit of detection, r2 value, PCR efficiency,
linear range and fluorescence amplification signals, we selected the
MagMAX Pathogen RNA/DNA extraction kit combined with the
TaqMan NA and EU PRRSV Reagents amplification kit as the most
optimal method. The same combination yielded also the best results
in a study conducted by Chittick et al., (2011). Nevertheless, all
possible extraction-amplification combinations showed rather high
PCR efficiency values (115.88% to 139.44%). Since efficiencies can be
improved by optimising the buffer and/or polymerase of the PCR
reaction, manufacturers of commercial PCR kits should be encouraged
to further optimise and improve their kits for PRRSV detection in
oral fluid.
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USE OF AN ENZYME-LINKED
IMMUNOSORBENT ASSAY (ELISA) TO
DETERMINE THE VACCINE UPTAKE
FOLLOWING DIFFERENT VACCINATION
SCHEDULES AGAINST MYCOPLASMA
HYOPNEUMONIAE (M.HYO)
Vaccines against Mycoplasma hyopneumoniae (M.hyo) have been
shown to induce serum antibodies, but these antibodies are not
suited to evaluate protective immunity. In this study, it was
investigated if these antibodies can be used to evaluate and compare
the uptake of different one-shot and two-shot vaccines in an M.hyo-
negative and M.hyo-positive herd. Fourteen and seventeen sows were
selected in an M.hyo-negative and M.hyo-positive herd, respectively.
From each of the fourteen and seventeen litters, six pigs were
randomly assigned to six groups, which were subject to different
vaccination protocols. Group 1 was vaccinated with Stellamune®
Mycoplasma at 1 and 3 weeks of life, group 2 was vaccinated with
Stellamune® One at 1 week of life, group 3 was vaccinated with
Stellamune® One at 3 weeks of life, groups 4 and 5 were vaccinated
with other one-shot vaccines at 3 weeks of life, and group 6 was left
non-vaccinated. Serum samples collected at 1, 3, 5, 7, 9, 12, 15, 18,
and 21 weeks of life were tested for the presence of antibodies
against M.hyo, using an enzyme-linked immunosorbent assay (ELISA)
(DAKO Mh). All five vaccination protocols were followed by a rapid
and long-lasting serological response in the M.hyo-negative herd,
showing that serology can be used to evaluate the vaccine uptake in
the absence of a natural infection. Except for a limited and transient
serological response in the two-shot vaccinated pigs, no serological
response was observed in the M.hyo-positive herd following the
vaccinations. However, all vaccinated pigs mounted a clear
anamnestic response upon a natural infection, suggesting a priming
of the immune system following the vaccinations. The number of
doses and the timing of the vaccinations did not have any impact
on the magnitude of the anamnestic response. This anamnestic
response could be used to evaluate the vaccine uptake in M.hyo-
positive herds.
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A NOVEL MYCOPLASMA HYOPNEUMONIAE
ELISA, SPECIALLY DESIGNED FOR HIGH
SPECIFICITY
Introduction: Mycoplasma hyopneumoniae (M.hyo) diagnostics are
considered to be a dilemma. For serology there is no true Gold
Standard available and until now serological assays lacked specificity.
On this basis there is a strong need for a highly specific assay with
good sensitivity. This paper describes the first set of results with a
high specificity M.hyo ELISA.
Materials and methods:
Sera sensitivity panel
This panel contains 108 samples from experimental infected animals.
Sera specificity panel
In total, 1695 samples from SPF herds from five different studies
of different geographical regions were tested. Samples were taken
from animals of different ages, different breeds and different farm
management systems.
ELISA
The BioChek Mycoplasma hyopneumoniae Antibody Test Kits was used.
Statistical analysis: For test evaluation, WinEpiscope 2.0 was used
to calculate Sensitivity and Specificity with a 95% confidence level.
Results and discussion: To serologically confirm the M.hyo free
status of herds, it is imperative that the test has high specificity
combined with good sensitivity to be sure that recent outbreaks are
not missed. In the different studies described, the overall specificity
of the ELISA is high, 99.2%, [95%CI: 98.8; 99.6] while at 21 days post
infection the sensitivity is 85.2% [95%CI: 78.5; 91.6]. This is
considerably sufficient in monitoring programs and therefore, based
on the overall results, the ELISA is suitable for this purpose.
Conclusion: The evaluated ELISA demonstrates high specificity and
very good sensitivity which makes this ELISA suitable for monitoring
M.hyo free herds.
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INTERPRETATION OF PCV2 ELISA RESULTS,
A NEW APPROACH.
Introduction: PCV2 is endemic in almost all swine herds in the world
and therefore antibodies against PCV2 can easily be found in animals.
Serology is commonly used to establish herd profiles to evaluate the
PCV2 dynamics. Since there are no DIVA vaccines for PCV2 on the
market, one cannot easily discriminate between field infected or
vaccinated animals. This paper describes an approach to discriminate
between vaccinated and field infected animals.
Materials and methods: Sera from natural (field) infected animals
and from vaccinated animals where evaluated with the BioChek
Porcine Circovirus 2 (PCV2) Antibody Test Kit. Sera were obtained
from different herds, different breeds and different ages. For
vaccination different commercial vaccines were used.
Results and discussion: Since the introduction of vaccines, it is not
only the detection of antibodies evoked by natural infection that is
important but also the detection of antibodies after vaccination. In
trade, proof of vaccination is often required, but since there are no
DIVA vaccines for PCV2 on the market, how can one discriminate
between field infected animals and vaccinated animals? The key to
this interpretation lies in the mean titre and percentage of coefficient
variance (%cv). From the results it is clearly evident that although the
mean titre can be the same in field infected and vaccinated animals,
the %cv is different. The differences between field infected and
vaccinated animals were consistent for almost all commercial
vaccines, proving that the approach for interpretation is meaningful.
Establishing more specific baselines for different vaccines and
vaccination protocols is on-going.
Conclusion: When using mean titre and %cv it is possible to
discriminate between PCV2 field infected animals and PCV2
vaccinated animals. Baselines for this are essential for interpretation.
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EVALUATION OF SERUM METHYLMALONIC
ACID AND HOMOCYSTEINE
CONCENTRATIONS IN POSTWEANING PIGS
BETWEEN 6 AND 26 WEEKS OF AGE
Cobalamin and folate play important roles in amino acid metabolism
and RNA/DNA synthesis. Two intracellular enzymes, methionine
synthase and methylmalonyl-CoA mutase are folate and/or
cobalamin-dependent, respectively. A lack of folate and/or cobalamin
on the cellular level leads to accumulation of serum homocysteine
(HCY) and methylmalonic acid (MMA), respectively. Altered serum
MMA and HCY concentrations can influence amino acid metabolism
and nucleic acid synthesis in pigs. Therefore, we aimed to evaluate
serum MMA and HCY concentrations in postweaning pigs at 6 to 26
weeks of age.
Serum samples from pigs (n=12) were collected at week (wk) 6, 7, 8,
9, 10, 14, 18, 22, and 26 as part of an unrelated study. Serum MMA
and HCT concentrations were measured using gas chromatography-
mass spectrometry method and compared in pigs among the different
time points by using a Friedman test with a Dunn’s post test.
In pigs, serum MMA concentrations differed significantly among the
time points (medians: wk-6: 1,661nmol/L, wk-7: 734nmol/L, wk-8:
799nmol/L, wk-9: 647nmol/L, wk-10: 655nmol/L, wk-14: 336nmol/L,
wk-18: 363nmol/L, wk-22: 396nmol/L, and wk-26: 318nmol/L;
p<0.0001). The pigs had significantly higher serum MMA
concentrations at wk-6, -7, -8, -9, and -10 than at wk-14, -18, -22,
and -26 (p<0.001). Serum HCY concentrations differed significantly
among the time points (medians: wk-6: 23.9µmol/L, wk-7:
24.4µmol/L, wk-8: 20.3µmol/L, wk-9: 18.4µmol/L, wk-10: 23.5µmol/L,
wk-14: 17.6µmol/L, wk-18: 18.2µmol/L, wk-22: 18.1µmol/L, and wk-
26: 18.1µmol/L; p<0.0001) in pigs. The pigs had significant higher
serum HCY concentrations at wk-6, -7, and -10 than at wk-8, -9, -14,
-18, -22, and -26 (p<0.01).
This study suggests that serum MMA and HCY undergo age dependent
changes post-weaning, possibly reflecting decreased availability of
intracellular cobalamin and folate for amino acid metabolism and
nucleic acid synthesis in pigs.
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FIELD EVALUATION OF LAWSONIA
INTRCELLULARIS (LI) QUANTITATIVE PCR
(QPCR) TOOL COMPARING INDIVIDUAL
FAECAL EXCRETION PROFILES (QPCR)
AND INDIVIDUAL SEROCONVERSION
PROFILES (ELISA LI) OF PIGS FROM WEANING
TO SLAUGHTER
In a farrow to finish farm located in Brittany (France), subclinically
infected by Lawsonia intracellularis (Li), we compared individual faecal
excretion profiles obtained by Li quantitative PCR (developed by
National Veterinary Institute, Denmark) and individual seroconversion
profiles obtained by Li ELISA (developed by Bioscreen Laboratory,
Germany); 14 pigs have been followed individually from weaning to
slaughter; faecal samples have been collected every two weeks, and
blood samples every four weeks. All tests have been performed in
LABOFARM-Finalab laboratory, in Loudéac (France). This field study
shows very consistent results when comparing individual profiles
obtained with these two different diagnostic tools; in most cases, Li
seroconversion appears two to four weeks after infection peak
detected by qPCR, in accordance with Guedes and Guebhart
observations on Li pathogenesis and immunology (2003). Moreover,
it also demonstrates a good concordance between individual qPCR
results and qPCR results obtained at pen level (with “pedichifs” = boot
swabs). This Li qPCR, now available in France, should allow swine
veterinarians to investigate more deeply Li infection dynamics at farm
level, using a very easy and useful field tool: “pedichifs”.
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INFLUENCE OF ANTIBIOTIC USE AND
EXTERNAL BIOSECURITY ON THE ACUTE
PHASE RESPONSE OF PIGLETS USING A
PIG-MAP ELISA
Primary objective of this study was to investigate the practical use of
the acute phase protein Pig-MAP in the surveillance and monitoring
of the health status and biosecurity practices on sow farms. Pig-MAP
has been suggested as the most sensitive APP for swine (Heegaard
2011) and could be used to differentiate the herd health status of
swine farms (Pineiro 2006).
Materials and methods: The first trial was carried out to estimate
the effect of antibiotic use on Pig-MAP profile. In a case control
setting 3 farms with a low antibiotic usage (DDD<5, LAU) were
compared to 3 farms with a high antibiotic usage (DDD>50, HAU).
The second trial was carried out to estimate the effect of a high
external biosecurity on Pig-MAP profile. In a case control setting 3
farms with an High External Biosecurity (SPF farms, HEB) were
compared to 3 farms with a Low External Biosecurity (absence of
external biosecurity protocols, LEB).
Blood samples were taken from 10 healthy piglets (5 male/5 female)
on each farm. To exclude stress due to weaning piglets were sampled
at the age of 8 weeks. Pig-MAP concentration was determined using
a commercial available Pig-MAP-Elisa (Pigchamp-Pro, Spain).
Results: In the first trial, HAU had a significant lower Pig-MAP
(p<0,001) concentration. No significant results were obtained from
the second trial although LEB tended (p = 0,09) to an increased Pig-
MAP profile.
Conclusion/discussion: High use of antibiotics results in a low Pig-
MAP profile and should be taken in consideration when using
Pig-MAP to assess the biosecurity level on a farm level. Farmers can
be motivated to improve and monitor their management skills by
the assessment of an acute phase profile. The presence study shows
that on average more than 10 samples are necessary to significantly
measure the health status on herd level.
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CAN YOU TRUST THE RESULTS FROM
HANDHELD HEMOGLOBIN ANALYSERS
USED ON BLOOD OBTAINED FROM SIMPLE
VEIN PUNCTURE?
Blood sampling is necessary to obtain hematological and clinical
chemical parameters. Trials have shown different results according to
different equipment and sampling methods. Handheld analysers, that
needs only a droplet of blood and can be used on site, have increased
popularity. Veterinarians seek easier accessible veins than the jugular
veins for blood sampling. The objective of this study was to compare
hemoglobin concentrations in blood from different veins analysed with
a handheld analyser with results from an accredited laboratory.
Fifty pigs, weight 8-26kg, were blood sampled in the jugular vein using
5ml EDTA vacutainers. An ear vein, a milk vein and a tail vein were
punctured on the same pigs and a droplet blood was directly absorbed
into a cuvette in HemoCueR Hb 201+ hemoglobin analyser. The blood
in the vacutainers was analysed the same day at the Central laboratory
at Norwegian School of Veterinary Science as well as in the HemoCueR.
The results from the laboratory were regarded as reference values and
correlation coefficients between these and the results from the
HemoCueR used on blood from the different veins were calculated.
The correlation coefficient between the laboratory results and the
HemoCueR on the same blood was 0.97. The correlation coefficient
between ear vein and laboratory results was 0.76, between tail vein
and laboratory 0.81 and between milk vein and laboratory 0.92.
The results showed a good correlation between the HemoCueR and
the laboratory on the same blood. Correlations between the
hemoglobin concentrations in blood from ear and tail veins blood and
the reference laboratory results were surprisingly low. Conclusions
based on blood from these veins with the technique described should
be interpreted carefully. Hemoglobin concentrations in blood from
the milk vein had the best correlation with reference values and can
be used in clinical work.
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HANDHELD HEMOGLOBIN ANALYSER
USED ON SOWS BLOOD SAMPLED FROM
DIFFERENT VEINS
Trials have shown different hematological results according to
equipment and techniques for blood sampling. Handheld analysers,
that needs only a droplet of blood and used on site, have increased
popularity, specially in sows, to avoid fixation of the sows with rope
on the jaw, veterinarians seek easier accessible veins than the jugular
veins for sampling. The objective of this study was to compare
hemoglobin concentrations in blood from different veins analysed in
a handheld analyser with results from an accredited laboratory.
Thirty-two sows were blood sampled in the jugular vein using 5ml
EDTA vacutainers. At the same time puncture of an ear vein and a tail
vein were done on the sows. From a milk vein one ml blood was taken
into a syringe. A droplet blood from each vein was absorbed into a
cuvette in HemoCueR Hb 201+ hemoglobin analyser. The blood in
the vacutainers was analysed the next day at the Central laboratory,
Norwegian School of Veterinary Science as well as in the HemoCueR.
The results from the laboratory were regarded as reference values
and correlation coefficients between these and the results from the
HemoCueR used on blood from the different veins were calculated.
The correlation coefficient between the laboratory results and the
HemoCueR on the same blood was 0.97. The correlation coefficient
between ear vein and laboratory results was 0.56, between tail vein
and laboratory 0.32 and between milk vein and laboratory 0.82.
The results showed a good correlation between the HemoCueR and
the laboratory on the same blood. Correlations between hemoglobin
concentrations from ear/tail veins blood and the laboratory results
were surprisingly very low. One should therefore be careful drawing
conclusions using blood from these veins with the technique
described. Hemoglobin concentrations in blood from the milk vein
had highest correlation with the reference values.
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IMPULSE OSCILLOMETRY IN THE SEARCH
FOR BIOMARKERS FOR LUNG SOUNDNESS
IN SWINE – COMPARISON WITH CLINICAL
AND PATHOLOGICAL FINDINGS
Objectives: Porcine health management needs to guarantee swine
production regarding economy, animal welfare and consumer
protection. Early diagnostics are among the most important
requirements to realise this goal in a satisfactory and sustainable way.
Therefore, the development of biomarkers will embody an important
objective in order to detect early onset of pneumonia which needs an
engrossed understanding of the complex pathogenesis and interacting
agents causing the porcine respiratory disease complex (PRDC). The
present study verifies and validates the diagnostic potential of impulse
oscillometry as an advanced clinical method to examine PRDC.
Materials and methods: Sixty four early fatteners (25-30kg) from
herds with a different PRDC status have been examined by standard
clinical, pathological and microbiological methods. The examination
was complemented by impulse oscillometry and bronchoalveolar
lavage (BAL). BAL and lung tissue samples were examined for
all relevant airway pathogens in swine using molecular and
microbiological methods.
Results: Parameters obtained from living pigs by impulse oscillometry
were highly correlated with substantial clinical, pathological and
microbiological findings. Detailed information on quality, quantity and
stadium of PRDC (e.g. acute, chronic) could be derived from lung
function testing which complied well with the overall outcome of lung
pathology. Information contents were far above standard clinical indices.
Discussion: Our preliminary results show interesting and specific
associations between distinct pathogens and lung function parameters.
Thus, impulse oscillometry might be a sensitive method for the
detection and classification of respiratory diseases and for the detection
and assessment of biomarkers for lung soundness in the future.
NOTES
POSTER PRESENTATIONS: DIAGNOSTICS
124
P048
Sergio Lizano1, Sheri Koller1 and Pablo Lopez1
1 IDEXX Laboratories, Inc., Westbrook, ME, USA. sergio-lizano@idexx.com.
DEVELOPMENT OF A NEW IDEXX ELISA
FOR THE DETECTION OF PRRS ANTIBODIES
IN SWINE ORAL FLUIDS
Testing of swine oral provides a convenient and cost-effective tool for
disease surveillance in commercial pig herds. Recently, Kittawornrat
et al., (J Vet Diagn Invest. 2012 Mar;24(2):262-9.) described detection
of antibodies to PRRS in oral fluids adapted using an overnight sample
incubation format adaptation of the HerdChek® PRRS X3 ELISA,
(IDEXX Laboratories, Inc.). In this study, we describe a new PRRS oral
fluids ELISA (IDEXX PRSS OF Ab Test) for same-day detection of PRRS
antibodies in swine oral fluids. An S/P ≥0.4 is considered a positive
result. A comparison between the new protocol and the standard
overnight protocol (SOP) using a set of reference standards consisting
of pooled oral fluids from vaccinated pigs indicated 100% agreement
between the two tests, with average S/P values 1.4 to 1.5-fold higher
than SOP. Moreover, analysis of a temporal series of paired oral fluids
and serum collected from individual boars 0-7 days before (negative
exposure status) and 21 days after (positive exposure status)
vaccination or experimental infection with type I or type II PRRSV
indicated a specificity of 98.7% and a sensitivity of 100% with new
IDEXX PRRS OF Ab Test. A temporal analysis of oral fluids from the pigs
infected with either type I or type II PRRSV revealed a similar ability to
detect both strains. Finally, evaluation of pen-based oral fluid samples
collected at various levels of prevalence (0%, 4%, 12%, 20%, and 36%)
of antibody-positive vaccinated pigs introduced at 14 days post-
vaccination into pens of PRRS-negative pigs indicated that the new
test detects PRRS antibodies in ≥96% of all collection events in pens
of at least 20% prevalence. These results describe the first commercially
available test for antibodies to PRRSV, in support the emerging use oral
fluids for frequent surveillance of pig herds by the swine industry.
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MONITORING PRRSV SEROCONVERSION
BY USING ORAL FLUID SAMPLE
Purpose: The aim of the present study was to follow the PRRSv post-
infection sero-conversion by analysing Oral Fluid (OF) sample at
different times post-challenge by ELISA and PCR.
Method: The study started with 30 groups of 9 gilts from PRRSV-free
farms (as confirmed by PCR and ELISA). After week 2 (wk2) 10 groups
were selected until the end of the study. Each group was infected in
isolation at wk0 using a field strain of PRRSV Type 1. The study lasted
for 8 weeks with weekly sampling of OF. The presence of antibodies to
PRRSV was evaluated by using the CIVTEST SUIS PRRSV E/S (Hipra).
OF samples were also analysed by qPCR. Individual serum samples of
all animals were also analysed at wk3 and wk7.
Results: 80% of the OF samples were positives by ELISA at wk2 and
100% of the samples resulted positives at wk3. Although the positivity
to the ELISA was maintained until the end of the study, PCR gave
negative results from wk4 to wk6 depending on the group. The kinetics
of sero-conversion presented a characteristic profile that had not been
previously observed in the serum samples. The use of an anti-IgA
conjugate improved sensitivity at the start of sero-conversion.
Conclusions: CIVTEST SUIS PRRS E/S presented good diagnostic
performance with OF. The results indicate that the ELISA is showing
adequate sensitivity even as an alternative to PCR. The kind of
conjugate used in the test has a certain effect on the earliness of
detection of sero-conversion
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USE OF BUFFERED SWIFFER® CLOTH
TO ASSESS THE RISK OF PRRS VIRUS SPREAD
BY EMPLOYEES AND FOMITES DURING
WARM WEATHER
Objective: To survey high risk areas to determine the risk for PRRS
virus contamination.
Methods: Each sampling kit included one unscented Swiffer® sweeper
pad (P&G Co.), one 50ml tube containing diluted neutralising broth,
one pair of latex gloves, and one resealable plastic bag. To establish a
baseline for the study, the Ingelvac PRRS MLV vaccine was used as a
positive control and sterile water as a negative control on clean service
vehicles. Sampling was completed by inserting the pad into the tube
containing neutralising broth and allowing it to soak. Latex gloves
were changed between samples. The pad was then removed from the
tube and wiped over the designated sample area. On service vehicles,
there were six sampling areas including the steering wheel, cell phone,
pedals, door handles, toolbox, and supplies. For warehouse and
laboratory testing, six high risk areas were chosen and sampled.
Clothing was sampled after wearing disposable coveralls in barns. After
sample collection, the soiled pad was placed into a resealable bag and
squeezed to remove the fluid. Contents from the bag were drained
back into the tube, labelled and placed on ice. In addition, a survey
was given to assess employee and farm biosecurity practices. All
samples were shipped to BIVI’s Health and Management Center
where they underwent qPCR analysis.
Results: Fifteen trucks, two labs, two warehouses and twelve clothing
samples were collected for a total of 204 samples. All samples, other
than the Positive control, were PCR Negative for PRRS virus. The
temperatures during sample collection days ranged from 28.8 to 31.1
degrees Celsius. Though it was possible for PRRS to be detected on
surfaces, as demonstrated by the positive control, the heat, time to
sample collection or effective use of PPE by personnel may have
contributed to the negative results seen.
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SET UP OF A SEMI-QUANTITATIVE
SCALE FOR PCV2 ANTIBODY LEVELS IN
PIG ORAL FLUIDS (OF) USING AN
IN-HOUSE-DEVELOPED ELISA TECHNIQUE
Introduction: PCV2 is an ubiquitous pathogen and the presence of
antibodies by itself is of poor meaning, rendering an only qualitative
evaluation useless. The objective of this study was to establish the
semi-quantitative scale for PCV2 antibody levels in oral fluids (OF)
obtained with an LDA22 in-house developed ELISA, best related to
blood sample antibody titres obtained with a commercial ELISA kit
in the same pigs.
Material and methods: A total of 38 collective pen-based OF samples
were collected from 4 to 22 week-old pigs of eight conventional farms
using cotton ropes. In the same pens, each pig was also blood sampled
individually. A pen-based “average” serum sample was prepared by iso-
volumes mixing from the individual serum samples. The OF samples
were assayed for anti-PCV2 antibodies by a ELISA technique developed
at LDA22. Three OD scales giving an ordinal score ranging from 1+
(low anti-PCV2 antibody level) to 4+ (very high anti-PCV2 antibody
level) were compared. Serum pools were titrated for anti-PCV2
antibodies using a commercial ELISA technique (SERELISA PCV2 Ab,
Pfizer Diagnostics). Linear regression models were fitted to choose the
best predicting scale. Mac Nemar’s test was used to statistically
characterise the relationship between OF levels and serum titres
following categorisation.
Results and discussion: Relationship between OF sample levels and
serum sample titres was shown to fit with a linear model for each scales
(p<0.001). The chosen scale provided a correlation coefficient of 90.8%
and a determination coefficient of 82.4%. There was no significant
sensitivity difference between the two techniques (p=0.174).
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INVESTIGATIONS ON THE USE OF
SWIFFER® SAMPLING TO DETECT
DIFFERENT RESPIRATORY PATHOGENS
VIA ENVIRONMENTAL SAMPLE COLLECTION
IN PIGBARNS
Introduction: It has been shown, that even after cleaning and
disinfection PRRSV could be found in livestock transporters (1) by
Swiffer® sampling. The question was: Is Swiffer® sampling suitable to
detect also other porcine respiratory pathogens in the environment.
Material and methods: The investigation was performed in two
farms with the history of respiratory disease. In farm A the samples
were taken in a large group nursery compartment with 120 piglets of
28kg in one group. In farm B three groups of 120 piglets were tested.
In farm A 10 tracheo-bronchial-swab (TBS) samples (2) in one group
and 10 Swiffers® samples (1) of the environment were taken. In farm
B 10 tracheo-bronchial-swab samples per age group and 10 Swiffer®
samples were taken. Samples were tested by nonaplex RT-PCR.
Results: Following pathogens could be detected:
Farm A: (TBS n=10/Swiffer® n=10): M. hyorhinis (10/7), PRCV (0/0)
PRRSV (EU) (3/2), M. hyopneumoniae (0/0), SIV (1/3), PCMV (1/0)
PCV2 (0/0).
Farm B: (TBS n=30/Swiffer® n=10): M. hyorhinis (28/7), PRCV (2/1)
PRRSV (NA) (1/0), M. hyopneumoniae (9/1), SIV (0/0), PCMV (10/3)
PCV2 (0/0). There were more weakly positive results (3/15, cumulative)
and not analysable (0/2, cumulative) samples in the Swiffer®-Groups.
Discussion: In principle detection of porcine respiratory pathogens
(PRRSV, SIV, M. hyopneumoniae, M. hyorhinis) in the environment by
Swiffer®-sweeping is possible, but further investigations are needed.
References:
1. Dee SA, Deen J, Otake S, Pijoan, C.
An experimental model to evaluate the role of transport vehicles as
a source of transmission of porcine reproductive and respiratory
syndrome to susceptible pigs. Can J Vet Res. 2004; 68: 128-133.
2. Fablet C, Marois C, Kobisch M, Madec F, Rose M.
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EXPERIMENTAL REPRODUCTION OF
GLÄSSER’S DISEASE IN FOUR MONTH
OLD PIGS
Haemophilus parasuis is a coloniser of healthy piglets and the
etiological agent of Glässer’s disease, a systemic disease
characterised by fibrinous polyserosytis. Historically, Glässer’s disease
has been considered a sporadic disease of young swine compromised
by stress. However, the epizootiologic picture in specific-pathogen
free or high-health-status herds that represent an immunologically
naive population is much different. Experimentally, some diseases
are easily reproduced in young piglets, but seem to be difficult in
older ones, probably due to their more mature immune system. The
objective of this study was to examine the effect of a H. parasuis
infection in fattening pigs. Thus, five four-month-old snatch-farrowed
colostrum-deprived pigs from a conventional farm were intranasally
inoculated with reference virulent strain Nagasaki (107 UFC/animal).
Clinico-pathological evaluation was performed and remaining pigs
were euthanised at 4 days post-infection (dpi). Lesions were assessed
and samples from peritoneal, thoracic, pericardial and nasal cavity,
meninges, bronchoalveolar lavage fluid (BALF) and joints were taken
for bacterial cultures. H. parasuis growth was semi-quantified as
previously described. After challenge, one pig had high rectal
temperature (1 dpi). At necropsy, 2/5 pigs had lesions of Glässer’s
disease: one pig with fibrinous poliserositis (pig which had to be
euthanised at 2 dpi) and one with arthritis (4 dpi). Remaining pigs
had slight multifocal pulmonary consolidation. H. parasuis was
recovered from 4/5 pigs. Pig euthanised at 2 dpi showed systemic
infection (isolation in brain, pericardium, BALF, blood and joints). At
4 dpi pigs exhibit large amounts of bacteria, mainly localised in brain
and BALF. Overall, these results show that Glässer’s disease can be
experimentally reproduced in growing-finishing pigs.
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COMPARISON OF ANTIBODY RESPONSES
IN SERUM FROM PIGS INOCULATED WITH
DIFFERENT DOSES OF SALMONELLA
TYPHIMURIUM AND SALMONELLA DERBY
USING THREE COMMERCIAL ELISA TEST KITS
Serology is widely used for salmonella screening purposes on pig herd
level. However, for the detection of salmonella infection in the individual
pig, a serological test is more dubious.
Thirty six, ten-week old pigs from a salmonella negative herd were
transported to experimental facilities and grouped into six groups.
After one week of acclimatisation each pig was orally inoculated with
salmonella. Each group of six pigs received one serotype of salmonella
(S Typhimurium or S Derby) in a low (0.65 x 103 CFU), medium (0.65
x 106 CFU) or high dose (0.65 x 109 CFU).
Faecal and blood samples were collected during eight weeks. The
levels of antibodies in serum were analysed using three commercial
ELISA kits (Svanovir® Salmonella, Herdcheck Swine Salmonella and
Salmotype® Pig Screen).
Results revealed differences between the three ELISA-kits on group
level as well as in individual pigs.
For Typhimurium, all three ELISA-kits demonstrated positive titers in
the six pigs in the high dose group, while only two out of six pigs
inoculated with a high dose of S Derby showed a clearly positive
serological response in all three test-kits.
In the medium dose groups, the seropositive response in pigs
inoculated with S Derby were in general seen a couple of weeks later
than in pigs inoculated with S Thypimurium. Also, in spite of several
weeks of faecal excretion of the bacteria, one pig in the Thypimurium
medium dose group were seronegative throughout the study period.
In the low dose groups no salmonella excretion was demonstrated
and, with two exceptions close to cut-off, no pigs became seropositive.
The detection of antibodies due to infection with Salmonella spp. is
dependent on several factors, e.g. the serotype of salmonella, the
immune response of the individual pig, the dose of exposure and the
test-kit used.
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DIAGNOSTIC PROTOCOLS FOR DETECTION
OF NON-TREATMENT-REQUIRING
DIARRHOEA AT BATCH-LEVEL
Introduction: Diarrhoea post weaning is the most common reason
for batch medication in Danish pigs. In approximately 25% of
the diarrhoea outbreaks only a few or no pigs have bacterial
enteritis/colitis. Such outbreaks should potentially not be subjected
to antibiotic batch medication.
Two aspects need to be addressed before recommendations on non-
treatment can be given. 1: is it possible to accurately diagnose such
non-bacterial diarrhoea outbreaks in practice and 2: will omission of
antibiotic treatment result in compromised animal welfare and/or
reduced productivity. The objective of the current study was to
determine if non-treatment-requiring diarrhoea in batches with pigs
post-weaning could be accurately diagnosed.
Material and methods: Each of 20 diarrhoea outbreaks (20 herds) was
classified as treatment-requiring (= positive outbreak) or non-treatment
requiring (= negative outbreak). Definition of non-treatment-requiring
outbreaks was: <15% of all the pigs in a room had bacterial
enteritis/colitis.
Different diagnostic protocols (n=29) using qPCR testing of faeces
(Lawsonia intracellularis, Brachyspira pilosicoli, Escherichia coli) were
developed and preliminary evaluated based on these outbreak
classifications. For the most promising diagnostic protocols
diagnostic sensitivity (Se), specificity (Sp), positive (PPV) and negative
(NPV) predictive values were calculated at batch-level using another
set of field data.
Results:The best two protocols included selecting 10 random diarrheic
pigs for qPCR analysis. The two protocols applied different cut-offs
(low/high) for faecal bacterial load for classification of test-positive
pigs. An outbreak was considered positive (treatment-requiring) if one
examined pig was above the qPCR cut-off. The low cut-off provided
batch-level Se=1.00, Sp=0.20, PPV=0.79 and NPV=1.00. The high cut-
off provided batch-level Se=1.00, Sp=0.60, PPV=0.88 and NPV=1.00.
Discussion:The non-treatment-requiring diarrhoea outbreaks can be
detected with an acceptable accuracy under field conditions. This could
lead the way for a reduction in antibiotic use, but effect of omitting
antibiotic treatment in these outbreaks must be further evaluated.
NOTES
POSTER PRESENTATIONS: DIAGNOSTICS
128
P056
Simone Schaumberger, BIOMIN Research Center, Tulln, Austria, Gerd
Schatzmayr, BIOMIN Research Center, Tulln, Austria.
ORAL E. COLI CHALLENGE IN WEANED PIGS
TO INDUCE AN ENDOTOXIN SHOCK
E. coli contributes colibacillosis, oedema diseases and endotoxin shock
in piglets and causes financial losses. Endotoxin is a virulence factor
in the cell wall of E. coli. It triggers inflammation and in worst case
leads to an overreaction, shock and death. Antibiotics are used to treat
E. coli related diseases. Bactericidal antibiotics lead to liberation of
endotoxins. In weakened animals this may have a fatal outcome. Aim
of the study was to induce a controlled endotoxin shock in weaned
pigs by oral application of E. coli in combination with an antibiotic.
Nine pigs were divided into three groups: group I and group II received
5x10^10 cfu of lyophilised E. coli (O55B5) as well as 2.5 mg per kg
body weight of enrofloxacin orally. Pigs in group I were administered
40 mg of omeprazol intravenously 8 hours before they received E. coli.
Group III served as a control group. Blood samples were taken 10 min
before application and then every two hours for 16 hours. At the end
all pigs were euthanised and necropsy was performed. Blood samples
were tested for the concentration of LPS, IL-6, IL-10 and TNF-α.
No severe clinical signs were observed. Only one pig in group II was
vomiting foam and refused feed intake. No severe macroscopic or
histological lesions were observed in the intestine beside dilatation
of the small intestine with watery contents. Small and large intestine
of all pigs were examined bacteriologically; no pathogens could be
isolated. No increase of blood concentration of LPS or TNF-α was
determined. The IL-6 and IL-10 concentration did not increase.
We were not able to induce an endotoxin shock with oral application
of E. coli in combination with an antibiotic. So far there is no
information on how to induce the endotoxin shock by oral application
of endotoxin.
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EVALUATION OF A COMMERCIAL ELISA TEST
KIT ON CLASSICAL SWINE FEVER ANTIBODY
DETECTION USING ORAL FLUID SAMPLES
This study is to evaluate possible use of a commercial enzyme-linked
immunosorbent assay of classical swine fever (CSF) antibody using
oral fluid samples. Oral fluid and serum samples were collected from
3 experimental groups of 20 days-old pigs (n=20); challenged (n=8),
vaccination (n=8) and negative control (n=4) groups. CSF antibody
was detected from an individual serum and pooled oral fluid in each
group using a selected ELISA compared to the results of neutralising
peroxidase-linked assay (NPLA). High levels of serum NPLA titers,
possibly from maternally-derived antibodies, were detected at 3 days
post inoculation (dpi) in all groups. As expected, the levels of serum
NPLA titer increased only in the challenged group at 10 dpi and the
vaccination group at 14 dpi. Interestingly, the low levels of NPLA
antibody titers could evidently be detected in the oral fluid samples.
Using an ELISA protocol as suggested by the manufacturer compared
to the conventional NPLA method demonstrated cut-off positive
NPLA titer when over log2 4. It should be noted that NPLA titers
detected in the pooled oral fluid samples in each group were equal
to or less than log 2 3, resulting in negative detection when tested
by the ELISA test kit. This experiment proved that CSF antibody could
be detected in the oral fluid samples using NPLA and ELISA methods.
However, validation of this commercial ELISA test kit is still needed
to improve the sensitivity and specificity of the detection when using
oral fluid samples. This evaluation contributes not only in the
facilitation of CSF antibody detection method, but nevertheless helps
in the rapid diagnosis and controlling aspects of CSF, particularly in
the CSF-free country.
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ZEARALENONE VALUES IN THE BILE OF UK
FINISHING PIGS
The mycotoxin zearalenone (ZON) is thought to be a common
contaminant of pig feeds and bedding in Northern Europe due to
wet harvest conditions causing spoilage by Fusarium graminearum
during storage. Conditions such as premature puberty in gilts and
infertility in sows have been attributed to suspected mycotoxin
contamination, in the absence of other discernible causes.
There is little information on typical exposure levels of pigs to ZON
under standard commercial conditions in the UK, thus 450 bile
samples from healthy finishing pigs were collected for testing. The
pigs came from 52 unrelated units. The aim was to obtain baseline
data on the range of values obtained from a representative sector of
the British pig industry.
The bile samples were tested individually. The process involved initial
overnight incubation with beta glucuronidase, then extraction of
ZON and ZON metabolites by immunoaffinity columns, then
quantification of captured material by ZON ELISA, with correction for
percentage recovery calculated from the spiked control values. The
minimum detection level of the test was 0.05ppb.
Eighteen herds (35%) had ZON values of <5ppb in all pigs, consistent
with low levels of exposure. Other herds showed considerable
variation in values between individual pigs. Fourteen herds (27%)
had average values of between 5-10ppb and 20 herds (38%) had
average values of >10ppb. Some results for individual pigs were as
high as 60-80ppb.
Although the value of ZON in bile does not necessarily correlate with
the concentration in the feed (Dänicke et al., 2008), values of >5ppb
indicate a source of ZON in the pigs’ environment, with the potential
for harmful consequences. The data presented provides useful
baseline information for comparison and interpretation of test results
in the future.
Dänicke, S. et al., (2008) in ‘Mycotoxins in Farm Animals’, Eds: Oswald,
I.P. and Taranu, I
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DIAGNOSIS OF SWINE INFLUENZA VIRUS
IN ORAL FLUIDS SAMPLES IN 20-DAY-OLD
PIGLETS: A FIELD CASE
Introduction: Oral fluid (OF) samples have been used for PRRSV,
PCV2 or swine influenza viruses (SIV) detection. This report describes
the on-field implementation of OF sampling for SIV detection in
piglets aged 20 days.
Case description: The farm, a 130-sow farrow-to-finish operation, is
located in Brittany, France. In October 2011, sows first displayed
anorexia and later, late abortions and/or early farrowings or gave
birth to weak piglets. No PRSSV DNA (PCR) was found in sow blood
samples nor PCV2 antibodies (ELISA) in body fluid obtained from
aborted foetuses. In February 2012 coughing was seen during
fattening. Flu infection (H1N1 avian-like subtype) was evidenced in
ill fatteners. Four days after, clinical signs spread back to weaned
piglets then to suckling piglets.
Following the first clinical signs in suckling piglets and laboratory
confirmation of SIV presence on nasal swabs from 2 litters, pen-based
OF samplings were performed using rope in suckling piglets. One rope
per 6 piglets (12 and 16-mm diameter, cotton or cotton/nylon) was
suspended at snout height during at least 60 minutes approximately
every 2 days until weaning. The two ends of the rope were chewable.
Piglets clinical status and behaviour was recorded. OF were extracted
by rope milking following in some cases lavage with 5ml of isotonic
solution and then centrifuged. Supernatants were assayed by RT-PCR
for the detection of Influenza m gene at LDA22.
Results and discussion: This study provided new insight about OF
sampling: piglets did not chew the rope(s) during the early febrile
phase. At least a 60-minute exposure seemed also to be necessary to
collect sufficient material. Only the 12-mm cotton rope was chewed.
SIV was detected in each oral fluid sample confirming the efficiency
of this sampling method. Nevertheless, quantities of virus collected
were low and did not allow SIV sub-typing.
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EVENTUAL IMPACT OF SEASONAL EFFECTS
ON THE MYCOPLASMA HYOPNEUMONIAE
PREVALENCE IN BELGIAN AND DUTCH PIG
HERDS USING A TRACHEO-BRONCHIAL
SWAB TECHNIQUE
Mycoplasma hyopneumoniae (M.hyo) is still important in modern
intensive swine farming in Europe. Diagnosis of infections with M.hyo
can be performed using different approaches, including the detection
of the pathogen through polymerase chain reaction (PCR) assays.
Recently, a tracheo-bronchial swab (TBS) technique has been
developed for the detection of M.hyo in pigs. Weather conditions can
affect the circulation and excretion of M.hyo, resulting in a different
clinical picture. The aim of the present study was to obtain data on the
distribution of M.hyo infections in closed pig herds in Benelux using
the TBS technique and to study eventual seasonal effects on this
distribution. Hundred and sixty-three closed pig herds were randomly
selected in Belgium and the Netherlands. In every herd, at least 30
piglets were sampled in two age groups. TBS were collected and
analysed as described previously. Several meteorological data related
to the specific sampling period were collected from a central weather
station point in the Benelux. Statistical analysis was performed using
logistic regression models. The presence of M.hyo at herd level at 3-5
weeks of age was significantly affected by the precipitation rate (β =
-0.026; P = 0.03) during the week preceding sampling. In older post-
weaning piglets, the risk for a herd to be M.hyo-positive was
significantly affected by season [with the highest risk (OR = 1.91) for
M.hyo positivity during autumn and the lowest risk (OR = 9.8) during
summer (β = 0.65; P = 0.003)] and the average outdoor temperature
(β = 0.02; P = 0.007) during the week preceding sampling. These
results are in accordance with Segalés et al., (2011), who also observed
a seasonal variation in M.hyo prevalence and circulation. In conclusion,
although early M.hyo infection may show a seasonal effect, piglets
may be infected with M.hyo throughout the entire year.
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PREVALENCE OF DIFFERENT RESPIRATORY
PATHOGENS DURING POST-WEANING
AND FATTENING PERIOD IN BELGIAN
AND DUTCH PIG HERDS USING A
TRACHEO-BRONCHIAL SWAB TECHNIQUE
Besides Mycoplasma hyopneumoniae (M.hyo), many other viruses and
bacteria can be concurrently present during respiratory problems in
pigs. Diagnosis of infections with these pathogens can be performed
using different approaches, including the detection of the pathogen
through Polymerase Chain Reaction (PCR) assays. Recently, a new
sampling technique has been developed and validated for the
detection of M.hyo in pigs using PCR, namely the tracheo-bronchial
swab (TBS) technique. A multiplex (m) [porcine respiratory coronavirus
(PRCV), porcine reproductive and respiratory syndrome virus (PRRSV),
swine influenza virus (SIV), porcine cytomegalovirus (PCMV), porcine
circovirus 2 (PCV2)] and duplex (d) [Actinobacillus pleuropneumoniae
(App), Haemophilus parasuis (Hps)] PCR assay were used to detect the
different pathogens in the TBS. The aim of the present study was to
obtain data on the distribution of different pathogens involved in PRDC
in closed pig herds in Belgium and the Netherlands using the TBS
technique. Closed pig herds were randomly selected in Belgium (n =
107) and The Netherlands (n = 91). In every herd, at least 30 piglets
were sampled in at least two age groups (3-5, 6-11 and 12-20 weeks
of age). TBS were collected as described previously and analysed using
mPCR and/or dPCR (IVD GmbH, Hannover, Germany). PCR results were
reported as negative or positive for the presence of PRCV, SIV, PCMV,
PCV2, App and Hps. For PRRSV, strain type EU/US or both was also
reported. The present study clearly shows that different viral pathogens
responsible for PRDC may already be present during the post-weaning
period. Concerning PRRSV, the most prevalent type was PRRSV-EU,
whereas PRRSV-US was far less frequent. Hps was more prevalent than
previously assumed. In conclusion, the present study showed that
many other respiratory pathogens are present during the post-weaning
and fattening period, which may complicate the clinical picture of
respiratory disease.
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TENTATIVE INDEX MODEL FOR THE
ASSESSMENT OF TECHNICAL
PERFORMANCES IN FRENCH SWINE FARMS
Introduction: Decision to vaccinate against pathogens inducing
subclinical troubles is not easy. The aim of this study was to set up a
synthetic index to summarise weaning-to-slaughter pig performance
based on growth, feed efficiency and mortality to help making this
kind of decision.
Material and methods: Every year, a detailed technical analysis uses to
be performed in more than 2000 French farrow-to-finish or wean-to-
finish reference farms independently of the economic environment. In
2011, a wean-to-finish (standardised 8-to-115-kg or W-F) margin index
expressed per pig was calculated and expressed in a normalised way
with an index base of 100: the higher the index, the better the technical
performances of the farm, in other words: >100 good to average
performance, =<100 average to low performance. The index was then
analysed using regression models to identify explanatory variables in
routinely recorded criteria measuring technical performances.
Results and perspectives: The selected model explained 99% of the
index variability with the following 3 significant (p<0,001) parameters,
i.e. growth (ADWG 8-115, g per day), feed conversion ratio (FCR 8-115)
and mortality (%):
W-F Index = -83.26214 x (FCR 8-115) + 0.06533 x (ADWG 8-115)
+ 4.06105 x (100 – mortality) -113.49504.
Further large scale data collection before and after vaccination is
necessary to evaluate the relevance of such an index.
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PREVALENCE OF PRRS VIRUS IN WALLONIA
(BELGIUM)
Porcine reproductive and respiratory syndrome (PRRS) causes major
economical losses in pig farms. In different parts of the world, there
is a growing consensus that PRRS virus (PRRSv) eradication should be
performed on a regional basis, particularly in low density areas of pig
production. The objective of the present study was to evaluate the
apparent prevalence of PRRSv in Wallonia, a low density area of pig
production (0.05 pig farms/km²). At this stage of the study, a phone
survey has been addressed to 61/276 Walloon breeding pig owners.
Fifty-eight answered to the questionnaire: 51 are responsible of a
farrow-to-finish farm, 6 of a farrowing farm and 1 of a PRRS-free boar
station. In 35% of the tested farms, sows are vaccinated with a
modified live virus (MLV) PRRS vaccine (n=11) or with a killed PRRS
vaccine (n=9). In two farms, both sows and piglets are vaccinated with
a MLV PRRS vaccine. Replacement gilts are purchased in 33% farms.
Among the 38 farms raising replacement gilts, 39% purchase boar(s).
Boar semen is purchased in 86% of the farms: 56% purchase only
boar semen; 30% purchase both semen and boar(s) and 14% of farms
only purchase boar(s). In 22/57 tested farms, clinical signs evocative
of PRRSv infection were observed over the last 10 years. In 30 farms
a PRRS diagnostic test was performed in the past with a positive result
in 17. When the pig owner did agree and if no vaccination was carried
out on sows or on piglets, a serological Elisa test was performed in 10
breeding pigs and/or 5 feeder pigs >70kg (or in all available sera if a
smaller number of pigs was present). Globally, at herd level and at
animal level, the apparent prevalence were respectively 35.2% (95%
CI: 23.0-47.4%) and 23.4% (95% CI: 20.1-26.6%).
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PREVALENCE OF PRRSV AND PCV-2
ASSOCIATED ABORTIONS IN UKRAINE IN
2007-2012 PERIOD.
A longitudinal study was carried out in Ukraine to determine whether
PRRSV and PCV-2 were causes of abortions at different stages of
gestation in pigs. It is widely known that these pathogens can directly
influence the development of the foetus, causing specific changes in
them.
The histological analysis in the case of PCV-2 identified myocarditis,
whereas the most frequently observed PRRS lesions are pneumonia,
depletion of thymus, bleeding in the lungs and the presence of
hyperplasia and hypertrophy of pneumocytes II.
Over a period of 5.5 years 1156 tissue samples from swine foetuses
were tested by PCR for the presence of 9 different infectious pathogens.
From this number, the amount of PCV-2 positive ones is 192, which is
nearly 17%. At the same time, PRRSV was detected in 125 samples
(nearly 11%).
Interestingly, co-infection by the two mentioned pathogens was
observed in just 17 cases, which is under 2%. We compared our data
from 2007-2009 with our results from 2010-2012 and detected an
increasing number of abortions connected with PCV-2 and PRRSV.
During the last 5.5 years we used the same method and the same
PCR test system for this research. We can make some deductions
about the tendency of PCV-2 and PRRSV to spread.
There are a number of factors contributing to the increase of the
aborting level connected with PCV-2 and PRRSV such as animal well-
being, increased herd size, presence of carriers from purchased
animals, and sperm. The main reasons accounting for an increased
spread of PCV-2 and PRRSV in Ukraine over the last 3 years are an
active animal trade, the purchase of pigs and semen from different
farms in Ukraine or from abroad, and insufficient management.
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CONTROL OF PORCINE RESPIRATORY
DISEASE COMPLEX BY SEROLOGICAL
TESTING OF BLOOD SAMPLES COLLECTED
AT THE ABATTOIR
Control of porcine respiratory diseases complex (PRDC) is a challenge
in intensive pork production systems. The purpose of the present study
was to assess the potential of blood samples collected at slaughter as
a new source of information to detect herd specific pathogens.
The objective of the study was to evaluate the degree of similarity for
detection of Mycoplasma hyopneumoniae (Mhyo), swine influenza
viruses (SIV), porcine reproductive and respiratory syndrome virus
(PRRSV), and porcine circovirus type 2 (PCV2) in pig lungs and
slaughterhouse blood by PCR and serological tests.
The study encompassed 20 farms, 491 pairs of blood and lungs were
gathered in a Southeast Bavarian slaughterhouse between May 2011
and February 2012. For PCR pools of 4-6 lungs originating from one
farm were generated.
The agreement between ELISA serology on blood and PCR on lungs
was for Mhyo 67.83%, for SIV 58.04%, for PCV2 53.04% and for
PRRSV 26.95%. The only significant ODDS ratio appeared for Mhyo
12.4 (Fisher p<.0001).
Infection with PRRSV and PCV-2 typically occurs early in the life cycle
of the pig and virus is already eliminated at slaughter. In contrast,
antibodies to Mhyo are associated with this pathogen in the lungs.
As PCR analysis on lungs is expensive, the slaughterhouse blood is a
cheaper alternative to receive an insight in the herd specific
pathogens. However, in case of uncertainty the lungs of the herd
should be analysed by PCR.
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DETERMINATION OF PATHOGENS
INFLUENCING PIG HERD PERFORMANCE BY
ANALYSING SLAUGHTERHOUSE BLOOD
Decisions in pig health management are rarely based on monitoring
slaughterhouse blood. Based on the serological analysis of blood at
slaughter the present study quantified the influence of pathogens
associated with the PRDC on the degree of pneumonia and herd
performance.
20 pig herds in the Southeast of Germany were selected. Randomly
30 blood samples were collected in four fattening periods.The
samples were submitted for ELISA-serology for Mycoplasma
hyopneumoniae (Mhyo), Actinobacillus pleuropneumoniae serotype
2 (APP2), Swine Influenza Viruses (SIV), porcine reproductive and
respiratory syndrome virus (PRRSV) and porcine circo virus type 2
(PCV2). Percentage of pigs with pneumonia was determined based
on the meat inspection results. Average daily growth rate (ADGR)
and average feed conversion rate (AFCR) were provided by the
farmer. Multiple regression analysis with backward elimination was
applied to determine the most influential pathogens.
APP 2 and SIV H1N1 were observed to increase the percentage of pigs
with pneumonia per herd. The presence of APP2 and SIV increased in
period 1 the ratio by 13.5 %, 20.8 % (P2) 32.1 % (P3), 23.5 % (P4).
PRRSV influenced mostly ADGR and AFCR during the first two
fattening periods. If all samples were positive for PRRSV, ADGR
decreased by 72g (P1) and 133g (P2). AFCR increased by 200 g feed for
on kg of growth (P1 & P2), for example from 1:2.6 to 1:2.8. In the third
and fourth period, PCV2 decreased ADGR by 79 g (P3) and increased
AFCR by 200g (P4). APP2 increased the AFCR by 200 (P3).
In conclusion, the pathogens influencing the occurrence of pneumonia,
ADGR and AFCR vary between the fattening periods. Therefore, no
generalisation is possible based on one round sampling to assess the
herd status. The results indicate that serology in slaughterhouse blood
is a valuable source of information.
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SERO-PREVALENCE OF PPV ANTIBODIES
IN SOW HERDS WITH AN SPF STATUS
AND A HIGH LEVEL OF BIOSECURITY IN
THE NETHERLANDS
Introduction: PPV (Porcine Parvo Virus) causes fertility problems in
pigs like mummification, small litters and stillborn piglets. Co-
infection with PCV2 possibly plays a role in the pathogenesis of
PMWS (Porcine Multisystemic Wasting Syndrome). PPV is endemic in
the Netherlands and in pig keeping countries worldwide. A large scale
inventory in the Netherlands in 1989 estimated the sero-prevalence
at 84% in sow herds. A recent study in Belgium mentioned a sero-
prevalence of over 95%.
However, in today’s pig farming it is conceivable that because of
intensive vaccination and improved biosecurity on farms, within
certain sow herds the prevalence of PPV might be considerably lower.
As a result, antibody titers in sows and maternal antibody levels in
piglets can be decreased and a substantial amount of piglets will
have no passive immunity against PPV. In that case we might have
to reconsider vaccination programs.
A small scale screening of test results at the laboratory of the Animal
Health Service in the Netherlands in 2009, showed that of 267
submitted samples form sow herds, only 65% was sero-positive.
Differences between sow herds seemed large.
Method: Four Dutch SPF sow herds were involved in the study. Blood
samples from 60 randomly selected representative sows per herd
were tested for PPV antibodies with an haemagglutination inhibition
test (HI). Antibody titers larger than 1:256 are considered to be
related to a field virus infection. Titers between 1:8 and 1:256 can be
caused by either vaccination or a field virus strain. A titer smaller
than 1:8 is sero-negative.
Results: In two of the farms the sero-prevalence (titers below 1:256)
was significantly lower than 80%, in two other farms it was above
85%. A possible relationship with specific biosecurity measures on
the farms is under investigation.
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ONLINE MONITORING OF PIG HEALTH IN
THE NETHERLANDS
The GD Animal Health Service in the Netherlands uses information
from phone calls, farm visits, and results from post mortem
investigations and laboratory tests to monitor pig health in the
Netherlands. The GD started the monitoring system for the pig
industry and the Dutch ministry of agriculture back in 2003. It
appeared to be an accurate way of detecting unexpected and special
events concerning pig health. However, this reactive and in fact
passive tool is not very suitable for trend analysis. For instance, in
2008 – 2009 GD veterinarians received many phone calls about
PCV2 but this was mainly caused by the introduction of new
diagnostics and vaccines, not because of serious health problems. Yet,
trend analysis is desired by the pig industry to be able to respond to
certain developments, for instance in relation to antibiotics use.
In order to get a more active and representative impression of the pig
health situation in the Netherlands, the GD developed an online
monitoring tool for veterinary practitioners. This application allows
practitioners to capture simple information during their consultancy
visits at pig farms and to send the data to the GD. This information
includes the age group involved (e.g. finishers), affected body system
(e.g. respiratory system), symptoms (e.g. coughing), probable
diagnosis (e.g. Influenza infection) and, if applicable, additional
confirming laboratory tests (e.g. serological tests). The GD processes
the data to make analyses of trends and regional differences, and
links back the results to the practitioners. Besides, the GD generates
relevant reports to support the pig industry. In the successful pilot
phase of the project four large veterinary practices participated.
Shortly more practices will be included and in the foreseeable future
interactive features will be added to the monitoring application to
support the participants with real time information.
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SEROTYPING AND SEROLOGICAL
PREVALENCE OF ACTINOBACILLUS
PLEUROPNEUMONIAE IN THE NETHERLANDS
Introduction: Kamp was the last to report data with respect to
A.pleuropneumoniae serotyping in the Netherlands1. This study
concerns serotyping of A.pleuropneumoniae isolates from 84 Dutch
cases of pleuropneumonia between 2009-2012. The seroprevalence
during that period was also studied.
Material and methods: 84 isolates from cases of pleuropneumoniae
were serotyped (RingPrecipitation)2 by MSD-AH laboratories between
2009-2012.
ResPig is a program with cross-sectional serological investigations.
The data were used to determine the seoprevalence (OMP elisa) in
10-week old nursery pigs and 22-week old fatteners.
Results:
1. App isolates 2009-2012: type 1:2(2.4%) type 2:45(53.5%) type
5b:5(6.0%) type 9:31(36.9%) type13: 1(1.2%)
2. App seroprevalence:
Nursery: 2009:73%-2010:88%-2011:100%
Fatteners: 2009:98%-2010:99%-2011:100%
Discussion: Of the 84 A.pleuropneumoniae isolates, 45 (53.5%) were
of serotype 2. The next most common was serotype 9: 31(36.9%))
followed by serotype5b,1 and 13. In the 1984-1985 study, the
predominant serotypes were 9(49%) and 2(32%) followed by serotypes
1 3 5,7 and 8.
25 years after the last serotyping study, serotypes 2 and 9 are still the
commonest strains in the Netherlands, although serotype 2 now
predominates, instead of serotype 9.
Serotype 9 is regarded as the more virulent of the two, likely due to
the difference in toxin production. Following the shift towards the
prevalence of serotype 2, less severe A.pleuropneumoniae problems
might have been expected in the field. However, practitioners
submitting the isolates complained about an increase in acute
pleuropneumonia problems and a tendency towards an increased
incidence of acute pleuropneumonia in the nursery (<10-week old
pigs). This is supported by the increased seroprevalence on farms
between 2009-2011 (up to 100% in 10-week old piglets)
The increase in problems and seroprevalence has probably been
influenced by the restrictions imposed on the use of antibiotics on
Dutch pigfarms.
Literature:
1.Kamp.E. et al., (1987) Vet.Microb. 13p.249-257; 2.Mittal.K. et al.,
(1982) Journ.Vet. Microb.,6p.1019-1023
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RELATIONSHIP BETWEEN LUNG LESIONS AT
SLAUGHTER AND PERFORMANCE OF PIGS
Mycoplasma hyopneumoniae (M.hyo) is the primary pathogen of
enzootic pneumonia and is a primary agent of the porcine respiratory
disease complex. As such, M.hyo causes major economic losses to the
pig industry due to a slower growth and higher feed conversion. The
objective of this study was to study the relationship between the
severity of lung lesions at slaughter and the performance of pigs. In
total 9324 pigs coming from 13 French pig herds having respiratory
disease due to M.hyo were included. The severity of lung lesions at
slaughter was evaluated using the lung lesion score method of Madec
and Kobisch (1982) and pigs were classified into four categories: score
of 0 (n=5241), score of 1 to 3 (n=2196), score of 4 to 8 (n=1431),
score of 9 to 24 (n=456). The performance was evaluated using the
average daily weight gain (ADWG) between birth and 115kg, the age
at 115kg and the weight at 180 days of age. The ADWG between birth
and 115kg was 12, 18, and 44 g/day lower in pigs having lung lesion
scores between 1 and 3, between 4 and 8, and between 9 and 24,
respectively when compared to pigs without lung lesions. Similarly,
pigs having lung lesion scores between 1 and 3, between 4 and 8, and
between 9 and 24 needed 4, 6, and 14 days longer to reach a weight
of 115kg and their weight at 180 days of age was 2.4, 3.7, and 9.4kg
lower when compared to pigs without lung lesions. The differences
between the four groups with different categories of lung lesion scores
at slaughter were statistically different between each other for all
three performance parameters. This study confirms that pneumonia
has a major impact on the performance of pigs.
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PREVALENCE OF SHOULDER AND PASTERN
ULCERS IN DANISH SOW HERDS
Introduction: In Denmark, shoulder ulcers are a common problem
but little is known about the prevalence in different stages of the
lactation period. Even less is known about pastern ulcers and to our
knowledge estimates of prevalence have not yet been reported.
Hence, the aim of this study was to estimate the prevalence of
shoulder – and pastern ulcers in lactating sows in Danish herds.
Materials and methods: The study design was cross-sectional. To
ensure a precision of +/-5% of the expected estimated prevalences,
19 herds needed to be included. The herds were recruited from
northern Denmark, and was only included if they had more than 20
sows per farrowing group and kept reliable productivity recordings.
Organic and outdoor herds were excluded. In each herd, 20 sows that
had farrowed within the last 1 to 4 days (grp1) and 20 sows closer to
weaning (grp2) were randomly selected and clinically examined once
by the same person. Any damage of the dermis in shoulder/pastern
regions was defined as “Ulcer” and the location was recorded.
Results: During May 2011 to December 2012, 29 herds were visited.
In total, 1153 sows were examined. The overall prevalence of shoulder
ulcers were 1.6±0.7% in grp1 and 8.2±1.6% in grp2. The overall
prevalence of pastern ulcers was 8.3±1.6% in grp1 and 12.6±1.9% in
grp2. The within-herd prevalence of shoulder ulcers ranged from 0 to
12.8% in grp1 and 0 to 20.0% in grp2. For pastern ulcers the within-
herd prevalence ranged from 0 to 20.0% in grp1 and 0 to 30,0%
in grp2.
Conclusion: In spite of large between-herd variation, the overall
prevalence of ulcers in grp2 was significantly higher than in grp1
(p<0.001 for both shoulder and pastern ulcers), suggesting that the
prevalence of ulcers increased during the lactation period.
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RETROSPECTIVE STUDY OF CONDEMNATION
ASSOCIATED WITH LYMPHADENITIS IN PIGS
REARED IN FREE-RANGE SYSTEMS
Pigs reared in outdoor systems interact with other domestic and wild
animals, being difficult to control the circulation of pathogens among
them. The present study is focused on a retrospective study from an
abattoir, where only free-range pigs are slaughtered, to determine the
impact of lymphadenitis in the condemnation of pig carcasses. A
documentary analysis of slaughtered animals from 5 seasons (January-
April), from 2007 to 2011, was performed. A database was created
compiling information regarding the main cause of condemnation,
location of the herds, geographical characteristics and the environment.
In addition, the following parameters were recorded: number of animals
slaughtered per year (ASY), number of slaughtering with condemned
animals (SCA), number of animals slaughtered in each slaughtering
with condemned animals (ASSCA), number of condemned carcasses
(CC), number of carcasses condemned due to lymphadenitis (CCL),
number of days of slaughtering (DS), and number of days of
slaughtering with condemnation of carcasses (DSC). In addition,
samples from submandibular lymph nodes, lung, liver and spleen were
collected during 2011 from condemned animals and subjected to
microbiological analysis, being corynebacteria and Streptococcus the
most frequently isolated (65.57%). An average of 91,032 animals were
slaughtered/season, with 6,946 (7.63%) partial or complete carcass
condemnation. One hundred and ninety six carcasses were totally
condemned, with a 85% condemned due to disseminated
lymphadenitis. An average period of 75,2 days of slaughtering was
recorded counting with a mean of 37,4 days of slaughtering with
condemned carcasses. Significant differences between years and areas
were observed. A marked association between cases of lymphadenitis
and proximity to natural parks was observed, highlighting the impact
of the interaction with wild species. This is the first study carried out
to determine the distribution and importance of lymphadenitis
condemnation in free-ranged pigs, and shows the main bacterial genera
to be considered in control measures.
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ARE ENZOOTIC PNEUMONIA LESIONS AT
SLAUGHTERHOUSE PREDICTABLE BY
MEANS OF MYCOPLASMA HYOPNEUMONIAE
SEROLOGY?
The objective of the present study was to assess the potential
association between mean Mycoplasma hyopneumoniae (M.
hyopneumoniae) serological S/P ratios using a commercial kit with
enzootic pneumonia (EP) lung lesion scoring in slaughter-age pigs. A
total of 56 batches of pigs from 56 different farms were included in
the study. A batch was defined as a group of pigs (with a mean of 97
animals per batch) belonging to the same farm that were sacrificed
on the same day at the slaughterhouse. Cranio-ventral pulmonary
consolidation (EP-like lesions) was individually examined using the
Madec & Kobisch method. An EP-like lesion average value per farm
(sum of individual lung EP-like lung scores/number of scored lungs)
was calculated. In addition, blood samples from 20 randomly selected
pigs within each batch were collected. Blood samples were tested
with a commercial kit (M. hyopneumoniae antibody test kit, Biochek).
A statistically significant association was observed between mean M.
hyopneumoniae S/P ratio of the randomly selected pigs and the mean
lung lesion scoring. Such association was observed both with the
proportion of animals showing EP-like lesions (p= 0.007 R= 0.36) as
well as with the mean S/P of the whole batch (p= 0.003 R= 0.38). The
higher the S/P value, the higher the mean lung lesion score. Results of
this preliminary work suggest that mean S/P ratio at slaughterhouse
could be used as a predictor of mean EP-like lesion scoring.
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ENZOOTIC PNEUMONIA SURVEY IN
ITALIAN SLAUGHTERED PIGS
From January 2010 to December 2012, lungs from 15174 pigs (160kg
slaughter weight, aged 9-10 months) belonging to 136 Italian farms,
were evaluated using the Madec grid. Bronchopneumonic lesions
suggestive of Enzootic pneumonia (EP like) were detected in 6976
lungs (45.9%). The EP-like lesion average value for all batches was
1.07, ranging from 0.16 and 3.11 among the 136 batches. The EP-like
lesion average values, obtained for each batch, were organised in four
categories (quartiles): best quarter <0.66; intermediate best quarter
from 0.66 to 0.98; intermediate worst quarter from 0.98 to 1.35 and
worst quarter >1.35. The distribution in categories of EP average
values can be used to rank a batch in comparison to the whole
population. In order to determine the possible differences in EP-like
lesions between different periods, a study was performed comparing
the considered period (2010-2012) to the data collected from January
2004 to December 2009 (lungs from 6380 pigs belonging to 60
batches). In the latter period (2004-2009) EP-like lesions were
detected in 3249 lungs (50.9%) and the average value for all batches
was 1.4 ranging from 0.43 and 4.44. The application of Madec’s grid
in the two considered periods confirms the high incidence of these
lesions in Italian swine herds. However, the EP-like average value (1.07)
of batches scored in 2010-2012 was significantly lower as compared
to that (1.4) obtained in the survey carried out in 2004-2009 (one
way Anova test p<0.01). These values are definitely lower than those
reported by Ostanello et al., (2006) based on lungs from 10041 pigs
scored in the period 2003-2004, in which the overall Ep-like average
value was 2.11. Overall, the results of the survey reported in this paper
shows an improvement of the control of EP in Italy.
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SEROLOGIC EVALUATION OF VACCINATION
HISTORY WITH CIRCOVAC®
Objective: The objective of the study was to show an anamnestic
serologic response in piglets vaccinated with CIRCOVAC at 3 and 10
weeks of age which differs from the serologic response of piglets only
vaccinated at 10 weeks of age.
Materials and methods: A selection of 20 piglets of 3 weeks old were
divided into 3 groups. One group (NVNV, 5 piglets) was not vaccinated,
a second group (NV10V, 5 animals) was vaccinated with CIRCOVAC
(0.5ml) at 10 weeks of age and one group (3V10V, 10 piglets) was
vaccinated at 3 and 10 weeks of age with 0.5ml CIRCOVAC. The animals
were blood sampled at 3, 10 and 12 weeks of age. Sera were analysed
with INGEZIM Circovirus IgG ELISA and optical density (OD)-values
were evaluated.
Results: At 3 weeks of age, NVNV and 3V10V animals had an OD-
value of 1.11 and 1.18, indicating good colostrum intake and animals
of group NV10V showed a lower OD-value (0.30). At 10 weeks of age,
all groups showed low OD-values for IgG, due to decreased maternal
antibodies. These titres were 0.23 (NVNV), 0.32 (3V10V) and 0.15
(NV10V) for the respective groups. At 12 weeks of age, there was a
clear increase of OD-value in the 3V10V group (0.53), while the OD-
values in the piglets not vaccinated at 3 weeks of age remained low:
0.14 for the NVNV group and 0.14 for the NV10V group.
Conclusion: The serologic response after vaccination with CIRCOVAC
at 10 weeks of age differs according to the vaccination history at 3
weeks of age. When no vaccination was performed at 3 weeks of age,
no increase in OD-value is observed. In conclusion, a 0.5-ml CIRCOVAC
injection at 10 weeks of age effectively recalls immune response after
a CIRCOVAC priming at 3 weeks of age.
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COMPARISON OF PIGLET VACCINATION
WITH CIRCOVAC® AND ANOTHER PCV2
PIGLET VACCINE REGISTERED IN EUROPE
ON PRODUCTION PARAMETERS UP TO
SLAUGHTER IN THREE DANISH FARMS
Introduction: The objective of this study was to compare the
efficacy of CIRCOVAC and another PCV2 piglet vaccine registered in
Europe (Vaccine X) vaccination on performance parameters under
Danish field conditions.
Material and methods: The study included two 2-site operations
(A,B) and one farrow-to-finish operation (C), breeding at between
340 and 725 sows, located in Denmark. In each farm, around 600
piglets weaned at 3 to 4 weeks of age were included and vaccinated
either with 0.5ml CIRCOVAC or injected with 1.0ml Vaccine X. The
experimental groups were randomised according to weaning
bodyweight, sex, age, dam parity, and litter size. The pigs were
weighed at weaning and at slaughter. Mann-Whitney’s W test or
Student’s t-test was used to compare standardised average daily
weight gain (ADWG 6-to-106kg) within each farm. Mortality was
compared between the groups using a Chi-square test.
Results: Whatever the farm, no significant difference in growth
performances was observed between the CIRCOVAC-vaccinated
group and the Vaccine X group. The real overall ADWG for the 3 farms
were respectively 751, 722 and 775 g/day. The average difference in
standardised ADWG (6-to-106kg) were for farm A: -5 g/day (p=0.32),
farm B: +4 g/day (p=0.60) and farm C: -2g/day (p=0.64) in favour of
the CIRCOVAC groups. Slaughter weights did not significantly differ
between the vaccinated groups. Overall average mortality rates was
similar 4.4% (Min 3.5 – Max 6.2) in the CIRCOVAC groups vs. 3.6%
(Min 3.1 % – Max. 4.3%) in the Vaccine X groups. (p>0.05).
Conclusion: Performance of pigs vaccinated with CIRCOVAC was
found as good as the one of piglets vaccinated with another PCV2
piglet vaccine registered in Europe in the same Danish farms.
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PREVALENCE OF MYCOPLASMA
HYOPNEUMONIAE AND RISK FACTORS FOR
THE INFECTION IN SUCKLING PIGS AT THE
AGE OF WEANING
The aim of the present study was to investigate the frequency of M.
hyopneumoniae infections in suckling pigs of endemically infected
herds and to identify individual risk factors potentially influencing
the infection status of suckling pigs at the age of weaning.
The animal level prevalence of M. hyopneumoniae infections in
suckling pigs examined in three conventional pig breeding herds was
3.6% (41/1127) at the time of weaning. A prevalence of 1.2% was
found in the same pigs at the end of their nursery period. In a
multivariable Poisson regression model it was found that incidence
rate ratios (IRR) for suckling pigs are significantly lower than 1 when
teeth grinding was conducted (IRR: 0.10). Moreover, adequate
temperatures in the piglet nest during the first two weeks of life
decreased the probability of an infection (IRR: 0.23-0.40). Contrary,
the application of PCV2 vaccines to piglets was associated with an
increased infection risk (IRR: 9.72).
Several individual risk factors being associated with the detection of
M. hyopneumoniae in suckling pigs at the age of weaning have been
identified. Since single infected piglets are supposed to act as
initiators for the transmission of this pathogen in nursery and
fattening pigs, the elimination of the risk factors described in this
study should help to reduce the incidence rate of M. hyopneumoniae
infections and thereby might contribute to a reduced probability of
high prevalence in older pigs.
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CLASSICAL SWINE FEVER VACCINATION IN
FYR OF MACEDONIA – COST BENEFIT STUDY
Classical swine fever (CSF) is an infectious viral disease affecting
domestic pigs and wild boar. It is not a zoonosis and does not affect
other livestock species. Its principal impact is therefore in terms of
the economic losses that it causes and its impact on international
trade. The disease has been reported sporadically from several Western
Balkans countries, including FYR of Macedonia.
This study assesses alternative strategies to control and eradicate the
disease in domestic pigs and wild boar within FYR of Macedonia. The
study considers the strategic context within which programmes for
the control and eradication of CSF must be implemented. It considers
the role that backyard pigs and free-ranging wild boar might play in
endemic disease.
The study considers the costs, benefits and risks of a shortlist of control
and eradication strategies, including mass vaccination in domestic pigs,
eradication of disease by stamping out, the use of emergency
vaccination in the face of an outbreak and systematic vaccination of
infected wild boar populations. The study identifies the combination of
options that offers the best value for money overall.
Finally, the study considers how implementation of the recommended
option might be funded, taking account of significant drivers in the
national economy.
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SURVEY ON FINNISH PIG FATTENING UNITS
WITH RESPIRATORY CLINICAL SIGNS
A total of 15 fattening pig units with an average of 246 (sd 122 pigs)
were included in a survey to investigate severity of symptoms and
pathogens involved during acute occurrence of respiratory signs and
the second time one month later. Altogether 182 pigs per herd (sd
111) were clinically observed during the herd investigation for:
coughing, sneezing, eye discharge, sitting and other symptoms. In each
herd, 23 affected pigs were examined more closely (temperature
measurement and nasal swab) and three clearly symptomatic pigs
were euthanised and their lungs and hearts were sent to laboratory
for bacteriological investigation. On average, 12% of the pigs observed
were sneezing and 5% coughing during a 5 minute follow-up time.
Altogether 23% had eye discharge and 4% was sitting on their back
legs. After laboratory examination of the lungs, 7 herds were
diagnosed with only Actinobacillus pleuropneumoniae (APP) infection,
2 with a mix infection of APP and PCV2, 2 with Ascaris suum, 1 with
a mixed infection of Pasteurella multocida and APP, 1 with Ascaris
suum and APP, 1 with only PCV2 and 1 with mixed Gram – bacteria.
All nasal swabs for swine influenza virus were found negative. Thirty
days later, after appropriate treatment with antibiotic or anthelmintic,
on average 5% of the observed pigs were sneezing and 0,5%
coughing, 14% had eye discharge and 5% was sitting on their back
legs. From this preliminary survey we found that in Finland the main
pathogen involved during respiratory outbreaks in fattening pigs was
APP and that Ascaris suum should be more considered when coughing
is present in fattening pigs units.
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DETECTION AND PREVALENCE
ESTIMATION OF BRACHYSPIRA
HYODYSENTERIAE IN POSITIVE BREEDING
HERDS IN NORTH CAROLINA, USA
The re-emergence of Swine Dysentery (SD), caused by Brachyspira
hyodysenteriae (B hyo) in North America has brought focus back to
this disease. While focus has been on diagnosis and impact of the
disease in growing pigs, there are a number infected breeding herds.
One challenge in controlling SD is the identification of positive
breeding herds which serve as a source for growing pigs. Diagnosis of
SD presents a challenge in breeding herds where estimated disease
prevalence is low. Detection in breeding herds is also important to
validate the success of medication and elimination programs. To
better understand the prevalence of B hyo, two field studies were
conducted on SD positive sow farms.
In study 1, samples were collected from a 2,200-sow farrow-to-wean
farm from 8 weanings over 17 weeks. Rectal swabs (liquid Stuart
medium) were collected from 60 sows and 60 pools (3 piglets per
pool) of piglet swabs, from the sows’ litter at each collection. Swabs
were shipped to the Iowa State University Veterinary Diagnostic
Laboratory, Ames, Iowa, USA for culture. The overall percent positive
was 1.04% (range 0-5%) for sows and 1.88% (range 0-5%) for piglet
pools. In total, 5 of 8 samplings had at least one positive sample. In
study 2, 150 sows were randomly selected from each of five farrow-
to-wean farms (size: 2,400-3,600 sows) and sampled as in study 1.
The percentage of sows positive for B hyo ranged from 0-1.33%. B
hyo was identified in at least 1 sample on 3 of the 5 herds.
The detection of B hyo in these studies ranged from 0 to 5% with 95%
confidence, which is consistent with limited published data. This
suggests that sampling schemes detecting disease at these levels should
be used in breeding herds to assist in identifying positive SD status.
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RESULTS RANKING ALTERNATIVES FOR
ANTIMICROBIALS FROM 4TH ESPHM
Introduction: During the 4th ESPHM in Bruges 2011 a paper
questionnaire was handed out to participants in which they were
asked to rank alternatives for antimicrobial usage for the European
consortium project “MINApig” (www.minapig.eu).
Materials and Methods:The questionnaire consisted of two general
questions (active practitioner, country), one question describing their
ultimate measures, two questions on the extend to what they
motivate their clients in reducing antimicrobial usage, two questions
in which they had to mention pro’s and contra’s for motivating clients.
The last part asked to rank 12 pre-listed alternatives for antimicrobial
usage on their effectiveness, feasibility and financial impact (ROI).
Results: 39 ESPHM participants returned the questionnaire,
reflecting 15 different countries. Alternatives proposed by
respondents were most frequently (19.1%) in the area of “internal
biosecurity” and the increased use of “vaccination and/or anti-
inflammatory products” (13.9%). On average respondents motivate
their clients “strongly” to reduce antimicrobial usage. Pro’s for
motivation on reduced antimicrobial use were “cost reduction”
(28%), “public health/antimicrobial resistance” (28%) and “better
work joy/better results” (24.7%). Contra’s were “animal welfare
impair/higher mortality/outbreaks” (22.2%), “ease of antimicrobials/
improve results/cover up management imperfections” (15.9%) and
“higher workload” (14.3%).
Ranking: Regarding “effectiveness” the highest scores were seen for
“improved internal biosecurity”, “reduced stocking density” and
“improved climate”. “Supplemental/improved vaccination” ranked
highest for “feasibility” as well as for “return on investment”.
“Phytotherapy” scored lowest for all three parameters. Based on all
three parameters, the overall five highest scoring alternatives were:
improved internal and external biosecurity, supplemental/improved
vaccination, climate and feed quality improvement.
Conclusion:This limited number of results provides a first impression
on the practitioners’ opinion on possible alternatives to antimicrobial
usage. The MINApig consortium will add complimentary information
and use these results to inform future field studies.
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PILOT VENTILATION PROJECT AS PART OF THE
PIG HEALTH IMPROVEMENT PROJECT (PHIP)
Good ventilation systems are essential for providing optimum living
conditions for pigs and those working with them. A well-managed,
functioning, efficient ventilation system draws fresh air into a building
and removes stale air containing microbes, dust, harmful gases and
water vapour. Pigs are very susceptible to drafts and the climatic zones
within a pen influence behaviour, especially lying and dunging as well
as being a trigger for vices such as tail biting. All of these factors have
implications for pig hygiene, health, welfare and physical performance.
Pleurisy and respiratory disease are significant health problems
affecting the welfare of pigs in England.
Evidence from BPEX knowledge transfer activity on-farm and producer
enquiries highlighted the issue that many pig buildings have ventilation
problems which are impacting negatively on pig performance, health
status and hygiene. These problems are found in both older and
new buildings.
The consequences of poor ventilation carry on after the pigs have
left a pen, as surfaces can be dirtier and harder to clean increasing the
likelihood of disease causing organisms to build up making Pig Health
Improvement Project (PHIP) objectives of disease control and
elimination harder to achieve.
Ventilation was reviewed in detail on the units of 25 English pig
producers who were participating in PHIP producer groups. The reviews
generated reports containing on-farm recommendations. The reports
and recommendations formed the basis of group discussions on best
practice for ventilation at the local PHIP producer group meetings along
with veterinary surgeons. This innovative pilot will support development
of a Best Practice Ventilation Guidance booklet for the whole industry
with case studies looking at improvements made on-farm and the
subsequent effect on health. The pilot encourages a collaborative
approach to problem solving in producer groups.
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MOLECULAR EPIDEMIOLOGY OF SWINE
DYSENTERY IN THE NORTH OF ENGLAND:
AN INVESTIGATION INTO ROUTES OF
TRANSMISSION
Swine dysentery (SD), caused by Brachyspira hyodysenteriae, is an
endemic disease of economic importance to the British pig industry,
causing mucohaemorrhagic diarrhoea with anorexia, fever and wasting.
It causes considerable losses in pig production through reduced feed
conversion efficiency, reduced daily live weight gain and increased
mortality, and is detrimental to pig welfare. The levy board for pig
producers in England (BPEX) has been working with farmers in the
north of England to eliminate SD from the local area, following an
outbreak in 2011.
Multi-locus sequence typing (MLST) of B. hyodysenteriae isolates
from infected farms in the target area has shown the existence of
genetically distinct groups of B. hyodysenteriae isolates. This study
aims to utilise this and more extensive MLST and whole genome
sequencing data derived from a substantial national archive, in an
exploratory epidemiological analysis to identify possible routes of
transmission during a recent outbreak.
A participatory survey of producers in the target area has documented
movements of pigs and potential fomites such as livestock hauliers to
and from affected farms during the period of concern, and assessed
individual units’ biosecurity arrangements. The data have been visually
represented in combination with the geo-phylogenetic MLST profile
of B. hyodysenteriae isolates in the area to produce a spatio-temporal
map showing the spread of distinct SD strains and hypothetical
transmission routes. MLST has value in exploring risk factors for
transmission in the target area and suggesting possible epidemiological
links. Findings are communicated to producers and incorporated into
strategies for SD prevention and control via BPEX’s Pig Health
Improvement Project. Statistical regression analyses applied to explore
causal relationships further allow the possibility for the outputs of this
investigation to be used in a future modelling exercise as part of a
control or eradication programme.
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PREVALENCE OF LAWSONIA
INTRACELLULARIS INFECTIONS IN WEANER
AND SUCKLING PIGS IN GERMANY
In Germany around 90% of finisher farms were tested seropositive for
Lawsonia intracellularis (LI). The current studies were done to confirm
that these results are still valid today and to investigate the prevalence
of LI infections in weaner pigs to optimise vaccination schedules. In a
first screening 10 pigs of three different age groups were sampled on
each of 51 farms. At least one seropositive animal was detected at the
age of 8 weeks in 10.9%, at the age of 12-14 weeks in 40.8% and at
the end of the fattening period in 96.0% of the farms. In a second
screening only oldest weaner pigs in the nursery units of 101 breeding
herds were tested, but sample size was increased (n=20) to find also
farms with lower intra-herd prevalence. Additionally faeces samples of
suckling pigs were examined by PCR to find out, if piglets already may
be infected by LI shortly before weaning.
At herd-level on 39.2% of the farms antibodies against LI were
detected. In 26 of 40 herds there was only one serologically positive
pig among the tested weaners.
Because intra-herd prevalence often was low or pigs from nursery units
were LI negative a vaccination against LI shortly after weaning thus
should lead to a sufficient active immunity in most of the herds in time.
A LI infection could be detected in only 4 out of 600 faecal samples
of suckling pigs (0.7%) from 60 herds. However, these findings show
that a carry-over of LI into rearing units is possible this way.
Furthermore, based on information about farm and reproductive data
as well as herd management (housing, feeding, measures with regard
to hygiene, prophylaxis and treatment) potential risk factors for an
LI infection of weaners will be identified by a statistical analysis.
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HERD HEALTH SCORE AND ITS FEASIBILITY
FOR PIG HERDS IN THE UK
Pig health is at the centre of a sustainable national pig herd that
contributes fully to national food security with reduced environmental
impact. These targets will be achieved by disease elimination and
disease impact reduction. Our objective was to investigate the
feasibility of developing a new or improved methodology to measure
herd health score (HHS) and cost calculator for pig breeding and
finishing herds in the UK. We have reviewed the literature to identify
existing HHS approaches and methods of estimating the costs of
disease. Two main HHS developed in Germany and France were found
in our review. The German methodology combines four health
parameters including: mortality rate, frequency of pathological lesions
on carcasses, animal-treatment index and duration of finishing period.
The French approach consists of evaluation of 14 health indicators
such as: hygiene, pneumonia, sows gait problems, bio-security, etc.
A total number of 2,608 batches belonging to 1,281 herds from the
BPHS dataset (January-June 2012) was then used to evaluate the
pathological indicators of the two HHS. Agreement between the two
approaches was tested using a Cohen kappa agreement test. Results
showed that the majority of batches and herds (58.4% for both) were
considered to have a good health score using the German HHS. Using
the French HHS, around 14% of batches and 9.7% of slap marks were
considered to have a good health score. There was a low agreement
between the two HHS. This evaluation exercise demonstrates the
feasibility of using the BPHS dataset in a HHS. However, farm level
management and clinical data are also needed to be included in a
HHS. For a HHS to be adopted it must be simple, like the German
HHS, and should be adapted to the British pig production system (e.g.
replacing ‘duration of finishing period’ by ‘average daily weight gain’).
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INTERPRETATION BY CLUSTER ANALYSIS OF
ESCHERICHIA COLI ANTIBODIES TITRATION
TESTS IN SOW COLOSTRUM FOR THE
ASSESSMENT OF THE QUALITY OF
VACCINATION AGAINST NEONATAL E. COLI
DIARRHOEA IN PIGS
Titration of E. coli antibodies in colostrum is used in the field to assess
quality of vaccination of sows but the interpretation of the herd
profiles can be difficult and disconcerting mainly because of non-
consistent results between the different antigen-specific antibody
titres. Thus, the objective of this study was to analyse field data by
cluster analysis and therefore suggest new rules of interpretation.
Colostrum was sampled, at the latest 6 hours after farrowing, out of
662 in 36 herds (18.4 colostra per profile) and information of the
vaccination scheme of sows against E. coli was obtained. Samples were
distributed between first, second and third and more parity ranks.
The colostrum samples were tested for the presence of antibodies
against E. coli virulence factors F4ab, F4ac, F5 and F6 fimbrial
antigens and Heat-Labile E. coli enterotoxin (LT) toxoid in ELISA
(MSD R&D Laboratory, Boxmeer, NL). The titres were expressed as
2log values and the mean titre was calculated for each herd and each
antigen. Four published profiles where the same ELISA was used (1,2),
two from non-vaccinated animals and to from Porcilis® Porcoli DF
vaccinated sows, were added to the dataset as references.
A typology of the herd profiles, using Principal Components Analysis
and Ascending Hierarchical Clustering was performed.
Clustering allowed classifying the profiles in 6 clusters which gathered
respectively 5, 5, 4, 9, 7 and 10 herds. We formulated and discussed the
hypothesis that cluster 1 contained non-vaccinated herds, cluster 2,
Porcilis® 5C vaccinated herds, cluster 4, and 6 Porcilis® Porcoli DF
vaccinated herd with medium and high levels of antibodies whereas
the biological meaning of clusters 3 and 5 remained unclear.
The results of this study may be used as a decision-support tool for
the interpretation of new profiles.
1. Riising, H.-J. et al., (2005); 2. Besson, H. et al., (2010)
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EFFECT OF VACCINATION WITH ECOPORC
SHIGA ON OVERALL MORTALITY AND USE
OF ANTIMICROBIAL MEDICATION DUE TO
EDEMA DISEASE (ED)
ED caused by Shigatoxin Stx2e producing strains of E. coli occurs
worldwide and is responsible for severe illness in pigs resulting in a high
mortality during the nursery period and substantial economic loss.
Therefore a new recombinant Stx2e-vaccine (ECOPORC SHIGA) was
developed as a one shot injection for active immunisation of piglets
from an age of 4 days on. The vaccination induces the development of
neutralising antibodies against Stx2e and therefore ensures protection
from ED after weaning during the entire nursery period.
For the assessment of efficacy regarding mortality and medication
longitudinal field studies were performed on two pig farms in
Germany. Both farms had a well-documented anamnesis of clinical
ED. Vaccination with ECOPORC SHIGA took place on the 4th day of
life. On farm1 piglets were weaned at 3 weeks of age and nursery
period lasted for another 9 weeks. Nine vaccinated farrowing groups
(2792 piglets) were compared with 6 unvaccinated groups. On farm2
weaning took place at 23 to 28 days of life and nursery period lasted
for another 10 weeks. 24 vaccinated farrowing groups (12344 piglets)
were compared with 8 unvaccinated groups. In the unvaccinated
previous control groups ED was suppressed by the oral use of Colistin
after weaning.
The all-cause mortality in nursery was lowered by vaccination on
farm1 from 3.66%±1.28 to 1.68%±0.85 (p-value=0.003) and on
farm2 from 2.58%±1.01 to 1.13%±0.48 (p-value<0.001). On both
farms the need for routine medication with Colistin changed from a
3 weeks period after weaning in unvaccinated groups to 0 days in
vaccinated groups (p-values<0.001).
The mortality in the vaccinated groups was significantly reduced by
2% resp. 1.5%. The use of E. coli-effective antibiotics was lowered to
zero. The vaccine ECOPORC SHIGA is an effective tool to reduce the
mortality due to ED and to lower the use of antibiotics in modern
pig husbandry.
NOTES
POSTER PRESENTATIONS: INFECTIOUS – ENTERIC
144
P088
Chan, Gloria; University of Guelph, Farzan, Abdolvahab; University of
Guelph, DeLay, Josepha; Animal Health Labs; McEwen, Beverly;
University of Guelph, Animal Health Laboratory, Prescott, John;
University of Guelph, Friendship, Robert; OVC – University of Guelph.
THE ETIOLOGICAL DIAGNOSIS OF
DIARRHOEA IN NEONATAL PIGLETS
IN ONTARIO, CANADA, BETWEEN 2001
AND 2010
The passive laboratory surveillance data of the etiological diagnosis of
neonatal piglet diarrhoea between 2001 and 2010 from the Animal
Health Laboratory, University of Guelph were analysed to determine
the relative importance and trends of different enteric pathogens
associated with neonatal piglet diarrhoea in Ontario. A total of 237
cases that included live or dead 1-to 7-day-old piglets were submitted
for the diagnosis of gastrointestinal illness between 2001 and 2010.
The combined frequencies for gastrointestinal illness cases involving
Escherichia coli, Clostridium perfringens type A, rotavirus, and
Clostridium difficile either as single pathogens or a complex of
pathogens accounted for 56% of the total cases. A total of 33% of
gastrointestinal illness cases did not have an etiological agent
identified. The frequency of cases diagnosed with enterotoxigenic E.
coli had a decreasing trend from 2007. Cases submitted in 2010 were
more likely diagnosed with C. perfringens type A compared to cases
submitted in 2002-2007 (P<0.05). A significant trend for submission
of samples in the winter was observed in cases diagnosed with C.
perfringens type A, enterotoxigenic E. coli, rotavirus, and Isospora suis
(P<0.05). Enterotoxigenic E. coli was less likely diagnosed if C. difficile,
C. perfringens, or rotavirus were detected (P<0.05). Younger piglet
cases were more likely to be diagnosed with C. perfringens type A
(P<0.05) and C. difficile (P<0.05) than older piglets. This study
indicated that E. coli, C. perfringens type A, rotavirus, and C. difficile
are enteric pathogens of concern for the Ontario swine farrowing
operations, and that further research is required to understand the
reasons for non-diagnosed cases.
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MOLECULAR FEATURES OF E. COLI ISOLATES,
SELECTED FROM PIGS WITH ENTERITIS
Escherichia coli is an opportunistic symbiotic organism and one of
the representatives of gastrointestinal tract of animals. However, the
pathogenic forms of this organism can cause diarrhoeal diseases in
hosts in case of disorder of its normal condition (such as depression
of the immune system, development of the co-infections). Such
consequences could appear due to the action of the virulence factors
that characterise only pathogenic E. coli. The diseases caused by
diarrheic strains of E. coli are called colibacillosis. Exactly, ETEC
(Enterotoxigenic Escherichia coli) and EHEC (Enterohemorrhagic
Escherichia coli) are the most frequent causes of diarrhoea and death
in neonatal pigs.
In this study, the samples from 29 piglets received from 22 farms
located in 12 Ukraine regions were analysed. All pathological lesions
were examined at necropsy and the fragments of lymph nodes and
intestine were sampled for PCR analysis. The targets for reactions
were: heat labile enterotoxin (LT), heat stable enterotoxin type A (STa)
and type B (STb), Shiga toxin type I (SLT-I) and type II (SLT-II).
After processing we marked the result as positive in case of detection
even one toxin. Thus we showed that diarrheic strains of E. coli were
present in 26 samples of the 29 tested (89%). Moreover, we set the
frequency of appearance of all examined toxins: LT-toxin was
detected in 62% (18 from 29) cases, STa-toxin in 28% (8/29), STb-
toxin in 62% (18/29), a SLT-II -toxin in 3% (1/29) cases, and SLT-I –
was not detected. After the study the map of pathogenic E. coli
spreading in Ukraine was characterised and it was shown that cases
of colibacillosis were diagnosed in 11 regions of the 12 tested.
NOTES
POSTER PRESENTATIONS: INFECTIOUS – ENTERIC
145
P090
Denise. K. Gessner1, B. Syed2, T. Steiner2, K. Eder1
1 Institute of Animal Nutrition and Nutritional Physiology, Justus-Liebig-
University Giessen, Germany;
2 BIOMIN Holding GmbH, Industriestrasse 21, 3130 Herzogenburg, Austria.
INFLUENCE OF A PHYTOGENIC FEED
ADDITIVE ON INFLAMMATORY PROCESSES
IN INTESTINAL CELLS
Several pathologic stimuli, including bacteria and viruses, are known
to stimulate inflammatory processes in the intestinal mucosa by
cytokine-mediated activation of the pro-inflammatory transcription
nuclear factor kappa B (NF-κB). NF-κB is considered the master
regulator of inflammation because its activation causes an up-
regulation of a series of genes mediating inflammatory response.
Through the subsequent release of inflammatory mediators, such as
tumor necrosis factor-alpha (TNFα), interleukin 6 (IL-6) or interfon γ,
(IFNγ) the inflammatory process is not only restricted to the
intestine, but may also affect other tissues. Considering that such
processes lead to an impairment of animal performance, the
inhibition of excessive inflammatory processes in the intestine is a
reasonable approach to maintain performance characteristics of
livestock animals. Protective effects on tissues, including intestine
are mediated by activating the Nrf2 pathway, which leads to the
induction of genes responsible for cellular defence against reactive
oxygen species and detoxification of xenobiotics.
The objective of this study was to explore the anti-inflammatory
potential of the phytogenic feed additive Digestarom® using
polarised Caco-2 cells, which are an established in vitro model for
intestinal epithelial cells.
To evaluate the anti-inflammatory action of Digestarom®, its effect on
TNFα-induced transactivation of NF-κB and mRNA levels of selected
NF-κB target genes interleukin-8 (IL-8), intercellular adhesion molecule-
1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) was
investigated. To study the effect of Digestarom® on activation of the
Nrf2 pathway, the mRNA levels of selected Nrf2 target genes heme
oxygenase-1 (HO-1), cytochrome P450 isoform 1A1 (CYP1A1) and
UDP-glucuronosyltransferases isoform 1A1 (UGT1A1) was determined.
The study shows that Digestarom® is capable of inhibiting
transactivation of the proinflammatory transcription factor NF-κB
and, thereby, the expression of several inflammation-related genes in
Caco-2 intestinal epithelial cells. Thus, Digestarom® may be useful in
(I) inhibiting inflammatory processes and (II) activating cell
protecting pathways in the intestinal mucosa of livestock animals.
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EFFECT OF ADMINISTRATION OF A
SINGLE DOSE OF SACCHAROMYCES
CEREVISIAE CNCM-I 1079 ON INCIDENCE
OF NEONATAL DIARRHOEA
Neonatal enteric health is dependent upon colostral intake, milk
consumption and pathogen exposure. In addition gut microflora is
especially important with regards to nutrition, pathogen prevention and
gut development. Early introduction of beneficial microbes, probiotics,
may benefit microflora; Saccharomyces cerevisiae CNCM-I 1079 (SCB)
is a yeast probiotic which affects the host’s pro-inflammatory response
and has anti-toxin and trophic effects in the gut. SCB has also been
reported as an effective therapy during rotavirus and Clostridium difficile
(C.diff) infection in human infants. The effect of SCB against these
pathogens, and its other beneficial qualities, suggest it may improve
porcine neonatal enteric health.
To investigate SCB’s effect a blinded randomised control trial was
conducted on a 600 sow unit in France. Within 24h of life litters were
given an oral dose of a control or probiotic paste (3.3 x 109 cfu SCB).
Incidence of neonatal diarrhoea was determined for the first week of
life incorporating 23 control and 23 SCB litters. Within diarrhoeic
litters the three pigs exhibiting the most severe clinical signs were
tested for Group A rotavirus (GARV), C.diff and C.diff toxin A and B
using rapid diagnostic kits. Piglets were weighed at birth, day 7 and
day 21. During the study the SCB group had significantly less days of
scour than controls p=0.01. There was no significant difference in
weight gain (to 21 days). In diarrhoeic pigs the incidence of GARV
and C.diff was the same between treatments. We therefore conclude
a single dose of SCB decreases the incidence of diarrhoea in young
pigs. We hypothesise SCB benefits the enteric health of the pig and
that subsequent doses, or inclusion in feed, may lead to continued
enteric health and improved production. We continue to investigate
the mechanism by which SCB reduced diarrhoea in this study.
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A STUDY ON THE VIRULENCE FACTORS
AND ANTIBIOTIC RESPONSE OF E.COLI
STRAINS ISOLATED IN CASES OF
DIARRHOEA IN SUCKLING PIGLETS IN SPAIN
From 2009 to 2012, a total of 147 samples of fresh feces coming
from suckling piglets suffering diarrhoea were processed at the
Laboratori Veterinari de Diagnosi de Malalties Infeccioses (UAB). E.coli
isolation and antibiogram was done to all samples, and typing was
done running a multiplex PCR of the fimbriae K88ab (F4), K88ac (F4),
K99 (F5), 987P, F41, F18 y EAE and toxins Sta, STb, LT, EAST1, VT1 y
VT2. The majority of the samples were also tested against the
presence of C.perfringens and if positive, PCR typing of its toxins, and
against Rotavirus using ELISA test.
Results: Regarding to the fimbriae, K88ab and K88ac were found in 4,7%
of the isolates. K99 in 2%, and 987P and F18 in only 1,3%. F41 was in
10,9%, and the most common fimbriae was EAE, found in 36.7% of the
samples. Regarding to the toxins, the most common one was EAST1
(90,5%), followed by STa (21.7%), STb (16,3%), VT1 (4,7%), VT2 (0,7%)
and LT (1,3%). 82% of the isolates were non-ß haeomlytic. Only 14
samples were positive to Rotavirus, and 11 showed positive PCR to ß
toxin of C.perfringens. Isolates showed the highest resistance to
tetracycline and streptomycin (100%), followed by amoxicillin (91%),
ampicillin (91%), doxicillin (86%), trimethoprim/sulfamethoxazole
(58%), lincospectin (50%), flumequine (52%), enrofloxacine (40%),
gentamicine (37%) and neomicine (36%) The antibiotics showing
higher sensibility were colistine (60%), cefquinome (66%), apramicine
(75%), florfenicol (84%) and tiamuline (89%).
Discussion: EAE and EAST1 were the most common fimbriae and toxin.
Although its pathological importance is not clear, these results suggest
that might be involved in clinical diarrhoea. K88ab, K88ac, K99 and 987P
were only found in not vaccinated farms. Nevertheless the majority
of the strains were non-ß haeomlytic and not enterotoxigenic,
highlighting the importance of controlling other points as management
and environmental factors.
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GROSS AND HISTOPATHOLOGICAL LESIONS
ASSOCIATED WITH A NEW NEONATAL
DIARRHOEA SYNDROME IN PIGLETS
Introduction: During recent years, an increased prevalence of
neonatal diarrhoea in piglets has been reported and different authors
have suggested that a new diarrhoeal syndrome has emerged (Gin
et al., 2010; Melin et al., 2010). Apparently, the previously well-known
neonatal diarrhoea pathogens are not related to this syndrome
(Kongsted et al., 2012). The aim of this study was to evaluate gross
and histopathological lesions in diarrhoeic and healthy piglets from
Danish herds affected by a neonatal diarrhoea syndrome which was
not caused by any common microbiological pathogens.
Materials and methods: In four herds, 51 piglets with diarrhoea for
two days or more and 50 healthy piglets were evaluated for gross and
histopathological lesions at the age of 3-7 days. All herds had a 1-2 year
history of neonatal diarrhoea, despite vaccination against Escherichia
coli and Clostridium perfringens type C. Microbiological examinations
for classic pathogens had not revealed any causative agents. A general
examination for gross lesions and histopathological examinations of
intestinal tissues were performed. Fisher’s exact test was used to test
differences between diarrhoeic and healthy piglets (α=0.05).
Results: Findings statistically associated with diarrhoea were; poor
body condition, flaccidity of the small and large intestine and liquid
contents of the large intestine. Empty stomachs were not seen in
any diarrhoeic piglets. Histologically, villous atrophy in the small
intestine was statistically associated with diarrhoea. Inflammatory
changes were rare and not associated with diarrhoea.
Conclusion: Neonatal piglets suffering from a diarrhoeal syndrome
without involvement of traditional pathogens had gross and
histopathological lesions which differentiated them from healthy
piglets. The lesions were, however, similar to those observed in
common neonatal diarrhoea outbreaks. Flaccidity of intestines and
intestinal villous atrophy were the most prominent findings, whereas
starvation was not a feature of the investigated syndrome
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PLANT EXTRACTS CONTAINING
POLYPHENOLS INHIBIT IN VITRO VIABILITY
OF LAWSONIA INTRACELLULARIS
The Gram-negative bacteria Lawsonia intracellularis (LI) are the
causative pathogens of proliferative enteropathy (ileitis) in pigs and
similar intestinal diseases in various other animal species. Ileitis is a
disease complex: the acute form can cause sudden mortality in
finishing pigs and induce abortion in sows, the chronic and subclinical
forms can cause poor and uneven growth in grower pigs. In vitro
research of LI is difficult, because it requires co-cultivation with a
host cell culture under microaerophilic conditions. In the present
study, an assay for fast and simple screening of potentially
antibacterial phytogenics without using host cells was developed. LI
were obtained from a live ileitis vaccine (Enterisol® Ileitis; Boehringer
Ingelheim) by dissolving the lyophilisate in PBS and seeding it in 96
well plates. Solutions of phytogenic samples in PBS or PBS alone
(negative control) were added and incubated for 30 min under
microaerophilic conditions. LI were stained using a commercial
viability kit (LIVE/DEAD® BacLightTM; Invitrogen) and analysed by
flow cytometry (ACCURITM C6; Becton Dickinson). Viable and dead
bacteria were distinguished by their fluorescence signals to
determine viability rates. The viability rates of sample-treated wells
were compared with the mean viability of the control wells to
calculate relative viability rates. Samples that showed a dose-
dependent antibacterial effect were used to calculate EC50 values
by probit regression. Several phytogenic samples that showed
antibacterial activity contained polyphenols. For example, an oak
wood extract inhibited LI at an EC50 of 172µg/mL. Oak wood and
bark are known to be rich in hydrolysable tannins, a class of
polyphenols. More detailed investigation of the bioactive compounds
and field trials are needed to provide insights into the mode of action
and to confirm findings from in vitro research. Phytogenics with
reliable antibacterial effect against LI may help in future control of
proliferative enteropathy.
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BEHAVIOUR OF WEANERS WITH
LAWSONIA INTRACELLULARIS INFECTION
USING A NOVEL ARENA-TEST
Introduction: Massive infection with Lawsonia intracellularis is
known to cause diarrhoea and severe intestinal lesions which may
cause pain and discomfort in affected pigs. The objective of this study
was to determine whether infection with Lawsonia intracellulariswas
associated with change in behaviour and welfare of pigs.
Materials and methods: The study was conducted in a Danish pig
herd at an outbreak of diarrhoea. A Novel arena-test in which pigs
were observed after transfer to a new environment, was performed
on 145 randomly selected pigs from 5 sections. Two arena types
occurred: One with access to snout contact amongst pigs and
another without physical contact. Expressed predefined behaviour
types were registered at 10 second intervals for 5 minutes. Lawsonia
intracellularis was determined by qPCR and categorised into four
levels of infection: Negative: 0, Low: <100000, Moderate: ≥100000
and Massive: ≥10000000 bacterial genomes/gram faeces.
Results: Of the examined pigs 42% suffered from diarrhoea.
Significant behaviour observations were made only in the stable with
snout contact to other pigs (n=87). Amongst these pigs 27 did not run
at all, and a significant relation between the level of Lawsonia
intracellularis and whether the pigs ran or not, was determined
(p=0.02). Amongst 13 massively infected pigs, 5 (38 %) were observed
running, whereas 55 (74%) of the 74 pigs with lower infection levels
of Lawsonia intracellularis were observed running.
Conclusion: In this study performing a Novel Arena observation test,
a difference in behaviour of Lawsonia intracellularis affected pigs was
determined in an arena with contact to other pigs. More pigs
massively infected with Lawsonia intracellularis spent no time
running, compared to pigs with a lower level of infection. The
reluctance of massively affected pigs to run may indicate weakness
or pain and thereby also reduced welfare in affected pigs.
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BEHAVIOUR AND WELFARE IN PIGS
SUFFERING FROM LAWSONIA
INTRACELLULARIS INDUCED DIARRHOEA
Introduction: Massive infection with Lawsonia intracellularis is
known to cause diarrhoea and severe intestinal lesions, which may
cause pain and discomfort in affected pigs. The objective of this study
was to determine whether infection with Lawsonia intracellularis was
associated with change in behaviour and welfare of pigs.
Materials and methods: The study was conducted in a Danish pig
herd at an outbreak of diarrhoea. Amongst 1,200 pigs 59 pigs were
selected at random and observed in the pen. Predefined behaviour
types and diarrhoea were registered. Faeces from 29 of 59 selected
pigs were analysed for Lawsonia intracellularis by qPCR and
categorised into two levels of infection: Low: <100,000 and High:
≥100,000 bacterial genomes/gram faeces.
Results: Pigs with diarrhoea (n=28) spent more time resting (74% vs.
67% of the observation time, p<0.05) compared to pigs with normal
faecal consistency. When lying, pigs with diarrhoea more often lay in
a sternal posture with forelegs in front compared to pigs with no
diarrhoea (22% vs. 8%, p<0.05). Normal pigs preferred a total lateral
position lying flat on the side with a straightened body compared to
diarrhoeic pigs (34% vs. 15%, p<0.05). Pigs in the High-level Lawsonia-
group (n=10) spent more time in sternal position compared to pigs
with a low level of Lawsonia intracellularis (n= 19), (46% vs. 25%,
p<0.05). Pigs in the low level Lawsonia-group preferred lateral posture,
compared to the high level Lawsonia-group 30% vs. 15%).
Conclusion: In this study a changed behaviour of pigs with diarrhoea
was observed. Also a difference in lying posture was found between
pigs with either minimal or high level of Lawsonia intracellularis in
faeces. This may indicate that pigs with a high infection level of
Lawsonia intracellularis suffer from abdominal pain and thereby
suffer from reduced welfare.
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NEONATAL PORCINE DIARRHOEA
ASSOCIATED WITH SMALL INTESTINAL
COLONISATION OF ENTEROCOCCUS SPP.
Introduction: Several countries report problems with neonatal
porcine diarrhoea (NPD) that cannot be attributed to infections
caused by traditional enteropathogens. The aim of this study was to
describe characteristic pathological findings discovered in several
neonatal piglets with diarrhoea.
Material and methods: Fifty neonatal diarrhoeic piglets and 20
healthy controls were selected from herds with a history of NPD and
examined post mortem. A subset of 18 diarrhoeic piglets was selected
based on the observation of enteroadherent cocci by light microscopic
(LM) inspection of the small intestine. Selected intestinal sections
were examined by Brown and Brenn-stain, immunohistochemistry for
active caspase 3 and fluorescent in situ hybridisation (FISH) with a
probe for Enterococcus spp (3, 4).
Results: Macroscopically 15 of 18 diarrhoeic piglets displayed a
dilated large intestine and five a dilated and/or congested small
intestine. The characteristic LM-finding was the small intestinal
colonisation of Gram-positive cocci only found in diarrhoeic piglets.
FISH-analysis recognised the enteroadherent cocci as Enterococcus
spp. The major histopathological findings included epithelial lesions
and villous atrophy, observed in ten and four animals, respectively.
Epithelial changes consisted of mostly shallow erosions of villous tips
with apoptotic, caspase 3-positive enterocytes. Infiltration of
inflammatory cells was similar in diarrhoeic piglets and controls.
Discussion and conclusion: Only few previous studies report
intestinal colonisation by Enterococcus spp. in association with NPD
(1, 2). Our pathological findings correlate well with these reports.
However, the presence of apoptotic enterocytes and demonstration
of enterococci in situ have previously not been published.
In conclusion, the present results suggest that intestinal colonisation
of enterococci should be considered in studies of NPD.
References:
1. Cheon and Chae: 1996, J Vet Diagn Invest 8: 123-124. 2. Drolet
et al.: 1990, Méd Vét Quebec 20: 114-116. 3. Duan et al.: 2003, J
Pathol 199: 221-228 4. Nicklas et al.: 2010, J Clin Microbiol 48:
2814-2820
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DEVELOPMENT OF OESOPHAGEAL
STOMACH ULCERS IN FINISHING PIGS
Finely ground feed predisposes pigs to develop oesophageal ulcers.
Studies in a small number of pigs using endoscopy have shown
oesophageal changes within days. However, considerable variation
among pigs on the same feeding regime is seen. The aim of this study
was to follow the development of oesophageal stomach ulcers in a
large group of pigs. A total of 440 pigs were fed non-pelleted coarse
feed from weaning to 30kg to ensure good stomach health. At 30kg,
the pigs were moved to the finisher unit, where they were fed finely
ground pelleted feed for four weeks. The feeding was then changed
to coarsely ground non-pelleted feed for six weeks. Throughout the
ten weeks of the study, 40 pigs were slaughtered each week. All
stomachs were macroscopically investigated for pathological changes
in the oesophageal area of the stomach using a scale from 0 to 10,
with a score of 6 to 10 indicating stomach with ulcer and/or scars in
the oesophageal area.
Results: After nine days with fine feed 76% of the pigs had ulcers in
the oesophageal area of the stomach (score 6 to 10). After four weeks
with finely ground feed, an average of 84% of the pigs had ulcers or
scars in the stomach at slaughter. The feeding was then changed to
coarsely ground feed in order to resolve the ulcers. The frequency of
stomach ulcers was reduced to an average of 49% in the last six weeks,
during which the pigs were fed coarse feed. The results emphasise that
pathological changes may develop in large numbers of pigs within days
and that these can be resolved within days or weeks if the feed is
changed to a coarse structure. Although other factors may induce
stomach ulcers, these were not included in this study.
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INTER-OBSERVER AGREEMENT FOR
ENUMERATION OF DIARRHOEIC FAECES
POOLS ON THE PEN FLOOR
Introduction: In Denmark batch medication of diarrhoea is initiated by
the farmer based primarily on assessment of diarrhoeic faecal pools on
the pen floor. Assessment of faecal pools is subjective and could be
subject to large variation between different observers. The objective was
to investigate inter-observer agreement for enumeration of diarrhoeic
faecal pools on the pen floor using a standard enumeration procedure.
Material and methods: One Danish nursery herd and four observers
were selected by convenience. The four observers were veterinarians
having different levels of practical experience with pigs. A standard
procedure for enumeration of diarrhoeic faecal pools was developed,
including explanations in text and pictures. The observers performed
a simultaneous examination of 48 pens but they were not allowed
to discuss the findings during the examination.
Results: Diarrhoeic faecal pools in the 48 pens were for Observer 1:
min=0, max=15, mean=2.9, standard deviation (sd)=3.3; Observer 2:
min=0, max=6, mean=1.6, sd=1.7; Observer 3: min=0, max=11,
mean=1.7, sd=2.5 and Observer 4: min=0, max=7, mean=0.9,
sd=1.4.The coefficient of variation (CV) for each of the 48 pens
ranged from was 20% to 200% (mean=106%). All four observers
agreed on the number of diarrhoeic faecal pools in only 4 pens (8%).
The larges difference between two observers in a pen was 11
diarrhoeic faecal pools. In 27 pens (56%) the observers disagreed on
the presence or absence of diarrhoeic faecal pools.
Discussion:A very poor inter-observer agreement for enumeration of
diarrhoeic faecal pools was demonstrated. The use of a standard
procedure has probably even increased the agreement compared to
the level that can be expected between different veterinarians or
farmers in the field. The result indicates that teaching and calibration
is extremely important when enumeration of diarrhoeic faecal pools is
performed, including the use in relation to antibiotic batch medication.
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APPLICATION OF CONCURRENT CLINICAL
SIGNS FOR DETECTION OF DIARRHOEA IN
NURSERY PIGS
Introduction: Diarrhoea in individual pigs can be difficult to detect
in practice because a large number of pigs have to be examined on
a daily basis. In Denmark farmers fail to detect a large number of
nursery pigs with diarrhoea1. Application of more permanent
concurrent clinical signs can potentially increase detection of pigs
with diarrhoea. The objective was to identify and evaluate the
diagnostic performance for such clinical signs.
Material and Methods: A cross-sectional study was performed in 16
Danish herds. In each herd 200 nursery pigs were selected and subjected
to a clinical examination including faecal consistency assessment.
Association between diarrhoea and concurrent clinical signs were
investigated in a predictive mixed model. For clinical signs significantly
associated with diarrhoea diagnostic sensitivity and specificity
were calculated.
Results: A total of 3060 pigs were included in the analysis. The
prevalence of diarrhoea was 33%. The concurrent clinical signs: body
condition, hollow lumbar region, rounded belly, long hair coat, pale
appearance, perianal faecal stain or irritation and unthrifty appearance
were combined to a single variable, because each individual clinical
sign had a very low prevalence. In total 3% of the pigs had one or
more of these clinical signs and the occurrence was significantly
associated to diarrhoea (p<0.0001). Using the combined clinical signs
for identification of pigs with diarrhoea provided diagnostic sensitivity
= 0.05, diagnostic specificity = 0.98, positive predictive value = 0.53
and negative predictive value =0.68.
Discussion: Applying the identified clinical signs for identification of
individual pigs resulted in unacceptable diagnostic performance.
Therefore these clinical signs do not offer an alternative to faecal
assessment from each individual pigs. This has practical implications,
including identification of pigs for individual antibiotic treatments.
References:
1. Jakobsen, A., Pedersen, K.S., Nielsen, J.P., 2011. Occurrence of
diarrhoea in non-medicated growing pigs. IPVS, 2012, p. 285.
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CRUDE DIETARY PROTEIN AND PARTICLE
SIZE IN FEED IS NOT ASSOCIATED TO
DIARRHOEA IN DANISH NURSERY PIGS
Introduction: Diarrhoea in nursery pigs is the most common cause of
antibiotic treatment in the Danish pig industry. Escherichia coli,
Lawsonia intracellularis and Brachyspira pilosicoli are the most
prevalent intestinal infections. In some cases of diarrhoea no infection
can be demonstrated and protein-associated diarrhoea has been
proposed under field conditions.1
The objective was to investigate association between dietary protein,
particle size, intestinal infections and diarrhoea under field conditions.
Material and methods: A cross-sectional study was performed in
12 Danish herds using home-mixed feed. In each herd randomly
selected nursery pigs were subjected to a clinical examination
including faecal consistency assessment. Faecal samples from a
subsample of pigs were examined for E. coli, L. intracellularis and B.
pilosicoli by qPCR. Feed samples were collected at pen-level and
analysed for crude protein content and particle size. Association
between diarrhoea, age of the pigs, crude protein, particle size and
intestinal infections were investigated in a mixed logistic model.
Results: A total of 770 pigs were included in the statistical analysis.
Dietary protein and particle size were not associated to diarrhoea.
Demonstration of intestinal infections was boarder line significantly
associated to diarrhoea (p=0.09; OR=1.4).
Discussion: Apparently dietary protein was not associated with
diarrhoea. This implies that a simple assessment of dietary protein in
practice should not be applied when feed is evaluated as a possible
cause of diarrhoea on a farm. Assessment of dietary protein could
be an oversimplification. Digestibility, protein source and interactions
between raw-materials should probably also be taken into account.
Similar interactions could explain that no effect of coarsely versus
finely ground feed could be demonstrated.
References:
1. Pedersen, K.S., Kristensen, C.S., Nielsen, J.P. 2012. Veterinary
Quarterly, 32:1, 45-49
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DIARRHOEIC POOLS AT PEN FLOORS IS A
POOR INDICATOR OF HIGH LEVEL OF
INTESTINAL DISEASE IN NURSERY PIGS
Introduction: Treatment of diarrhoea is common in Danish pig herds.
Batch medication is initiated by the farmer based on clinical signs,
including assessment of diarrhoeic faecal pools on the pen floor.
Previous research has demonstrated that farmers fail to detect some
batches (rooms) of pigs with a high prevalence of diarrhoea and
intestinal infections1. The objective was to investigate association
between diarrhoeic faecal pools, prevalence of diarrhoea and
intestinal infections.
Material and Methods: Data originated from a cross-sectional study
performed in 16 Danish herds1. In each herd 200 nursery pigs were
randomly selected. Prevalence at room-level for diarrhoea and
intestinal infections (Escherichia coli, Lawsonia intracellularis,
Brachyspira pilosicoli) were estimated. The number of diarrhoeic faecal
pools (loose and watery faecal pools) at the pen floors was counted.
Results: A total of 62 rooms were examined and included in the
analysis. Diarrhoeic faecal pools could not be demonstrated on the
floor in 8% of the rooms (diarrhoea prevalence= 28%, intestinal
infection prevalence= 38%). In 52% of the rooms the average number
of diarrhoeic pools per pen ranged from >0 to1 (diarrhoea prevalence=
27%, intestinal infection prevalence= 42%). Finally 40% of the rooms
contained more than 1 (max = 2.1) diarrhoeic pools per pen (diarrhoea
prevalence= 41%, intestinal infection prevalence= 47%).
Discussion: Apparently a high prevalence of diarrhoea and intestinal
infections may occur although few diarrhoeic pools are observed on
the pen floors in a nursery room. This probably explains the
difficulties in detection of treatment requiring batches with high
prevalence of intestinal disease. More successful parameters are
needed for decisions on batch medication of nursery pigs.
References:
1. Jakobsen, A., Pedersen, K.S., Nielsen, J.P., 2012. Occurrence of
diarrhoea in non-medicated growing pigs. IPVS, p. 285.
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THE IMMUNE PROPHYLAXIS AS A PART
OF THE CONTROL OF DIARRHOEA IN
PIGLETS ASSOCIATED WITH CLOSTRIDIUM
PERFRINGENS TYPE A
Objective: Clostridium (C.) perfringens type A is often associated
with diarrhoea in suckling piglets. The impact of the alpha (α) and
beta (β) 2 toxins for the pathogenesis of the disease has not been
answered conclusively. In the past autologous vaccines were used to
control this disease. The aim of our investigation was the testing of
the efficacy of a commercial vaccine against the C. perfringens type
A associated diarrhoea using an animal intoxication model. Material
and methods: In order to test the α and β2 toxoid containing C.
perfringens type A vaccine (Clostriporc A, IDT Biologika GmbH), 18
gilts were vaccinated twice in the last third of gestation. A total of 19
gilts were administered a placebo and served as controls. Before the
1st and 2nd vaccination and after birth serum and colostrum samples
were taken and tested for antibodies against α and β2 toxins using
ELISA tests. For the evaluation of the vaccine, piglets of the
vaccinated and control sows were challenged intraperitoneally with
a α and β2 toxin containing supernatant of a heterologous C.
perfringens type A strain on the first day post natum.
Results: The vaccination produced antibodies against the α and β2
toxins in the serum of the sows which were transfered to the
offspring by colostrum. Piglets were significantly protected (p<0.05)
by the antibodies after being challenged with the α and β2 toxin
containing supernatant of a C. perfringens type A strain.
Conclusion: Using the intoxication model, this vaccine showed
significant protective effects against the α and β2 toxins. The first
results of the clinical field trials support the results of these
laboratory trials.
NOTES
POSTER PRESENTATIONS: INFECTIOUS – ENTERIC
152
P104
G. Wang, Y. Chen, Y. Zhao, Animal Medical Research Center of Dabeinong
Group, Haidian District, Beijing 100089, People’s Republic of China, K.
Mellits, S. McOrist, University of Nottingham, Sutton Bonington, Leics,
United Kingdom.
PATHOGENICITY OF CURRENT PORCINE
EPIDEMIC DIARRHOEA VIRUS INFECTIONS
IN CHINA
Recent outbreaks of highly pathogenic porcine epidemic diarrhoea
(PED) in east Asia are of major concern. Previous challenge exposure
studies in pigs with Asian PED strains have largely been limited to
vaccine-related inoculations, with a consequent difficulty in relating
the genome shifts in current Asian wild-type PED strains to
pathogenicity. We detected PCR products consistent with PED virus in
426/756 intestinal samples (56%) derived from 26/48 farms (54%)
located across China, which had had clinical outbreaks resembling
PED. We isolated and partially sequenced wild-type PED virus from
nine of the PCR-positive samples. Phylogeny tree analyses based on
the deduced amino acid sequences of the M gene and the nucleotide
sequence of ORF3 gene of these recent isolates indicates that several
isolates formed new clusters of distinct lineages, suggesting that the
Chinese PED coronavirus strains show strong mutation and possible
recombination potential. A total of 24 piglets were challenged orally
(4 pigs per isolate) with 4 control sham-inoculation piglets. Three days
after inoculation, all challenged piglets showed clinical, pathological
and PCR reactions consistent with PED virus. This suggests that the
recent PED isolates retain their strong pathogenicity in the field and
challenge study situation, even though considerable shifts have
occurred in major viral membrane protein genes.
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RESPIRATORY DISEASE IN NEONATAL
PIGLETS CAUSED BY PCV2A
Pig rearing is one of the most important occupations of rural society
in India. Porcine Circovirus 2 (PCV2) is considered to be an important
emerging pathogen associated with a number of different syndromes
and diseases in pigs. In an investigation conducted in 2012 to
elucidate the cause of heavy neonatal mortality in an organised farm
in Uttar Pradesh, India, evidence of PCV2 involvement with respiratory
disease was found. Piglets with a history of respiratory distress and
sudden death at necropsy revealed important lesions such as
edematous, enlarged and congested inguinal lymph nodes, non-
collapsing pneumonic lungs, and rarely, icteric liver. Severe
hydrothorax and ascitis were presented in most of the cases.
Histopathological examination revealed severe lymphoid depletion in
various lymphoid organs with infiltration of histiocytes. Multiple,
sharply demarcated large spherical basophilic or amphophilic
intracytoplasmic inclusions were detected in cytoplasm of histiocytes.
Lungs revealed interstitial pneumonia, multinucleated giant cells in
thickened interstitium, hyperplasia and hypertrophy of type II
pneumocytes. PCV 2 antigen in affected lungs and lymphoid organs
could be demonstrated by immunohistochemistry using PCV2 specific
sera. Samples were analysed by PCR with in-house designed primers
specifically amplifying the ORF 2 region of PCV2. The PCV2 ORF gene
sequence confirmed that the isolate showed closest homology with
PCV2a circulating in Canada, Netherland and Germany.
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LESIONAL DIAGNOSIS OF ATROPHIC
RHINITIS: COMPARISON OF THE LESION
SCORE PERFORMED ON SNOUTS SECTIONS
AND THOSE MADE ON COMPUTER
TOMOGRAPHY IMAGES (CT)
Atrophic Rhinitis prevalence is often assessed by scoring nasal lesions
after cutting snouts at the slaughterhouse, however, the saw blade
can damage the snout structure. The objective of this study is to
compare the rhinitis lesions scored performed on snout sections with
a saw and those made on computer tomography images (CT). The
influence of the anatomical area section is also studied.
203 snouts, from 5 batches, with intensity lesions from medium to
high atrophic rhinitis were collected at the slaughterhouse. Cross
sectioned images were taken every millimetre by CT, then snouts
were cut with a hand-held saw. Sections of snouts and CT images
obtained at the first premolars were graded by an experienced
operator; according to the IFIP reference method (scored 0 to 20). To
assess the impact of the cutting area, 50 snouts were scored on three
tomography images taken at the first premolars, at one centimetre
in front and one centimetre behind, by 5 experienced operators.
Cutting with a saw did not change the nasal septum and the
turbinates structure: 99 % of the snouts had the same score as CT.
The atypical morphologies of the turbinate structure (turbinate
crushed, partially joint or with a winding inverted concave structure
instead of convex), observed after sectioning some snouts, were still
present on the CT images. These atypical morphologies reduce the
filtering effects of the turbinates and increase the expression of
respiratory disease. The causes of which need to be examined;
genetics, ambient conditions, some pathogens or their toxins?
At one centimetre in front of the first upper premolars, the score was
significantly higher (more atrophys of turbinates and less deviated
septum); one centimetre back, the score was the same. It is advisable
to make the cut just after the first premolar and not score the snouts
before cutting.
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RELATIONSHIPS BETWEEN COUGH,
PNEUMONIA-LIKE GROSS LESIONS
AND MYCOPLASMA HYOPNEUMONIAE
INFECTION DYNAMICS IN 125 FARROW-
TO-FINISH HERDS
The aim was to investigate the relationships between coughing,
pneumonia-like gross lesions and Mycoplasma hyopneumoniae
(Mhp) infection in 125 farrow-to-finish herds. In each herd, coughing
was recorded in four batches (4, 10, 16 and at least 22-weeks-old).
Tracheo-bronchial swabs were taken from 10 pigs of 4, 10 and 16
weeks of age. Pneumonia was scored at slaughter and lung samples
were collected from 30 pigs corresponding to the batch aged of at
least 22 weeks. Swabs and lung samples were analysed by nested
PCR to detect Mhp. Hierarchical clustering was performed to relate
frequencies of coughing, pneumonia scores and n-PCR results. Three
clusters of herds were identified. A cluster (30 herds) was
characterised by a high frequency of pigs without pneumonia, a low
level of coughing at 16 and 22-weeks-old and low frequencies of pigs
infected by Mhp (average within-batch frequencies of n-PCR-positive
pigs of 5.6%, 5.6%, 10.7% and 46.5% at 4, 10, 16 and 22 weeks
respectively). A cluster mainly comprised herds with a low level of
coughing from 4 to 22 weeks, a high frequency of pigs with moderate
pneumonia scores and a high frequency of n-PCR-positive pigs for
Mhp at 22-weeks-old (average within-batch frequency of 85.9%).
The third cluster (36 herds) was characterised by a high level of
coughing in batches of 4, 10, 16 and 22-weeks-old (with 2.6, 4.1, 7.2,
and 11.4 coughing per 100 animals/6 minutes respectively), a high
frequency of pigs with high pneumonia scores and high frequencies
of pigs infected by Mhp (average within-batch frequencies of n-PCR-
positive pigs of 26.9%, 28.4%, 58.0% and 92.6% at 4, 10, 16 and 22
weeks respectively). A low Mhp infection pressure throughout the
pigs’ lifetime decreases the probability of pneumonia incidence and
related symptoms. Acute symptoms and high pneumonia scores are
associated to early massive Mhp infection.
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FACTORS ASSOCIATED WITH
ACTINOBACILLUS PLEUROPNEUMONIAE
SEROTYPE 2 INFECTION IN 125
FARROW-TO-FINISH HERDS
The aim was to identify the factors associated with Actinobacillus
pleuropneumoniae serotype 2 (App2) infection in slaughter-aged pigs
from 125 farrow-to-finish herds. Pigs from four different batches in
each herd (aged 4, 10, 16 and ≥22 weeks) were sampled. Data related
to biosecurity, management, housing and climatic conditions were
collected during a farm visit. Mycoplasma hyopneumoniae, porcine
reproductive and respiratory syndrome virus (PRRSV) and porcine
circovirus type 2 (PCV2) were detected by serological or PCR tests
from samples taken in the four batches. Samples from the slaughter-
aged pigs (≥22-weeks-old) were tested for App2 antibodies and
swine influenza viruses (SIV) H1N1 and H1N2 antibodies by
serological tests. A herd was deemed infected by App2 if at least one
pig was sero-positive for App2. Multiple correspondence analysis was
used to identify factors associated with App2 infection at the herd
level. Large herd size, low biosecurity measures and no SIV
vaccination of the replacement gilts were factors associated with
App2 infection. Herds infected by App2 were also characterised by
the lack of warming the post-weaning room before loading the pig,
old post-weaning buildings (>25 years), a low mean inside
temperature in the finishing room (≤23.5°C), a temperature range
of less than 5°C for the ventilation control rate and a temperature
setpoint of the ventilation controller in the finishing room below or
equal to 21°C. PRRSV and SIV infections and a high infection
pressure towards PCV2 before 16 weeks old were associated with
App2 infection. Risky herd profiles were therefore found as regard to
App2 infection. Improvement of management, housing and climatic
conditions at all rearing steps should significantly reduce the risk of
App2 infection in slaughter-aged pigs.
NOTES
POSTER PRESENTATIONS: INFECTIOUS – RESPIRATORY
155
P109
Maria Fort, Pfizer Olot S.L.U., Spain; Mark Mombarg, Pfizer Olot S.L.U., Spain;
Mònica Balasch, Pfizer Olot S.L.U., Spain; Lucas Taylor, Pfizer Animal Health,
MI, USA; Alicia Urniza, Pfizer Olot S.L.U., Spain.
COMPARISON OF TWO DIFFERENT
CHALLENGE PROCEDURES
(TRANSTRACHEAL INJECTION VS.
ENDOTRACHEAL INOCULATION) AND TWO
DIFFERENT INOCULUM PREPARATIONS
(LUNG HOMOGENATE VS. FRESH
M. HYO. CULTURE) FOR THE INDUCTION
OF MYCOPLASMA HYOPNEUMONIAE
INFECTION IN YOUNG PIGS
Thirty six 5-week-old conventional pigs, serologically negative to M.
hyo were assigned to five experimental groups. Two groups were
inoculated with 10ml of a lung homogenate containing 4.6log10
CCU/ml of the pathogenic M. hyo strain 232, via the transtracheal
(T01) and the endotracheal (T02) routes; another two groups were
inoculated with 10ml (8.5log10 CCU/ml) of an M.hyo culture
prepared from the same lung homogenate, via the transtracheal
(T03) and the endotracheal (T04) routes. Four pigs were left as
controls (NTX group). Animals were randomly assigned to treatment
groups using a generalised randomised block design based on body
weight and room. This experiment was carried out in compliance with
national legislation and subjected to local ethical review.
Pigs were monitored for the presence of clinical signs every 2-3 days.
At day 29, pigs were euthanised and lungs were evaluated for the
presence of M.hyo-associated lesions. Bronchi were swabbed to
detect M.hyo genome by qPCR and lung tissue was collected to
perform an in situ hybridisation (ISH) technique.
M.hyo challenge was successful regardless of treatment group, since
the percentage of pigs showing lung consolidation ranged from 75 to
100%. Back transformed least square means varied from 2.0 to 7.3.
The presence of M.hyo genome was confirmed by qPCR and ISH in
87% and 46% of the inoculated pigs, respectively. Challenge groups
did not differ statistically on the percentage of consolidated tissue,
neither did they on the amount of M.hyo DNA copies detected by
qPCR. Clinical signs compatible with an M.hyo infection were
observed in all four challenge groups and included coughing and to
a lesser extent sneezing and dyspnea. Significantly higher percentage
of pigs showing dyspnea was detected in T01 group compared to
T02. No significant differences were observed among groups in any
of the other clinical signs evaluated.
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ACTINOBACILLUS PLEUROPNEUMONIAE
SEROTYPES ASSOCIATED WITH PNEUMONIC
LESIONS IN FINLAND
Objectives: Pleuropneumonia caused by Actinobacillus
pleuropneumoniae (APP) is a significant respiratory disease in pigs in
Finland. Worldwide a total of 15 APP serotypes have been identified,
while the virulence and geographical distribution of the serotypes vary.
The aim of this study was to determine which APP serotypes cause
respiratory disease in the Finnish pigs. There is an interest to examine
herds serologically for their status concerning virulent APP serotypes.
Material and methods: The analysed APP isolates were recovered
from pneumonic lesions of pigs obtained for pathological examination
from 19 farms during 2011-2012. A total of 27 APP isolates were
analysed using three multiplex PCR assays: one for serotypes 2, 5 and
6 (1), one for serotypes 1, 7, 12 (2) and one for serotypes 3 and 8 (3).
Results and conclusions: All the isolates from inflammatory lung
lesions were of APP serotype 2. This is the first time where APP isolates
from Finland were serotyped using PCR. In a previous study from the
1990s, antibodies against several APP serotypes were detected in the
country, and those to serotypes 3 and 2 were the most prevalent (4).
This study indicates that at present APP pneumonia is caused by
serotype 2 in Finland, and we can focus serological testing for APP
pneumonia on this serotype. In contrast to serological monitoring for
freedom from Mycoplasma hyopneumoniae infection, serological
testing for APP was never included in the Finnish health monitoring
schemes of pig herds. Future testing will show if herds free from APP
serotype 2 exist in Finland.
1. Jessing SG et al., (2003) J Clin Microbiol 41:4095-100. 2. Angen O
et al., (2008) Vet Microbiol 132:312-8. 3. Zhou L et al., (2008) J Clin
Microbiol 46:800-3. 4. Levonen K et al., (1996) J Vet Med B 43:489-495.
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PREVALENCE OF MYCOPLASMA
HYOPNEUMONIAE INFECTIONS AT
WEANING AGE IN EUROPEAN PIG HERDS
Mycoplasma hyopneumoniae (M.hyo) is the primary pathogen of
enzootic pneumonia, a chronic respiratory disease in pigs. Infections
with M.hyo are highly prevalent in almost all swine-producing areas
and the disease causes major economic losses to the pig industry due
to a slower growth and higher feed conversion. Moreover, M.hyo is
also considered to be one of the primary agents involved in the
porcine respiratory disease complex (PRDC). It has been demonstrated
by several research groups that infections with M.hyo may already
occur starting from 3 weeks of age, as demonstrated by the detection
of M.hyo in nasal swabs by polymerase chain reaction (PCR)
(Calsamiglia & Pijoan, 2000; Ruiz et al., 2003; Sibila et al., 2007; Fano
et al., 2007; Villarreal et al., 2010). Recent studies have shown that
tracheo-bronchial swabs may be 3.5 to 4.5 times more sensitive for
the detection of M.hyo than nasal swabs (Marois et al., 2007; Fablet
et al., 2010). The aim of the present study was to estimate the
detection rate of M.hyo infections in European piglets around weaning
age by the use of tracheo-bronchial swabs. The study started in
January 2011 and to date, 255 pig herds in Belgium, France, Germany,
Italy, the Netherlands, Portugal, and Spain were included. In each herd,
a minimum of 20 tracheo-bronchial swabs were collected from 3 to
5-weeks-old piglets and tested for the presence of M.hyo using PCR.
To date, 105 out of the 255 tested herds (41.2%) and 492 out of the
6985 tested piglets (7.0%) tested positive for M.hyo. The minimum
within-herd detection rate was 0.0% and the maximum within-herd
detection rate was 96.7%. In conclusion, the present study confirmed
that 3 to 5-weeks-old piglets may already be infected with M.hyo.
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RESPIRATORY INFECTIONS IN NURSERY
PIGLETS OF LARGE SOW FARMS –
PRELIMINARY RESULTS
Pleuritis and pneumonia are common findings in slaughter pigs. Partly
the respiratory problems in fattening farms originate from sow herds
and nursery units. The aim of this work was to study the progress and
level of respiratory infections in nursery units of large herds.
In three sow farms (2400, 900 and 1990 sows) piglets were sampled
at the age of 3.5 (before weaning), 7 and 11 weeks. Clinical signs of
respiratory infections were recorded as the number of coughs and
sneezings in 5 minutes after the piglets were forced to stand up.
Altogether 48 piglets (16 per age group) in each farm were euthanised
for autopsy.
In two herds observed coughing was very little or no coughing at all.
In one herd it increased from 0 coughs before weaning to 11.3
coughs per 100 piglets. Sneezing was more common (average 11.6
sneezings per 100 piglets). Altogether 12 (8.3%) out of 144 piglets
had small local pleural attachments while no large attachments were
found. Pneumonic lesions were detected in 34.7% of the piglets.
Most commonly cultured bacteria with pneumonic lesions was
Actinobacillus pleuropneumoniae (16.7%) and Streptococcus suis
(14.6%). In nasal cavity mild to severe turbinate atrophy (TA) was
detected in 47.9% of the piglets. Most common bacterial foundings
with TA were Bordetella bronchiseptica (33.3%) and nontoxigenic
Pasteurella multocida (20.3%).
Though the respiratory signs were low, pathological pneumonic lesions
were found in 1/3 of sampled piglets. Hence the clinical signs don’t
seem to correspond with spread and severity of respiratory infections.
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DETECTION OF CLINICAL SIGNS AND
HISTOLOGICAL LESIONS IN THE LUNGS OF
PIGS FOLLOWING INOCULATION WITH PCV2
Porcine circovirus 2 (PCV2) is an important pathogen affecting the
global swine population. It causes a variety of syndromes and is now
recognised as a major respiratory pathogen. Twelve weaned, colostrum
fed pigs were recruited. Before enrolment onto the study pigs screened
by PCR and ELISA for PCV2 antigen and antibody. On Day 0 of the
study, pigs (N=6) were intra-nasally inoculated with a field strain of
PCV2 and control pigs (N=6) were intra-nasally inoculated with virus
free culture media. Clinical signs were recorded daily and body weight
documented weekly. Pigs were euthanased 8 weeks post inoculation.
Cadavers were subject to post mortem examination and standard
samples were collected from the lung lobes and bronchial lymph
nodes. Sections were submitted for histological analysis,
immunohistochemistry and quantitative polymerase chain reaction
(qPCR) was used to determine viral load. PCV2 inoculated pigs
displayed increased sneezing (p<0.05) and diarrhoea (p<0.05)
compared with the control pigs. Although no gross lung lesions were
observed in the PCV2 inoculated group a range of histological lesions
observed. A mild, diffuse, bronchiointerstitial or interstitial pneumonia
predominated (N=4) the PCV2 inoculated group, of which two had
granulomatous exudation into the bronchioles. Interstitial infiltration
was mononuclear and affected the cranial lobes more severely.
Immunohistochemistry targeting PCV2 antigen failed to convincingly
label any positive cells within the lung tissue but there was positive
staining in the bronchial lymph nodes within follicular centres. In the
control group, all pigs remained negative for PCV2 throughout the
study. All PCV2 inoculated pigs tested positive by qPCR. In conclusion
histological lung lesions typical of PCV2 infection and clinical signs
consistent with PCV2 infection were significantly higher in animals
inoculated with a field strain of PCV2 compared with control pigs.
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EICOSANOIDS IN HEALTHY AND DISEASED
PORCINE LUNGS: IMMUNOHISTOCHEMICAL
AND BIOCHEMICAL INVESTIGATIONS
Eicosanoids derive from the metabolism of arachidonic acid and
serve as intracellular and extracellular signals, which are able to affect
a wide variety of biologic processes, including inflammation.
We summarise herein our data about 5-lipoxygenase (5-LOX) and
cyclooxygenase-2 (COX-2) dependent enzymatic pathways in healthy
and diseased porcine lungs. In detail, the following pulmonary diseases
were investigated: Metastrongylus spp.-induced porcine parasitic
bronchopneumonia, chronic enzootic pneumonia caused by
Mycoplasma hyopneumoniae (Mh), acute pleuropneumonia by
Actinobacillus pleuropneumoniae (App) and interstitial pneumonia
caused by Porcine Circovirus type 2 (PCV2). Pulmonary tissue samples
from healthy controls and diseased pigs were collected from
slaughtered (healthy controls, Metastrongylus spp. and Mh-infected
pigs) or spontaneously died (App and PCV2-infected pigs) animals, and
adequately processed for histopathology, immunohistochemistry (IHC)
and biochemical investigations. IHC was carried out by using polyclonal
goat antibodies anti-5-LOX (C-19, Santa Cruz Biotechnology, 1 in 500)
and anti-COX-2 (C-20, Santa Cruz Biotechnology, 1 in 250). 5-LOX
and COX-2 dependent enzymatic pathways were further investigated
by Western blotting analysis and enzymatic activity assays. Arachidonic
acid metabolites (namely leukotriene B4 and prostaglandin E2) were
also quantified (Leukotriene B4 EIA kit™; Prostaglandin E2 EIA kit™;
Cayman Chemical Company, USA). Our results confirm that 5-LOX
and COX-2 are constitutively expressed in healthy porcine lungs.
Furthermore, our data suggest that both investigated enzymatic
pathways are significantly modified and/or over-expressed in porcine
lungs affected by acute and chronic pneumonia caused by different
etiological agents. Remarkably, 5-LOX-dependent biochemical pathway
– which has been poorly investigated in veterinary medicine and is not
inhibited by nonsteroidal anti-inflammatory drugs – seems to strongly
participates in acute and chronic inflammatory response in porcine
pneumonia.
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PATHWAY DEREGULATION AND EXPRESSION
QTL IN RESPONSE TO ACTINOBACILLUS
PLEUROPNEUMONIAE IN SWINE
Objectives:Actinobacillus pleuropneumoniae (APP) is among the most
important pathogens in worldwide pig production. The agent can cause
severe economic losses due to decreased performance, acute or chronic
pleuropneumonia and an increased incidence of death. Therapeutics
cannot be used in a sustainable manner, and vaccination is not always
available, but discovering more about host defence and disease
mechanisms might lead to new methods of prophylaxis. Recent
research has provided evidence for a genetic predisposition in
susceptibility to APP in a Hampshire x German Landrace F2 family.
Material and methods: Under controlled conditions, 170 F2 animals
of a Hampshire/Landrace family, with known differences in founder
populations regarding A. pleuropneumoniae resistance, were challenged
with an APP serotype 7 aerosol followed by a detailed clinical,
radiographic, ultrasonographic, pathological and bacteriological
examination. Genome wide gene expression from the 50 most and 50
least susceptible F2 pigs was monitored and expressed QTL were
mapped. Data were examined by network analyses and functional
characterisation using gene set enrichment analysis.
Results: F2 pigs differed distinctly in clinical, pathological and
microbiological parameters after challenge with APP. Genome wide
transcriptome profiling resulted in 171 genes being differentially
expressed. We mapped 193 eQTL for 105 differentially expressed
genes, significant on at least a chromosome-wide level. The study
identified a functional hotspot on SSC13, including 55 eQTL. The
integration of the different results provides a resource for candidate
prioritisation for fine mapping strategies, such as TF, TFRC, RUNX1,
TCN1, HP, CD14, among others.
Conclusion: The results indicate the genetic background of APP
resistance in swine and provide new insights into the genetic
architecture of resistance/susceptibility to porcine pleuropneumonia.
The results will be helpful in identifying underlying genes and
mechanisms.
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WHITE BLOOD CELL COUNTS DURING AN
ACUTE OUTBREAK OF ACTINOBACILLOSIS
White blood cell (WBC) counts and defining subpopulations is a
classic way to reveal infections that only rarely have been used in
pigs due to cost. Recently, automatic WBC-analysers have been
introduced to veterinary medicine – reducing price and cutting time
when defining subpopulations.
A fattening herd with nine units received 300 growers aged 85 days
from a piglet producer with 600 sows every fortnight. Both herds
effectuated strict age segregated rearing. Despite this, the fattening
herd was severely affected by Actinobacillus pleuropneumoniae
serotype 2, confirmed by serology and by isolation of the bacteria. At
slaughter, 24±5% of the pigs was registered with pleuritis. Entire
batches of fattening pigs were suddenly affected with acute
actinbacillosis, often around 3-4 weeks after arrival. Probably the
short distance between units located in the same building
contributed to spread of disease, since the ninth unit that was
located in a building 250 meters away from the rest of the farm
experienced no problems.
A sudden onset of acute respiratory signs was recorded in a unit 23
days after arrival. At that day, blood was collected from 6 pigs with
clinical signs of disease (feed refusal and forced breathing, eventually
also coughing) and from 6 apparently healthy pigs.
All pigs were seronegative to Actinobacillus pleuropneumoniae,
indicating an acute infection. The WBC counts in the apparently
healthy pigs were normal (20.6±2.6 x 109 leukocytes per ml blood)
with 42±4% neutrophils and 46±4 % lymphocytes. In contrast,
leukocytosis was observed in the pigs with clinical signs of respiratory
disease (45.3±14.2 x 109 leukocytes per ml blood), with a
pronounced increase of the neutrophils (76±6%) on behalf of a
decreasing concentration of lymphocytes (14±4%).
The results indicate that WBC and differential counts is efficient in
detecting disease at an early phase of an infection also in pigs.
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CHANGES OF INF-GAMMA, IL10 AND FOXP3
IN PRRSV NATURALLY INFECTED PIGS.
PRRSV is one of the major pathogens affecting the swine industry
worldwide. PRRSV is a positive-sense ssRNA enveloped virus of the
family Arteriviridae, genus Arterivirus, responsible for the respective
syndrome named PRRS. This study aims at assessing the modulation
of the gene expression of pro-immune (IFN-γ) and immune-regulator
(IL-10) cytokines as well as a transcriptional signal of immune-
regulation (FoxP3) in pigs naturally infected by PRRSV. Two groups of
animals ageing 21 days were allocated into two groups: one group
(10 pigs) was vaccinated with a ML-PRRSV vaccine (EU prototype)
(V-PRRSV) at inclusion and the other group was kept un-vaccinated
(NV). Three weeks post-vaccination the animals were naturally
exposed to a PRRSV field isolate by commingling all of them with
infected pigs resident in the recipient barns. At 6, 8, 10, 12, 14 and 16
weeks of age the animals were bled and peripheral blood mononuclear
cells (PBMC) were collected from the buffy coat. From serum samples
viremia was detected by RT-PCR. Viremia was detected at 8 weeks to
16 weeks of age, peaking at 12 weeks. No differences in term of the
magnitude of viremia and of the proportion of viremic animals were
detected. The course of IFN-g was different comparing the two groups.
In fact, concomitantly to the increase of viral load the V-PRRSV group
showed statistically significant higher levels as compared to control.
Conversely, NV group showed higher levels of gene expression of IL-
10 before the peak of viremia and a significant increase of FoxP3
during the whole course of infection. The obtained results support the
hypothesis that PRRSV infection can have a role in the induction of
the regulatory compartment of the immune system. Moreover, in
vaccinated animals, even if infected, the gene expression of FoxP3 did
not show significant changes running together with viremia.
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APPLIED STUDY TO EVALUATE LYMPHOCYTES
ASSOCIATED WITH PRRSV INFECTIONS
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) evades
the immune system through various mechanisms including the
induction of specialised immune cells, called regulatory T lymphocytes
(Tregs; CD4+CD25+FoxP3+). The primary objective of this study was
to quantify the numbers of Tregs and other lymphocytes during PRRSV
infections in commercial farms. Blood samples were collected from
pigs at 2, 4-5, and 7-8 weeks of age. For each age, 20 samples were
collected from pigs on farms with clinical PRRSV infections, and from
pigs on PRRSV-negative farms. Complete blood cell counts and flow
cytometry were used to quantify the number of Treg cells, CD4+,
CD8+, CD4+CD8+, γδ cells, CD3+, and CD21+ cells. Quantitative PCRs
confirmed the presence of PRRSV (1.75x106 and 4.3x107 copies/ml)
in the clinical pigs at 2 and 7 weeks of age. In general, percentages and
numbers of immune cells increased with age with few notable
differences due to PRRSV status. The number of CD4+ cells increased
with age, but the CD4+ percentages were less (p<0.05) in pigs at 7 wk
than at 2 or 4 wk. Prior to 7 weeks of age, PRRSV status did not affect
the percentage of Treg cells; however, the percentage was dramatically
greater in PRRSV pigs (29+6.0) compared to the negative counterparts
(5.9+0.4) at 7 weeks. The presence of Tregs at this age likely contributes
to immunosuppression and increased susceptibility to secondary
infections in commercial pigs. With a greater understanding of Tregs,
our goals are to develop strategies to manipulate the Tregs, which in
turn should facilitate vaccine efficacy and control of the disease.
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HISTOLOGICAL AND SEROLOGICAL
SEQUENCES OF EVENTS IN A PCV2
INFECTION
As part of a large study, an in vivo disease model using PCV2 virus
was developed. A total of 108 weaned, PCV2 free Large White x
Landrace pigs were recruited at 4 weeks of age. Pigs were randomly
allocated to 9 pens with two groups of 6 pigs in each pen. Treatment
pigs (8 pens) were inoculated intranasally a 1x10^10 PCV2
particles/5 mL virus media. Control pigs (1 pen) were inoculated with
5mL of virus free media. Blood samples were collected weekly and
animals were euthanased at 8 or 10 weeks (12 or 14 weeks of age)
post inoculation (PI). For the current study, two 10-week kill groups
were used. Post-mortem examination was conducted and samples
collected. Viral copy numbers as analysed by qPCR of sera showed
that control pigs remained virus free for 7 weeks PI. By week 10 PI all
control pigs had detectable virus in serum indicating a breach in
biosecurity. Virus was no longer detectable in the serum of treatment
pigs from 7 weeks PI and IHC detected scant to moderate labelling
in lung, lymph node or intestine. In contrast, IHC of tissues from
control pigs revealed variable PCV2 antigen labelling in lungs, lymph
nodes and intestines from scant to abundant. The primary site of
replication of PCV2 is still unknown. However, we have detected
PCV2 in a range of tissues in the immediate post-infection period
and further examination of these tissues may reveal the primary site
of PCV2 replication.
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ONE VACCINATION WITH UNISTRAIN PRRS
DURING GESTATION REDUCES VIRAEMIA
AND VERTICAL/HORIZONTAL TRANSMISSION
OF HETEROLOGOUS PRRS VIRUS INFECTION
Introduction: Vaccination is the main tool for controlling Porcine
Reproductive and Respiratory Syndrome virus (PRRSV) infection;
however the use of modified live vaccines during gestation has been
controversial. There are in vitro evidences for vaccine-induced
protective immunity against heterologous challenge (Martínez-Lobo,
2011). In our study the control of the pathogenic virus was evaluated
as an efficacy parameter (viraemia, shedding and vertical transmission)
in UNISTRAIN PRRS vaccinated gestating sows compared to non-
vaccinated group.
Materials and methods: The recommended administration
programme of the vaccine was applied at 8-9 weeks of gestation (IM)
to 9 naïve sows. Nine control gestating sows remained unvaccinated.
The efficacy was evaluated by means of an intranasal infection at 90
days of gestation with a heterologous European pathogenic PRRSV
(Spanish strain isolated at 2007; 106.54 CCID50/sow). The homology
with the vaccine strain was 86% (ORF5). Virus detection was
performed by virus isolation (VI) in alveolar macrophages.
Results and discussion: Vaccination with UNISTRAIN PRRS
significantly reduced the percentage of viraemic sows (11.11% in
vaccinated vs. 100% in control group) and shortened the length of
viraemia induced by the heterologous strain in sows (2.22±4.41 days
in vaccinated vs. 21±4.5 days in control group). The viraemia was
punctual in vaccinated group whereas in control one was broad in
time; in consequence, vaccination significantly inhibited in 90.1% of
the cases the vertical transmission of the pathogenic PRRSV to piglets
(viraemia at birth). Moreover, there was a significantly shedding
reduction in milk (50% control vs. none of vaccinated sows) and a
reductive tendency in nasal shedding, decreasing the possibility of a
horizontal transmission of the pathogenic PRRSV to piglets during
lactation. So vaccination with UNISTRAIN PRRS enabled gestating
sows to clear the virus and reduced its vertical and horizontal
transmission to foetuses after a heterologous PRRSV infection.
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CAN PORCINE CIRCOVIRUS TYPE 2 (PCV2)
BE ERADICATED BY MASS VACCINATION?
The present field study evaluated the feasibility to eradicate Porcine
circovirus type 2 (PCV2) in a conventional farm in North Eastern
Spain by vaccinating both sows and piglets using a commercially
available vaccine. This vaccination strategy implied that all sows,
boars and gilts of the farm were vaccinated with 1ml of Ingelvac
Circoflex® every four months. In addition, all piglets were vaccinated
with 1ml of the same vaccine at 4 and 7 weeks of age. This
vaccination strategy was started in December 2010. Previously,
piglets had been vaccinated using an off-label scheme. After 12
months (January 2012), mass vaccination was stopped to evaluate if
eradication was successful. Blood samples from 15 animals were
taken cross-sectional at 4, 8, 12, 16, 20 and 24 weeks of age. All
samples were tested by ELISA and PCR. The percentage of PCV2
detection by PCR was 7.7% (n=11/143) and 1.4% (n=3/221) before
and during the mass vaccination program, respectively. During the
vaccination program, three consecutive groups of animals (n=45)
were also followed longitudinally, and no evidence of infection (no
seroconversion and negative PCR results) occurred in these batches.
These results suggested that eradication might have been successful.
However, after stopping PCV2 vaccination, seroconversion and PCV2
infection were observed again (8.3%, n=11/132) in the cross-
sectional studied groups. Results of the present study indicate that
one year of mass vaccination reduced infectious pressure (below
detection limit of the longitudinal sampling scheme), but was not
able to prevent PCV2 re-infection when vaccination was stopped.
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EXPLORATION OF THE IMMUNE RESPONSE
TO THE PORCINE RESPIRATORY AND
REPRODUCTIVE SYNDROME VIRUS (PRRSV)
BY A MODELLING APPROACH: CONDITIONS
FOR VIRAL CLEARANCE
PRRSV replicates mainly in the pulmonary macrophages which (i)
are responsible for inflammation and viral destruction by
phagocytosis and (ii) participate in the induction and orientation of
the adaptive immune response. Experimental studies have shown
that PRRSV is able to inhibit innate immunity, to reduce the gamma
interferon synthesis and to limit the efficiency of neutralising
antibodies. Moreover the virulence and the resulting interaction with
the host immune system are variable between viral strains. Our
limited understanding of the interaction between the virus and the
immune system is the main obstacle in the evaluation of control
measures and the development of more efficient vaccines. To explore
these complex mechanisms and test biological hypotheses, we
propose an original model of the immune response centred on
macrophage – virus interactions in the lung. Comparatively to
previous modelling studies we highly detailed the temporal dynamics
of the innate immune response to better understand the effect of
the macrophage-virus interactions on the viral clearance. To explore
the relative influence of the immune mechanisms on the infection
outcome we conducted a multivariate sensitivity analysis using the
R package multisensi. We showed that the first steps of macrophage-
virus interactions are crucial. We used the model to explore the
immune response to strains of variable virulence and to determine
the required conditions for viral clearance.
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PHILOGENETIC ANALYSIS OF A PRRS STRAIN
IN ORDER TO EVALUATE ITS VARIABILITY
The study identified the strains present in a production pyramid, and
their evolution over a period of five years. The pyramid of 14000
females is composed of four production units: a breeding farm (MEP);
two farms producing 6kg piglets (MDB1, MDB2); and MEB, 18kg
piglets. Since 2005 various outbreaks have been diagnosed, with
different degrees of pathology and total of twelve strains were
sequenced. It was studied the genomic variability between the field
strains, the reference Lelystad virus (M96262), the strain included in
the vaccine Amervac PRRS (Hipra), and in Porcilis PRRS (MSD AH).
Results were following analysed using a Maximum Probability
analysis and a Neighbor-Joining Analyses.
The identity matrix of all sequences show that the strains found in
MEP, MDB1 and MDB2 are related to the originary strain that caused
first outbreak in 2005, being all strains philognetically very close to
each other. The strains MEB 2009 and 2010 seem to be in a different
cluster, showing a variance of 5%, which is considered too high to be
only due to time genetic drift. Studying the rest of the strains, it can
be noticed that while all strains are related, MEB strains follow a
different path to the rest.
The high viral activity of this production system makes it especially
important to have available information related to homology
between strains, its grade of genetic drift and the distribution of the
affected farms regarding to its infection date. The results are of main
importance in order to control future PRRSv circulation and to
determine the adaptation protocol to the replacement stock and the
protection of the herd with a modified live vaccine, by intradermal
route (IDAL® device), and reinforce the biosecurity measures, in order
to maintain PRRSv stability in the production system.
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HIGHER FEED AND PORK PRICES CAN
LEAD TO INCREASED DISEASE COSTS IN
AFFECTED HERDS
New animal welfare standards, increasing feed prices, strong
international competition and a more concerned society are some of
the future challenges the European pig production is facing. This paper
estimates the impact of changing market prices (pork and feed) on the
estimated costs of disease in non-vaccinated and affected herds.
For the analysis a French finishing unit of 2.100 places (wean to
finish) was considered. Typical performance data for average daily
weight gain (ADWG: 720 g/day), feed conversion rate (FCR: 2.6kg/kg)
and mortality rate (Losses: 4 %) were included as a baseline scenario.
The costs of disease were estimated for three major swine diseases:
Porcine Circovirus Associated Disease (PCVAD), Ileitis and Enzootic
Pneumoniae (EP). For each disease a mild and a severe form was
assumed. Prices for feed and pig meat ranged from €250/ton –
€1,35/kg in 2010 to €320/ton – €1,80/kg in 2012, respectively. The
Boehringer Ingelheim Economic Calculator (BECAL) was used to
evaluate the impact of the different disease scenarios at the pig level.
The evaluation demonstrated higher costs for 2012 compared to
2010. They moved up in average by 30%. Depending on the disease
situation, estimated costs in 2012 ranged from about €2.5/pig to
up to €7/pig, compared to about €2/pig to €5.50/pig in 2010.
In conclusion, increasing feed and pork prices lead to higher costs of
swine diseases in affected herds. Therefore the prevention of such
costly swine diseases becomes more valuable. Vaccination is a widely
accepted and successful method to prevent disease. Thus, especially
in times of high prices, vaccination helps to minimise cost of disease
and maximise producer’s profit.
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A NOVEL PLANT EXTRACT REDUCING
THE NEED FOR ANTIMICROBIAL AGENTS
IN MODERN PIG FARMS IN ORDER TO
MAINTAIN THE HEALTH OF PIGLETS:
RESULTS OF SEVERAL INTERNATIONAL
STUDIES AND VETERINARIAN TRIALS
Conclusion of several studies and trials to evaluate the effect of a
novel plant extract on performance,health and prevention of
diarrhoea in pig units with the aim to reduce the usage of antibiotics.
The novel plant extract is activated when cell damage in plant cells
causes the compounds of the extract to mix with catalytic enzymes.
This triggers a highly efficient wound healing and pathogen resisting
response found throughout the plant kingdom.
Injured animal mucosa present enzymes with similar catalytic
capability and can therefor be used to target specific challenged areas
of the gastro intestinal tract. The first study shows the effect of the
plant extract used through the drinking water on the postweaning gut
health of piglets. It can be useful in the prevention of postweaning
diarrhoea with an associated improvement of performance.
Also was demonstrated that the product resulted in a lower crypth
depth, a smaller number of mucosal macrophages after E coli
challenge thus confirming the possible protective functional role after
bacterial challenge.
The second study shows that the product has an antibacterial activity
after proven determination of MIC against selected pathogens with
veterinary importance.
In the third study the conclusion is that the novel plant extract
displayed a level of LPS binding level comparable to that of tannine
which is known to interfere with bacterial adhesion.
In field trials on large pig units in the Netherlands and the USA finally
it was demonstrated that the administration of the product reduced
scour and mortality before weaning and reduced the need for
antimicrobial agents in order to maintain health of piglets.
NOTES
POSTER PRESENTATIONS: MANAGEMENT
164
P126
Veronica Brewster, Royal Veterinary College;
Mandy Nevel, Royal Veterinary College.
THE EFFECT OF IMMUNO-CASTRATION ON
THE BEHAVIOUR OF PIGS AT UNLOADING
AT THE ABATTOIR
Immunocastration has been shown to affect the behaviour of pigs on
farm. However, the effect of immunocastration on the ease of
unloading and the behaviour of pigs at unloading at the abattoir has
not been studied. The aim of this study was to identify differences in
unloading behaviour between immunocastrated pigs compared with
unimmunised controls.
Pigs at 11 weeks were randomly allocated to either immunocastration
(2ml Improvac® [administered according to manufacturer’s directions]
Pfizer Animal Health, n=90 pigs, Group I) or control group (2ml saline,
n=88, Group C). Group I and C were unloaded separately and recorded
using a hand-held video camera. Videos were analysed and time taken
to unload recorded. Vocalisations (whistles and shouts) and hands-on
encouragement (pats and pushes) by stockmen were also recorded.
Unloading took 4 minutes 4 seconds (I) Vs 7 minutes 35 seconds (C).
Vocalisations differed between groups with 45 and 106 (I) and 75
and 161 (C) whistles and shouts required to unload the pigs.
Immunocastated pigs required less hands-on encouragement from
the stockman 41 (I) Vs 60 (C). All Immunocastrated pigs moved in a
forwardly direction whereas 3 control pigs turned 180° and re-
boarded the lorry blocking the exit, consequently increasing pushing
and fighting between pigs. In conclusion, immunocastrated pigs
required less encouragement from the stockman, appeared calmer
and unloaded more easily. Quicker unloading and a reduction in
unnecessary handling of pigs could benefit the stockmen, producer
and abattoir. Less physical unloading will reduce losses incurred by
carcass damage as well as improving animal welfare. In addition, the
stress experienced by stockmen appeared to be reduced. Although
only two groups of animals were studied, the differences in behaviour
of the animals were striking and this warrants further confirmation.
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CAN LOW BIRTH WEIGHT PIGS EXHIBIT
CATCH UP GROWTH POST WEANING IF FED
ACCORDING TO THEIR SIZE?
Variation in body weight (BW) is a concern for the pig industry, low
birth weight pigs (LBW) can contribute to this, exhibiting poor
postnatal growth rates. The aim of this study was to determine if
LBW pigs will respond to enhanced nutrition post weaning (9-13
weeks of age).
A 3 X 2 factorial design was used with 180 pigs, treatments were BW
at day 63 (N, NR and L) and food specification (High or standard
lysine). Pigs were selected at birth by BW, either normal BW (N) (1.7
to 2.0kg) or low BW (L) pigs (≤1.2kg). From day 49-63 two groups of
N pigs received restricted amounts of feed (NR) with the remaining
N and L groups fed ad libitum. From day 63-91 groups were fed a
high (16 g/kg) or a standard lysine (13 g/kg) diet. Pigs were weighed
twice weekly and feed intake was recorded.
BW on day 63 was 25.41, 21.00, 21.26kg (0.38 s.e.d) for N, NR and
L pigs. There was a significant effect of BW on performance (day 63-
91), with L pigs exhibiting the lowest ADG and FCE. NR pigs exhibited
the highest ADG however there was no difference in FCE when
compared to N pigs (P>0.05). There was no difference in performance
of pigs fed a high or standard lysine diet (P>0.05), nor was there a
significant interaction between BW and food specification (P>0.05).
L pigs did not exhibit catch up growth, even on a higher specification
diet, and consistently exhibited the lowest ADG and FCE. NR pigs
exhibited higher ADG post restriction than both N and L pigs. This
suggests feeding LBW pigs a higher specification diet, has no effect
on performance and it might not be possible to enhance the growth
of LBW pigs post weaning.
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WELFARE (PRODUCTIVITY) CONSEQUENCES
OF THE DANISH “YELLOW CARD” DEBATE
Introduction: During 2010, the concept “Yellow Card” was introduced
in Denmark. The authorities wished to reduce the antibiotic (AB)
consumption for pigs by pointing out herds with high AB usage and
subject them to a number of precautions. Even before the program
was instigated, the public debate made many farmers reduce the AB
consumption and the overall usage dropped by >20% in the following
year. Hence, the aim of this project was to determine if this decrease
had any effects on animal welfare (partly measured as productivity)
in affected herds.
Material and methods: Herds with an AB consumption of >3,5kg
active compound in the year before June 2010 and with a reduction
of AB consumption of >10% the following year were randomly
selected from the national database, Vetstat. Herds with finishers had
to deliver to either one of the two largest Danish slaughterhouse
companies. Organic and outdoor herds and herds that had suffered
severe disease outbreaks, had performed eradication programs or
made any other major changes during the study period were
excluded. Data on number of animals produced, mortality, daily
weight gain (ADG), lean meat percent, pathological findings and
weight at slaughter were collected for the entire study period.
Results: 270 herds were included in the study. At present, data from
63% is collected. The average herd size was 2652 pen places (475-
11000). For growers the overall mortality one year before and one
year after June 2010 was 2,7% (0,8-6,6%) and 3,1% (0,8-7,3),
respectively (P=0,042) and overall ADG before and after June 2010
was 454 g (295/737) and 444 g (296/677), respectively (P=0,314).
Complete data including pathological findings will be presented in
the final proceeding/poster.
Conclusion: Preliminary results suggest that the AB reduction may
have caused increased mortality and a tendency towards decreased
ADG in affected herds.
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EFFECT OF OREGANO ESSENTIAL OIL IN
THE PREVENTION OF SWINE DYSENTERY
RECRUDENCES
The trial was aimed at assessing the potential role of Oregano
essential oil in the prevention of the recrudescence of dysentery in
pigs recovered from Swine Dysentery (SD) after antibiotic treatment.
The efficacy has been evaluated by measuring the clinical signs (score)
of dysentery and the re-isolation of Brachyspira hyodysenteriae (Bh)
from individually collected faecal samples and the daily weight gain.
Twenty pigs suffering from dysentery, ageing 65 days, were selected
from a farm with a history of SD. The day after the arrivals (day 1) all
the animals enrolled, suffering from dysentery (confirmed by
microbiological investigation from their feces), have been treated
with Tiamulin intramuscularly at the effective dose to Bh. At day 5
(recovering from dysentery) the animals have been randomly divided
into two groups and identified by a numbered ear tag. Pigs belonging
to group A have been fed with a commercial feed with the inclusion
of Natural Oregano Essential Oil at 37.5 ppm (Dosto Green at the
dosage of 500 ppm) and group B received a commercial feed without
any additive. All pigs have been examined and scored twice a day for
diarrhoea, level of consciousness, appetite, dehydration. The clinical
observations where aimed at assessing the appearance of
recrudescence of the watery/mucous-hemorrhagic diarrhoea
(dysentery). At the arrival, at 5 (end of Tiamulin treatment), 10, 17,
24, 31 and 38 days fecal rectal samples were collected. On fecal
samples microbiological exams have been carried on. In the treated
group (A) we observed: no recrudescence of dysentery from day 5
to 38 days of treatment (in untreated/control animals the rate was
19.5%); no isolation of B.h. compared to 62.5% of the controls; an
increase of the average daily weight gain (85 gr/day).
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THE EFFECT OF CLEANING AND
DISINFECTION ON MICROBIAL LOAD FROM
DIFFERENT MATERIALS IN PIG HOUSING
Determining effective cleaning and disinfection (C&D) regimes of pig
housing is vital to improve the health of resident animals and reduce
zoonotic disease. A cleaning regime consisting of scraping, soaking
with or without detergent (treatment and control), pressure washing,
disinfection and natural drying was applied to multiple pig pens. After
each stage of cleaning samples were taken from stock board, metal
(galvanised steel) and concrete and enumerated for total aerobic
count (TAC) and Enterobacteriaceae (ENT). Soaking with detergent
caused significantly greater reductions in levels of TAC and ENT on
metal, and TAC on concrete, compared to control pens. Disinfection
effect was independent of prior detergent treatment. Disinfection
significantly reduced TAC and ENT on concrete and stock board but
no counts on metal. 24 hours after disinfection TAC and ENT on
metal and stock board were significantly reduced; no significant
reductions occurred in the subsequent 96 hours of drying. Counts on
concrete did not significantly reduce during the entire drying period
(120 hours). It can be concluded that both detergent and disinfectant
have varying bactericidal effects according to the surface they are
applied to; despite this variation, both should be included in a C&D
regime to lower bacteria levels effectively, along with a minimum
drying period of 24 hours.
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NON-SLIP FLOORS IN GESTATION UNITS
FOR LOOSE HOUSED SOWS
Lameness and claw lesions are frequent causes of discomfort or pain
in loose housed gilts and sows. They are also common causes of
compromised animal well-being and economic loss for the producers.
Leg problems were identified as the most common cause of
sow mortality on 37 Danish farms (1). Causes of lameness are
multifactorial, but claw lesions are one of the primary causes of
lameness, and they often develop in the gestation unit (2). The
lesions probably develop on concrete slatted floor in the activity area
during grouping and as a result of aggressions among the pigs at
entry to the feeding station. It may be possible to improve the non-
slip properties of floors by using “soft flooring” as this increases floor
contact and consequently provides an even pressure on the claws.
The aim of this study was to investigate whether “soft flooring”
reduces medical treatments due to leg problems.
Materials and methods: Three types of flooring in the activity area
were included: concrete slatted floor, rubber floor and DUO-plastic
modules. The investigation was conducted on a Danish farm with
1,100 sows and loose housing with electronic sow feeding. Gilts and
sows were housed in pens with approx. 90 animals, and each floor
was tested by seven batches of gilts/sows. The three types of flooring
were compared in terms of medical treatments in the gestation pens.
Results: The investigation included recordings of 1,722 gilts/sows. There
were 412 medical treatments as a result of leg problems. Sows in the
pen with DUO-plastic modules had a significantly higher frequency
(p<0.03) of medical treatments compared to sows on concrete and
rubber floor. Young sows had a higher frequency of treatments.
1. Vestergaard K. et al., (2004) Trial report 656, PRC
2. Anil S. et al., (2005) Allen D. Leman Swine Conference
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A SURVEY OF ATTITUDES AND PRACTICES
OF FARMERS AND VETERINARIANS TO
PAIN AND THE USE OF PAIN RELIEF IN
BREEDING PIGS
This study aimed to assess the level of use of analgesics for breeding
pigs by UK pig farmers and veterinarians and gauge their attitudes to
pain in pigs. Respondents were asked to identify anti-inflammatory
drugs they use and how often they use them for selected conditions
in pigs. They were also asked to rate the painfulness of different
conditions and indicate their level of agreement with various
statements about pain. A web-based survey was distributed to
veterinarians. A web  or paper-based survey was distributed to UK pig
farmers via various industry bodies and publications. Preliminary results
indicate that the most frequently used anti-inflammatories are
meloxicam and dexamethasone. For vets, males rated lameness and
respiratory disease as being more painful compared to females; whilst
females scored farrowing and shoulder sores higher than males. There
was almost complete agreement that pigs recover better when given
pain relief. Many farmers and vets agreed that it is difficult to recognise
pain in pigs. Vets were asked if they keep up-to-date with all the latest
literature on pain relief for pigs and 56% agreed, 27% disagreed and
15% neither agreed nor disagreed. Both farmers and vets were asked
how much they agree that pain relief drugs are too expensive for pig
farmers to use regularly. Almost a third of vets agreed with this
statement and 24% neither agreed nor disagreed, whereas very few
farmers agreed, with the majority disagreeing and some neither
agreeing nor disagreeing. Almost all farmers agreed that recognising
and managing pain is an important part of pig keeping and a large
proportion would like to know more about pain and how to treat pain
in pigs. Understanding the attitudes of pig farmers and vets may help
target future education, training and research into pain in pigs.
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GRAIN QUALITY AT INTAKE; A STUDY
OF QUALITY CONTROL PROCEDURES
OPERATED BY IRISH ANIMAL
FEED COMPOUNDERS IN 2012
Objectives: To examine the ability of Mill quality control procedures
to establish the quality of grain at intake and to forewarn them of a
risk of substandard grain being delivered, which if incorporated in a
compound feed, could have a negative impact on the health and/or
nutritional status of animals to which the final manufactured
compound feed is fed.
Materials and methods: Data collection involved the preparation
of a questionnaire which contained the key parameters that relate to
grain quality. Quality personnel in the individual mills in the Republic
of Ireland were contacted by telephone or by plant visit for the
purpose of documenting the quality control procedures in relation to
the purchase and mill intake of grain (wheat and barley).
Results and Conclusions: Sampling procedures varied between Mills.
With the exception of fines the systems adopted would normally
predict the bushel weight (kg/hl) and moisture content of the load to
within acceptable tolerances. The likelihood of detecting the presence
of randomly distributed clumps of mouldy product, caused by poor
supplier storage conditions in a 500-1000g sample is very small. Such
substandard product could contain high concentrations of highly toxic
mycotoxins which could contaminate large quantities of final product
within the mill and subsequently impact negatively on animal health.
In addition to the supplier, the driver of the delivery truck played a
key role in forewarning them of any potential changes in the source(s)
or quality of the delivered product since they could visually appraise
the grain and the store during the truck loading process.
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EFFECT OF CROSS-FOSTERING ON LITTER
PERFORMANCE WITH PARTICULAR
REFERENCE TO LOW-WEIGHT PIGLETS
Our objective was to study the effect of cross-fostering on litter
performance, focusing on piglets born with less than 1351 g (SP)
body weight. The experiment was performed in a Brazilian
commercial farm and 68 mutiparous sows and their litters were used.
Cross-fostering was performed 24 h post-partum and litters were
fixed by number (HL), or fixed with most of the piglets being SP
assuring sows with thin nipples (LL). Piglets were weighed on d 1 and
19 post-partum. Mortality was recorded. As expected, LL litters had
lower mean BW (mBW) at d 1 than HL litters (1.19 vs. 1.54±0.129;
P<0.05), and HL litters had higher mBW at d 19 than LL litters (5.52
vs. 4.77±0.129kg; P<0.001). LL sows had also lower within litter CV
of BW (CVBW) at d 1 than HL sows (17.4 vs. 21.8±4.39 %; P<0.05)
but they did not differ in CVBW at d 19 (23.2 vs. 23.4±1.72 %;
P>0.10). HL sows had lower number of dead piglets (0.78 vs. 1.95;
P<0.05) and lower rate of dead SP (6.5 % vs. 15.7 %; P<0.05) at d 19
than LL sows. Cross-fostering small piglets to LL litters did not reduce
litter mortality nor did it improve CVBW, moreover, it increased SP
mortality rate at the end of lactation. Performing cross-fostering to
obtain HL litters is an easier and faster management procedure in
the farm than obtaining LL litters and, according to our results, it can
be concluded that it is also the best option for SP survival.
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HERD DIAGNOSIS OF IRON
DEFICIENCY IN PIGLETS
Introduction: Iron supplementation regimes for piglets are very
standardised with little focus on variations in birth weight, growth rate
or weaning age. Dose calculations are rarely based on haematological
measurements. A critical time for iron deficiency is immediately before
weaning. An optimal haemoglobin (Hb) blood concentration may be
defined as 110 g/l. The objective of this study was to design a herd
diagnostic procedure for evaluation of iron supplementation in the
suckling period.
Materials and methods: In a Norwegian sow herd 134 piglets were
followed from birth to weaning. All piglets were offered oral iron
throughout the suckling period. In addition half of the piglets (split
litters) were dosed subcutaneously with 180 mg iron dextran at birth.
Piglet Hb concentration and body weight was determined at 35 days
of age. Total iron content in piglets was calculated by assuming a
blood volume of 8.5 % of the body weight, an iron content of 3.4
mg/g Hb and an additional 25% iron in other body components such
as myoglobin and ferritin.
Results: Piglets receiving 180 mg iron dextran had an average Hb
blood concentration of 101 g/l compared to 66 g/l in pigs without
parenteral iron supplementation (p<0.001). The corresponding
average body weights were 12.2kg compared to 10.7kg (p<0.05).
Given the assumptions above the parenterally dosed piglets
contained an average 445 mg iron per animal compared to 255 mg
iron in the orally dosed animals. This difference corresponds well to
the 180 mg iron given parentally.
Conclusion: By measuring Hb values in a representative sample of
piglets at weaning, it is possible to determine whether desired Hb
levels are reached. Additional iron supplementation required to obtain
optimal growth rates may be calculated based on these figures.
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THE ASSOCIATION BETWEEN SERUM
VITAMIN D LEVELS AND AVERAGE DAILY
GAIN (ADG) AND MORBIDITY OUTCOME IN
WEANED PIGLETS
Piglets are born with low serum concentrations of the vitamin D
metabolite 25-OH-D3 resulting in a predisposition to vitamin D
deficiency. Recent studies have demonstrated that oral supplementation
of piglets is necessary to attain serum vitamin D levels within the
normal published range. It has subsequently been hypothesised that
vitamin D deficiency may predispose the weaned piglet to increased
morbidity and decreased ADG. The objective of this study was to
determine the association of serum vitamin D levels with ADG and the
probability of clinical morbidity in weaned piglets.
One hundred and eighteen piglets, from a commercial farm
experiencing high post-weaning morbidity, were individually identified
and randomly assigned at weaning (24-days-old) to 1 of 2 treatment
groups (Day 1). Group #1 (n=60): administered 1ml strawberry syrup
orally. Group #2 (n=58): administered orally 1ml (1.042 g/ml) of
commercially prepared vitamin D syrup. Piglets were weighed, and
serum samples were taken for vitamin D level analysis, on Day 1 and
28 of the trial. Observations were recorded daily for morbidity
outcomes. Investigators were blinded to the treatment groups.
Group #2 had a higher vitamin D serum level when compared to
Group #1 at Day 28 (P<0.05). However, using multilevel linear
regression, there was no significant difference in ADG in the first 28
days after weaning between the two groups. There was also no
significant difference, using multilevel logistic regression, in morbidity
outcomes between the two groups. All analyses used pen as a
random effect, and controlled for repeated measures, sex, parity, and
weaning weight.
Supplementation with oral vitamin D at weaning achieved higher
serum vitamin D levels when compared to controls. However,
supplementation did not decrease the probability of morbidity and
did not improve the ADG in weaned piglets.
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FIELD EFFICACY OF POTASSIUM
PEROXYMONOSULFATE (PMS) OXIDISING
DISINFECTANT (VIRUSNIPTM) AGAINST
PORCINE CIRCOVIRUS TYPE 2 (PCV2) IN
GILT ACCLIMATISATION UNIT
Potassium peroxymonosulfate (PMS) is an oxidising disinfectant that
demonstrate high efficacy against various viruses in vitro. However, no
field experiments of this agent existed until the present. This is the
first study of determining the virucidal activity of VirusnipTM, the
representative of disinfectant containing PMS as an active ingredient,
under field condition. In this study, 1:200 concentration of VirusnipTM
was sprayed for 15 minutes in gilts acclimatisation area.
Environmental swabs from the floor and oral fluid samples were
collected to determine the quantitative PCV2 copies between treated
and untreated pens using qPCR specific for ORF1 of PCV2. The result
demonstrated that the VirusnipTM showed virucidal capability against
PCV2 under field condition and the viral load in the environment was
minimised dramatically. Interestingly, PCV2 vaccine was used twice
when gilts were 25 and 29 weeks old but at the end of this study the
untreated group still shed the virus with the higher levels than those
VirusnipTM treated group. Significant reduction of PCV2 copies
shedding in the oral fluids was demonstrated. Under a various factors
according to field condition, proper disinfection practice may play a
significant role when combining with a suitable vaccination program
in an infected herd. PMS contains disinfection demonstrated virucidal
effects in treated environment and specific immunity activated by
PCV2 vaccination had an impact on minimising viral shedding
detecting in oral fluid samples.
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PRENATAL STRESS INFLUENCES ON PIG
HEALTH, WELFARE AND PRODUCTIVITY
A number of experimental studies in pigs have clearly shown that early
life experiences can have a substantial impact on outcomes of great
relevance to later health, welfare and productivity. In particular, stress
or under-nutrition experienced by the sow during pregnancy has been
shown to have important effects on how her offspring cope with their
social, physical and infectious environment. However, the possible
importance of sow management during gestating may be under-
appreciated. This paper will briefly review some of the major findings
relating to prenatal stress effects in pigs. A number of maternal factors
have been found to be positively or negatively associated with later
offspring outcomes. In particular, the social environment during
gestation has been found to have a major impact on progeny pig
welfare. Mixing during pregnancy has been shown to alter offspring
behaviour, stress reactivity, immune function and growth rates. Given
the current transition from gestation stalls to group housing in Europe
and many other regions around the world, optimisation of the social
environment during pregnancy is a challenged faced by many
producers. On many farms, social mixing as a prenatal stressor could
be negatively affecting herd health and performance. The obvious
corollary of the negative outcomes previously identified (as a
consequence of social stress or other factors) is that optimal prenatal
management, through increasing progeny robustness, could play an
important role in supporting positive welfare and efficient production.
Identifying and understanding the possible contribution of the prenatal
environment to farm performance may therefore be an important
effort for farmers and veterinarians.
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USE OF ANALGESIA DURING CASTRATION
IN PIGLETS: EFFECT OF TOLFENAMIC ACID
ON BEHAVIOURAL AND PHYSIOLOGICAL
INDICATORS OF PAIN
Surgical castration of male piglets without using pain relief is a
common management practice performed to avoid the occurrence
of boar taint. For the increasing animal welfare concerns and the
public opinion pressure, alternative methods will have to be
implemented. Aim of this study was to evaluate, by behavioural and
physiological indicators, the effectiveness of tolfenamic acid
administered before castration to alleviate the pain. The study
involved 96 male piglets of 5 days of age, divided into four groups: 24
handled only (H), 24 castrated without pain relief (C), 24 treated with
tolfenamic acid (Tolfedine cs® 0,05ml/kg intramuscular) 1h before
castration (T), and 24 treated with placebo (physiological saline
solution 0,05ml/kg intramuscular) 1h before castration (P). Twelve
piglets for each treatment were assigned to blood collection, whereas
12 were used for behavioural observation in order to avoid
modification due to additional handling influence. Behaviour was
observed using a scan-sampling technique for 15 minutes at 4 time
point from castration (0h00, 0h16, 1h00, 1h15). Blood samples were
collected 0h30 and 4h00 after castration for cortisol concentration.
Data were processed by PROC MIXED (SAS 9.2, SAS Institute Inc.)
using Bonferroni test. Results showed significant differences for all the
parameters in H group compared to C and P groups (P<0,001),
excluding cortisol level at 4h00 which was similar in each group. B
ehaviours such as ‘walking’ and ‘standing’, and cortisol at 0h30,
showed no significant difference between T group and H group
(P>0,05). In conclusion, administration of tolfenamic acid before
castration reduces behavioural and physiological indicators of pain in
piglets. The findings suggest that tolfenamic acid administered IM at
2 mg/kg could decrease the pain induced by castration in piglets,
improving the health and welfare of piglets in practice.
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INFLUENCE OF BIO-ACTIVE PEPTIDES FROM
FPP (FERMENTED POTATO PROTEIN) ON
LITTER SIZE AND LITTER WEIGHT IN SOWS
Increasing environmental temperature has a potentially large impact
on the pig industry, especially during summer season. The sow’s litter
size is largely impacted by ambient temperatures. Previous research
demonstrated a positive effect of Lianol®, a complementary feed based
on highly digestible fermented potato protein, on plasma insulin-like
growth factor-1 (IGF-1) levels in pigs. IGF-1 is involved in many
metabolic processes including fertility. Therefore it can be expected
that Lianol® can affect reproduction parameters in sow production.
The objective of this research was to evaluate the effect of this new
complementary feedstuff on litter size. Litter size is highly correlated
with the total litter weight, which was also observed.
This trial was conducted at Pig Innovation Centre Sterksel (part of
Wageningen University, The Netherlands). Most sows were a
crossbred (Dutch Landrace * Large White) and they were inseminated
with the same Large White growing-finishing boar line. Reproduction
parameters of a control group of 43 sows were compared with the
results of a group of 43 sows that received Lianol® Ferti Tablet around
weaning (from 3 days pre weaning until 2 days post weaning). Both
groups had an equal parity distribution. The litter size and litter
weight was observed. This trial demonstrated a large effect both on
live born and total born piglets per litter. Supplementing the new
product resulted in an increased litter size of 0.76 piglets. The number
of live born piglets per litter increases by 0.66 per litter. With
increasing litter size, an effect on the individual birth weight can be
expected. In this trial, only a slight decrease in individual birth weight
could be noted (20 grams per live born piglet). The total litter weight
in the Lianol® group, however, slightly increased by 135 g per litter.
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INFLUENCE OF PROVIDING BIO-ACTIVE
PEPTIDES FROM FPP (FERMENTED POTATO
PROTEIN) IN LACTATION DIETS ON
PRE-WEANING SURVIVABILITY AND PIGLET
WEIGHT AT WEANING
The amount and quality of sow milk is a pivotal factor in piglet
survival, growth, development and pre-weaning body composition.
Numerous researches have demonstrated that heavier weaning
piglets reach market weight faster, reducing the production costs. This
has sparked the increasing interest in exploiting the lactation period
to enhance overall piglet growth and pork production efficiency.
Previous research demonstrated a positive effect of Lianol®, a
complementary feed based on highly digestible fermented potato
protein, on plasma insulin-like growth factor-1 (IGF-1) levels in pigs.
IGF-1 is involved in many metabolic processes including milk
production. Therefore it can be expected that the inclusion of Lianol®
in lactation diets can affect pre-weaning production parameters
in piglets.
The objective of this research was to evaluate the effect of this new
complementary feedstuff on litter weight at weaning and pre-weaning
piglet survivability.
This trial was conducted on a group of 192 control sows and 191
treated sows at a commercial Austrian farm. The farm had a history
of high pre-weaning mortality. All sows were hybrid sows. Both
treated and control animals were housed under identical conditions.
The treated group received the same lactation feed as the control
group, except for a supplementation of 1kg of Lianol® Solapro per
ton of feed. Piglets were weaned at 27 days. Piglet birth weight and
the number of live born piglets did not differ significantly between
both treatments. The supplementation of the lactation feed with
Lianol® Solapro significantly (P<0.001) increased the weaning weight
by 119 grams; from 7.261 to 7.380kg. Furthermore, the pre-weaning
survivability improved significantly (P<0.004) from 76.9% to 82.1%
in the control and treated group respectively.
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TRIALS TO INACTIVATE ANTIBIOTICS IN THE
WATER PIPE SYSTEM AFTER ORAL
MEDICATION BY THE WATER HYGIENE
BIOZIDE VIRBAC CLEAN PIPE (VCP)
Introduction: Biofilms develop fast in each water pipe system. Beside
water intake reduction and to be source of health relevant germs, an
existing biofilm is catching up antibiotics during a water medication
phase. Field data have shown that these molecules are set free again
over 6-8 weeks (depends from the molecule).
Virbac Clean Pipe (VCP) as a special formulation of sodium hypochlorite
is giving a strong oxidation power by its 19 % free Chlorine. Therefore
laboratory trials and field trials were set up to show the antibiotic
inactivation activity.
Material and methods: Double concentrations of common
treatment solution of Doxycyclin (Pulmodox 500 mg/g, Virbac)
1000g/1000 litre, Tiamulin (Stalimox 364,2mg/g, Virbac) 400 g/1000
litre and Amoxicillin (Suramox 100%, Virbac) 400 g/1000 litre were
mixed 1:1 with the double concentrated Hypochlorite-Product (Virbac
Clean Pipe, Virbac) 40ml/1000 litre. After 1, 6 and 24 hours aliquots
of 1ml were kept and a logarithmic titration row where build up.
25µl of these 1:10 solutions were given in the test tube with the test
germs (PremiTest, biopharm) and incubated over 3 hours at 37°C
according biopharm instructions.
An antibiotic effect was detected when the colour of the tube didn’t
change. Without antibiotic effect the germ growth induces a clear
change from violet to yellow.
Results: It was shown that VCP inactivated Doxycyclin and Tiamulin
>99% within 6 hours. 90 % of the antibiotic effect of Amoxicillin
was stopped to that time. The antibiotic activity was destroyed over
99,99 % within 24 hours for all tested antibiotics.
Discussion: Therefore VCP could be used as a cleaner after each
water medication period to stop the antibiotic effect. First field trials
confirmed these laboratory test results. A VCP-cleaning phase let
control cross-contaminations as a contribution to antibiotic
resistance development prevention. Beside this VCP is reducing
already resistant germs in system by disinfection.
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EFFICACY OF VEVOSTART® PREMIX IN
THE FEEDING OF ESCHERICHIA COLI K88
CHALLENGED PIGLETS
Feed with VevoStart® (a vitamin-mineral premix with benzoic acid)
was evaluated as an alternative to medicated feed in weaning pigs
challenged with Escherichia coli K88. 140 piglets weaned at 26 d of
age were distributed into 28 pens and offered, for 28 days, 4 dietary
treatments consisting of a non-supplemented diet (Control) and the
same diet supplemented with VevoStart® (2%), Colistin (80 ppm) or
Zn-oxide (3,000ppm). All the piglets were given an oral dose of
5x10^8 cfu E. coli K88 at day 4 post-weaning. ADG and ADFI were
measured, faecal score was monitored, and fresh faeces were
collected to quantify E. coli shedding by traditional plate culture and
quantitative PCR. The piglets offered VevoStart® had higher (P<0.05)
weight gain (366g/d) and better feed efficiency ratio (0.76) than
those offered the Control diet (303g/d and 0.69), Colistin (306g/d
and 0.69) or Zn-oxide (291g/d and 0.70; P<0.05). The piglets offered
Colistin had a better faecal score than those fed the Control diet
(0.07 vs. 0.21; P<0.05). Faecal E. coli shedding (log cfu/g faeces)
measured with traditional culture methods was lower (P<0.05) in
the piglets fed Colistin (1.3) than in those offered the Control diet
(2.2), VevoStart® (2.1) or Zn-oxide (2.1). When faecal E. coli shedding
was measured using quantitative PCR higher recoveries were
obtained, and there was an interaction between dietary treatment
and sampling day. E. coli shedding was higher (P<0.05) in the piglets
fed ZnO than in those fed Colistin, particularly between days 4-13
post-weaning (7.5 vs. 7.0log cfu/g faeces). It is concluded that, under
the tested challenge conditions, the feed with VevoStart® premix
significantly improved the performance of the piglets and appears
to be a valid alternative for the use of medicated feeds.
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EFFECT OF BOVINE COLOSTRUM ON
GROWTH PERFORMANCE AND SURVIVAL
OF SUCKLING PIGLETS
In the present study the effects of bovine colostrum supplementation
(Veracus® Vetilan COLOSTRUM BOOST, Veracus) on growth
performance and survival of suckling piglets were examined. In total,
388 newborn piglets of 30 sows were randomly assigned to three
different treatment groups. The piglets received either 1ml of bovine
colostrum per piglet at the first day of life (group A), on three
consecutive days (group B, 1ml/piglet at the first, second and third
day of life) or remained as negative controls (group C) with no
additional colostrum supplementation. All piglets were clinically
investigated daily from study day (SD) 1 to 10 and body weight was
measured on the first, forth and 10th day of life. Over investigation
time, 35 piglets (9 %) died revealing no significant differences
between treatment groups and 25 out of the dead 35 piglets (71 %)
had a birth weight less than 1000 g. No significant differences were
seen for the average daily weight gain from days one to 10 between
the three treatment groups. Piglets weighing less than 1000g at birth
had better chances of survival by bovine colostrum intake, which was
partly significant. Piglets of group A and group B (p= 0,002) survived
one and two days longer than group C piglets, respectively. The
results of the present study suggest that supplying bovine colostrum
to underweighted newborn piglets improves their resistance
providing the farmer more time finding them an appropriate nurse
sow ending in better chances for each single piglet to survive.
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A QUESTIONNAIRE SURVEY TO
INVESTIGATE ASSOCIATIONS BETWEEN
FEEDING PROCEDURES FOR GESTATING
FEMALES AND PIGS BORN DEAD IN
JAPANESE COMMERCIAL SWINE HERDS
The objective of the present study was to examine associations
between feeding procedures for gestating females and percentages
of pigs born dead (PPBD) in commercial herds. Questionnaires were
sent to 115 herds in 2008 to obtain information about gestation
feeding procedures. Data from 96 completed questionnaires (83.5%)
were coordinated with the reproductive data of individual females.
The dataset included 15,407 gilt records and 74,174 sow records.
Participating herds were classified into two groups based on the upper
25th percentile of PPBD: high-PPBD (12.0% or higher) or non-high-
PPBD herds. At the herd level, a two-sample t-test was used. Two-level
mixed-effects models were applied, by using a herd at level two and
an individual record at level one. Mean (± SEM) PPBD of gilts and sows
were 8.8 ± 0.12 and 9.8 ± 0.05%, respectively. Feed quantity was
increased in mid-gestation in 69.5 and 86.3% of the herds for gilts
and sows, respectively. Mean gestation age when the diet was
increased for gilts and sows was 68.5 ± 4.45 and 58.8 ± 4.38 days,
respectively. Diet quantity was also decreased in 55% of the herds
prior to farrowing. The mean diet quantity prior to farrowing was 2.1
± 0.07kg/day for gilts and 2.3 ± 0.08kg/day for sows. High-PPBD herds
had larger herd size than non-high-PPBD herds (P<0.05), but no
differences between the two herd groups were found significant for
number of total pigs born (P = 0.08). In two-level analysis, no
procedures for sows were associated with higher PPBD (P>0.10),
whereas in gilts higher PPBD was associated with greater diet quantity
pre-farrowing, and increasing the diet at an earlier gestation age
(P<0.05). Therefore, these results indicate that in gilts PPBD is
increased when diet is increased in mid-gestation and pre-farrowing.
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ECONOMIC IMPACT OF CIRCOVAC®
VACCINATION IN PIGLETS UNDER SPANISH
FIELD CONDITIONS
Introduction: This study aimed to assessing the economic benefit
provided by the improvement and homogenisation of pig slaughtering
weights pigs after CIRCOVAC vaccination under Spanish conditions.
Material and methods: Animal records: Data was obtained following
a controlled, randomised and blinded trial conducted under good
clinical practices in 2 Spanish farms (A,B) affected by PCVD. A total of
1239 piglets was included then either vaccinated with CIRCOVAC
(n=619) or injected with a placebo (n=620) at weaning. Allocation to
treatment groups was performed following randomisation according to
weaning bodyweights. The unvaccinated and vaccinated batches were
weighed before shipment to the slaughterhouse at 168 and 189 days
of age depending on the site. Distribution parameters of the carcass
weights were calculated within each batch and farm following the
estimation of carcass weights.
Rentability calculation: Individual prices were calculated with a
standard slaughterhouse paying matrix with a bonus/penality applied
to ranges of weights (paying scheme used in Spain in 2011 as a
reference). Carcass quality with a 1.5-euro base price was assumed.
The average prices between treatment groups were compared in each
farm. Statistical simulation studies using the carcass weight distribution
parameters were performed to assess the economic benefit of carcass
weight general improvement. The impact of bodyweight
homogenisation in each farm was assessed by equalising means.
Results and conclusion: CIRCOVAC vaccination induced a +€2.55
average gain per carcass (GPC) in farm A and +€4.34 in farm B. The
simulation study showed an average expectation of respectively
+€4.22 and +€3.93 GPC. The gain due to homogenisation of the
bodyweights was estimated to a €0.29-0.32 GPC and could reach
€1.47. In conclusion and under the condition of the study, a clear
economic gain of approximately €4 per pig could be expected
following CIRCOVAC vaccination in piglets.
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REAL WELFARE – PREVALENCE OF WELFARE
INDICATORS IN THE ENGLISH PIG INDUSTRY
The Real Welfare project has developed and tested a set of practical and
useable protocols that will be used in the English pig industry to
measure and compare the welfare standards under which pigs are kept.
Ahead of the EU and EFSA recommendations, England has been
developing outcome-based welfare measures i.e. how pigs cope with
their environment, rather than measuring components of the housing
provided. From a wide range of potential welfare indicators, work
from 2006 at Bristol University (in collaboration with Newcastle
University and BPEX) identified five finisher* (>50kg) and seven sow
measures which are scientifically validated and practical comparators
of welfare and production in pigs. Working with the English pig
industry, BPEX then concentrated on establishing an initial network
of assessors, and refining the methods in a wider commercial setting.
22 veterinarians from 14 practices with regular involvement with
pigs attended standardisation days to become familiar with the
protocols and definitions needed for objective, accurate data
recording. These vets completed extended pilot trials of the protocols
across 2011, assessing 157 farms, and resulting in the first large scale
measures of body marks, tail lesions, lameness, “hospital” pigs, and
enrichment use across the UK finisher population, with similar
measures including shoulder and vulva lesions and low body
condition also scored in dry sows.
These initial prevalences give us a set of benchmarks to use within
industry, showing what is achievable commercially, as well as
providing useful baseline data against which to assess unit changes
and industry trends. The value of this approach has been recognised
by the Red Tractor assurance scheme, which incorporates 92% of
British pigs; a consultation exercise is underway on the proposal to
include Real Welfare assessment of finisher pigs as a requirement for
this assurance scheme for inclusion in Spring 2013.
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INFLUENCE OF A PHYTOGENIC FEED
ADDITIVE ON THE PERFORMANCE OF SOWS
Weaning up to 30 piglets/sow/year is nearly unexceptional in
developed countries.
High selection rates already in early production stages reduce the
average utilisation time of sows, thus affecting lifetime performance.
Several studies have shown the positive influence of phytogenic feed
additives on sow and litter performance when used in the lactation
feed. Sows had higher feed intake during lactation, produced more
milk, converted the ingested feed more efficiently, lost less body
weight and their litters grew better.
The objective of this study was to explore the influence of the
continuous use of the phytogenic feed additive Digestarom® in
lactation as well as in gestation feed on production parameters. The
study was carried out in a large scale sow unit keeping two different
herds, each with an average stock of more than 4.700 sows.
Both herds were fed under the same feeding program, with the same
basal diet. Digestarom® Sow, a blend of herbs, spices and essential
oils, was applied at a concentration of 150 g/t complete feed in all
diets of the trial herd.
The study showed that continuous use of the phytogenic feed
additive reduced the losses of sows, especially in early parities, for
fertility reasons by more than 30%. Simultaneously production
parameters like farrowing rate and piglet index (number of live-born
piglets/100 first services) were enhanced over all parities. Compared
to the first production cycle in which the additive was applied, the
trial herd showed higher and more stable piglet indexes over all parity
numbers in the second production cycle.
Finally the replacement rate was reduced in the trial herd (51,5%)
compared to the control herd (54,9%).
Thus, the continuous use of the phytogenic feed additive
Digestarom® Sow not only enhances the zoo-technical performance,
but also contributes to a longer utilisation time and lifetime
performance of the sows under field conditions.
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BEHAVIOUR OF LOOSE HOUSED SOWS
DURING MATING – ANIMAL WELFARE AND
ANIMAL WELFARE
Sows are for animal welfare reasons housed lose in Sweden. Pens
with deep-litter-straw provide a large total area, allowing non-
dominant sows to avoid confrontations with dominant sows during
the dry period. However, during heat the sows differ in behaviour.
Two pens with deep-litter-straw were filmed (12h/day) from weaning
to mating. The pens housed 22 (parity number 2.9±2.2) and 17 sows
(parity number 6.0±2.1), respectively. The sows were fed a dry feed
three times daily and steadily ate for about one hour per day.
Following feeding, they were looked up for a total of another two
hours per day, thereby being lose for 9 of the 12 hours filmed per
day. Day 2 post weaning, they spent 6.3-6.9 hours of this time
sleeping or resting.
From Day 2 to Day 4 the activity of the younger and older sows
increased from 2.8 to 4.8 hours and from 2.0 to 3.2 hours,
respectively. The aggressive interactions increased from 17 to 111
for young, and from 10 to 62 for old sows. These interactions were
head-to-head, indicating social competing. Simultaneously, the
incidence of mounting other sows from the rear increased, from 2 to
146 and from 0 to 66 among young and old sows, respectively. On
day five, the mountings increased to 174 in the young group, whereas
it decreased to 38 in the old group. On Day 6, activity, aggressiveness
and mountings were significantly reduced in both pens.
The behaviour of the sows mirrored the state of heat well, since the
majority (71%) of the old sows was inseminated day 4, while
younger sow in general (77%) was inseminated day 5. The results
indicate that lose housed sows may hurt each other during heat due
to mountings and aggressiveness, and that precautions aimed to
prevent this ought to be discussed.
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COATED CALCIUMBUTYRATE: A POTENTIAL
TOOL TO CONTROL SALMONELLA IN HIGH
RISK PIG-HERD
Salmonella is an important foodborne infection in humans. A large
number of human Salmonellosis cases is caused by the consumption
of contaminated pork. To decrease the number of human cases
biosecurity measures are needed at herd-level. An additional measure
which may be effective is the administration of additives to feed or
drinking water. One specific additive that already demonstrated its
beneficial effect on Salmonella is coated calciumbutyrate. This study
describes the effect of adding coated calciumbutyrate in the feed of
finishing pigs on a Belgian Salmonella high risk pig-herd.
Overshoes (n=14) were taken after cleaning and disinfection and
before population. Fifteen randomly selected piglets were sampled at
arriving (20kg), 40kg, 75kg and at slaughter by taken individual blood
and faecal samples. Overshoes (n=39) were taken at the same times.
Blood samples were analysed using an indirect LPS-Salmonella ELISA
(Idexx). Bacteriological analysis for Salmonella in feces and overshoes
was performed by a standard enrichment method according to ISO
6579-Annex-D (MSRV). Two kg of coated calciumbutyrate (Globamax
Performant, Sanluc) per 1000kg feed was added during one fattening
period. No additional measures were taken.
Twenty percent of the overshoes taken before introduction of pigs
was bacteriological positive. The piglets themselves were serological
(S/P<0.1) and bacteriological negative when at arriving. During the
fattening period the S/P-ratio increased with the age of the pigs. The
highest S/P-ratio was found at slaughter and was 0.24. All individual
fecal samples and overshoes during the trial were negative.
In conclusion, as none of the S/P-ratios exceeded the cut-off value of
0.6, coated calciumbutyrate proved to be a useful tool to improve the
serological Salmonella status in this specific herd. The results of this
study suggest coated calciumbutyrate may also be beneficial in other
Salmonella high risk herds. Therefore other future studies may be useful.
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DETECTING SALMONELLA IN PIGS
AT SLAUGHTER – A COMPARISON OF
SAMPLE TYPES
Salmonella infection in pigs represents a potential hazard to public
health and it is anticipated that the EU will set targets for reduction for
all Member States. Surveys to estimate the prevalence of Salmonella
in slaughter pigs are conveniently conducted at the abattoir. In this
study, four different samples were collected from each of 622 pigs –
ileo-caecal lymph node, caecal content and carcass swabs for culture
together with meat juice samples to detect antibodies against Group
B and C1 Salmonella in an ELISA test. Considered individually, there
were 138, 137, 95 and 294 positive results. Each sample could be
positive or negative to each test, yielding 16 different possible
combinations of result. All of these were observed in the data. A
Bayesian analysis was conducted that enabled these results to be
combined and to estimate the sensitivity and specificity of each
method. The inevitable imperfect agreement amongst these samples
reflects firstly, the nature of the sample and its relationship to the
salmonella status of the pig and secondly, the sensitivity and specificity
of the laboratory tests that were employed. Crudely, it may be
considered that a positive ileo-caecal lymph node arises through
infection on farm, that a positive caecal sample arises through infection
on farm or ingestion of contaminated material during transport or in
lairage, a positive carcass swab result from external contamination
through faecal leakage after slaughter or cross-contamination and a MJ
ELISA positive reflects prior infection on farm. In addition to providing
estimates of prevalence at slaughter, each outcome may be useful to
evaluate interventions on farm or in the abattoir. Carcass swabs may
reflect public health risk, ileo-caecal lymph node culture and MJ ELISA
results to indicate impact of farm factors and caecal content to
demonstrate risk at the entry to the abattoir.
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DEVELOPMENT AND VALIDATION OF ZNCP
SALMONELLA FARM RISK ASSESSMENT TOOL
The control of Salmonella on pig farms is an important measure to
reduce the risk to humans of contracting Salmonella from pig meat.
In July 2012, the UK Zoonoses National Control Programme for
Salmonella in pigs (ZNCP) suspended the serological surveillance of
Salmonella exposure in slaughter pigs by ELISA testing of meat-juice
samples. The level of serological sampling was only adequate to
indicate Salmonella prevalence at a national level; it did not provide
sufficient data to effectively assess the prevalence on individual herds
(Sayers & Cook, unpublished data) and therefore did little to motivate
control measures by farmers. Instead, the ZNCP has introduced a
Salmonella Farm Risk Assessment Tool for producers to assess on-
farm control of putative risk factors for Salmonella. The Farm Tool
requires users to input farm information and answer questions relating
to biosecurity practices and pig management. Prior to introduction of
the Farm Tool, a pilot study was run on 24 farms where responses to
the Farm Tool were compared against ZNCP meat-juice ELISA scores
and evidence of Salmonella by faecal culture. The potential impact of
biosecurity measures on the proportion of positive samples on each
farm was assessed. Principal Component Analysis identified that a
farm was more likely to have a lower ZNCP score by adopting a
combination of good biosecurity practices, rather than focusing on a
single aspect of biosecurity. The pilot study also enabled evaluation of
the Farm Tool in terms of scoring, ease of use and relevance. Use of
the Farm Tool by pig producers will enable qualitative categorisation
of farms according to risk of Salmonella infection, which falls in line
with European Food Safety Authority recommendations for measures
to reduce risk to consumers. Control efforts could be targeted towards
units deemed to be “high risk” by the Farm Tool.
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SEROSURVEY OF SALMONELLA SPP. AND
YERSINIA SPP. IN FATTENING PIGS REARED
IN FREE-RANGE SYSTEMS
Zoonotic agents, such as Salmonella spp. and Yersinia spp., are
considered high-risk zoonotic pathogens by the European Food
Safety Agency (EFSA) and have a significant public health impact.
Determining the prevalence of these pathogens represents a useful
tool for establishing basic control measures directed to reduce their
impact. A serological survey was conducted to determine the
seroprevalence of Salmonella spp. and Yersinia spp. in pigs reared in
outdoor systems from South Spain. A total of 1,187 serum samples
were collected at two different abattoirs from 80 farms and analysed
for specific antibodies against the above mentioned pathogens using
commercial ELISA kits. Antibodies against Salmonella spp. were
detected in 1,052/1,187 pigs (88.63% individual prevalence) from
80 of 80 herds (100% herd prevalence), ranging from 40% to 100%
positive pigs/herds (median=93.33%), with a cut-off optical density
(OD) % of 20. However, when a cut-off OD% of 40 was used,
antibodies against Salmonella spp. were detected in 669/1,187 pigs
(56.36 % individual prevalence) from 80 of 80 herds, ranging from
6.67% to 100% positive pigs/herds (median=53.85%). Antibodies
against Yersinia spp. were detected in 1,111/1,187 pigs (93.60%
individual prevalence) from 80 of 80 herds, ranging from 26.67% to
100% positive pigs/herds (median=100%), with a cut-off OD% of
20. When a cut-off OD% of 40 was used, specific antibodies against
Yersinia spp. were detected in 970/1,187 pigs (81.72% individual
prevalence) from 80 of 80 herds, ranging from 13.33% to 100%
positive pigs/herds (median=86.67%). Different cut-off OD%s may
be used depending on the expected seroprevalence of the examined
pathogen. A high risk of infection posed by Salmonella spp. and/or
Yersinia spp. might be expected from the targeted population of this
study due to their high seroprevalence, however, microbiological
analyses are necessary to confirm the impact of these pathogens in
meat products.
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INTERANNUAL VARIABILITY ON
SEROPREVALENCE OF SALMONELLA SPP.
IN FREE-RANGE FATTENING PIGS IN
SOUTH SPAIN
Salmonella spp. is considered as one of the most important zoonotic
pathogens of swine. Despite of several attempts are being conducted
to control Salmonella prevalence there is still lack of studies to
improve control measures in pigs reared in outdoor systems. The aim
of this study was to evaluate the effect of interannual variability on
Salmonella seroprevalence at herd and individual levels in pigs reared
in free-range systems in South Spain. To carry out this study blood
samples from 10-15 animals/herd, from 40-62 herds, which belonged
to the same stockbreeding cooperative, were collected at the
abattoir. Serum samples were analysed to detect specific antibodies
against Salmonella spp. using the same commercial ELISA kit
(SalmotypePig Screen+E, Labor Diagnostik Leipzig, Leipzig, Germany;
cut-off >40%). The sample size was determined using Win Episcope
v.2.0 software on the basis of the number of samples required for a
previous unknown prevalence, assuming a 95% level of confidence
and an accepted error of 9%. The interannual variability was
calculated from samples collected during the same season (January-
April) from 2008 and 2011. In 2008, antibodies against Salmonella
spp. were detected in 136/620 pigs (21.94% individual prevalence)
from 48/62 herds (77.42% herd prevalence), ranging from 10% to
90% positive pigs/herd (median = 30%). In 2011, a marked increased
in Salmonella prevalence was observed both at individual (350/599
pigs; 58.43% individual prevalence) and herd level (40/40 herds;
100% herd prevalence), ranging from 6,66% to 100% positive
pigs/herd (median = 60%). The marked increased observed in the
seroprevalence of Salmonella in our study highlights the importance
of including interannual surveys on Salmonella seroprevalence in
free-range pigs, pointing out to the analysis of serum samples as a
useful tool for surveillance and control studies on Salmonella.
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SALMONELLAAND TOXOPLASMAANTIBODIES
IN FATTENING PIGS – COMPARISON
BETWEEN SERUM AND MEAT JUICE
Objective: Various commercial ELISAs to detect antibodies against
Salmonella spp. or Toxoplasma gondii are on the marked. Most of
them are validated for serum as well as meat juice. Aim of the study
was to compare the results of Salmonella and Toxoplasma gondii
antibody detection with ELISA in serum and meat juice in fatteners
at the slaughter.
Material and methods: Serum and meat juice of 1376 slaughter
pigs from 73 fattening farms were tested for antibodies against
Salomella spp. (PrioCHECK® Salmonella Ab porcine 2.0, Prionics) and
Toxoplasma gondii (PrioCHECK® Toxoplasma Ab porcine, Prionics).
Results: Six (6) farms (8%) had at least one pig with positive antibody
result against Salmonella in serum. Four of them were found positive in
meat juice, too. 19 farms (26%) were found positive for Toxoplasma
gondii antibodies. 11 of them showed also positive results in meat juice.
Salmonella antibodies in serum were found in 30 pigs (2.2%), in meat
juice of 23 pigs (1.7%), whereat 14 positive results were according.
Antibodies against Toxoplasma gondii were detected in 136 serum
samples (9,9%) and in 76 meat juice samples (5,5%), 70 of them
were according.
Strongly positive antibody results against both infectious agents in
serum were found more often corresponding with meat juice than
weak positive results.
Conclusions: Serum seems to be until now the most sensitive
medium for Salmonella and Toxoplasma antibody detection on farm
level as well as on individual level.
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EFFICACY OF A BLEND OF ENCAPSULATED
ACIDS AND ESSENTIAL OILS TO REDUCE
SALMONELLA CARRIAGE IN SLAUGHTERING
PIGS
Salmonella is one of the most frequent food borne zoonosis along
with Campylobacter. Organic acids are well known for their anti-
salmonella activity. The antimicrobial effect of specific essential oils
has also been proven. The aim of this trial was to evaluate the ability
of an encapsulated source of formic and citric acid along with a blend
of essential oils (FormaXOLTM) to reduce the rate of Salmonella
carrier pigs in a fattening farm. 600 pigs of 90 days of age were
allocated in the same barn and randomly split in two groups, control
and treatment. The control group received the commercial growing-
finishing diets, while the treatment group received the same diet with
FormaXOL at 4kg per tonne during the first 4 weeks. After this period
FormaXOL was included at 1kg per tonne of feed until slaughtering.
At arrival thirty pigs per group were sampled by rectal swab and bled.
All rectal swabs tested negative and only one pig of the treatment
group had antibodies versus Salmonella. At approximately 200 days of
age, environmental contamination was detected in various boxes of
both groups by pooled faecal sampling. At slaughtering, 30 mesenteric
lymph nodes and 60 blood samples were collected from both groups.
The rate of lymph node Salmonella carriers was 23/30 and 2/30 in
control and treatment group respectively (Fisher Exact Test, p<0,01).
The rate of sero-positive pigs was 58/60 and 51/60 in control and
treatment groups respectively. The difference between the two groups
was not significant but, interestingly, there was a different distribution
of S/P ratio with 18 and 8 pigs with S/P ratio >3 in control and
treatment group respectively. The results of this study confirm the
efficacy of the tested product in reducing the rate of Salmonella
carrier pigs at slaughter.
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LOOK NO HANDS! VISUAL INSPECTION
OF PIG CARCASES REDUCES MICROBIAL
CONTAMINATION
The focus of traditional methods of meat inspection is the detection
of gross lesions that make a carcass unfit for human consumption.
These methods are not always suitable for detecting some of the
important food-borne pathogens (e.g. Salmonellae and Yersiniae).
One supporting argument for a move to a visual-only inspection
system is that it could reduce the cross contamination of carcasses
that may occur via the hands and knives of meat inspectors. In this
study we compared the microbiological status of outdoor fattening
pig carcasses after both methods of inspection.
Microbiological samples were taken from a systematic random sample
of carcasses in a British abattoir, immediately after both inspection
points during a field trial of the visual inspection method. Samples
were processed for total aerobic plate and Enterobacteriaceae count
(indicators for the hygiene process), and Salmonella and Yersinia spp.
isolation.
No Salmonellae were isolated. Thirteen Yersiniae were isolated. There
was no statistical difference in the proportion of Yersinia contamination
of carcasses found and in the mean of the log10 of total aerobic plate
contamination of carcasses after the two inspection methods. There
was a statistically significant difference in the mean of the log10 of
the Enterobacteriaceae count when present; the level of contamination
of carcasses was lower after visual-only inspection compared to
traditional inspection.
The abattoir used for the field study had a particularly good hygiene
process with considerable attention being paid to procedures on the
line to ensure this. It is possible that a change in the inspection method
from traditional to visual would lead to a similar result in any abattoir
with a level of contamination as low as or higher than the study
premises. Measures used within this abattoir could be championed as
‘best practice’ for hygiene processes in other premises in the UK.
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PREVALENCE AND PREVENTION OF
PATHOGENIC YERSINIA ENTEROCOLITICA
ON PIG FARMS
Yersinia enterocolitica is a foodborne pathogen that causes human
yersiniosis. Symptoms include gastroenteritis with fever and diarrhoea.
Post-infectious sequela such as reactive arthritis, erythema nodosum
and uveitis are possible. Yersiniosis is the third most commonly reported
foodborne zoonosis in the EU. Pigs are considered the major reservoir
of Y. enterocolitica. The pathogen is carried to the slaughterhouses by
pigs that are already infected on farms. The contamination of pig
carcasses could be reduced by decreasing the presence of Y.
enterocolitica at farm level.
Faecal (n=1481), blood (n=334) and environmental (n=120) samples
were collected from 30 pig farms. Y. enterocolitica was cultured from
faeces and environmental samples. Yersinia antibodies were determined
from blood samples. Farm practices and conditions were recorded
during each sampling visit and their association with the presence of Y.
enterocolitica and Yersinia antibodies on farms were tested.
Y. enterocolitica was isolated from 67% and antibodies were detected
on 88% of farms. The presence of the pathogen varied significantly in
different age groups. No Y. enterocolitica was detected in piglets below
one month of age. Eighteen per cent of one to two months old piglets
excreted Y. enterocolitica in faeces, whereas 41% of two to three
months old and 26% of three to five months old pigs excreted the
pathogen. Only 16% of five to six months old finishing pigs and 4% of
sows excreted Y. enterocolitica. I n contrast, the level of Yersinia
antibodies was the highest in five to six months old finishing pigs (78%).
Buying pigs from no more than one supplier at a time, generous use
of bedding, using all-in all-out system in the weaning and fattening
units and the use of municipal water were discovered to be protective
factors against the presence of Y. enterocolitica. These factors should
be considered in prevention of Y. enterocolitica on farms.
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A REVIEW OF DISEASE INCIDENTS DUE
TO TOXICITY IN PIGS OVER THE LAST TEN
YEARS IN ENGLAND AND WALES
Disease events due to toxicity in pigs which are diagnosed by the
Animal Health and Veterinary Laboratories Agency (AHVLA) raise
concerns regarding food safety. A risk assessment is undertaken taking
into consideration the toxic substance identified and whether the
exposed pigs are destined for the food chain. Incidents are reported to
the Food Standards Agency and, where appropriate, voluntary
restrictions are applied requiring withdrawal from the toxic substance
and a specified time to elapse before pigs can be slaughtered for
human consumption. Between 2002 and 2012, 22 separate disease
incidents due to toxicity were diagnosed in pigs submitted to AHVLA.
The majority of incidents were due to plant poisoning with bracken
toxicity (Pteridium aquilinum) being most common. Bracken poisoning
in pigs usually results from exposure over a prolonged period and is
due to the thiaminase toxic component. It causes a cardiomyopathy
and heart failure and post-mortem findings reflect this with pulmonary
oedema, pleural effusion and, sometimes pallor of the myocardium.
Clinical signs may be predominantly respiratory distress and dyspnoea
but, in many cases, pigs were found dead without signs having been
seen. The second most common cause of toxicity is coal tar in which
phenol is the main toxin and causes a hepatopathy and non-specific
clinical signs including malaise, inappetance and deaths, sometimes
widespread. The sources of coal tar included road waste, roofing
materials, tar flooring and clay pigeon remnants. Perhaps surprisingly,
anticoagulant rodenticide poisoning is rarely diagnosed. Risk factors
for poisoning include keeping pigs outdoors in less controlled
paddocking than used in large commercial pig herds, with access to a
wider range of wild plants in woodland or rough grazing. Cases are also
seen where owners have fewer stockmanship skills and unwittingly
allow pigs access to toxic materials.
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PK/PD OF FLORFENICOL ADMINISTERED
ORALLY AGAINST COMMON SWINE
PATHOGENS
Objective: The objective of the paper was to compare the
pharmacokinetics (PK) of florfenicol (Florvio ™ – Novartis Animal Health
Inc.) administered orally by gavage and in the drinking water with the
pharmacodynamics (PD) of various common swine pathogens.
Materials and methods: The PK of florfenicol administered by capsule
(1) at 15mg/kg bwt showed the product was very well absorbed giving
a Concentration maximum (Cmax) of 14.8µg/ml and Area under the
curve (AUC 24h) of 100.5µg/ml. When administered in drinking water
(2) for 3 days at 100 and 150ppm (approximately 10-15mg/kg bwt)
the AUC 24h for day 1, 2 & 3 at 100ppm was 28.3, 25.7 and
21.6µg.h/ml and 29.8, 27.6 and 22.9µg.h/ml at 150ppm. This was
surprising, as there was comparatively little difference between the
100ppm and 150ppm florfenicol treated pigs (6.2%). The AUCs were
far lower than the single oral dose with a mean at 100ppm of
25.2µg.h/ml (25.1%) and a mean at 150ppm of 26.8µg.h/ml (26.6%
of the oral gavage figure), associated with a marked drop in water
intake. The mean Concentration steady state (Css) for 100ppm over 3
days was 1.05µg/ml and at 150ppm 1.12µg/ml. The PD for florfenicol
(3) showed the MIC50 and MIC90 for Actinobacillus pleuropneumoniae
and Haemophilus parasuis to be 0.25 and 0.5µg/ml for both,
respectively; for Pasteurella multocida, 0.5 and 0.5µg/ml, respectively
and for Streptococcus suis 2.0 and 2.0µg/ml, respectively.
Results and conclusions: Florfenicol administered at 100ppm in the
drinking water reached concentrations in excess of the MIC90 for A.
pleuropneumoniae, H. parasuis and P. multocida but not the MIC50
and MIC90 for S. suis.
References: 1. Voorspoels et al., 1999. Vet. Record, 145, 397-399. 2.
Gutierrez et al., 2011. J. Anim. Sci.89, 2926-2931. 3. Zolynas, et al.,
2003. Proc. AASV Meeting, Orlando, Florida, USA, pp 211-214.
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PK/PD OF TIAMULIN ADMINISTERED BY
INJECTION AGAINST COMMON SWINE
JOINT PATHOGENS
Objective: The objective of the paper was to compare and contrast
the pharmacokinetics (PK) of tiamulin (Denagard 200 Injectable –
Novartis Animal Health Inc.) in joints with the pharmacodynamics
(PD) of various common joint pathogens.
Materials and methods: The PK of tiamulin given by injection at
15mg/kg bodyweight in the plasma and joint fluid of young piglets
were previously reported (1, 2). Areas under the curve (AUC24h) of
17.4 and 11.2µg.h/ml (64%) were calculated for plasma and joint
fluid respectively (1, 2). The Concentration maximum (Cmax) were
1.64 and 0.77µg/ml and Concentration steady state (Css) were 0.73
and 0.47µg/ml for plasma and joint fluid respectively. The MIC90 for
Mycoplasma hyosynoviae and Mycoplasma hyorhinis were recorded
at 0.025 and 0.25µg/ml, respectively (3). The MIC50 and MIC90 for
Streptococcus suis, a common bacterial joint pathogen in piglets,
were 1.0 and 2.0µg/ml (4) and for Haemophilus parasuis (UK
isolates) were 4.0 and 16µg/ml (5), respectively.
Results and conclusions: The MIC90s for M. hyosynoviae and M.
hyorhinis were well below the Css for tiamulin in joint fluid and with
AUC/MIC90 figures of 448 and 45h, respectively, showing a strong
inhibition of both Mycoplasma spp, especially M. hyosynoviae.
However, it is considered unlikely that tiamulin would reach inhibitory
joint concentrations for the MIC50s or MIC90s of S. suis and H. parasuis
at this dosage rate in young piglets.
References:
1. Klein et al., 2012. Proc. 22nd IPVS Congress, Seoul, S. Korea,
p715. 2. Klein et al., 2012. Proc. 22nd IPVS Congress, Seoul, S.
Korea, p719. 3. Hannan et al., 1997. Antimicrob. Agents &
Chemother., 41, 9, 2037-2040. 4. Martel et al., 2001. Vet.
Microbiol., 83, 287-297. 5. Martin de la Fuente et al., 2007. Vet.
Microbiol., 120, 184-191.
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COMPARATIVE EFFICACY OF ZUPREVO 4%®
IN THE EARLY TREATMENT OF H. PARASUIS
INFECTION
The aim of this study was to evaluate the field effectiveness of
Tildipirosin (Zuprevo 4%) as early treatment in the control of
H.parasuis infection, but also to evaluate its efficacy and profitability
in comparison with Tulathromycin.
The trial was undertaken in a closed herd of 1200 sows. All piglets
were vaccinated against MHyo (one dose vaccine, 10d of age) and
against PCV2 (18-20d, just before weaning). The farm had a known
history of Glässer’s Disease affecting piglets 7-10 days post-weaning.
All piglets were injected on a regular basis at 18-20 days of life with
0.15ml of Draxxin®. Although clinical symptoms improved, results
were not totally satisfactory. It was decided to change antibiotic
therapy, and all piglets weaned after June 2012 were treated with
0,5ml of Zuprevo 4%® at weaning. The performance of a total of
12198 piglets treated with Zuprevo® was compared with animals
treated with Tulathromycin (12630 piglets). No significant difference
in production data before weaning was detected, so the two study
groups were considered to be comparable.
Mortality during the weaning period was compared between groups
(Levene test and Pearson’s chi-square test).
Results: The animals treated with Zuprevo showed a significant
reduction in mortality rate compared to the ones treated with
Tulathromycin. (0.9% Mt Zuprevo group vs 2.4% Mt Tulathromycin
group; p<0.001). The percentage of culls was also reduced. Additionally,
while in the tulatromycine group 70 of the animals should receive an
extra antibiotic treatment (amoxiciclyne or enrofloxacine), only 10-
30% of the animals of the Zuprevo® group required extra treatment.
Conclusions: An economic model taking account only the differences
in mortality yielded a financial benefit of treating with Zuprevo® instead
of tulatromicyn of €0,42/pig, including the cost of the product.
Zuprevo 4% was shown to be an effective and profitable investment
to control H.parasuis infections.
NOTES
P163
S. Hillen1, H. Willems1, G. Baljer2, W. Herbst2, J. Rohde3 and G. Reiner1
1 Department of Veterinary Clinical Sciences, JLU Giessen, Germany;
2 Institute for Hygiene and Infectious Diseases of Animals, JLU Giessen,
Germany;
3 Institute for Microbiology, Department of Infectious Diseases, University
of Veterinary Medicine, Hannover, Germany.
MUTATIONS IN L3 AND 23S RRNA OF B.
HYODYSENTERIAE FIELD ISOLATES
ARE ASSOCIATED WITH MINIMUM
INHIBITORY CONCENTRATIONS (MIC)
OF PLEUROMUTILINS
Objectives: The causative agent for swine dysentery, Brachyspira
hyodysenteriae (B. hyo), is responsible for severe mucohaemorrhagic
colitis with considerable financial loss in worldwide swine production.
Recent investigations show increasing resistance to Pleuromutilins,
resulting from excessive medication and prophylaxis – often without
adequate diagnostics. Pleuromutilin resistance involves alterations of
the peptidyl transferase center (PTC) of the ribosomes and the
ribosomal protein L3 by methylation and point mutation. Knowledge of
the underlying mechanisms might lead to efficient molecular resistance
testing for a faster and more efficient diagnostic in the future.
Material and methods: We studied mutation patterns in ribosomal
proteins L3, L2, L22, L4 and in sequences of the 23S rRNA involved
in the PTC. A set of 64 German field isolates, collected between 1990
and 2011 were included. MICs were determined by the broth dilution
method. Single nucleotide polymorphisms (SNP) and combinations
were associated with minimum inhibitory concentrations (MIC).
Results:We identified 4 SNPs in L3 and 13 SNPs in 23S rRNA of the
64 strains. One of the L3 SNPs and one of the 23S SNPs were
significantly associated with MICs for Pleuromutilins. Combined, these
SNPs explained 80 percent of MIC variation, with respect to a threshold
of 0,625µg Tiamulin/ml. SNPs in L2, L4 and L22 were silent mutations.
Conclusion:We identified significant associations between two SNPs
– one in 23S rRNA, one in L3 – and their combinations and the MICs
of Pleuromutilins. The explanation of 80% of MIC variation implies
further mechanisms of resistance in B. hyo. Together with mutations
published by other groups, but not present in the recent strains, our
data suggest distinct sets of mutations as the molecular basis of
Pleuromutilin resistance. Such patterns could be used by next
generation diagnostic tools to provide a closer link between B. hyo
diagnostics and antibiotic therapy.
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IN VITRO STUDY, MINIMUM INHIBITORY
CONCENTRATION OF PORCINE
MYCOPLASMAS TO SIX ANTIMICROBIALS
This study aimed to evaluate the MIC of 209 porcine mycoplasma
strains to their six drugs of choice including doxycycline, enrofloxacin,
lincomycin, tiamulin, tylosin, and valnemulin. The MICs were carried
out using broth micro-dilution method. The test concentration
ranged from 0.006-12.5µg/ml for lincomycin, tiamulin, tylosin, and
valnemulin, and from 0.048-100µg/ml for doxycycline and
enrofloxacin. Result showed the highest MIC90 to enrofloxacin at
25µg/ml, the resistant rate (%) was 38.3% (80/209). Tylosin was the
highest resistant antimicrobial to Mycoplasma spp. at 40.2%
(84/209) with the MIC90 at 12.5µg/ml. Its maximum range of MIC
was exceed at >12.5µg/ml. Doxycycline and lincomycin were the
susceptible antimicrobials to the tested isolates with lower resistant
rate at only 2.9% (6/209) and 5.3% (11/209), and MIC90 at 6.25
and 3.12µg/ml, respectively. The highest MIC value to doxycycline
was 25µg/ml while the highest value to lincomycin was exceed the
highest concentration in the test (>12.5µg/ml). All tested
mycoplasmas were susceptible to tiamulin and valnemulin, the
members of pleuromutilin group, Furthermore, the lowest MIC90 to
valnemulin was 0.024µg/ml, while that of tiamulin MIC90 was
0.78µg/ml. The MIC90 to pleuromutilin antimicrobials was less than
1µg/ml to all mycoplasmal strains from this study. In conclusions,
Porcine mycoplasmas were most susceptible to Pleuromutilins,
tiamulin and valnemulin, without any resistance. Mycoplasma spp,
showed more resistant to tylosin and enrofloxacin.
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MYCOPLASMA HYOPNEUMONIAE
ERADICATION IN A 800 SOW HERD BY
PARTIAL DEPOPULATION AND MEDICATION
WITH TYLVALOSIN (AIVLOSIN®),
TULATHROMYCIN (DRAXXIN®) AND
TIAMULIN
Objective: Eradication of M. hyopneumoniae from an 800 sow
nucleus herd. Three elements were considered crucial1: avoidance of
reinfection by biosecurity improvements, only pigs (except suckling)
older than 11 months and medication.
Tylvalosin was selected for oral antibiotic medication due to its
mycoplasmacidal activity at close to MIC level2. Injectable
tulathromycin and tiamulin were selected to increase success rate3.
Materials and methods: The farm is in Spain with weaned piglets
and replacement animals on-site. Barrows and the remaining gilts
are reared off-site.
The property was double fenced surrounded with an extra vegetation
border to prohibit wild boars approaching the farm. A closed corridor
was constructed connecting the farm with an external loading bay to
prevent any contact with outside. In August 2011 800 sows, suckling
piglets and 300 replacement gilts (>11 months) were on-site. For 8
weeks all weaners, finishers and replacement gilts were taken off-
site. Buildings were cleaned and disinfected with peracetic/peroxide
and 4 weeks later quaternary ammonium compound. Slurry pits were
cleaned with caustic soda.
All animals received 2,125mg/kg BW tylvalosin in-feed for 4 weeks.
Tulathromycin 2,5mg/kg BW was given to piglets (D3/17 days of age)
and sows (twice, 15 days apart) Sows at farrowing and with reduced
appetite received 9 mg/kg BW tiamulin. Success was based on lung
checks (100/month), PCR on lungs (321 in 2011 and 30/month in
2012) and ELISA serology (389 in 2011, 22/month in 2012)
Results: No clinical signs of Mh, i.e. coughing, have been observed in
14 months following the programme and all PCR and ELISA tests and
lung checks have been negative.
Discussion: The farm is considered Mh negative. The combination
of oral (tylvalosin) and injectable (tulathromycin/tiamulin) treatment
proved to be effective in eradicatingM.hyopneumoniae.
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STUDY OF EFFICACY AND SECURITY
OF ZUPREVO 40MG/ML (TILDIPIROSIN)
APPLIED TO TREATMENT OF PIG
RESPIRATORY COMPLEX
We study the efficacy and safety of ZUPREVO 40 mg/ml intramuscular
inject for early treatment of piglets with Respiratory Complex after
weaning on commercial closed 1.400-sow farm positive to Pasteurella
multocida, Bordetella bronchiseptica, Haemophilus parasuis y
Streptococcus suis. All piglets are vaccinated to Mycoplasma
hyopneumonia and Porcine Circovirus before weaning.
The trial was carried out over two groups of piglets in the same
weaning week. First with treatment at weaning (300) and second
without treatment (159). Our study involve 5 weeks period time after
weaning, and take some different parameters each week: mortality,
PIEC index, failure treatment, piglets way out, piglet treatment, life
weight and relapse. No adverse effects of treatment were observed in
any of the treated piglets.
Zuprevo piglets group obtain positive statistical significant difference
around weight increase time (6,55 vs 6,16kg), average daily gain (191
vs 161g), mortality rate (4,33 vs 10,06%), retired piglets (13,33 vs
27,04 %), index of treatment (1/3,90 vs 1/1,82), PIEC index (1,22 vs
1,41), failure piglets (1 vs 1,67 %) and relapse piglets (5,33 vs 26,42%).
Zuprevo 4% was shown to be safe and efficacious for the early
treatment of an acute outbreak respiratory complex disease, with
statistically significant improvements over the untreated piglets. The
constant effects over 35 days of the trial demonstrated the excellent
duration of product action.
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SOLUBILITY AND STABILITY OF VARIOUS
CONCENTRATIONS OF FLORFENICOL IN
LIQUID FEED FOR PIGS
The use of liquid feed for pigs has increased world-wide during the last
decade. In the European Community, it has been estimated that around
30% of finishing pigs are fed liquid diets. The administration of
antibiotics through liquid feed is a common practice when medicating
pigs, however little is known about the behaviour of antibiotics in such
feed preparations. The aim of the present study was to evaluate the
solubility and stability of various concentrations of florfenicol (2.3%
oral solution, SELECTAN® ORAL), in liquid feed for pigs.
Four samples of liquid feed (dry feed, feedstuffs, water) were prepared.
Each sample had a different concentration of florfenicol (FFC) taking
into account: 1) a medication of a 20kg b.w. pig with 10 mg FFC/day;
2) the different possibilities of use of liquid feed in pig farms. The four
FFC concentrations tested were: C1 (change of soup every 24 hours)
= 0.06 g/L; C2 (change of soup every 12 hours) = 0.13 g/L; C3 (change
of soup every 8 hours) = 0.20 g/L; C4 (change of soup every 6 hours)
= 0.26 g/L. After preparation of the medicated soups, samples were
taken at 0, 2, 4, 6 and 24 hours (h) to determine the FFC concentration
by HPLC. The recovery of FFC in the different soups were: C1: 0h =
97.6%; 2h = 95.8%; 4h = 101.6%; 6h = 97.4%; 24h = 97.2%; C2: 0h
= 96.7%; 2h = 98.6%; 4h = 100.0%; 6h = 96.8%; 24h = 95.9%; C3:
0h = 100.0%; 2h = 101.9%; 4h = 100.4%; 6h = 101.8%; 24h =
101.1%; C4: 0h = 99.7%; 2h = 100.2%; 4h = 99.6%; 6h = 99.7%; 24h
= 99.7%. The FFC remained soluble and stable (96-100% recovery) in
the liquid feed for 24 hours regardless of its initial concentration.
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ERADICATION OF MYCOPLASMA
HYOPNEUMONIAE IN A 2,450 MULTIPLIER
SOW HERD USING TYLVALOSIN (AIVLOSIN®)
WITHOUT PARTIAL DEPOP-REPOP
Objective: To eradicate M. hyopneumoniae (Mh) using tylvalosin
medicated feed in a 2450 multiplier sow, with replacement gilts
(from 10 weeks of age onwards) on-site and pigs weaned off-site,
without production stop or partial depop-repop.
Materials and Methods – Pre-medication actions: All sows received
a 1-shot Mh vaccination (Stellamune One, ELANCO). The number of
replacement animals was increased to prolong the period before new
animals entering the farm to 2 months. Biosecurity was reviewed. All
unhealthy and non-productive animals were culled.
Medication: Animals received feed containing tylvalosin at 2.125
mg/kg BW for 28 (sows) or 56 (replacement gilts) days. Sows with
reduced feed-intake and all suckling piglets were injected with
tulathromycin (2.5mg tulathromycin per kg BW)
Results: No clinical signs of Mh (coughing) for 14 months after
eradication. Blood samples taken 1 year after eradication (27
sentinels and 72 young sows born after eradication) tested negative
using Mycoplasma hyopneumoniae Antibody Test Kits (BioChek BV,
Netherlands).
Discussion: It was concluded that the Mh eradication on a herd level
was successful using medication without (partial) depop-repop.
Besides the benefits of cost reduction (Mh vaccination, improved
FCR, reduced medication cost) due to eradication of Mh1 and
treatment of Lawsonia intracellularis2, the major component on
PRDC (Mh) is eradicated from this complex giving an additional
benefit on the overall health status and performance on the farm.
1 Marco, 2008, Reduction in production costs after an eradication of
Mycoplasma hyopneumoniae with tylvalosin from a sow farm, 20th
IPVS, 809
2 Miljkovic et al, 2010, Field Evaluation of the Effect of Aivlosin®
(Tylvalosin) for the Control of Porcine Proliferative Enteropathy using
two Dosing Regimens. 21st IPVS, P.411
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THE EFFECT OF ANTIMICROBIAL
SUBSTANCES ON THE OUTER MEMBRANE
OF GRAM-NEGATIVE BACTERIA AND THEIR
EFFICACY IN WEANING PIGS
The outer membrane (OM) of gram-negative bacteria protects cells
from external agents. Permeabilisers destabilise the OM and increase
the permeability of the OM to other antimicrobials. The potential of
a permeabiliser (PS) (Biomin® Per4izer, BIOMIN, Austria) to weaken
OM was tested in in-vitro trials. An increase in the uptake of a
hydrophobic probe, 1-N-phenylnaphthylamine was used to measure
permeabilisation of OM. The PS was shown to effectively destabilise
the OM of Salmonella typhimurium and E.coli.
The effect of the mixture of organic acids, cinnamaldehyde and PS
(ACPS) in-vivo was tested in weaning pigs. Growth performance, the
pH in the gastro-intestinal tract (GIT), microbial population in the
ileum and villus height in the jejunum was determined. Ninety-six
weaning pigs were assigned to three treatments and fed commercial
diets. The negative control group diet contained no feed additives,
whereas the positive control group was supplemented with
antibiotics Colistin (100 g/t) and Chlortetracycline (100 g/t). The trial
group was fed ACPS (1kg/t). Results showed that at the 56th day of
trial, body weight, average daily gain and feed intake were higher in
the trial group compared with the two control groups. The pH of
digesta collected from the stomach was lower in the group fed ACPS
in comparison with the control groups. Microbial analysis showed
that the number of E. coli and Salmonella spp. in the ileum of pigs
were reduced in the groups fed ACPS and antibiotics in comparison
with the negative control. Counts of Lactobacilli and Bifidobacteria
in the ileum were higher in the trial group than in the other two
groups. The villus height in the jejunum was greater in the positive
control group and in the trial group in comparison with the negative
control. In conclusion, ACPS positively influenced the intestinal
microbiota and growth of weaned pigs.
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FIELD EFFICACY OF FORCYL® SWINE FOR
THE TREATMENT OF METRITIS-MASTITIS-
AGALACTIA (MMA) SYNDROME IN SOWS
An international, multi-centre, randomised, blinded, parallel design field
study was performed, assessing the efficacy and safety of Forcyl® Swine
in the treatment of Metritis-Mastitis-Agalactia (MMA) syndrome in
sows. Eleven farms in France, Spain and Germany were included.
Recently farrowed sows were selected with clear signs of MMA
(hyperthermia, appetite loss, mammary inflammation and/or vulva
discharge). The study included 155 sows and they received either
Forcyl® Swine (1 injection, 8 mg/kg), or Marbocyl® 10% (3 injections,
2 mg/kg 24h apart). Depending on the affected organ, milk and/or
uterine secretions were sampled (D0 and D4), to appraise the
bacterial aetiology of the syndrome. Sows were clinically monitored
daily (D0 to D4, then D7).
At D4, therapeutic response was observed as 90.2% (Forcyl® Swine
group), and 90.4% (Marbocyl® 10% group) (p<0.001 for non-
inferiority testing). Respectively, 73.2% and 71.2% (Forcyl® Swine,
Marbocyl® 10%) of sows treated were deemed cured on D4. All
clinical parameters improved similarly in both treatment groups. No
relapse was observed during the study. Average daily weight gain of
piglets was 185.4g in Forcyl® Swine group and 190.7g in Marbocyl®
10% group (not statistically significant, p=0.06).
On D0, Staphylococcus spp. was particularly isolated for milk (38.5%
of samples) whereas E. coli was the main isolate found from uterine
secretions (36.1%). On D4, E.coli strains were found in only 3.1% of
milk samples and in 30.1% of uterine secretions samples.
No adverse event was observed with Forcyl® Swine throughout
the study.
In conclusion, a single injection of Forcyl® Swine at 8 mg/kg revealed
efficacious and well tolerated in the treatment of MMA syndrome
in sows.
NOTES
P171
Luis Sanjoaquín1, V.Rodrigez-Vega2, S.Figueras2, T.Coll2, I. Hernández-Caravaca2
1 Swine Vet. Consultant. Spain;
2 Boehringer-Ingelheim España. Spain.
POST FARROWING TREATMENT OF SOWS
WITH ORAL MELOXICAM (METACAM®
15MG/ML ORAL SUSPENSION FOR PIGS)
OR INJECTABLE KETOPROFEN FOR
SUBCLINICAL MMA : COMPARISON OF THE
PIGLET WEIGHT GAIN DURING LACTATION
Introduction: In previous field studies, Oral Metacam® 0.4 mg/kg
b.w (Boehringer Ingelheim Vetmedica GmbH) has proven to be
effective in the treatment of MMA.
The aim of this study was to compare the convenience and the
efficacy of the use of a single administration of Metacam® 15 mg/ml
oral suspension for pigs (Oral Metacam®) versus other injectable
NSAID (ketoprofen 10%) on sows and in piglet performance.
Material and methods: The field trial was conducted on one farrow-
to-wean farm (750 sows) located in the northeast of Spain. Overall,
87 sows were randomly allocated the day of farrowing (d0) in two
homogeneous groups regarding parity, number of piglets per sow and
weight at birth.
One group (n=44) was given 0.4 mg/kg b.w of Oral Metacam®
directly into the mouth of the sow on the day of farrowing. The other
group (n=43) was treated with ketoprofen 3mg/kg b.w. intramuscular.
Different parameters were evaluated: Average daily gain (per litter),
body weight (at weaning) and mortality parameters (n= 1144 piglets).
Results: Total piglet mortality rate up to weaning was lower in the
Oral Metacam® group (14,2% vs.15,9%, p>0.05). This slight difference
in mortality could be due to less piglet crushing rate immediately
after the treatment.
Piglets from sows treated with Oral Metacam showed a higher ADG
compared to the piglets of ketoprofen group (0.238 vs.0.226 g,
respectively; p<0.05). This resulted in a higher weight at weaning in
Metacam group compared to the piglets of ketoprofen group (6.02
vs. 5.717kg, respectively; p<0.05).
Conclusions: This new oral meloxicam presentation reduces the
number of injections during the farrowing period and result in
additional benefits for sow welfare.
Regarding efficacy, Oral Metacam® treatment in sows significantly
increased the pre-weaning piglet ADG and the weight at weaning
compared to ketoprofen 10%.
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OPTIMAL SYNERGY BETWEEN
TRIMPETHOPRIM AND
SULPHAMETHOXASOLE IN COMBINATION
FOR ORAL ADMINISTRATION VIA DRINKING
WATER FOR PIGS AND POULTRY
Introduction: The aim of this study is to show that plasma time
curves of TMP and SMX in poultry and swine show a similar pattern,
which would be an prerequisite for the synergy to occur to the
maximum extent
Materials and methods: In order to determine the pharmacokinetic
properties of the TMP SMX combination following oral administration
through the drinking water to pigs a study was performed at RIKILT.
Following a controlled drug free period, twenty-two pigs (inclusive 2
reserves) received medicated drinking water ad libitum for 4 days at
a target dosage of 25 mg TMP/SMX (Methoxasol, REG NL 109720
Eurovet Animal Health BV) per kg body weight per day.
Heparinised blood samples were taken from 8 pigs at regular time
points hours after start of medication and at 3, 6, and 12 h after
cessation of medication and analysed by HPLC.
The HPLC methods were validated according to EU guidelines. The
limit of quantification of the HPLC method for TMP was 25 ng/g for
plasma. The limit of quantification of the HPLC method for SMX was
50 ng/g for plasma. A similar exercise was performed with poultry.
Conclusion: Following water medication of Methoxasol at an
intended dosage of 25 (swine) to 33 (broiler) mg TMP/SMX/kg/day
during 4 consecutive days, a fast absorption of TMP and SMX
occurred revealing a steady state plasma concentration within 9-12
h after start of medication. The medication induced no clinical
noticeable side effects. Following cessation of medication a fast
decrease in plasma TMP and SMX concentrations was observed.
With this finding is it shown that pharmacokinetic patterns of both
TMP and SMX are very similar both in swine and poultry and that
both actives are cleared from plasma relatively fast, leaving no room
for single component blood levels inducing resistance.
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MONTECARLO APPROACHES TO PREDICT
THE TREATMENT EFFICACY OF RESPIRATORY
DISEASE WITH FLORFENICOL IN PIGS
Antimicrobial drugs have been classified as concentration-dependent
or time-dependent. The concentration-dependent are those where
increasing concentrations at the locus of infection improve bacterial
kill. The time-dependent are those where exceeding the minimum
inhibitory concentration (MIC) for a percentage of the inter-dosing
interval (T>MIC) correlates with clinical efficacy. Florfenicol is an
antimicrobial widely used in swine medicine that has been described
as concentration or time-dependent relying on the bacterial species
involved. Montecarlo approaches involve the use of computer
software, via simulation platforms, to provide predictions of the
achievement of therapeutic targets.
A model was developed to predict the likelihood of attainment of
the Pharmacokinetic (PK)/Pharmacodynamic (PD) parameters that
determines florfenicol efficacy on Actinobacillus pleuropneumoniae
(APP) and Pasteurella multocida (PM). Area under the curve
(AUC)/MIC over 50 and T>MIC 40% of the dose interval are the
PK/PD parameters to be associated with antibacterial efficacy
according to the literature for florfenicol. For this analysis, Montecarlo
simulations were performed using the pharmacokinetic data
calculated for Selectan® (HIPRA) and the MICs for Actinobacillus
pleuropneumoniae and Pasteurella multocida published in the
scientific literature. The software used for the simulations was
CrystalBall Software (V. 11.1.2.0.00; Oracle Corporation,
RedwoodShores, CA, USA). After running the model, the probability
of clinical success, using the AUC/MIC>50 and the T>MIC 40% of
the dose interval as a threshold values, were 90% and 94.7% for APP
and 87.7% and 94.2 for PM, respectively. In conclusion, it is highly
probable that the antibiotic treatment with florfenicol of pig
respiratory disease due to APP and PM would be efficacious.
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FLEXIBLE POLYMER AND EMULSION
ADJUVANTS FOR COMBINED LIVE AND
INACTIVATED SWINE VACCINES
Introduction: Live vaccines are widely used in pig farming practice
and are usually not adjuvanted. We have shown previously that the
addition of polymeric or oil in water emulsion adjuvants in a PRRS
live vaccine enhanced the protection to challenge of vaccinated
animals, and allowed to reduce the antigenic load of such vaccine. In
this study we show that these adjuvants can also allow the
formulation of efficient combined inactivated/live vaccines for swine
against Swine Influenza and Aujeszky’s disease.
Methods: Inactivated vaccines against Swine influenza (SIV) were
formulated with polymer adjuvant Montanide™ Gel 01 (Gel),
emulsion adjuvant Montanide™ ISA 15A VG (15A) or without
adjuvant. A non vaccinated group was used as negative control. At
day 0, 10 seronegative pigs (15kg) were vaccinated in each group
intramuscularly in the neck simultaneously with 2ml of inactivated
SIV vaccine and 2ml of Aujeszky’s disease attenuated live vaccine.
Efficacy was followed by antigen specific ELISA and by a challenge
procedure against Aujeszky’s virus and SIV (day 42). After challenge
clinical signs were followed, nasal viral loads and bacterial over-
infections of the lungs were scored.
Results: All vaccines tested were safe. Antibody titers and protection
to challenge against SIV was significantly superior for Gel or 15A
adjuvanted formulations compared to the non adjuvanted vaccine.
Protection conferred by the attenuated part of the vaccine was not
reduced by the presence of either adjuvant. Moreover, viral shedding
after Aujeszky’s challenge was reduced in the Gel group.
Conclusions: These results show that relevant aqueous adjuvants
such as Montanide™ Gel 01 or Montanide™ ISA 15A VG are
compatible with both inactivated and attenuated viral vaccines for
swines. Such adjuvants allow the formulation of multivalent combined
inactivated/live vaccines. Such combined vaccines can allow the
reduction of the number of injections given to pigs in the field.
NOTES
P175
Peggy De Backer1, Eva De Jonghe1, Guy Cluydts1
1 SCS Boehringer Ingelheim Comm.V, Brussels, Belgium.
FIELD EXPERIENCE USING A NEEDLE-FREE
DEVICE FOR INTRAMUSCULAR INJECTION
OF A PCV2/M HYO VACCINE MIXTURE
COMPARED TO CONVENTIONAL INJECTION
WITH A NEEDLE
Needle-free devices offer various advantages compared to
conventional needles including a reduced risk of haematogenous
spread of pathogens and no risk for broken needles. On the other
hand, the high pressure that is applied to vaccines when injected
needle-free might have a negative impact on vaccine efficacy. While
efficacy of the mixture of Ingelvac CircoFLEX® and Ingelvac
MycoFLEX® (referred to as FLEXcombo®) with conventional needles
and syringe has been demonstrated extensively, little information is
available on the use with needle-free devices. This study compared
the performances of pigs vaccinated against PCV2 and Mycoplasma
hyopneumoniae (M hyo), either using a needle-free device or a
conventional needle, under field conditions on a Belgian farm,
positive for M. hyo and PCV2.
Piglets were vaccinated and weighed the day of weaning (~21.4
days) with FLEXcombo®. In total, 329 piglets were vaccinated i.m.
with a syringe and needle and 330 piglets were vaccinated i.m. with
a needle-free injection device. Ten piglets were left unvaccinated as
controls, and were blood sampled at 16 and 21 weeks of age.
Individual carcass weights were recorded per treatment group.
Serology in the control pigs confirmed challenge with PCV2 and M
hyo. No significant differences were observed between the treatment
groups with regard to weights, growth days or mortality.
Under the conditions of this study pigs vaccinated i.m. with a full
dose (2ml) of FLEXcombo® using a needle-free device performed as
well as pigs vaccinated with a syringe and conventional needle on a
farm challenged with PCV2 and M hyo. This indicates that the efficacy
of FLEXcombo® was not impaired by the high pressure used when
applying the vaccine needle-free. Based on practical experience,
special care needs to be taken with needle-free vaccinators to ensure
that the device is used properly and a full dose of vaccine is applied.
NOTES
POSTER PRESENTATIONS: THERAPEUTICS – VACCINES
189
P176
Camprodon A., Gibert X., Montané J., Perozo E., March R., Maldonado J.
HIPRA, Amer-Girona, Spain.
EFFICACY OF SUISENG® AND RHINISENG®
WHEN COMBINED IN A SINGLE INJECTION
IN GILTS
Objective: The aim of the present study was to compare the
serological responses after vaccination of the vaccines Suiseng® and
Rhiniseng®, against neonatal diarrhoea and atrophic rhinitis of swine,
respectively, when they are mixed together and injected in gilts, in
comparison with the injection of these two vaccines separately.
Materials and methods:Twenty-four eight-month old gilts, clinically
healthy and free from antibodies against Pasteurella multocida toxin
(PMT), Bordetella bronchiseptica (Bb), and main pathogenicity factors
of Escherichia coli, were randomly assigned to 4 groups of 6 each.
Groups 1-3 were vaccinated twice intramuscularly 3 weeks apart
with Suiseng® and Rhiniseng® mixed together (4ml), with Suiseng®
alone (2ml), or with Rhiniseng® alone (2ml). Group 4 received a 2ml
injection of sterile PBS (placebo). Animals were bled on day 0 (when
the first dose was applied), 3 weeks later (when the second dose was
applied) and 3 weeks afterwards. Serum samples were stored at
-20°C until testing. The serological methods used were: i) a
commercially available ELISA assay for the detection of antibodies
against Pasteurella multocida dermonecrotic toxin; ii) the micro-
agglutination test for Bordetella bronchiseptica; iii) and in-house
ELISA assays for the detection of antibodies against relevant
Escherichia coli fimbrial adhesins, and heat labile toxin.
Results and conclusions: There were no significant differences in
the seroconversion against PMT and Bb, when compared the
combination of Suiseng® and Rhiniseng® to the group of Rhiniseng®
alone. Similarly, no significant differences were observed in the
seroconversion against E. coli when compared the combination of
Suiseng® and Rhiniseng® to the group of Suiseng® alone. These
results indicate that Suiseng® and Rhiniseng® can be combined, and
administered in a single injection to adult pigs, without involving a
negative effect in efficacy, as measured by the serological response
against all the antigens contained in the two vaccines.
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SAFETY OF SUISENG® AND RHINISENG®
WHEN COMBINED IN A SINGLE INJECTION
IN GILTS
Objective:The aim of the present study was to asses both local and
systemic safety of the vaccines Suiseng® and Rhiniseng® against
neonatal diarrhoea and atrophic rhinitis of swine, respectively, when
they are mixed together and injected in gilts, in comparison with the
injection of these two vaccines separately.
Materials and methods:Twenty-four eight-month old gilts, clinically
healthy and free from antibodies against Pasteurella multocida toxin
(PMT), Bordetella bronchiseptica (Bb), and main pathogenicity factors
of Escherichia coli, were randomly assigned to 4 groups of 6 each.
Groups 1-3 were vaccinated twice intramuscularly 3 weeks apart
with Suiseng® and Rhiniseng® mixed together (4ml), with Suiseng®
alone (2ml), or with Rhiniseng® alone (2ml) following manufacturer’s
instructions. Group 4 received a 2ml injection of sterile PBS. Body
temperature, local and systemic reactions to vaccination were
evaluated and recorded.
Results: None of the two vaccines administered alone or in
combination, caused abnormal local reactions at the inoculation site.
Similarly, no systemic reactions were observed in any of the vaccinated
animals, and no significant differences in body temperature were
detected among vaccinated animals regardless the vaccination method.
Conclusions: Although Suiseng® and Rhiniseng® are products with
safety parameters that fulfil the requirements for their separate
administration in adult pigs; usually they are mixed together and
injected in a single shot. This is a common practice that clearly reduces
labour and animal stress. The results obtained in the present trial
demonstrate an optimal safety of this combination under field
conditions in gilts. Consequently, there are no safety concerns that
may prevent this practice.
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INDUCTION OF MATERNAL IMMUNITY BY
VACCINATION OF SOWS AT END OF
GESTATION WITH PROGRESSIS®
Introduction: The objective of this report was to assess the benefit
of the vaccination with PROGRESSIS at day 90 of gestation (D90)
on the antibody titre in piglets and on the PRRSV infection pattern
during nursery period.
Material and methods: Data was collected in a well-managed 300-
sow farrow-to-finish farm located in one of the most densely
populated swine regions in The Netherlands experiencing long-lasting
problems ligated with PRSSV in nursery despite a sow vaccination
with a commercial EU type MLV vaccine every reproduction cycle, 6
day after farrowing. A new vaccination schedule was applied: primary
immunisation, two injections 3 weeks apart, followed by a booster at
D90 with PROGRESSIS. Serum samples were collected from piglets
of 3 batches (2/3 batches using PROGRESSIS) at 4, 7 and 10 weeks
of age for anti-PRRSV antibodies titration by ELISA kit (Idexx) and
by IPMA test. Oral fluids were collected from the oldest piglets (7
and 10 weeks of age) of the two last batches for Multiplex PCR test
against respiratory pathogens.
Results: Circulation of PRRSV between 5 and 10 weeks of age was
serologically confirmed in the batch before implementation of
vaccination with PROGRESSIS. Anti-PRRSV maternally-derived
antibodies were higher and lasted longer following vaccination with
PROGRESSIS. No seroconversion against PRSSV was observed in piglet
up to at least 8 weeks of age after implementation of PROGRESSIS.
Absence of PRSSV was also evidenced in oral fluids after
implementation of PROGRESSIS except in one batch at 10 weeks of
age. These last result has nevertheless to be taken with caution
regarding low specificity of the Multiplex PCR test.
Conclusion: These results demonstrated that the use of PROGRESSIS
just before farrowing can be an efficient tool to induce a prolonged
passive immunity and to reduce early infection in piglets. Further
investigations on a larger scale are needed to confirm this observation.
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BETTER PERFORMANCE OF PIGLETS BORN
FROM UNISTRAIN PRRS VACCINATED
GESTATING SOWS AFTER HETEROLOGOUS
PRSV SOW CHALLENGE
Introduction: Porcine reproductive and respiratory syndrome virus
(PRRSV) can be transmitted from females to piglets during late
gestation. Surviving neonates may be weak and can exhibit the
respiratory form or be more susceptible to secondary infections during
the lactation period. Piglet lactation performance after a heterologous
challenge of PRRSV was compared between piglets born from
UNISTRAIN PRRS vaccinated and non-vaccinated gestating sows.
Materials and methods: The recommended administration
programme of the vaccine was applied at 8-9 weeks of gestation (IM)
to 9 naïve sows. Nine control gestating sows remained unvaccinated.
The efficacy was evaluated by means of an intranasal challenge at 90
days of gestation with a European heterologous pathogenic PRRSV
(Spanish strain 2007; 106.54 CCID50/sow). The homology with the
vaccine strain was 86% (ORF5).
Results and discussion: After sow infection, global piglet performance
was better in piglets coming from vaccinated sows: piglets were
healthiest during lactation period (28d) (respiratory distress was the
main amelioration, affecting 6.5% in vaccinated group vs. 10.5% in
non-vaccinated one). The mean of weaned piglets/sow also
significantly increased in vaccinated group compared to the control
one (11.2±1.4 piglets/vaccinated sow vs. 5.7±2.0 piglets/non-
vaccinated sow). Moreover, the mean weight at birth was higher in
vaccinated group (1.54±0.41kg vs 1.42±0.39kg in non-vaccinated
group) and also at weaning time (7.02±0.27kg in vaccinated group vs.
the non-vaccinated that was 6.49±1.47kg). Consequently, the average
daily gain (ADG) was also drastically improved in the vaccinated group.
The mean ADG was of 194.38g/piglet/day (±39.06g) in vaccinated and
in the non-vaccinated group was 176.31/piglet/day (±47.64g). In
conclusion, vaccination of gestating sows with UNISTRAIN PRRS
allowed piglets born from these females, and after PRRSV infection, to
survive and clearly perform better during lactation period than piglets
born from non-vaccinated and infected sows.
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BETTER PERFORMANCE OF PIGLETS BORN
FROM UNISTRAIN PRRS VACCINATED GILTS
AFTER HETEROLOGOUS PRRSV CHALLENGE
Introduction: Porcine reproductive and respiratory syndrome virus
(PRRSV) can be transmitted from females to piglets during late
gestation. Surviving neonates can exhibit the respiratory form or be
more susceptible to secondary infections during the lactation period.
Piglet lactation performance after a heterologous challenge of PRRSV
was compared between piglets born from UNISTRAIN PRRS
vaccinated and non-vaccinated gilts.
Materials and methods: The recommended administration
programme of the vaccine was IM applied 4 weeks before mating to
8 naïve gilts. Eight control gilts remained unvaccinated. The efficacy
was evaluated by means of an intranasal challenge at 90 days of
gestation with a heterologous European pathogenic PRRSV (strain
isolated in Italy, 106.8 CCID50/gilt). The homology with the vaccine
strain was 89% (ORF5 sequence). This study was carried out under
a randomised and blinded basis.
Results and discussion: Piglets were examined daily for 28 days after
birth. Global piglet performance was significantly better in piglets born
from vaccinated gilts: they were healthiest during lactation period
(reduction of weakness was the main improvement in 16.7% in
vaccinated group vs. 57.2% in non-vaccinated one) and the number of
weaned piglets also incremented when vaccinating females with
UNISTRAIN PRRS (8.5±2.51 piglets/vaccinated gilt vs. 3.88±2.90
piglets/non-vaccinated gilt). Moreover, piglets of vaccinated group had
higher weights at birth (1.65±0.32kg in vaccinated vs. 1.33±0.29kg in
non-vaccinated group) and at weaning (8.08±0.18kg in vaccinated
group vs. the non-vaccinated that was 6.80±1.76kg). Consequently,
the average daily gain (ADG) was drastically better in the vaccinated
group. ADG was of 228g/piglet/day (±44.95g) in vaccinated and in the
non-vaccinated group was 193.15g/piglet/day (±54.92g).
In conclusion, vaccination of gilts with UNISTRAIN PRRS allowed
piglets born from these females, and after PRRSV gilt infection, to
survive and clearly perform better during lactation period than piglets
born from non-vaccinated and infected gilts.
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ONE DOSE OF UNISTRAIN PRRS IN
GESTATING SOWS CLINICALLY
PROTECTS AGAINST HETEROLOGOUS
PRRS VIRUS INFECTION
Introduction:Vaccination is still the principal means used to control
Porcine Reproductive and Respiratory Syndrome virus (PRRSV)
infection; however the use of modified live vaccines (MLV) during
gestation has been controversial. After evidences for vaccine-induced
protective immunity against non-homologous challenge, in this study
the heterologous efficacy of UNISTRAIN PRRS was assessed in a
naïve gestating sow model. Reproductive performance was the main
parameter to claim the efficacy.
Materials and methods: The recommended administration
programme of the vaccine was applied at 8-9 weeks of gestation (IM)
to 9 naïve sows. Nine control gestating sows remained unvaccinated.
The efficacy was evaluated by means of an intranasal infection at 90
days of gestation with a heterologous European pathogenic PRRSV
(Spanish strain isolated at 2007; 106.54 CCID50/sow). The homology
with the vaccine strain was 86% in the ORF5 sequence. This study
was carried out under a randomised and blinded basis.
Results and discussion: Vaccination with UNISTRAIN PRRS
significantly reduced reproductive failure caused by wild-type
infection during gestation. After vaccine administration there was not
any adverse effect derived from vaccination. After experimental
infection no abortion occurred in any vaccinated sow (100%
farrowing rate) and the gestation length was the optimum for the
right foetal development. Consequently, vaccination compared to
non-vaccinated group significantly reduced the number of stillborn
and the presence of mummies. Also there was an increment of the
number of liveborn piglets/sow (12.56±1.67 in vaccinated group vs.
9±2.6 in control group) and a drop in the birth of weak piglets/sow
(0.67±0.71 in vaccinated group vs. 2.33±1.80 in control group). Thus
it was clearly confirmed that vaccination with UNISTRAIN PRRS
during the second term of gestation was safe and able to reduce
reproductive consequences of a heterologous PRRS infection at third
trimester (were sows are more sensitive to the virus).
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ONE VACCINATION WITH UNISTRAIN PRRS
IN GILTS REDUCES VIRAEMIA AND
VERTICAL/HORIZONTAL TRANSMISSION OF
A HETEROLOGOUS PRRS VIRUS INFECTION
Introduction: Vaccination is still the main tool used to control
Porcine Reproductive and Respiratory Syndrome virus (PRRSV)
infection. Evidences for vaccine-induced protective immunity against
heterologous challenge has been demonstrated (Martínez-Lobo,
2011). The control of the viraemia is essential for the posterior PRRSV
consequences, so demonstrate the reduction of viraemia conferred in
vaccinated gilts with UNISTRAIN PRRS was the principal goal of our
study. The transplacental transmission to piglets of the pathogenic
PRRSV and its shedding were also evaluated.
Materials and methods: The vaccine was applied 4 weeks before
mating to 8 naïve gilts (IM). Eight control gilts remained
unvaccinated. The efficacy was evaluated by means of an intranasal
infection at 90 days of gestation with an Italian type 1 pathogenic
strain of the PRRSV (106.8 CCID50/gilt). The homology with the
vaccine strain was of the 89% in the ORF5. Virus detection was
performed by virus isolation (VI) in alveolar macrophages.
Results and discussion: The administration of UNISTRAIN PRRS
vaccine statistically reduced the percentage of viraemic gilts (12.5%
vaccinated gilts vs.100% control ones) and reduced also the length
of viraemic period induced by experimental infection (22.5 days
control group vs. 4 days in vaccinated gilts). Furthermore, vaccination
significantly inhibited in 59.5% of the cases the vertical transmission
of the heterologous PRRSV to piglets (virus detection at birth). There
was also a tendency in reducing the shed of the infectious virus in
vaccinated gilts, decreasing the possibility of a horizontal
transmission to piglets during lactation (50% gilts shed virus by nasal
secretions vs. only 12.5% of the vaccinated gilts did). So vaccination
with UNISTRAIN PRRS enabled gilts to clear the virus and reduced its
vertical and horizontal transmission to their piglets after a
heterologous PRRSV infection.
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VACCINATION ONCE WITH UNISTRAIN PRRS
IN GILTS CLINICALLY PROTECTS AGAINST
HETEROLOGOUS PRRSV INFECTION
Introduction: Vaccination is still the principal means used to control
Porcine Reproductive and Respiratory Syndrome virus (PRRSV) infection.
The use of modified live vaccines (MLV) has been controversial, but its
safety has been now fully proved. Moreover, evidences for vaccine-
induced protective immunity against heterologous challenge have been
also demonstrated. In this study the heterologous efficacy of
UNISTRAIN PRRS was assessed in a naïve gilt model. Reproductive
performance was the main parameter to claim the efficacy.
Materials and methods: The recommended administration
programme of the vaccine was IM applied 4 weeks before mating to
8 naïve gilts. Eight control gilts remained unvaccinated. The efficacy
was evaluated by means of an intranasal challenge at 90 days of
gestation with a heterologous European pathogenic PRRSV (strain
isolated in Italy, 106.8 CCID50/gilt). It has a homology with the
vaccine strain of the 89% in the ORF5 sequence. This study was
carried out under a randomised and blinded basis.
Results and discussion: Vaccination with UNISTRAIN PRRS
significantly reduced reproductive failure caused by wild-type
infection during gestation. After vaccine administration no heat
repetition occurred and there was 100% of fertility. After infection no
abortion occurred in any vaccinated gilt (100% farrowing rate).
Gestation length was the optimum for the right foetal development
in vaccinated group (115.3±0.99 days vs. only 113.13±2.17 days in
control), and consequently there were more liveborn (9.75±2.05 in
vaccinated vs. 7±2.67 piglet/gilt in control group) and less weak-born
piglets (0.25±0.46 in vaccinated vs. 1.25±0.89 piglet/gilt in control
group). Among vaccinated group there was also significantly less
dead-born piglets (stillborn and mummies). Once more, it was
demonstrated a heterologous cross-protection capability of the MLV.
Thus it was clearly confirmed that the use of a unique dose of
UNISTRAIN PRRS vaccine reduces clinical disease associated with a
heterologous PRRSV infection.
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ONE-SHOT VS. TWO-SHOT VACCINATION
WITH INACTIVATED STX2E-TOXIOD
VACCINE TO PREVENT OEDEMA DISEASE:
PRELIMINARY RESULTS FROM A FIELD-TRIAL
Introduction: Edema disease is caused by certain Shiga toxin (Stx2e)
producing strains of Escherichia coli, and is an important cause of
post-weaning mortality in pigs worldwide.
Objective:The aim of this field-trail was to compare the effectiveness
of one-shot (off label) vs. two-shot vaccination of a commercially
available inactivated Stx2e-toxoid vaccine (Suivac EDT®, Dyntec) in
preventing post-weaning mortality caused by edema disease in a
Norwegian pig herd.
Material and methods: The herd is self-recruiting farrow-to-feed
producer with 5.5-week batch farrowing. The herd has approx. 150
sows and 21.9 weaned pigs/sow/year. It had post-weaning mortality
caused by edema disease in the range of 5-8 % over time. Before the
start of the field-trial, the diagnosis was confirmed by post-mortem
examinations of 34 pigs combined with bacterial cultures and
verification of E.coli serotype O139. Vaccination was carried out in
two consecutive batches. All piglets (n=686) were vaccinated with
subcutaneous injection of a inactivated Stx2e-toxoid vaccine (Suivac
EDT®, Dyntec) in the inguinal skin fold at approx. 2 weeks of age. The
batches were split by litters, and half of the piglets (n=336) were re-
vaccinated two weeks later. The remaining piglets (n=350) were not
re-vaccinated.
Results: A total of 4 (0.6 %) pigs died after weaning. There were no
post-mortem findings indicative of edema disease in any of the dead
pigs, but all had lesions indicative of other cause of death.
Discussion/conclusion: This field trial indicates very good
effectiveness of the vaccine in preventing mortality caused by edema
disease in this particular herd. There was no difference in effectiveness
between one-shot and two-shot vaccination. The trial was carried
out in a single herd without the use of control group. Thus, the
transferability to a larger population is unknown, and further studies
are needed to investigate this.
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COMPARATIVE EFFICACY OF TWO
VACCINATION STRATEGIES AGAINST
MYCOPLASMA HYOPNEUMONIAE AND
PORCINE CIRCOVIRUS TYPE 2 IN A FRENCH
FARROW-TO-FINISH HERD
Mycoplasma hyopneumoniae (M.hyo) and porcine circovirus type 2
(PCV2) are primary agents of the porcine respiratory disease complex
and vaccines against both pathogens are the most widely used swine
vaccines in Europe. The objective of this study was to compare the
efficacy of two vaccination strategies against both pathogens under
field conditions in France. A total of 1074 piglets of 4 consecutive
batches of a 600-sows farrow-to-finish herd were randomly allocated
to 2 groups: group A (n=536) was vaccinated with Stellamune® One
(Elanco) and Circovac® (Merial) at weaning (21 days of age); group B
(n=538) was vaccinated with Ingelvac® M.hyo (Boehringer Ingelheim)
and Ingelvac® CircoFlex (Boehringer Ingelheim) at weaning (21 days
of age). The efficacy was evaluated using clinical [prevalence of lung
lesions at slaughter, lung lesion scores at slaughter (Madec and
Kobisch, 1982)] and performance [average daily weight gain (ADWG)
between birth and 115kg, age at 115kg, lean meat content, carcass
price] parameters. Performance parameters were analysed using
ANOVA. Prevalence of lung lesions was analysed by Pearson’s Chi-
square or Fisher’s exact test or, if possible, with Mantel-Haenszel test
adjusted on batch. Lung lesion scores were analysed by Kruskall and
Wallis test. 79.8% and 81.7% of the pigs of groups A and B,
respectively had lung lesions at slaughter (P=0.467) and their average
lung lesion scores were 4.13 and 4.42 (P=0.230). The ADWG between
birth and 115kg was 568.6 and 561.6 g/pig/day in groups A and B,
respectively (P=0.092) and their age at 115kg was 202.7 and 205.1
days (P=0.164). The lean meat content was 60.51 and 60.29 in groups
A and B, respectively (P=0.165) and their carcass price was €99.62
and €98.45 (P=0.138). Under the current field conditions with a high
infectious pressure with M.hyo, there were no differences in efficacy
between both vaccination strategies.
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COMPARISON OF PIGLET VACCINATION
WITH CIRCOVAC® AND ANOTHER
REGISTERED PCV2 PIGLET VACCINE IN
EUROPE ON PRODUCTION PARAMETERS
UP TO SLAUGHTER UNDER GERMAN
FIELD CONDITIONS
Introduction: The objective of this randomised blinded trial was to
compare the efficacy of CIRCOVAC® and another registered PCV2
piglet vaccine in Europe (Vaccine X) vaccination on homogeneity of
pigs and production parameters during post-weaning and fattening
periods under German conditions.
Material and methods: The study was conducted in the north of
Germany in a farrowing farm with 600 sows and a nearby connected
fattening farm. A total of 338 pigs were included at weaning (21
days) and vaccinated either with 0.5ml CIRCOVAC® (n= 169) or
injected with 1.0ml Vaccine X (n= 169). The randomisation was done
by litter and sex of the piglets. Piglets were weighed individually after
vaccination, at entry into the fattening unit (68 days) and at
slaughter (174 days). Student’s t-test was used to compare both
groups on their weights, growth parameters (average daily weight
gain). The homogeneity of bodyweights was compared using a
Fisher’s test. Chi-square test was used to compare mortality.
Results and conclusion: Following post-weaning and fattening
periods, growth was similar between the two groups (CIRCOVAC®:
668 g/day versus Vaccine X: 663 g/day, p=0.54). Moreover, mean
bodyweights at slaughter as well as homogeneity of bodyweights
were not different (p=0.48, p=0.46 respectively) between the groups.
In both groups there was no mortality due to PCV2 and no statistical
difference was evidenced regarding global mortality. In conclusion
and under the conditions of the study, CIRCOVAC® and Vaccine X
provided similar performances regarding growth, homogeneity in
bodyweights and mortality.
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IMPLEMENTATION OF PROGRESSIS®
VACCINATION IN FATTENERS IN CZECH
REPUBLIC: PRELIMINARY FIELD EXPERIENCE
Introduction: The aim of this field study was to assess the benefit
provided by the implementation of PROGRESSIS vaccination in
fattening unit experiencing high loss rate due to PRSSV under Czech
Republic conditions.
Material and methods: The study was conducted in a 6000-pig
finishing operation located in Czech Republic. Pigs were purchased
from an unique Danish supplier complying with the rules of the SPF
Health Status Department (Blue SPF). The herd was free from Swine
influenza virus, Actinobacillus pleuropneumoniae but PCV2 circulation
was evidenced by IHC in lesions. Pigs regularly experienced an acute
outbreak of respiratory disorders 6 weeks after arrival with increasing
mortality. At the end of the fattening period. This respiratory
syndrome was complicated by Mycoplasma hyopneumoniae
and Pasteurella multocida type-D. Interestingly circulation of EU
PRRSV in the first month of arrival was serologically and virologically
repeatedly confirmed.
Four successive batches before implementation of the PROGRESSIS
vaccination program (control group) and 2 successive vaccinated
batches were monitored. In order to vaccinate healthy animals with
no clinical signs, the pigs were vaccinated twice at 2-week interval
with 1.0 mL of PROGRESSIS as early as the second day after arrival.
Approximately 640 fatteners were loaded in each batch. Mortality
and runts were recorded.
Results and conclusion: PROGRESSIS vaccination induced a clear
decrease in both mortality rate (1.2% versus 4.2%) and runt rate (0.5%
versus 2.3%). Total loss rates decreased from 6.4% to 1.7%. Further
controlled trial would be necessary to confirm this observation.
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SUCCESSFUL REDUCTION OF MORTALITY BY
VACCINATION AGAINST OEDEMA DISEASE
Oedema Disease is an Escherichia coli enterotoxaemia in pigs usually
occurring in the first two weeks after weaning, but older pigs can also
be affected. In Denmark the disease has been caused by haemolytic
F18-positive E. coli which produces Shigatoxin Stx2e (verotoxin 2e).
Each year 30-50 new cases are diagnosed in Denmark by laboratory
examinations. The clinical signs are oedema of the palpebrae and
forehead, neurological disorders and sudden death. The disease can
be prevented by the same measures as post weaning diarrhoea i.e.
low protein, restricted feeding, zinc oxide, antibiotics etc. However,
these measures might reduce the performance of the pigs and cause
consumer concern about antibiotic use. The objective of this study
was to investigate the safety and efficacy of vaccination with
ECOPORC SHIGA in preventing Oedema Disease in weaned piglets.
The study was performed on one commercial farm. It was performed
as a masked trial with one vaccine group (257 piglets) and one control
group (255 piglets). The piglets were vaccinated with 1ml when most
piglets were four days old. The inclusion criteria were: healthy pigs, age
>2 days, body weight >800 gram. Antibiotic treatments were allowed
only by injection. Vaccinated and non-vaccinated pigs were mingled
and housed in the same pens. The main response variable was the
proportion of pigs that died of post weaning Oedema Disease. All dead
piglets were subject to laboratory examinations.
Vaccination reduced the mortality due to Oedema Disease in the
nursery from 8% in the control group to 1% in the vaccine group
(p=0.01). During the nursery period vaccinated piglets gained
numerically 16g/day more weight than the control piglets (p=0.07).
No adverse reactions were observed.
Successful control of Oedema Disease by vaccination can reduce the
use of other more problematic preventive measures, e.g. zinc oxide
and antibiotics.
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NOVEL MYCOPLASMA HYOSYNOVIAE
VACCINATION OF ONE HERD FAILED TO
PREVENT LAMENESS IN FINISHING PIGS
Infection with Mycoplasma hyosynoviae (M. hyosynoviae) is a known
cause of arthritis and lameness in finishing pigs. Although antibiotic
therapy will cure many cases, other ways of preventing M. hyosynoviae
arthritis are warranted. The National Veterinary Institute has recently
developed a M. hyosynoviae vaccine formulated with formalin-fixed
whole-cell M. hyosynoviae and CAF01 (Statens Serum Institut,
Denmark) as an adjuvant. This vaccine has recently shown promising
results in experimentally infected pigs with development of both
humoral and cell-mediated immune responses. The objective was to
test this novel vaccine in a field trial in one Danish herd with recurrent
arthritis problems due to infection with M. hyosynoviae.
A total of 399 weaner pigs were included in a clinical trial. The pigs
were vaccinated twice, two and five weeks after weaning. Half of the
pigs were vaccinated with the novel M. hyosynoviae vaccine, and the
other half were placebo injected (adjuvant + buffered saline). Two
ml doses of both were injected intramuscularly in the neck.
Vaccinated pigs and placebo pigs were mixed in the pens. There were
no cases of lameness until the pigs were moved to the finishing unit
at a bodyweight of 30kg. In the finishing unit, arthritis due to
infection with M. hyosynoviae was diagnosed by culture before and
during the vaccine trial. Lameness was recorded in 23% of the
vaccinated pigs and in 28% of the placebo pigs. The data were
analysed by logistic regression, and no significant difference in the
prevalence of lameness was found (P=0.157). All lame finishers were
treated with Lincosin® and Flunixin® by injection for three days. In
conclusion, this novel M. hyosynoviae vaccine could not successfully
prevent the development of lameness in finishing pigs presumed to
have been caused byM. hyosynoviae arthritis.
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LOCAL AND SYSTEMIC IMMUNE RESPONSES
IN PIGS INTRAMUSCULARLY INJECTED
WITH AN INACTIVATED MYCOPLASMA
HYOPNEUMONIAE VACCINE
The immune response induced by intramuscular administration of a
commercial inactivated Mycoplasma hyopneumonie whole-cell
vaccine (Suvaxyn®MH One) was investigated in conventional M.
hyopneumoniae-free pigs. The animals were assigned randomly to
two groups: non-vaccinated and vaccinated. Pigs in the vaccinated
group were injected intramuscularly with the vaccine at 7 days of
age, whereas non-vaccinated pigs received physiological saline
solution (PBS). Pigs were euthanised and necropsied at 30, 36 and
58 days of age. Blood, bronchoalveolar lavage (BAL) fluid, spleen, lung
and bronchial lymph nodes (BLN) were collected. Serum and BAL
fluid were tested for the presence of antibodies by ELISA.
Monomorphonuclear cells from the peripheral blood and tissues were
isolated to quantify the T cell subsets by flow cytometry, and
cytokine production by ELIspot and ELISA. Antibodies against M.
hyopneumoniae were detected in serum of most vaccinated pigs at
30 days of age. M. hyopneumoniae specific IgG, IgM and IgA were
detected in BAL fluid from vaccinated animals, but not from control
animals. Significantly higher numbers of IL-12 secreting cells were
observed in the lung at day 58 in the vaccinated than in the non-
vaccinated group (P<0.05). The number of IL-10 secreting cells from
BLN was also higher in the vaccinated group at day 58 (P<0.05). After
restimulation in vitro, lymphocytes from BLN and lungs secreted
significantly higher levels of IL-12 in the vaccinated group at day 58.
These results show that the vaccine induced both systemic and
mucosal cellular and humoral immune responses.
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EFFICACY OF GRIPOVAC®3/RESPIPORC®
FLU3 AGAINST CHALLENGE WITH A RECENT
H1N2 SWINE INFLUENZA VIRUS IN PIGS
Introduction: GRIPOVAC®3/RESPIPORC® FLU3 is a trivalent vaccine
containing each of the three swine influenza virus (SIV) subtypes that
are endemic in pigs in Western Europe. We have examined the efficacy
of this vaccine against intratracheal (IT) challenge with a recent H1N2
SIV. Additionally, we compared the IT challenge method with intranasal
(IN) challenge, which is closer to the natural route of infection.
Materials and methods: Twenty-four influenza-negative pigs were
vaccinated twice, 24 pigs were left unvaccinated. Three weeks after
the second vaccination, a vaccinated and a challenge control group
of 12 pigs each were challenged by IT or IN route with 7 log10 EID50
of A/sw/Gent/102/07 (H1N2). The pigs were monitored for serum
haemagglutination-inhibition antibody titres before challenge and
for clinical and virological protection post challenge. Virus titres were
determined in nasal swabs and lung samples.
Results: After the second vaccination, all pigs had antibodies against
all three vaccine strains and the challenge virus. In most unvaccinated
controls IT challenge induced fever, tachypnea and/or dyspnea,
whereas IN inoculation produced a largely subclinical infection.
In both vaccinated groups, clinical signs were observed in fewer
animals and they were milder.
Both inoculation methods resulted in high virus titres in the lungs of
unvaccinated control pigs. Both vaccinated groups had reduced mean
virus titres in the lungs, but the reduction was only significant at
selected time points. Nasal virus excretion was delayed after IT as
compared to IN inoculation. With both challenge methods, there was
a reduction in nasal swab virus titres in the vaccinated pigs, but it
was not significant after IN challenge.
Conclusion: GRIPOVAC®3/RESPIPORC® FLU3 induces a protective
response against challenge with a recent European H1N2 strain with
95,5% amino acid homology (HA1) with the H1N2 vaccine strain.
The IN challenge method could be used as an alternative for the
technically difficult IT method in SIV vaccination-challenge studies.
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COMPARISON OF CIRCOVAC® AND
ANOTHER PCV2 PIGLET VACCINE REGISTERED
IN EUROPE UNDER BELGIAN CONDITIONS
Objective: The objective of this study was to evaluate the
performance of pigs vaccinated at 3 weeks of age with CIRCOVAC
during the fattening period and to compare these results with
historical data of pig vaccinated with another PCV2 piglet vaccine
registered in Europe (Vaccine X) in the same Belgian farms.
Materials and methods:A comparative field study was performed in
14 Belgian farms where performance data of 25 groups of pigs (13420
pigs in total) vaccinated with Vaccine X was compared with data of 14
groups of pigs (7127 pigs in total) vaccinated with CIRCOVAC. All
groups were purchased from only one origin and were vaccinated at
the different source herds around 3 weeks of age against Mycoplasma
and PCV2. All animals were slaughtered between July and December
2011. Average group data including mortality, number of fattening
days, feed conversion ratio (FCR) and average daily weight gain
(ADWG) were compared between groups. In the slaughterhouse, meat
building index of the carcass, meat percentage and average slaughter
weight were compared between the different groups. Significance of
differences was evaluated using t-tests.
Results: Overall, no significant differences were observed between
the groups vaccinated with CIRCOVAC vs. groups vaccinated with
Vaccine X. Mortality was on average 2.18% (Min 0.20 – Max 5.00) in
the CIRCOVAC groups vs. 3.17% (Min 0.88% – Max. 7.50%) in the
Vaccine X groups (p=0.054). Number of fattening days (CIRCOVAC:
134.9 vs. Vaccine X: 135.6), FCR (CIRCOVAC: 3.04 vs. Vaccine X: 3.07)
and ADWG (CIRCOVAC: 661.9g/day vs. Vaccine X: 650.5g/day) were
not significantly different (p>0.05). At slaughter, no differences were
observed for average body weight, meat percentage and meat
building index.
Conclusion: Performance of 14 groups of CIRCOVAC-vaccinated pigs
was found at least as good as historical data of piglets vaccinated
with another PCV2 piglet vaccine registered in Europe in the same
Belgian farms.
NOTES
P193
Joel Nerem, Pipestone Veterinary Clinic, Pipestone, Minnesota.
Tom Wetzell, Boehringer Ingelheim Vetmedica, St. Joseph, Missouri.
Jeff Luebbe, Boehringer Ingelheim Vetmedica, St. Joseph, Missouri.
Jeff Husa, Boehringer Ingelheim Vetmedica, St. Joseph, Missouri.
COMPARATIVE EFFICACY OF ENTERISOL®
ILEITIS AND VIRGINIAMYCIN VERSUS A
TYLOSIN FEED PROGRAM FOLLOWING
A LAWSONIA INTRACELLULARIS CHALLENGE
IN PIGS HOUSED UNDER COMMERCIAL
CONDITIONS
The objective of this study was to compare an Ileitis vaccine
(Enterisol® Ileitis) program to a tylosin (Tylan®, Elanco Animal Health)
feed grade program as a control measure for pigs challenged with Li.
Three week old pigs (n=2080) were weaned into a two-room wean to
finish facility and randomly allocated into 80 pens (26 pigs/pen).
Treatments consisted of: 1) Enterisol Ileitis (EI)/Virginiamycin 10 g/ton
(Stafac®) or 2) Tylosin Phosphate (Tylan® 100/Tylan® 40). Treatment
was randomly assigned to room. Room 1 was vaccinated through the
drinking water with EI at 6 weeks of age. At 6 weeks post-vaccination,
when vaccine shedding period had ended, 50% of pens were randomly
shuffled between rooms. Following pen transfer, 10% of the
population (2-3 pigs/pen) was inoculated by gavage with gut
homogenate containing 4.5 x 109 virulent Li. Treatment group 1
received 10 g/T virginiamycin from day of inoculation for 80 days.
Treatment group 2 received 100 g/T tylosin phosphate for 18 days
post-challenge followed by tylosin phosphatet 40 g/T for an additional
62 days. Due to severity of the Li and significant Actinobacillus suis
and SIV challenges, all pigs were mass treated with 60 ppm tiamulin
(Denagard®) through drinking water on d 45-49 post-challenge.
Individual pigs in both groups required treatment with injectable
tylosin. Pigs on the EI/virginiamycin program had improved (P=0.05)
feed efficiency compared to pigs on the tylosin program (0.420 vs
0.411). No differences (P>0.10) were detected in final BW, ADG, and
ADFI between the treatment groups. A significant Li challenge was
proven by positive Li histopathological lesions in randomly sampled
pigs. Pigs on the Enterisol Ileitis program had a 2.1% improvement in
feed efficiency from weaning to day 126 compared to pigs on the
Tylosin program.
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FIELD SAFETY STUDY OF PORCINE
CIRCOVIRUS TYPE 2 VACCINATION IN
PREGNANT SOWS
Recently, field findings have indicated sow vaccination may have a
positive impact on reproductive and farrowing unit performance.
Practitioners inquire if sow PCV2 vaccination could help stabilise a
sow herd. The objective of this study was to evaluate if sow
vaccination interferes with piglet vaccination, as well as to evaluate
the safety of sow vaccination in late gestation. This abstract focuses
on the data related to the safety aspect. The study was conducted in
a 2,400 head sow herd located in the Midwest, U.S.A. Sows and gilts
were blocked by parity and randomised into two treatment groups,
vaccinated (Vx, n=124) and non-vaccinated (NVx, n=128). Vx dams
received 2x2ml of PCV2 vaccine (Ingelvac CircoFLEX®, at 6 and 3
weeks pre-farrowing). The elevated dosage (2ml) and two
applications were used to test the possible impact on piglet
vaccination and safety in sows in a more rigorous situation. Farrowing
rate (FR), average total born (TB) and average born alive (BA) were
recorded and livability (BA/TB) was calculated. No significant
differences in these parameters were observed between the
treatment groups. No adverse events were noted following the use
of PCV2 vaccine in the sows. Vaccination was administered in the
last 42 days of gestation, a time when a negative impact would have
affected farrowing rates and in-utero foetus livability. However, this
study indicates there was not a negative impact from vaccination. A
previous publication had already shown that sow vaccination did not
interfere with the efficacy of piglet vaccination (Edler et al., 2008).
Future studies are needed to determine the effect of whole herd
vaccination on reproductive performance. However, as reproductive
failure associated with PCV2 is only seen sporadically, it may be
difficult to scientifically prove the benefits of sow vaccination in
controlled, side-by-side studies under field conditions.
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FIELD SAFETY STUDY OF PORCINE
MYCOPLASMA HYOPNEUMONIAE
VACCINATION IN SOWS
Sow to piglet transmission of Mycoplasma hyopneumoniae (M hyo)
might have a relevant impact on the epidemiology of M hyo in a herd.
While benefits still need to be further clarified, M hyo sow vaccination
is already commonly practiced in US swine herds. The objective of
this study was to evaluate the clinical safety of M hyo vaccination in
late gestation. A breeding group of sows (n=144), part of a 3,100
head sow herd located in USA, were either vaccinated (Vx, 1ml of
Ingelvac MycoFLEX®, at 5 and 2 weeks pre-farrowing, n=72) or not
vaccinated (NVx, n=72). Percent farrowed (FR), average total born
(TB) and average total born alive (BA) were recorded and percent
liveability was calculated. FR was 95.5% for the vaccinates and 98.5%
for the non-vaccinates (P=0.62). TB (P=0.81) was 13.1 and 13.3, BA
(P=0.99) was 11.8 and 11.8, for Vx and NVx sows, respectively. The
percentage of viable pigs post-farrowing (P=0.70) was 90.4% and
89.5% for Vx and NVx groups, respectively. No adverse events were
noted following the use of the M hyo vaccine in the dams. In this
study, prefarrow administration of an M hyo vaccine to sows had no
negative impact on reproductive performance. The product is labelled
as a one dose administration; however, a two dose application was
implemented as a more rigorous evaluation of safety and for use in
a subsequent maternal interference study. Based on the results of
this study, Ingelvac MycoFLEX® has been shown to have no negative
impact on late gestation sows or the in-utero foetuses. A previous
publication has already demonstrated the lack of interference with
piglet vaccination at 3 weeks of age (Angulo et al., 2012).
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COMPARISON OF THE CONCURRENT USE OF
A PCV2 AND AN M HYO VACCINE WITH THE
COMBINED USE OF THOSE TWO VACCINES
IN PIGS GROWN FOR NINE MONTHS
Reducing the number of injections required to vaccinate pigs against
diseases reduces stress for the pigs, time needed for vaccination, the
risk of iatrogenic spread of pathogens, broken needles and injuries
due to accidental self-injection. Based on efficacy and safety studies,
in 2008 a licence was granted in the EU for two vaccines based on
the identical adjuvant to be mixed prior to use: Ingelvac CircoFLEX®
and Ingelvac MycoFLEX® (mixture referred to as FLEXcombo®). This
concept allows protecting pigs against PCV2 and M hyo with a single
injection. The present study evaluates the performance of the vaccine
mixture compared to separate injections of the individual products
under the conditions of swine production in Northern Italy, growing
pigs for 9 months or more. On a single-site M hyo and PCV2-positive
700 sow farm in total 880 piglets were vaccinated at weaning (26.5d)
either with FLEXcombo® or two separate injections of Ingelvac
CircoFLEX® and Ingelvac MycoFLEX®. Losses (mortality and runts)
were recorded per production phase. Samples for serology were taken
4 times. Lung scoring was done according to the method described
by Madec and Kobisch (1982). ADG was calculated based on carcass
weight, an estimated carcass yield of 80%, an estimated birth weight
of 1kg and the number of days to slaughter. Serological results
confirmed the presence of PCV2 and M hyo during the study.
Performance and slaughter check results did not indicate any
statistical significant differences between the two treatment groups
with regard to losses, ADG, or lung scores.
Under the conditions of this study no significant differences were
observed in the performance of pigs vaccinated with a PCV2-M hyo
vaccine mixture and pigs vaccinated with a PCV2 and M hyo vaccine
separately. These results confirm the efficacy of the vaccine mixture
compared to separate injections of the individual vaccines.
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COMPARISON OF TWO PCV2 PIGLET
VACCINATION PROGRAMMES
The aim of this evaluation was to compare the benefits of two
different piglet vaccination programmes under commercial conditions
in the central region of Spain.
The field observation was carried out in a 2.350 sow farm. The total
number of piglets included in this study was 47.780. In the first period,
an amount of 18.390 piglets aged 3 weeks, were vaccinated with 1ml
of Ingelvac CircoFLEX® and moved to 7 independent fattening units
(group A). Afterwards, the vaccination program was changed and an
amount of 29.390 piglets were vaccinated with 0.5ml of an inactivated,
oily PCV2 vaccine and moved to 10 independent fattening units (group
B). PCV2 infection was confirmed in group B by clinical signs, ELISA
(IgG, IgM), histopathology and In situ hybridisation (ISH). The fattening
performance parameters analysed were: average daily gain (ADG, g/d),
feed conversion rate (FCR), mortality (%), medication costs, culls (%),
and weight gain (kg) during the fattening period.
Average mortality was 46% less in group A (3.55%) vs. group B (6.52%).
The difference of FCR was 33 grams between group A and group B and
animals in group A grew 125.8 grams more per day. The medication
costs were 53% lower in group A (€0.82/pig) vs. group B (€1.73/pig)
and the average percentage of culls was 57% lower in group A, too.
Group A needed 6.5 days less to reach the slaughter weight.
Under the conditions of this study, the results of ADG, mortality,
medication costs, and weight gain observed in group B were
significantly worse compared to the Ingelvac CircoFLEX® group. Taking
into account the production costs, the use of Ingelvac CircoFLEX
showed a return on investment of €5.92 compared to the other PCV2
piglet vaccination program.
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INVESTIGATION OF THE EFFICACY OF AN
INACTIVATED TRIVALENT SWINE
INFLUENZA VIRUS VACCINE AGAINST
EUROPEAN PORCINE H1N2 VIRUSES
In the course of several reassortment events the novel swine influenza
A virus subtype H1N2 emerged in Scotland in the 1990s and spread
over Europe. Its lacking cross-reactivity to bivalent H1N1+H3N2
vaccines required the development of a new trivalent swine flu vaccine.
Such a vaccine was developed and licensed in 2010 under the trade
names RESPIPORC FLU3 and GRIPOVAC3. This vaccine contains
inactivated cell culture grown viruses of subtypes H1N1, H3N2, and
H1N2. A substance from the carboxyvinylpolymers group was used as
an adjuvant which provides a high safety because it is well tolerated
by pigs.
A major focus of investigation was the proof of efficacy against
heterologous H1N2 field strains in experimental infection trials. Five
challenge experiments were conducted on a total of 158 pigs. Three
recently isolated field isolates of subtype H1N2 were used for the
experiments. The strains were sequenced and analysed phylogenetically.
Pigs were vaccinated twice. Vaccinated pigs displayed neutralising and
hemagglutination inhibiting antibodies as early as 7 days after the
second vaccination. For proof of efficacy an aerosol method was used
in which high doses of field viruses were sprayed by a generator.
Vaccinated animals had almost no clinical symptoms after infection,
whereas unvaccinated animals exhibited fever, dyspnea and
sleepiness. The viral load in the lungs was significantly lower in
vaccinated pigs compared to unvaccinated animals. Lung lesions
typical for influenza were observed in the apical parts of medial and
cranial lung lobes of the control animals, whereas vaccinated pigs
showed no lesions. Moreover, histological investigations revealed a
higher degree of inflammation in the unvaccinated pigs.
Vaccinated pigs were protected against all three H1N2 field strains
used in the challenge trials.
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AN M HYO/PCV2/PRRS VACCINE MIXTURE
ACHIEVES COMPARABLE RESULTS AS
SEPARATE INJECTIONS OF AN M HYO/PCV2
VACCINE MIXTURE AND A PRRS VACCINE
Diseases in swine production are becoming more complex and on
many farms pigs are vaccinated against multiple diseases around
weaning. Reducing the number of injections needed to protect pigs
against major pathogens, like Mycoplasma hyopneumoniae (M hyo),
PCV2 and PRRSv is not only more convenient, but reduces the stress
for the pigs as well. In 2010 a licence was granted in the US for the
mixing of Ingelvac MycoFLEX®, Ingelvac CircoFLEX® and Ingelvac®
PRRS MLV prior to use (referred to as 3FLEX®). The objective of this
study was to compare the efficacy of 3FLEX® with the concurrent
application of Ingelvac® PRRS MLV and FLEXcombo® (the mixture
of Ingelvac MycoFLEX and Ingelvac CircoFLEX®) under German
field conditions.
The experiment was conducted on a commercial 700 sow farrow-
to-finish farm in Germany. At 21 days of age one group of piglets
was vaccinated with the M hyo/PCV2/PRRS vaccine mixture (n=399),
while the other group (n=400) received the M hyo/PCV2 vaccine
mixture and the PRRS MLV vaccine at two different injection sites.
Both groups were weighed individually at 3, 11, 17 and 23 weeks.
Blood samples were collected in 2-3 week intervals until slaughter
and tested for antibodies against PCV2 and PRRSv. Broncho-alveolar
lavage fluid (BALF) samples were collected from 15 pigs per group at
3, 7, 11 and 17 weeks and analysed by PCR.
BALF results confirmed challenge with M hyo, PCV2 and PRRSv EU.
No significant differences were observed between the two groups
with regard to wean-to-finish weight gain, mortality or lung lesions
at slaughter. Based on the results of this study it can be concluded
that a single injection of the M hyo/PCV2/PRRS vaccine mixture
provided the same level of efficacy and performance as the separate
injections of the M hyo/PCV2 vaccine mixture and PRRS MLV.
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HYPER-IMMUNISATION OF PRIMIPAROUS
SOWS IMPROVES PRODUCTIVE
PERFORMANCE OF THEIR OFFSPRINGS IN
NURSERY PERIOD
The aim of this experiment was to evaluate the effect of hyper-
immunisation of gilts on productive and health status of their
progenies. The experiment was conducted in a farrow-to-finish
commercial farm in Mantova (Italy). A total of 48 sows (32 gilts and
16 mature sows) were used for the experiment and managed as
follows: 16 gilts (GILT) under usual vaccination program (Aujeszky,
PRRS, Erysipela, Parvovirus); 16 gilts (H-GILT) were hyper-immunised
adding the ones against circovirosis and colibacillosis; and mature
sows (SOW), parities 3-6, under usual vaccination program. Fostering
was allowed within sows in the same treatment group. Three nursery
rooms, including 12 pens each (12 pigs/pen; 4 pens/treatment and
room) were used. Pigs were weighed at birth, weaning (about 21 days
of age) and at the end of nursery period (63 days of age). Average
daily gain (ADG) was calculated in lactation and in nursery periods.
Percentage of mortality and ADG of piglets were analysed by GLM
models using glimmix and GLM procedures of SAS. In lactation, ADG
was higher in SOW than in GILT pigs, while H-GILT group did not
differ from any of them. However, both SOW and H-GILT pigs
showed a similar ADG in nursery period, being higher than in GILT
pigs (P=0.013). Consequently, final body weight was lower
(P=0.0001) in GILT (14.6kg) than in H-GILT (16.2kg) and SOW
(16.6kg) pigs. Percentage of mortality was lower in SOW than in GILT
pigs, especially in the nursery period (0.64% vs 7.04%; P=0.02). In
this sense, antibiotic interventions, especially against diarrhoea, were
also higher in GILT than in SOW pigs, while H-GILT were in between
closer to GILT group. In conclusion, hyper-immunisation of gilts was
efficient to improve productive performance and health status of
their progeny during lactation and nursery periods.
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EFFICACY OF A MODIFIED LIVE PRRSV
VACCINE (FOSTERA™ PRRS) AGAINST A
THAI HP-PRRSV COMPARING TO A MILD
PATHOGENIC TYPE 1 PRRSV
A licensed modified live PRRS vaccine (Fostera™ PRRS) was given to
three week old PRRSV-free pigs. Comingling among non-vaccinated
and vaccinated pigs in each group with equal number of pigs was
conducted when challenged at 21 days post vaccination (dpv) by a
Thai highly pathogenic-PRRSV (10PL1) (n=11) or a Thai mild type 1
PRRSV (01NP1) (n=12) at 105.5 TCID50/ml in the appropriated
groups, respectively. Growth performances, clinical signs, specific
cytokine levels, levels of viraemia using real time RT-PCR, mortality
rate, and lung lesion scores were evaluated. A few vaccinated animals
showed off-feed with no increased rectal temperature after
vaccination but average daily weight gain (ADWG) and FCR were not
significantly different (>0.05). Evidently, viral vaccine was detected at
low levels until 7 dpv. After challenged with the HP-PRRSV, the
vaccinated group showed reduced mortality rate (45.5 % mortality
rate) and delayed onset of death when compared to the non-
vaccinated group (74 % mortality rate), but no pigs died in the
01NP1 Challenged group. However, after challenged with both
PRRSV isolates, both vaccinated and non-vaccinated animals had no
different averaged levels of viraemia or lung scores. Interestingly, the
increased levels of gamma interferon (INF-g) in the vaccinated pigs
infected with 01NP1 was observed but not significantly different
(>0.05). This present study suggested that Fostera™ PRRS is able to
improve survival rate when challenged with the HP-PRRSV but the
mechanisms of protection are not clearly elucidated.
NOTES
POSTER PRESENTATIONS: THERAPEUTICS – OTHERS
202
P202
C. Browne, A. Loeffler, D.H. Lloyd and A. Nevel
Royal Veterinary College, London, UK.
LABORATORY ASSESSMENT OF SILVER
NANOPARTICLES AS A POTENTIAL METHOD
OF REDUCING INFECTIOUS AGENTS OF PIGS
Silver nanoparticles have been shown to be effective in reducing MRSA
loads in the environment of pigs in controlled conditions. Mycoplasma
hyopneumoniae (M. hyopneumoniae) is the causal agent of enzootic
pneumonia (EP) in pigs. Methods to reduce disease cause by M.
hyopneumoniae include bio-security, vaccination and medication. On
an affected herd disease severity will be influenced by many factors
but primarily the amount of pathogen to which the pigs are exposed.
The aim of this work is to investigate the potential of silver
nanoparticles in reducing pathogens including M. hyopneumoniae in
the environment of pigs. Reference strain M. hyopneumoniae 232 was
used in the log stage of growth. Briefly, one ml of either Friis medium
(F), PBS, dH20 or silver nanoparticles (Ag) was added to a pellet of M.
hyopneumoniae and re-suspended. Additionally, the efficacy of three
commercially available disinfectants (V, T and P) was compared with
silver nanoparticles in the same experimental design. Experiments were
repeated in duplicate. After incubation growth of M. hyopneumoniae
was assessed at various time points (1min, 60min and 12h) by direct
culture and quantified by colour changing units (CCU). Quantification
(CCU) of M. hyopneumoniae showed silver nanoparticles inhibited
growth by 60 min (0.5CCU/ml) whereas there was good growth with
F, PBS and dH2O at all time points (1min, 60min and 12h) (10
CCU/ml). As expected there was no growth with V, T and P (0 CCU/ml).
Colonies were visible on Friis agar in F, PBS and dH2O, but not V, T, P
and silver after 60min. Silver nanoparticles have been shown to inhibit
the growth of M. hyopneumoniae within minutes of application.
Further work is needed to determine the efficacy of silver nanoparticles
in reducing infectious agents in the environment of the pig.
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DETOXIFICATION OF FUMONISINS –
ENZYMATIC DEGRADATION AND SAFETY OF
THE RESULTING METABOLITE
Among toxic mycotoxins, Fumonisins (FUM) are of major concern in
terms of animal health, economic losses and worldwide occurrence.
They are toxic to animals and exert their effects through mechanisms
involving disruption of sphingolipid metabolism.
We investigated the potential application of a carboxylesterase as a
feed enzyme for gastrointestinal hydrolysis of FUM. This bacteria-
borne enzyme possesses the ability to remove the tricarballylic acid
side chains of FUM, resulting in hydrolysed FUM (HFUM).
Two separate studies were then conducted in pigs for evaluating both
safety and efficacy of the biotransformation strategy. First, our
comparative study showed that HFUM, initially obtained by the
enzymatic treatment, is much less toxic than the parent compound
FUM. The effects were markedly less pronounced in terms of lesions
or inflammatory response in liver, alteration of the integrity of the
intestinal epithelium, and modulation of the cytokine expression in
the digestive tract. This low intestinal and hepatic toxicity of HFUM
correlated with its inability to alter the metabolism of sphingolipids.
In a second experiment, this similar absence of effect on sphingolipids
has been observed in plasma of pigs fed with FUM-contaminated
diet treated with the carboxylesterase. This suggests a reduced
bioavailability of FUM in the intestinal tract, and most likely accounts
for the reduced effects observed in these pigs in comparison to the
ones fed the same diet but non-treated with the enzyme. Indeed,
the addition of the enzyme was able to partially to totally neutralise
the effects on the neutrophil concentration, the pulmonary lesions,
and the immune response (cytokine expression and lymphocyte
proliferation).
In conclusion, the management of FUM based on the treatment of
contaminated commodities with this enzyme would be a suitable
approach to limit the toxicity of this mycotoxin.
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ADMINISTRATION OF ORAL METACAM®
15MG/ML TO CONTROL SUBCLINICAL MMA
IMPROVED PIGLETS PERFORMANCE WHILE
TAKING SOW WELFARE INTO ACCOUNT
Mastitis-metritis-agalactia (MMA) is a complex syndrome in which
hypogalactia or agalactia occurs in a clinical or subclinical way within
the first hours postfarrowing; subclinical MMA (also called Postpartum
Dysgalactia Syndrom PDS) can lead to major financial losses, as it
causes mortality and decreased growth performances in sow offspring.
Around farrowing, many injections are often performed on sows
increasing their stress and pain. Metacam® 15 mg/ml (oral suspension)
has already been successfully implemented in farms concerned by
subclinical MMA (I. Hernandez-Caravaca and al., 2012, 4th ESPHM),
improving piglets performances, while taking sow welfare into account;
in this field study, carried out in a French farrow-to-finish farm, ten
batches of sows were included in total (5 batches in Group Metacam®:
212 sows, 5 batches in Control Group: 209 sows); every other batch,
sows received Metacam® 15 mg/ml oral suspension at the end of
farrowing (Boehringer Ingelheim Vetmedica GmbH; meloxicam: 0.2
mg/Kg of body weight). The administration of Metacam® 15 mg/ml
was made directly into the mouth using the dosing syringe supplied
with the product, and graduated in kg liveweight. The repetition of the
study on ten successive batches avoided farrowing room effect. Each
batch of sows was also receiving exactly the same treatments and care
at farrowing, in accordance with normal farming practices; any
adoption between batches was strictly prohibited. In this study, the
use of oral Metacam® 15 mg/ml (meloxicam) allowed to reduce the
number of postpartum injections, improving sow welfare. It also
permitted efficient control of subclinical MMA, decreasing offspring
pre-weaning mortality (Metacam® group: 11.5 % vs Control group:
14.7 % p<0.001), and leading to an increased number of piglets
weaned per sow (Metacam® group: 11.39 vs Control group: 10.99).
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EFFECTS OF PAIN RELIEF UPON
LOCOMOTION AND ACTIVITY OF LAME PIGS
A high incidence of lameness has been found in growing pigs and
sows, compromising animal welfare. It is not yet common practice to
treat these animals with one of the several analgesics registered for
use in pigs and the effects of pain medication on the pig’s welfare are
hardly studied
The objective of this study was to examine the effects of a strong
analgesic (buprenorphine) in lame pigs. We hypothesised that the
analgesic treatment partially restores normal gait, activity, heart rate
and breathing rate.
Twenty piglets, that were clinically lame at one leg, were randomly
assigned to a group treated intramuscularly with 0.04 mg/kg
buprenorphine or a group receiving placebo (an equal volume of
physiologic saline solution). Before treatment visual lameness scoring,
footscan, heart rate and breathing rate measurements, and open field
test (OFT) were performed. Starting four hours after treatment with
buprenorphine or placebo, all measurements were repeated. Then,
the pigs were euthanised and submitted for necropsy. Asymmetry
indexes (ASI) were derived from the footscans. Data were analysed
using Mann-Whitney analysis in SPSS.
Before treatment, activity in the OFT did not differ between
treatment groups. Activity in the OFT decreased after treatment in
the saline-treated group. This decrease of activity in the second test
is a normal finding in repeated OFT. The buprenorphine-treated group,
however, appeared to be more active after treatment than before. This
difference between treatment groups was statistically significant.
Load rate ASI slightly increased after treatment in the saline-treated
group. The load rate ASI of the buprenorphine-treated group
decreased after treatment, showing a significant difference between
the two groups.
Treatment with analgesics does not only decrease objective lameness
scores but also increases activity levels. These findings support the
notion that analgesics should be used routinely as part of the
treatment protocol for lame pigs.
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POST FARROWING TREATMENT OF SOWS
WITH ORAL MELOXICAN
(METACAM®15CM/ML ORAL SUSPENSION
FOR PIGS) OR INJECTABLE FLUNIXIN
MEGLUMINE AGAINST SUBCLINICAL MMA
ON THE PREWEANING PIGLET WEIGHT
Introduction: In several field studies, post farrowing intramuscular
administration of meloxicam (Metacam®20mg/ml, Boehringer
Ingelheim; 0.4 mg/Kg body weight) to sows significantly increased
the proportion of piglets reaching the expected target weight at
weaning compared to intramuscular administration of flunixin
meglumine (2.2mg/Kg b.w.).
The aim of this study was to compare the convenience and the
efficacy of the use of a single administration of Metacam® 15 mg/ml
oral suspension for pigs (Oral Metacam®) versus other injectable
NSAID (flunixin meglumine) on sows and in piglet performance.
Material and methods: The field trial was conducted on one farrow-
to-wean farm (900 sows) located in the southeast of Spain. Overall,
30 sows were randomly allocated the day of farrowing (d0) in two
homogeneous groups regarding parity, number of piglets per sow and
weight at birth.
One group (n=15) was given 0.4 mg/kg b.w of Oral Metacam®
directly into the mouth of the sow on the day of farrowing. In the
other group (n=15) sows were treated with flunixin meglumine
2,2mg/kg b.w. intramuscular.
Different parameters were evaluated: Average daily gain (per litter),
body weight (at weaning) and mortality parameters (n= 353 piglets).
Results: Mortality rate up to weaning was similar; (p=0.89) in both
groups.
Piglets from sows treated with Oral Metacam® showed a higher ADG
compared to the piglets in the flunixin group (0.178 vs. 0.155 g,
respectively; p<0.05). This resulted in a higher weight at weaning in
the Oral Metacam® group compared to the piglets in flunixin group
(5.43 vs. 4.86kg, respectively; p<0.05).
Conclusions: This new oral meloxicam presentation reduces the
number of injections during the farrowing period and result in
additional benefits for sow welfare.
Regarding efficacy, Oral Metacam® treatment in sows significantly
increased the pre-weaning piglet ADG and the weight at weaning
compared to injectable flunixin.
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EFFECT OF A GNRH ANALOGUE (PEFORELIN)
ON SUBSEQUENT REPRODUCTIVE
PERFORMANCE AND PIGLET BIRTH WEIGHT
ON A HIGH PRODUCTIVE FARM
Peforelin, a GnRH analogue, has been shown to influence the estrus
behaviour of gilts and sows by stimulating the secretion of follicle
stimulating hormone (FSH) from the pituitary. Consequently, peforelin
could have a positive impact on oocyte quality, ovulation rate,
embryonic survival, and litter weight and uniformity. The purpose of
this field study was to investigate the impact of a peforelin treatment
on reproduction parameters and piglet birth weight. Gilts (n=36),
primiparous sows (n=19) and multiparous sows (n=117) of a high
productive farm (WP/S/Y=32.5) were randomly allocated to either
C-group (untreated control, n=92) or M-group (peforelin administered
at 150µg for gilts and multiparous sows and at 37.5µg for primiparous
sows, n=80). Peforelin was administered to gilts at 48 hours after the
last supplementation of altrenogest and to multiparous and
primiparous sows at 24 hours after weaning. Live-born piglets per
litter were recorded and individually weighed within 12 hours after
birth (n=1559). The farrowing success rate (the number of litters per
100 animals included) and the piglet index (the number of live-born
piglets per 100 animals included) were calculated. Differences
between both groups were analysed using a paired T-test. Due to
external factors, the farrowing success rate was low, but tended to be
higher in M-group (70%) compared to C-group (62%). The piglet
index was higher in M-group (980) compared to C-group (928)
(P=0.0288). Piglet birth weight was significantly higher in M-group
(1235 ± 300 g) compared to C-group (1197 ± 288 g) (P=0.010), but
variation was 24% for both groups. Overall, M-group had 4% more
piglets above 1600 g and 1% less piglets below 800 g than C-group.
From these preliminary results, it can be concluded that peforelin
treatment resulted in improved quality of live-born piglets.
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multiparous sows
Van Soom, A. O17 Slaughterhouse examination of culled sows in commercial pig herds
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Wang, C. O29 Detection of PRRSV Antibody in Oral Fluid specimens from individual boars using a commercial
PRRSV serum Antibody ELISA
Wang, G. P104 Pathogenicity of current porcine epidemic diarrhoea virus infections in China
Ward, A. P058 Zearalenone values in the bile of UK finishing pigs
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I joined the Pig Veterinary Society in 1976 and attended my
first meeting in Aberdeen. It had already been going for 13
years and was a small but thriving Society. It was a great
privilege to rub shoulders with the good and the great in the
pig world and I hoped that a little of their knowledge and
expertise would rub off on me. Colin Maclean (75-77) was
president at the time and was the first industrial (BOCM)
president and future head of the MLC. Alistair Douglas (87-
89) kindly helped me with the earlier presidents and the first
one Major Hugh Clay (63-65) invited him to join the
Framlingham practice in 1971. Dr Jack Done (65), renowned
for his work on Atrophic Rhinitis was the second for a short
time, followed by Peter Storie-Pugh (67-69), ex Colditz and
Cambridge University. John Strang (69-71) was a practitioner
from Essex and was followed by Dick Melrose (71-73) from
MLC. Gruff but kind, Doug Forsyth (73-75) from Selby, who
taught me the value of clinical inspection on farm visits in the
first Irish meeting in 1977 was superseded by Prof Richard
Penny from RVC London, also a great instructor and enthusiast
of the UK pig industry. Richard also started the Pig Journal and
after 8 editions it was taken over by Terry Heard (79-81), the
first solely pig practitioner, and he edited the Journal until
1998 when I took over. John Stoker (81-83) from Elanco, who
have given great support to the Society over the years, was
followed by John Oldham (83-85) a practitioner and pig
farmer in Hedon, Yorkshire. Tom Alexander (85-87) from
Cambridge University, co-discoverer of Brachyspira
hyodysenteriae with Prof David Taylor (04-05) of Glasgow, was
the lead vet in PIC for many years and helped develop MEW
and 3-site production for the control of PRRS. Mike Muirhead
(89-90) of Beeford was one of my early mentors, when I
worked at the Garth practice and brought his outstanding yet
steady expertise to two established breeding companies, JSR
and NPD (now ACMC). John Walton (90-91) from Liverpool
University was a great teacher and was followed by Philip
Blackburn (91-92) of Ripon, a meticulous practitioner and
author of the Guide to Casualty Slaughter, which is still
available today. Bob Stevenson (92-93) from Usk, also a BVA
and RCVS President was succeeded by Bill Smith from SAC
Craibstone, a notable Scottish diagnostician. Colin Silver (94-
95), a great musician and practitioner in Scotland, was
followed by John Mackinnon (95-96) who was the first
president of the EAPHM (10-12). John Wilkinson (96-97) from
Thetford is now a respected humanist and was followed by
Christianne Glossop (98-99) who was the President of the
IPVS in Birmingham in 1998 and is CVO for Wales. Gareth
Williams (98-99) an entrepreneurial practitioner in Cheshire
was succeeded by another practitioner, Mark White (99-00),
our Society’s acknowledged ‘Mr Grumpy’ and organiser of this
ESPHM in Edinburgh. Prof Stan Done (00-01) is the lynch pin
of the Society as Honorary Secretary, Chief Scientific Editor
of the Pig Journal and all matters scientific, especially CSF,
PRRS, & PCV2, even today. Richard Potter (01-02) took over;
an expert in outdoor production, he saw us through the FMD
outbreak, his early death was tragic. He was followed by Anne
Jones (02-03) a diagnostician in MAFF and in her own LVLabs.
David Chennells (03-04) from Bedford is an expert in welfare,
our great Clinical Club organiser and current Chairman of the
Publications Committee, which produces the Journal. Roger
Harvey (05-06) a practitioner in Stowmarket set up the 2nd
Irish meeting in Dublin, which took place in my year (David
Burch 06-07). Prof Jill Thomson (07-08) from SAC Edinburgh,
our reference for enteric diagnostics, also saw us through the
last FMD outbreak. Derek Armstrong (08-09) of BPEX, often
understated but is a fantastic source of knowledge regarding
the UK pig industry. Pete Bown (09-10) from Malmesbury,
followed with his amazing knowledge from organic farming
through to being lead PIC vet. Nigel Woolfenden (10-11)
following on the Ripon traditions of sound pig practice was
succeeded by Mike Wijnberg (11-12) the main vet of BQP, the
largest pig producing group in the UK. Steve McOrist (12-13)
is our current President, the co-discoverer of Lawsonia
intracellularis when at Edinburgh University. Grace Webster
(13-14) from Aberdeenshire will take over in May and we wish
her every success in her year and as much enjoyment as we
all have had.
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